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ABSTRACT 
 
Host and Pathogen Transcriptional Profiles of Acute Brucella melitensis Infection. 
(August 2007) 
Carlos Alberto Rossetti, D.V.M., Universidad de Buenos Aires; 
M.S., Universidad de Buenos Aires 
Chair of Advisory Committee: Dr. L. Garry Adams 
 
 The parallel gene expression profiles of Brucella melitensis and the host have not 
been elaborated. In this study, I analyze and discuss the transcriptional profiles of B. 
melitensis invasive-associated genes, the expression profile of intracellular B. melitensis 
and B. melitensis-infected non-phagocytic cells in the first 12 h post-infection (PI), and 
the in vivo temporal global transcriptome of both B. melitensis and the infected bovine 
host in the first 4 h PI.  The initial study found that B. melitensis at late-log phase of 
growth were more invasive in non-phagocytic cells than at early-log or stationary growth 
phase. Microarray-based studies identified 454 Brucella genes differentially expressed 
between the most and the least invasive growth phases. Additionally, B. melitensis 
strains with transposon interrupted in loci BMEII0380 (acrA) and BMEI1538 
(hypothetical protein) were found to be deficient in internalization compare with the 
wild-type strain.  A second experiment was designed with the goal of characterizing host 
and pathogen transcriptome in parallel. For detecting intracellular Brucella gene 
expression, a combined protocol consisting of a linear amplification of sense-stranded 
RNA biased to pathogen transcripts to the previously enriched host:pathogen RNA 
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mixed sample, was developed. RNA samples were hybridized on human and Brucella 
cDNA microarrays, which analysis revealed a common down-regulation transcriptional 
profile at 4 h PI that was reverse at 12 h PI. The integrity of B. melitensis virB operon 
and the expression of host MAPK1 were confirmed as critical for early B. melitensis 
intracellular survival and replication in non-phagocytic cells. Finally, a temporal 
morphological and molecular characterization of the initial B. melitensis:bovine host 
interaction using a calf ileal loop model was performed. B. melitensis was isolated from 
intestinal Peyer’s patches as soon as 15 min and from systemic blood after 30 min post-
intra luminal inoculation. Microarray results revealed a common transcriptional profile 
in Brucella, but two different transcriptional profiles were identified in the host in the 
first 4 h PI. The importance of differentially expressed biological processes, pathways 
and individual genes in the initial Brucella pathogenesis is discussed. 
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CHAPTER I 
INTRODUCTION 
 
GENERAL ASPECTS OF GENUS Brucella 
 Bacteria from the genus Brucella are the etiological agents of brucellosis, a 
worldwide zoonotic disease that has a negative economic impact on animal production 
and human public health (41, 92). The brucellae are small aerobes non-motil Gram 
negative coccobacilli that are facultative intracellular pathogen in vivo. Based on its 16S 
rRNA sequence, Brucella spp. are included in the α2 subclass of the class Proteobacteria 
among with other plant (Agrobacterium and the Rhizobiaceae) and mammalian 
(Bartonella and the Rickettsiae) pathogens (161). The genus Brucella consists on 6 
recognized species, based on their primary host: B. melitensis infects sheep and goats; B. 
abortus, cattle; B. suis, swine; B. ovis, sheep; B. canis, dogs and B. neotamae, desert 
wood rats (171). Recently, isolates from aquatic mammals have been proposed as new 
specie, but the official recognition is still pending (195). With the exception of B. ovis 
and B. neotomae that exclusively have pathogenic effects on their primary hosts, 
brucellae are able to infect other susceptible animals with similar pathogenic effect (66). 
For instance, B. abortus and B. melitensis infect other ruminants; B. suis infects a 
broader spectrum of animals incluiding hares, reindeers, caribous, wild pigs and dogs, 
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while B. canis affects wild canids. All 4 species of Brucella are also virulent for humans 
and the first three are bioterrorist agents. 
 
CLINICAL MANIFESTATIONS OF BRUCELLOSIS 
Among animal species, most mammals are susceptible to brucellosis. The 
success of the infection and the severity of the clinical disease depend on: age; 
immunological competence of the host; animal host; infective dose; strain virulence; and 
species of Brucella. Natural infections occur primarily through mucosa membranes of 
the alimentary tract for B. melitensis and B. abortus, and the genital tract for B. ovis, B. 
suis and B. canis (2, 171). Following penetration of mucosal epithelium, invading 
brucellae are transported, either free or within phagocytic cells, to the regional lymph 
nodes. Failure to destroy Brucella within the primary lymph node results in persistence 
of infection and dissemination of the agent via lymph and blood (66, 171). Brucella may 
localize and produce lesions in multiple organs, i.e. bones, joints, eyes, and brain; 
however, the agent has a predilection for lymphoid tissues, mammary gland, 
reproductive tract, placenta and fetal organs (2, 66). Placentitis, abortion and temporary 
infertility are the principal clinical manifestations of brucellosis in pregnant females. 
Brucella infection in males causes orchitis and inflammation of the accessory sex organs 
resulting in permanent or temporary infertility.  
The clinical manifestations of brucellosis are different in humans, resulting in 
intermittent fevers, chills, sweats, weakness, myalgia, osteoarthricular complications, 
endocarditis, depression and anorexia (243). Human brucellosis is an occupational-
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related disease associated with accidental contact with infected animals, clinical 
specimens or foodborne disease associated with the consumption of contaminated 
animal products. The severity of the symptoms and signs vary depending on the species 
of Brucella: B. melitensis causes the most severe and acute symptoms, followed by B. 
suis, while B. abortus and B. canis tend to produce milder disease and subclinical 
infections in humans (243).  
 
CELL BIOLOGY OF Brucella INFECTION 
Brucella infects hosts principally by penetrating the natural mucosa from where 
it disseminates to the rest of the body (66). An experimental infection found that the oral 
cavity - pharynx and the intestine were the two main gates of entry for oral infection of 
B. abortus in calves (30). Conjunctivae, intranasal mucosa and vagina were also 
permeable to Brucella infection (156, 157, 181). The evaluation of the invasion process 
of B. abortus through calf intestinal Peyer’s patches found that lymphoepithelial but not 
enteroabsorptive cells, engulfed individual brucellae that remain inside vesicles, 
phagolysosomes and large vacuoles (1). After transepithelial migration, many bacteria 
were observed alive inside neutrophils, mononuclear phagocytes or free in the 
interstitium and lymphatic vessels of lamina propria. The invasion process via 
conjunctiva was accompanied by an submucosal inflammatory reaction with the 
bacterium consistently being isolated from the parotid lymph node 2 to 4 days post-
inoculation (66). These observations suggest that Brucella invades the host by 
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transepithelial migration, escape the submucosal defenses and disseminate free or inside 
phagocytic cells to regional lymph nodes by lymphatic drainage.  
In addition to in vivo studies required for full understanding of Brucella 
pathogenesis, in vitro assays performed on cell lines or primary cultures are informative 
for a more complete understanding the host:agent relationship. The bacterial adhesion to 
cell membrane is an essential first step in the establishment of infection (199). Brucella 
attaches as a single organism to cultured epithelial cell lines via receptor molecules 
containing sialic acid or sulphated residues, and at 8 h post-infection begin to form 
microcolonies which subsequently become larger with extended time (31). It has been 
demonstrated that rough strains are more adherent and invasive to non-phagocytic cells 
than smooth ones (53), in part because the O-polysaccharide structure of the Brucella 
outer membrane protein would obscures unspecific ligands and consequently decreases 
the ability of the bacteria to bind the cell surface. Within a few minutes after binding 
non-professional phagocytic cells, Brucella is internalized by receptor–mediated 
phagocytosis (52, 53). Detailed studies have shown that the Brucella uptake by 
epitheloid-like cells is not a passive but an active mechanism, where the bacteria induces 
its own internalization by activating small GTPases of the Rho subfamily (i.e. Rho, Rac, 
Cdc42) and modulate rearrangements of the host cell actin cytoskeleton and 
microtubules (98). However, only a limited number of non-professional phagocytic cells 
in a monolayer are permissive to invasion (53, 180), suggesting heterogeneous 
susceptibility and/or invasiveness among cells and bacteria, respectively. After in vivo 
invasion of non-professional phagocytic cells, such as trophoblasts, Brucella localizes 
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and replicates within the rough endoplasmic reticulum without restricting basic cellular 
functions. However, after extensively intracellular replication infected cells develop 
signs of degeneration and necrosis, leading to a release of free bacteria into the media 
and the infection of the other cells proceeds (8). In vitro studies have found that during 
the first minutes after invasion, virulent Brucella transiently interacts with an 
intracellular compartment related to the early endocytic network that is gradually 
transformed in a multimembranous autophagic vacuole. Later, Brucella is delivered into 
a rough endoplasmic reticulum-like compartment in the perinuclear area, where massive 
intracellular replication occurs (53, 179). The benefits for the pathogen of being 
associated with the endoplasmic reticulum of non-professional phagocytic host-cell, an 
event also observed in Toxoplasma gondii (214), have not been identified yet, although 
the hypothesis of taking advantage of utilizing metabolites synthesized or translocated to 
this compartment is an attractive concept (93). The type IV-secretion system (T4SS) 
encoded by virB operon in virulent Brucella controls its own intracellular trafficking, 
bypassing late endosomal compartments and avoids its degradation by inhibiting 
phagosome-lysosome fusion in non-professional phagocytic cells (39). 
Once infected, natural hosts and humans can remain infected for life. After 
translocating the epithelium layer, Brucella is endocytosed by local macrophages and 
transported to the regional lymph nodes. Failure to destroy the bacteria at this stage, 
results in dissemination to organs that are rich in elements of the reticuloendothelial 
system, such as spleen, bone marrow and lymph nodes (66). The chronic nature of the 
disease lies in the ability of virulent brucellae to survive and replicate inside 
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macrophages (194). On the contrary as observed in non-professional phagocytic cells, 
differences in mechanisms of binding and entering of each individual bacterium into 
macrophages determine its fate within intracellular compartments and the outcome of the 
infection (28, 190, 236). Opsonized Brucella binds professional phagocytic cells through 
complement and Fc receptors, whereas non-opsonized organisms seem to bind via lectin, 
fibronectin and/or other unknown receptors (28, 190). More recently, two papers have 
addressed the possibility that lipid rafts could serve as docking sites for non-opsonized 
Brucella to stabilize the bacteria-macrophage interaction previous to internalization 
(167, 236). As soon as the bacteria contact the macrophage membrane, F-actin and 
annexin I-associated structures transiently accumulate beneath or around the pathogen, 
regardless of whether the bacteria were previously opsonized or not (134). Phagocytosis 
occurs within few minutes after contact, and opsonized Brucella, but not non-opsonized, 
induce major morphological changes in the macrophages cell membrane consisting on 
membrane ruffles that surround and capture the bacteria, in a zipper-like interaction 
between receptors and ligands (134, 190). The initial formation of two types of Brucella-
containing phagosomes, one tightly-fitting, representing the survival-permitting 
compartment, and other spacious, representing the killing compartment, was observed 
after Brucella engulfment (11, 190). The delayed phagocytosis observed in wild type 
Brucella compared with virB mutant was interpreted as a necessary time for the fully 
virulent pathogen to alter the plasma membrane in order to create a specialized organelle 
permissive for survival and replication (236). These Brucella-containing phagosomes 
briefly interact with early-endosomal compartments, and 1h post infection co-localize 
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with late-endosomal markers in cell lines (11, 17) but not in primary macrophages (33). 
Simultaneously, the deliver of the proton pump ATPase to the phagosome membrane 
causes a rapid acidification inside the vacuole, a condition necessary during the early 
phase of infection for survival and replication of Brucella in macrophages (11, 17, 183, 
190). Paradoxically, the number of Brucella inside macrophages decreases in the first 
hours post-infection and only few phagocytosed organisms are capable of surviving, 
redirecting their intracellular trafficking and replicating inside phagosomes, a process 
highly dependent on a functional T4SS (11, 17, 33, 104, 190). This initial killing is 
probably due to the capability of macrophages to generate toxic oxygen-dependent 
mechanisms during phagocytosis (103). After the adaptation phase, Brucella begin 
replicating. Nevertheless, the Brucella-replicative niche in macrophages is controversial. 
It has been observed that Brucella replicates inside compartments with phagolysosomal 
characteristics (11), endoplasmic reticulum-like compartments (17, 33) and non-acidic 
phagosomes (17). Among all the differences reported, the replication inside 
phagolysosome vacuoles is the most curious, because experimental evidence seems to 
support the proposed that Brucella intracellular survival in macrophages resulting from 
an inhibition of Brucella-containing phagosome and lysosome membrane fusion (33, 
166, 184, 190). However, the reported differences in Brucella intracellular trafficking 
within macrophages may in part be due to different cells (primary cultures vs. cell lines, 
human vs. mouse origin), Brucella strains and conditions used (opsonized vs. non-
opsonized bacteria).  
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In addition to macrophages and cells of the reticulo-endotelial system, Brucella 
has predilection for the gravid uterus ultimately causing abortion with huge numbers of 
organisms being expelled in the fetus and fetal fluids (4). In the placenta, Brucella 
replicate initially in the phagosomes of erythrophagocytic trophoblasts of the placentome 
and later in the rough endoplasmic reticulum of the periplacentomal chorioallantoic 
trophoblasts (8). The subsequent fetus invasion and replication in placental cotiledones 
leads to extensive placentitis and abortion. Despite the the important role that 
trophoblasts play in brucellosis there is no detailed description of how Brucella invade 
and intracellularly traffick. 
 
Brucella VIRULENCE FACTORS 
Brucella was first isolated in 1887, and today still little is known about the 
molecular mechanisms and the bacterial factors responsible for the clinical 
manifestations of brucellosis and host restriction. To date, the complete genome 
sequences of 4 strains of Brucella belonging to 3 different Brucella species (36, 51, 102, 
175) and other related studies (128, 165, 185) provide an opportunity to initiate the 
identification and understanding of the mechanisms of Brucella pathogenicity and host 
specificity. Except for B. suis biovar 3 that has only 1 chromosome (128), other Brucella 
genomes consists of 2 circular chromosomes, coding from 3200 to 3400 ORFs. The 
largest chromosome (ChrI) is about twice the size of the other chromosome (ChrII) and 
it would seem that both chromosomes arose from a single ancestral chromosome via 
recombination between 2 rRNA operons (128). Comparisons of genomic sequences of B. 
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abortus, B. melitensis and B. suis genomes reveal extensive similarity (> 94%) to each 
other at the nucleotide level and gene organization (102), with B. abortus and B. 
melitensis being more closely related than to B. suis (36). In addition, single-nucleotide 
polymorphisms among B. melitensis and B. suis is very low (175). These observations 
suggest that the small number of differences among the 3 species sequenced might be 
responsible for their variable host preference and pathogenicity.  
The genomes of the 3 species of Brucella sequenced document the absence of 
well characterized virulence factors present in other pathogenic bacteria such as 
capsules, pili and/or fimbriae, cytolysins, exotoxins, resistant forms, antigenic variation, 
phage-encoded toxins, lysogenic phages, virulent plasmids and pathogenicity islands 
(51, 102, 175). In spite of the lack of these classical virulence factors, Brucella is able to 
infect, replicate and persist inside the host, yet these effects have been attributed to a 
small number of identified virulent factors that are present and conserved across 
Brucella genome.  
Brucella, like other bacterial pathogens, adapts their gene expression according 
to different environments, mediated in part by two-component regulatory systems. The 
two components of these systems generally are a sensor protein located in the 
cytoplasmic membrane that responds to an environmental stimulus, and a cytoplasmic 
response regulator which activates transcription factors that mediate changes in gene 
expression after binding specific DNA sequences (76). Three of 8 two-component 
regulatory systems encoded in the Brucella genome, have been described (58, 59, 216), 
but only one (BvrR/BvrS) is apparently involved in virulence. The two-component 
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regulatory system BvrR/BvrS, highly conserved in the 6 species of the genus (149), has 
been studied in Brucella abortus. The system was found to be critical for the control of 
polycation peptides resistance, invasion and intracellular survival in this specie (216). A 
more recent study found that BvrR/BvrS regulates the structure of outer membrane 
components important for homeostasis and virulence. The expression of at least 2 outer 
membrane proteins, Omp3a (formerly Omp25), well known for being involved in 
Brucella virulence (62, 127) and Omp3b, related to B. melitensis Omp31, a haemin-
binding protein (47), was observed to be transcriptionally regulated by this two-
component system (99). Another report suggests that the system also regulates the 
degree of lipid A acylation and is involved in recruiting and assembling surface bacteria 
molecules necessary for penetration, vacuole maturation and intracellular trafficking 
(149); however, the environmental factor “sensed” by the system is unknown. 
A well recognized virulence factor in Brucella is lipopolysaccharide (LPS), a 
major component of the outer membrane, although its precise role in the pathogenesis of 
brucellosis is not clear yet (122). LPS has 3 domains: lipid A, the core oligosaccharide 
and the O antigen (or O chain). The O antigen appears to be the most important LPS 
component in Brucella virulence: it protects the bacteria from cellular cationic peptides 
(154), oxygen metabolites and complement-mediated lysis (40, 72), inhibits cytopatic 
effect on host cells (73, 176), impairs cytokine production from infected cells (122, 191) 
and is an in vitro down-regulator of T-cell activation (79). The presence or absence of 
the O chain in the LPS determines smooth or rough phenotypes respectively. Well 
characterized rough strains of B. abortus, B. melitensis and B. suis were attenuated for 
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survival in vivo (5, 91, 122, 155, 228), attributed in part because rough mutants of B. 
abortus are more susceptible than parental smooth strains to lysis mediated by 
complement (40). However, differences in survival of rough mutants of B. abortus in 
vivo were not consistent with those observed in complement mediated-lysis (5). 
Moreover, rough mutants of B. melitensis were found to be resistant to complement-
mediated killing (72). Together, these results suggest that the differences in in vivo 
survival between smooth and rough strains of Brucella should be attributable to 
differences in intracellular survival rather than extracellular killing activities. 
Nevertheless, in vitro studies of replication of genetically defined rough mutants inside 
professional and non-professional phagocytes produced contradictory results (5, 82, 91, 
147, 228). And it is not clear why naturally rough strains of B. canis and B. ovis are 
virulent in their primary hosts. Further studies are needed for better understanding of the 
contribution of LPS to the virulence of brucellae. 
The importance of the O antigen for the proper uptake of Brucella and it 
intracellular fate has been recently reported (184, 236). These studies demonstrated that 
smooth but not rough Brucella, enter the host cells via lipid rafts, and from an unknown 
complementary mechanism, there is an inhibition of the phogosome-lysosome fusion 
and a modification in the intracellular trafficking. Lipid rafts are cholesterol-rich 
microdomains that participate in the organization of receptors and signaling molecules 
on cell membranes, being also used for many pathogens to adhere and invade the host 
cells (230). The connection among smooth Brucella, lipid rafts and phago-lysosome 
fusion is a new virulence factor called cyclic B-1,2-glucan. This molecule described in 
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Brucella abortus, is produced inside of phagosome and interacts with cholesterol 
molecules, disrupting the formation of lipid rafts on phagosomal membranes that prevent 
lysosomal fusion to the benefit of the pathogen (10).  
Little is known about molecular mechanisms and factors involved in Brucella 
invasion. Recently, one surface protein of B. abortus associated with adhesion and 
invasion of non-professional phagocytic cells has been characterized (32). This adhesin 
called SP41 for Surface Protein 41kDa, is 433aa length and encoded by ugpB gene 
(BMEII0625). A wild-type strain of B. suis was 40 to 50 times more invasive to 
epithelial cell line than a ugpB mutant strain, indicating that invasion was affected in the 
absence of the gene product, i.e. SP41. Even if its counterpart is still unknown, the 
preliminary data suggest that this adhesin/invasin protein would interact with receptors 
containing sialic acid residues located in the host cell membrane. The presence of 
antibodies against SP41 in 70% of human patients with acute brucellosis indicates some 
role during initial stage of in vivo infection. 
The T4SS is another major virulence factor in brucellae that has received special 
attention due to its importance in intracellular survival of the agent. The T4SS 
ancestrally related to bacterial conjugation and used to mobilize macromolecules across 
the bacterial membrane to the extracellular space or into other cells, has been found in 
the genome of the reference strains of the 6 Brucella species (169). T4SS have been 
found to play a key role in virulence for other pathogens such as Agrobacterium 
tumefaciens (133), Bordetella pertussis (238), Legionella pneumophila (234) and 
Helicobacter pylori (34) where the system is used to translocate effector proteins or 
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DNA that interfere with the host cell machinery. The exact role of T4SS in Brucella 
virulence is unclear. It has been demonstrated that the expression of virB operon, that 
encodes the secretion apparatus in B. melitensis, B. abortus and B. suis, is essential for 
intracellular survival and multiplication in professional and non professional phagocytic 
cells and for persistence in mice (22, 33, 50, 82, 109, 169, 213). virB is expressed 
intracellularly starting at 15 min and reaching the maximum expression at 5 h post-
infection apparently by acidification of the Brucella-containing vacuola (22, 212) and is 
repressed intracellular at high bacterial density by a 12-carbon homoserine lactone (222). 
It has been hypothesized that the putative effector molecules secreted by T4SS remodel 
the phagosome compartment and perturb the intracellular trafficking in infected cells, 
allowing Brucella to establish a niche in which it multiplies (33, 39).  
The presence of open reading frames encoding homologues of flagellar related 
proteins, were found in the 3 Brucella genomes sequenced (51, 102, 175). However, as 
Brucella has long been described as a non-motile bacterium and some of the ORFs are 
truncated and other important components of flagellar apparatus are missing. It is 
thought that flagellar genes are remnants from evolution (160). Nevertheless, the 
importance of flagellar genes in Brucella virulence was detected after the isolation of an 
in vivo and in vitro attenuated B. melitensis 16M mutant with disruption on fliF gene, 
which encodes a protein of a basal component of the flagellum (147). In a more recent 
report, the expression of B. melitensis genes that encodes for basal and distal part of the 
flagellar apparatus and the flagellar structure was detected in specific moments of 
growth phase and infection (84). Apparently, the expression of both flagellar genes and 
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T4SS are under the control of the quorum-sensing transcriptional regulator vjbR 
(BMEII1116), which in the presence of the quorum sensing signal molecule, down-
regulates expression of these two virulence factors (48). Mutations of several flagellum 
genes produced phenotypes unable to persist in a murine intraperitoneal model of 
infection, which suggests some role of the flagellum apparatus in chronic infection. The 
biological function of Brucella flagellum has not been determined yet, and there is the 
possibility that the flagellar apparatus, due to the phylogenetic relationship between 
flagellar and type III secretion system, is involved in secretion rather than in motility 
(147).  
The virulence factors described above are involved in invasion, intracellular 
replication or survival, but little is known about how Brucella modulates the host 
immune response to establish a chronic infection. However, a recent identification of a 
B. abortus immunomodulatory protein, PrpA, will partially help unravel the molecular 
mechanisms of persistence (217). This protein encoded by the locus BAB1_1800, 
belongs to the proline-racemase family and has the capacity to induce a T cell-
independent B cell-nonspecific polyclonal activation. In vitro, it was observed that PrpA 
induced naïve mice-splenocyte proliferation while in the mouse model of infection this 
factor was involved in persistence and in the transient immune suppression within a 
limited period of time post-infection. Further analysis identified that the proliferative 
response of mice splenocytes results in a state of immune suppression modulated by 
IL10 cytokine secretion.    
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In the systemic search for virulence factors, many other genes which expression 
would seem to be required for full virulence of brucellae at different stage of the 
infection process, have been identified using transposon mutagenesis, signature-tagged 
mutagenesis or differential fluorescence induction, and described elsewhere (6, 12, 49, 
50, 68, 82, 101, 109, 131, 132, 140, 146, 147, 193). However, their biological function in 
the context of the infection process is not always completely understood and further 
characterization of these potential virulent elements is needed to understand their role in 
Brucella pathogenicity.  
 
 THE HOST RESPONSE TO Brucella INFECTION 
The host immune response to an infectious agent is divided in innate and 
adaptive. The first one consists on preexisting or rapidly responding chemical and 
cellular defense mechanisms and is non-specific, while the second one is specific against 
the infected agent but takes more time to become effective (225). Lately, innate 
immunity has been intense subject of study, basically because it was recognized as a 
central defense mechanism that influences the development of adaptive immunity and an 
important component of local immunity in mammals (77). Immunity against brucellae 
involves cellular and humoral response. The immediate innate immune response to 
Brucella spp. in naïve animals begins when Brucella lipoproteins (LP) contacts non-
activated antigen-presenting cells (APC), mainly dendritic cells and local macrophages, 
through CD14 and Toll-like receptor 2 (TLR2) dependent mechanisms (90, 113). This 
initial contact generates a receptor–induced signaling that stimulates infected cells to 
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secrete cytokines such as TNFα, IL1a, IL6 and IL12 that modulate the development of 
specific Type I cellular immune response to promote a clearance of the bacteria (56, 
245). The set of cytokines secreted by Brucella-infected APC stimulate a T helper 0 cells 
(Th0), a subpopulation of CD4+ α/β T lymphocytes, to differentiate them in Th1 cells, 
which result in IL2, IL18, TNFβ and IFNγ secretion. All together, these cytokines 
stimulate activation of macrophages, promote B-cell switching of immunoglobulin and 
recruit more immune cells to the site of infection (119). Natural killer (NK) cells, 
neutrophils, CD8+ and γδT lymphocytes are part of the secondary innate immune 
response and migrate immediately to the infection site to contribute to resolve the 
infection (56).  
Secondary infection boosts a Brucella-specific immune response. At that point 
humoral response plays a major role, being Brucella-specific antibodies available to bind 
and opsonize the agent, facilitating uptake by phagocytic cells (71). On the other hand, 
specific CD4+ T cells (Th1) secrete INFγ that activates macrophages and enhances their 
killing activity (119, 126), and specific CD8+ T lymphocytes (cytotoxic T cells) that 
recognize and kill Brucella-infected cells by binding them through the microbial antigen 
displayed on the surface (170). These cytotoxic T cells not only secrete proteolytic 
enzymes that trigger apoptosis in the infected cells, releasing the intracellular microbes 
that can then phagocytosed by activated macrophages, but they also produce substantial 
amounts of INFγ involved in macrophage activation (246). 
Natural resistance to brucellosis in domestic animal has been observed since 
1940 (26, 224). Bovine Slc11a1 (former NRAMP1) gene has been pointed out as a 
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candidate element for controlling intracellular replication of B. abortus in macrophages 
(15); however its biochemical function and how it contributes to resistance the infection 
remain unclear (242). Inheritance of Brucella-infection resistance involves more than 
one gene (3), but no other genetic element responsible for control of infection has been 
identified. 
The global host response to Brucella infection was analyzed in murine 
macrophage-cell lines by microarray technology (69, 104). Eskra et al. (2003) identified 
148 genes differentially expressed in RAW267.4 macrophage cell line at 4 h post-
infection with B. abortus. Sixty nine of these genes were up-regulated, mainly genes 
encoded for pro-inflamatory cytokines and chemokines, and pro and anti-apoptotic 
factors, and 79 genes were down-regulated, mainly those encoded for cell cycling, 
proliferation and intracellular trafficking. In a more recent paper, He et al. (2006) 
analyzed a temporal transcriptional profile of the J774.A1 murine macrophage cell line 
infected with B. melitensis. The authors reported that the most significant changes in 
gene expression of B. melitensis-infected murine macrophages occurred early post-
infection and the transcriptional profile returned to normal 24h post-infection. In 
concordance with Eskra et al., they also found that genes involved in general cellular 
activities were down-regulated and genes involved in immune response, inflammation 
and cellular defense were up-regulated in infected macrophages compared with the 
control cells at 4 h post-infection. Microarray analysis also revealed that intracellular B. 
melitensis survival and replication may be a consequence of apoptosis inhibition by 
suppressing mitochondrial activity, thereby preventing activation of caspase cascades.  
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At the same time Brucella has developed its own strategies to avoid being 
recognized and eliminated by the host immune system. For instance, B. abortus, suis and 
B. melitensis were found to impair apoptosis in human and bovine macrophages, which 
preventing infected host cell elimination (73, 86, 96). Moreover, Brucella alters the 
production and secretion of cytokines of infected host cells (29, 127, 217), inhibits 
degranulation of neutrophils (19, 172), impairs NK cells activity (198) and modulates 
the host immune response (217). These are reasonably well defined examples of how the 
agent influences the host response, and ultimately the outcome of the infection. 
  
MODELS TO STUDY Brucella:HOST INTERACTION 
Most of the available information on molecular pathogenesis of Brucella and 
Brucella:host interaction originates from in vitro studies performed on primary cultures 
or cell lines of non-professional phagocytic cells such as epithelioid-like cells (179), 
fibroblasts (53) or trophoblasts (200), and professional phagocytic cells such us 
macrophages (11, 27), dendritic cells (20), lymphocytes (215) or neutrophils (172). 
However, in vitro studies may result in not only different but also contradictory results, 
in part because of the different conditions used or parameters employed. Although, in 
vitro studies reveal only a partial representation of the in vivo host:agent interaction, a 
caveat that must be kept in mind when experimental data are analyzed and interpreted. 
For example, when cell cultures are not in their original microenvironment, different 
gene expression and responses induced by injury are expected. Moreover, the majority 
of the cell lines derive from transformed cells, which are not truly representative of in 
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vivo tissue. Another limitation is that epithelial cells are polarized in vivo, where 
different surfaces are exposed to different environments and express different surface 
molecules. Quite the opposite, cellular surfaces are not differentiated in cell lines or 
primary cultures growth in monolayer, so that surface molecules are irregularly 
distributed. Polarized cell culture or three-dimensional cell cultures may partially resolve 
this problem (168). For example, in vivo mucosal surfaces are covered with a protective 
layer of viscous mucus, inhabited by resident microflora and bathed in solutions that are 
very difficult to mimic in an in vitro system. Additionally, in vivo cells are naturally 
organized in tissues formed by more than one cell layer and by different cell types, 
something that it is also very difficult to mimic in vitro. The host immune response is 
largely under represented in in vitro models. Despite all the limitations mentioned, in 
vitro studies do allow detailed studies and are useful for generating and testing 
hypotheses for subsequent in vivo evaluation. 
On the other hand, in vivo studies are more time consuming, more expensive to 
develop and some of them require special facilities; but they are a sine qua non condition 
for fuller understanding of bacterial pathogenesis. Also to consider is the difficulty of 
identifying appropriate laboratory animals that reproduce the disease and developing 
lesions similar to those encountered in natural hosts (87). The most studied-model 
system for in vivo Brucella:host interactions is the murine model (14). In the mouse, 
Brucella persists in the spleen and lymph nodes after 8 weeks post-inoculation (87) 
which makes the model useful for studying the mechanisms of persistence. However, 
over time the agent is cleared and become undetectable, which is quite different than 
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what is observed naturally in primary hosts or humans. In addition, the model has other 
caveats, because the mouse is not a natural host of any Brucella species and 
consequently the response to infection is different than it is in natural host animal 
species (120). On the other hand, the mouse model has the advantage that there are an 
immense genetic tools and resources available. The guinea pig is another laboratory 
animal model widely used for in vivo Brucella studies. In contrast to mice, guinea pigs 
are much more susceptible to Brucella infection (88); however, results must be carefully 
interpreted. Under certain circumstances and with some limitations, information from 
laboratory animals can be extrapolated to man and natural host species (87).  
In contrast to laboratory animal models, defined models of Brucella primary 
natural hosts for studying host:agent interaction have not been standardized. This results 
in greater variability making comparisons among labs more difficult, yet reflects more 
accurately the realities of in vivo infectious process in the natural host. Recently, a 
caprine model for studying ruminant brucellosis was proposed (65). According to the 
authors, colonization, pathogenicity and vaccine efficacy can be effectively monitored. 
In addition to the obvious advantages that this model has over murine model for 
studying ruminant brucellosis (goats are natural hosts and ruminants), the authors also 
mention some advantage over large ruminant’s model: less expensive, requires less 
space and shorter gestation time.  
Cattle are the natural host of Brucella abortus, but can also be infected by B. 
melitensis under specific epidemiological conditions (129, 231), and by B. suis 
experimentally (78). The alimentary tract is the major route in the transmission of B. 
  
  
21
melitensis and B. bortus (2), having been the agent isolated from calf’s intestine after an 
experimental oral infection (30). Calf ligated ileal-loop model has been clearly 
documented to be an excellent model for studying host:agent interaction for orally-
ingested pathogens (21, 152, 201, 218). Our lab has been using the model extensively 
(204, 247), and we have found the model to be very informative for understanding 
primary in vivo host:Brucella interactions.  
 
THE GOAL 
The epithelium layer is the first barrier against Brucella infection. Precise and 
detailed descriptions on Brucella internalization and intracellular trafficking in non-
professional phagocytic cells have been published, but a global temporal molecular 
characterization of these phenomena has yet to be accomplished. The overall objective 
of this study is to characterize the transcriptome of Brucella and Brucella-infected host 
cells during the initial infectious process for understanding the initial strategies 
employed for the pathogen to survive and replicate intracellularly and to identify 
perturbations of major gene(s) modulating critical cellular pathways during initial 
infection. The second chapter of this dissertation explores the invasiveness of B. 
melitensis in non-phagocytic cells and characterizes the transcriptional profile of in vitro 
B. melitensis cultures at different growth phases in cell culture media for the 
identification of candidate invasive-associated genes of Brucella. Moreover, 2 B. 
melitensis strains with transposon interrupted in different loci were found deficient in 
internalization compare with the wild-type strain. Chapter III characterizes the 
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transcriptome of B. melitensis and B. melitensis infected non-phagocytic host cells at 4 
and 12 h post-infection in an in vitro model of infection. One candidate host and 
Brucella genes identified by dynamic Bayesian modeling analysis from the expressed 
transcriptomes as relevant for early brucellosis were knocked down in HeLa cells using 
siRNAs and transposon interrupted in B. melitesis, to verify their role in the early 
infection process and establish a phenotype. Chapter IV analyses the morphological and 
molecular temporal B. melitensis bovine host initial interaction in vivo. The importance 
of expressed pathways and genes in the context of initial Brucella pathogenesis is 
discussed. 
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CHAPTER II 
IDENTIFICATION OF Brucella melitensis INVASIVE CANDIDATE GENES IN 
NON-PROFESSIONAL PHAGOCYTIC CELLS BY MICROARRAY ANALYSIS 
 
 
INTRODUCTION 
Genomic analysis of Brucella species has largely failed to identify well-
characterized virulence factors, such us capsules, pili and/or fimbriae, cytolysins, 
exotoxins, resistant forms, antigenic variation, phage-encoded toxins, lysogenic phages, 
virulent plasmids and pathogenicity islands, that are present in other pathogenic bacteria 
(51, 102, 175). In spite of the lack of these classical virulence factors, Brucella can 
readily infect, replicate and persist inside the host.  
Natural Brucella infections occur primarily through adhesion and penetration of 
mucosal epithelium (2, 171). Detailed in vitro studies have demonstrated that Brucella 
bind sialic acid residues present on eukaryotic cells membrane (31) and are uptake by 
epitheloid-like cells by an active mechanism in which the organism induces its own 
internalization by activating small GTPases of the Rho subfamily and modulating 
rearrangements of the host cell actin cytoskeleton and microtubules (98). Recently, the 
first Brucella surface protein, called SP41, associated with invasion in non-phagocytic 
cells was characterized (32). Nevertheless, very little is known about the molecular 
mechanisms underlying Brucella adhesion and internalization in eukaryotic cells. Our 
goal in this study was to characterize the Brucella melitensis invasion-related 
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transcriptome as a preliminary approach for identifying pathogen candidate genes 
involved in the non-professional phagocytic cell invasion process.  
 
MATERIALS AND METHODS 
Bacterial strains, media and culture conditions. Smooth virulent Brucella 
melitensis 16M Biotype 1 (ATCC 23456) (American Type Culture Collection, 
Manassas, VA), re-isolated from an aborted fetus goat and its derivatives were 
maintained as frozen glycerol stocks. Mutants were created by transposon mutagenesis 
using two different transposon systems (Table 1) and constructed as previously 
described (5, 241). Individual 50 ml conical tubes were filled with 10 ml of cell culture 
media [F12K medium (ATCC) supplemented with 10% heat-inactivated fetal bovine 
serum (HI-FBS) (ATCC)], inoculated with 0.1 ml (1:100 for early-log cultures), 0.25 ml 
(1:40 for late-log cultures) and 1 ml (1:10 for stationary cultures) of a saturated culture 
of B. melitensis 16M and incubated at 37ºC with 5% CO2 overnight with loose lids and 
200 rpm shaking. Growth curves of cultures were determined by comparing the optical 
density (OD) of the culture at 600nm with bacterial colony forming units (CFU). 
Bacterial numbers were assessed by plating a serial dilution on tryptic soy agar (TSA) 
(BD, Franklin Lakes, NJ) and incubating at 37ºC with 5% CO2 for 4 days. Kanamycin 
(100 µg ml-1) (Sigma, St. Louis, MO) was used to supplement TSA media when 
necessary. 
Determination of invasiveness. HeLa S3 cell line (ATCC CCL-2.2) between 
passages 8 and 15 was grown in F12K medium containing 10% HI-FBS at 37ºC with 5% 
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TABLE 1. Identification of the sequences disrupted by transposon mutagenesis 
 
Mutant Transposon Locus interrupted Homologous protein 
BME5D1 Tn5 BMEI1414 Perosamine synthetase (wbkB) 
QW154H11 Himar1 BMEI1416 
O-antigen export system ATP binding 
protein RfbB 
BME5F3 Tn5 BMEI1538 Hypothetical protein 
BME8A6 Tn5 BMEI1707 Mandelate racemase 
QW81G10 Himar1 BMEII0025 
Attachment mediating protein VirB1 
homolog 
QW70F8 Himar1 BMEII0034 Channel protein VirB10 homolog 
QW184B9 Himar1 BMEII0380 
Acriflavin resistance protein A 
precursor (acrA) 
QW73H12 Himar1 BMEII0472 Membrane fusion protein MtrC 
 
 
CO2. Twenty-four hours prior to infection, the cells were suspended and cultured in 25 
cm2 plastic flasks (Corning, Corning, NY) at a concentration of 2x106 cells/flask and 
replaced in the incubator. Before infection, cells from 1 flask were detached and 
counted. Infection with B. melitensis 16M or its derivatives was done by replacing the 
medium overlying the HeLa monolayers by a bacterial inoculum grown on cell culture 
media, at a ultiplicity of infection of 1000 bacteria per cell (MOI 1,000:1). Bacteria were 
centrifuged onto the cells at 800 X g for 10 min followed by 30 min of incubation at 
37ºC. Then, cells were washed once with PBS to remove extracellular bacteria and re-
incubated with F12K media supplemented with 100 µg ml-1 of gentamicin solution 
(Sigma) for 1 hour. To determine the intracellular viable number of bacteria, infected 
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cultures were washed 3 times with PBS and then lysed with 0.1% Triton X-100 (Sigma). 
Lysates were serially diluted and cultured on TSA plates (supplemented with 
kamamycin as necessary) for quantitation of CFU.  
Isolation of total RNA from B. melitensis 16M. Total RNA was isolated from 4 
different cultures of B. melitensis 16M grown in F12K supplemented with 10% HI-FBS 
at late-log and stationary growth phase as previously described (189). Briefly, ice-cold 
ethanol/phenol solution was added to the B. melitensis culture and the bacteria recovered 
by centrifugation. The media was then removed and the pellet suspended in TE buffer–
lysozyme solution containing 10% SDS (Ambion, Austin, TX). After 2 min of 
incubation, acid water-saturated phenol was added to the lysate and mixed, and the 
sample incubated for 6 min at 64ºC. Tubes were kept on ice for at least 2 min and then 
centrifuged at maximum speed. The upper layer, containing the RNA, was transferred to 
a new tube, mixed with an equal volume of chloroform and then separated by 
centrifugation. The aqueous phase was mixed with 100% cold ethanol and stored at -
20ºC. After at least one hour of incubation, RNA was pelleted by centrifugation, washed 
in 80% ethanol and suspended in DEPC-treated water (Ambion) with 2% DTT and 1% 
RNase inhibitor (Promega, Madison, WI). Contaminant genomic DNA was removed by 
RNase-free DNase I treatment (Ambion) according to the manufacture’s instructions, 
and samples were stored at -80ºC until used. The quality of the RNA samples was 
determined using the Agilent 2100 Bioanalyzer (Agilent, Palo Alto, CA). 
Isolation and labeling of B. melitensis genomic DNA. A pellet from a saturated 
culture of B. melitensis 16M grown on tryptic soy broth (TSB) (BD) was washed with 25 
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ml of J-buffer [0.1M Tris pH 8.0; 0.1M EDTA; 0.15M NaCl] and then lysed in 1 ml of 
J-buffer containing 10% lysozyme solution (10mg/ml in 0.25M Tris, pH 8.0). After 10 
min of incubation, DNA was released from the cells by sodium salt of N-lauroyl 
sarcosine (Sigma) followed by degradation of RNA by DNase-free RNase (Roche 
Applied Science, Indianapolis, IN), and digestion of proteins with proteinase K (Roche 
Applied Science). The resulting solution was transferred to a dialysis bag and dialyzed 
against TE [10mM Tris, pH 8.0 and 1mM EDTA] overnight at 37ºC. DNA was 
subsequently extracted twice using neutral water-saturated phenol (Ambion) first and 
then twice with ether (Sigma) before dialyzing overnight against TE. DNA concentration 
was determined by absorption spectrophotometry at 260 nm (NanoDrop® ND-1000) 
(NanoDrop, Wilmington, DE) and stored at 4ºC until used.  
B. melitensis genomic DNA was labeled overnight by directed incorporation of 
Cy5-dCTP (Amersham Pharmacia Biosciences, Piscataway, NJ) during reverse 
transcription using random primers solution and Klenow fragment from BioPrime DNA 
labeling system kit (Invitrogen, Carlsbad, CA) and 50X dNTPs (1:2 dCTP) (Invitrogen). 
The reaction was stopped by adding 5 µl of stop buffer from the BioPrime kit and 
unincorporated Cy dye was removed using PCR purification kit (Qiagen, Valencia, CA), 
eluted in 1mM Tris pH 8.0 and kept at 4ºC until used. 
Construction of cDNA microarrays. A set of unique 70-base oligonucleotides 
representing 3,227 ORFs of B. melitensis strain 16M and unique / divergent genes from 
B. abortus and B. suis were designed at the Pathogen Expression Core and purchased 
from Sigma-Genosys (The Woodland, TX). Oligonucleotides were suspended in 3X 
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SSC (Ambion) at the final concentration of 40 µM before robotic arraying in triplicate 
onto ultraGAPS coated glass slides (Corning) using a Spotarray 72 microarray printer 
(Perkin Elmer, Downer’s Grove, ILL). Printed slides were steamed and UV cross-linked 
and stored in a desiccators until use. 
Sample preparation and slide hybridization. The labeling and hybridization 
procedures were based on a adaptation of the protocol developed by The Institute for 
Genomic Research (105). Briefly, 10 µg of total RNA from B. melitensis 16M grown in 
F12K to late-log and stationary growth phases were reverse transcribed overnight to 
amino-allyl cDNA using 6 mg of random hexamer primers (Invitrogen), 0.6 µl 50X 
dNTPs (Invitrogen) / aa-dUTP (Ambion) mix (2:3 aa-dUTP:dTTP) and 400U 
Superscript III (Invitrogen). The reaction was stopped by incubating the samples with 
1M NaOH at 65ºC for 15 min and neutralized by adding 1M HCl. Unincorparated aa-
dUTPs and free amines were removed by column passage (Qiagen). Speedvac-dried 
samples were rehydrated in 0.1M Na2CO3 buffer (pH 9.0) and labeled with Cy3-ester 
(Amersham Pharmacia Biosciences). After one hour incubation in the dark, uncoupled 
dye was removed using columns (Qiagen) and Cy3 incorporation calculated by 
NanoDrop®. Dried samples were suspended in nuclease–free water and mixed with 0.5 
µg of labeled gDNA to the final volume of 35 ul. Samples were heated at 95ºC for 5 min 
and then kept at 45ºC until hybridize. Right after hybridization, 35 µl of 2X formamide-
based hybridization buffer [50% formamide; 10X SSC; 0.2% SDS] was added to each 
sample, well mixed and applied to oligoslides. The microarrays were kept in 
prehybridization buffer [5X SSC, 0.1% SDS; 1% BSA in 100ml of water] at 45ºC for at 
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least 45 min followed by 4 washes in distilled water, one wash in 100% isopropanol and 
finally drying by centrifugation. Four slides for each condition were hybridized at 45ºC 
for ~20 h in a dark humid chamber (Corning) and washed for 5 min at 45ºC with low 
stringency buffer [1X SSC, 0.2% SDS] followed by two 5-min washes in a higher 
stringency buffer [0.1X SSC, 0.2% SDS and 0.1X SSC] at room temperature with 
agitation. Slides were dried by centrifugation at 800 X g for 2 min and immediately 
scanned. 
Data acquisition and microarray data analysis. Immediately after washing, the 
slides were scanned using a commercial laser scanner (GenePix 4100; Axon Instruments 
Inc., Foster City, CA). The genes represented on the arrays were adjusted for 
background and normalized to internal controls using image analysis software 
(GenePixPro 4.0; Axon Instruments Inc.). Genes with fluorescent signal values below 
background were disregarded in all analyses. Data were analyzed using GeneSpring 7.0 
(Silicon Genetics, Redwood City, CA), Significance Analysis of Microarrays (SAM) 
(Stanford University, Stanford, CA) and Spotfire DecisionSite 8.2 (Spotfire, Inc., 
Somerville, MA). Computational hierarchical cluster analysis and analysis of variance 
(ANOVA) were performed using Spotfire DecisionSite 8.2. ANOVA was also 
performed, as an additional filtering aid, using GeneSpring. For each software program 
used, data were first normalized by either mean (for Spotfire pairwise comparisons and 
SAM two-class comparisons) or percentile value (for GeneSpring analyses). 
Normalizations against genomic DNA were performed as previously described (219).  
Microarray results validation. One randomly selected gene from every cluster 
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of ortholog genes (COGs) functional category (n = 18) that had differential expression 
between late-log and stationary growth phase by microarray results was analyzed by 
quantitative RT-PCR (qRT-PCR). Two micrograms from the same RNA samples used 
for microarray hybridization were reverse transcribed using TaqMan® (Applied 
Biosystems, Foster City, CA). For relative quantitation of target cDNA, samples were 
run in individual tubes in SmartCycler II (Cepheid, Sunnyvale, CA). One SmartMix 
bead (Cepheid) was used for 2 - 25 µl PCR reaction along with 20 ng of cDNA, 0.2X 
SYBR Green I dye (Invitrogen) and 0.3 µM forward and reverse primers (Sigma 
Genosys) designed by Primer Express Software v2.0 (Applied Biosystems) (Table 2) to 
produce an amplicon length of about 150 bp. For each gene tested, the individual 
calculated threshold cycles (Ct) in late-log and stationary samples were averaged among 
each condition and normalized to the Ct of the 16S rRNA gene from the same cDNA 
samples before calculating the fold change using the ∆∆Ct method (Applied Biosystems 
Prism SDS 7700 User Bulletin #2). For each primer pair, a negative control (water) and 
an RNA sample without reverse transcriptase (to determine genomic DNA 
contamination) were included as controls during cDNA quantitation. All samples were 
run on 1% agarose gel after qRT-PCR to verify that only a single band was produced. 
Array data were considered valid if the fold change of each gene tested by qRT-PCR 
was > 2.0 and in the same direction as determined by microarray analysis. 
Statistical analysis. Determination of invasiveness of cultures of B. melitensis 
wild-type at different phases of growth was performed in triplicate on three independent 
experiments. Screening of mutant invasion in HeLa cells was performed once in
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TABLE 2. Primers for Real-time PCR analysis of tested genes in B. melitensis 
 
Functional 
categories Locus ID Gene product Forward primers (5'-3') Reverse primers (5'-3') 
     
Cell division BMEI0073 Cell division protein FtsX CATCGAGGTGCTGCATTTCAT ATAGGATGCCCACCAGGAGAA 
Carbohydrate 
metabolism BMEI0344 
Phosphoglucosamine mutase/phosphoacetylglucosamine 
mutase/phosphomannomutase CTTATCTCCGCGCTCCAGAT CTGATTTCACGCGTTTGTTTTC 
Cell envelope BMEI0402 31 KDA outer-membrane immunogenic protein precursor GGCTTCACCCCGACTGAAC GTTGGTGACGGCGTATTCTACA 
Energy 
production BMEI0475 Cytochrome C1 GCTGCAGCGGCTAATAATGG CGGTCAAAAGCGAATGGATATAA 
Nucleotide 
metabolism BMEI0608 Thymidylate synthase TGCCCTGTTGACGATGATGA ATGCATCACCGGCAGCTT 
Membrane 
transport BMEI0642 Urea transporter GTTTCTGGTCCTTGCAGCCTAT ACGGCATTGTTGAGGAGGAA 
Post-
translational 
modification BMEI0645 Urease accessory protein UreF AGCCTCGGGCTTGCTTTT TCGCCTCCAGCAGAATTTTT 
AA metabolism BMEI0730 Lactoylglutathione lyase CAGCCCCCTCCGATACAGAT AGCTTCTCGCAGGTGGCATA 
Cofactor 
transport  BMEI0842 Molybdenum cofactor biosynthesis protein C CGCGCACTAGCCCGATT CGCCGCTTTTTTCGATCA 
Transcription BMEI1384 Transcriptional regulator, AraC family  CGCAGTTCACCAAGGCATT GCGTGTTCAGAGGCGATCTT 
Translation BMEI1798 23S ribosomal RNA methyltransferase CATGGGCTCGGTCTTTTCC TGTTCATTGCCCATTATCAGGAT 
Signal 
transduction BMEI2034 Sensor protein ChvG GCCTGTTCCGCATTCCCTAT GCGCATTGGAATCACCATTT 
Lipid 
metabolism BMEII0047 Lysophospholipase L2 GGCTATGTGCGCAGCTTCA GGGAGGAGAGCCGTTCCA 
Secondary 
metabolism BMEII0079 Isochorismatase CGCCTTGCGCTGAAATATGT GCGAATCGAGGCCGTAGAG 
Cell motility BMEII0150 Flagellin GCGGTTGACAAGATCACTGTCA CGAGAGAAGCAAGAGCGGTTT 
Defense 
mechanism BMEII0382 Acriflavin resistance protein D TTGCAGGATCAGAATGCGATT CATCCGACAGGCGGAAGA 
DNA replication 
& repair BMEII0663 Phosphohydrolase (MutT/NUDIX family protein) CGGAGGTGGAGACCCAGAA TCAAGCTGCGTATCCATCAAAA 
Inorganic ion 
transport BMEII1120 Iron(III)-binding periplasmic protein precursor  GCAAGAAGGGCCTCGAATTC TTCGGGATGATGGTTTCCA 
Control AF220147 16S rRNA  CCTTACGGGCTGGGCTACA TGATCCGCGATTACTAGCGATT 
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triplicate. Subsequent evaluations of invasion were performed on nine separate occasions 
only on mutants exhibiting statistically significant differences compared with the WT 
strain in the screening test. Statistical significance of differences was determined using 
Student’s t test. A p value < 0.05 was considered significant. 
 
RESULTS 
B. melitensis 16M at late-log phase of growth was more invasive in non-
professional phagocytic cells than early-log and stationary growth phases. Under 
our growth conditions, logarithmically growing cultures (early-log) had 0.5x109 
CFU/ml, late-log cultures had 2x109 CFU/ml and stationary-phase cultures had 5x109 
CFU/ml. B. melitensis 16M cultures grown in tissue culture media were added directly to 
confluent monolayers of HeLa cells and co-incubated for 30 min and then washed and 
re-incubated 1 h with fresh media containing gentamicin to kill extracellular bacteria. In 
three different experiments, each performed in triplicate, late-log growth phase cultures 
were 2.2 (p < 0.05) and 4.8 (p < 0.01) times more invasive than cultures at early-log and 
stationary growth phases, respectively. The average number of intracellular bacteria 
recovered was 60 CFU at early-log, 130 CFU at late-log and 27 CFU at stationary 
growth phase per every 106 bacteria inoculated onto cells (Fig. 1). 
B. melitensis express different sets of genes in late-log and stationary phases 
of growth in F12K tissue culture medium. In order to understand the molecular 
differences in the invasion process, four biological replicates of cultures at the most 
(late-log) and the least (stationary) invasive growth phases were analyzed using 
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FIG. 1. The ability of B. melitensis 16M at different phases of growth to invade HeLa cells. B. 
melitensis 16M were grown overnight with shaking in F12K cell culture media supplemented with 10% 
(v/v) heat-inactivated fetal bovine serum to the early-log, late-log and stationary growth phases. HeLa cell 
infections were performed at MOI 1,000:1 with centrifugation for 10 min. Following 30 min incubation, 
extracellular bacteria were killed by 1 h gentamicin-treatment. Infected cultures were washed 3 times with 
PBS before lysing, and the lysates were serially diluted and cultured on TSA plates for quantitation of 
CFU. The intracellular number of late-log growth phase cultures of B. melitensis was significantly 
different from those grown to early-log (* = p < 0.05) and stationary (** = p < 0.01) growth phases. 
Results are presented as the number of CFU from internalized bacteria 30 min post-infection per every 106 
inoculated. Data presented are the mean + SD (error bars) of triplicate samples from one of 3 independent 
experiments with similar results. 
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cDNA microarray technology. Genomic DNA was used as an internal standarization 
control for each experiment in order to allow experiment to experiment comparisons 
(219). The experiments we report had little variability between gDNA signals from array 
to array, even under the two different conditions examined (i.e., late-log and stationary 
growth phase). The R2 value for any two arrays (for gDNA Cy5 fluorescent values) was 
between 0.78 and 0.89, even before normalization. When the values for each conditional 
replicate were averaged (four arrays each for log phase and stationary growth phases), 
the resulting R2 value was 0.88 (Fig. 2). Comparisons of RNA Cy3 fluorescent signals 
(log versus log and stationary versus stationary phases) yielded similar R2 values (data 
not shown).  
In order to further minimize the incidence of false positives and increase the 
consistency and reliability of the microarray analysis results, the data were analyzed 
separately using four different techniques: GeneSpring combinatorial analysis, Spotfire 
DecisionSite 8.2 pairwise comparisons, SAM two-class unpaired comparisons, and 
ANOVA. A change in gene expression was considered significant if the p value was less 
than 0.05, the fold change at least 2.0, and the gene expression alteration occurred for all 
replicate experiments. We further expected each gene to be significantly differentially 
expressed for at least two of the three replicate spots for each experimental array set 
(stationary versus late-log phase). Based on these criteria, genes that were deemed 
significant by all four analytical methods (GeneSpring, Spotfire DecisionSite 8.2, SAM, 
and ANOVA) were organized by COGs functional categories (NCBI Brucella melitensis 
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FIG. 2. Fluorescent signal values of B. melitensis gDNA in microarrays co-hybridized with 
B.melitensis RNA at late-log and stationary growth phases. Average Cy5 (gDNA) fluorescent signal 
values for B. melitensis grown in F12K tissue culture medium to late-log and stationary phases (4 arrays 
each) were plotted in Excel. Each dot represents the signal value for an individual spot on the array. 
Fluorescent signal values for gDNA co-hybridized with B. melitensis RNA extracted at stationary growth 
phase are indicated on the ordinate, and fluorescent signal values for gDNA co-hybridized with B. 
melitensis RNA extracted at late-log phase are on the abscissa. Stat refers to stationary phase, log refers to 
late-log phase, and gDNA refers to genomic DNA. The R-squared value (0.8841) is displayed in the upper 
right-hand quadrant of the graph. 
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16M genome project web page: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db= 
genomeprj&cmd=Retrieve&dopt=Overview&list_uids=180) and compiled into a list 
that included 454 genes (different loci) that were up- or down-regulated when B. 
melitensis were grown to late-log phase, compared to stationary phase (Appendix A). A 
direct comparison of the signal intensity values of these genes indicate that the 
difference between log and stationary phases was specifically due to differential gene 
expression and not array spatial bias, as indicated in Figure 3. When the average gDNA 
intensity values for these 454 genes were plotted (stationary phase versus log phase), the 
R2 value was 0.83 (Fig. 3A). However, the R2 value for the same genes comparing 
instead the Cy3 fluorescence values (labeled cDNA amplified from RNA) was extremely 
low (R2 = 0.049, Fig. 3B). 
Of the 454 genes significantly altered in B. melitensis during late-log phase (14% 
of B. melitensis genome), 414 (91%) were up- and 40 (9%) were down-regulated, 
compared to when the bacteria were allowed to reach stationary phase of growth. The 
relative changes in gene expression ranged from a 386.5-fold induction of the Glycerol-
3- phosphate regulon repressor gene (BMEII1093) to a 60.5-fold down-regulation of the 
locus BMEII0615 (hypothetical protein). The vast majority of these up-regulated genes 
were those associated with DNA replication, transcription and translation (57 genes), 
nucleotide, amino acid, lipid and carbohydrate metabolism (65 genes), energy 
production and conversion (24 genes), membrane transport (56 genes) and cell envelope, 
biogenesis and outer membrane (26 genes), while the 40 down-regulated genes were 
distributed among several COGs (Fig. 4). These results suggest a more active
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FIG. 3. Fluorescent signal values of B. melitensis transcript or gDNA from differentially expressed 
genes at stationary and late-log phases of growth. Average Cy5 (gDNA) or Cy3 (transcript) signal 
values for B. melitensis grown in F12K tissue culture medium to late-log and stationary phases (4 arrays 
each) were plotted in Excel. Each dot represents the signal value for an individual spot on the array, 
determined to be significantly differentially expressed between late-log and stationary phases. (A) 
Comparison of genomic DNA levels of significant genes at stationary and late-log phases of growth. 
Stationary phase gDNA signal values are on the ordinate, and late-log phase signal values are on the 
abscissa. The R-squared value (0.8341) is displayed in the upper right-hand quadrant of the graph. (B) 
Comparison of transcript levels of significant genes at stationary and late-log phases of growth. Stationary 
phase transcript signal values are on the ordinate, and late-log phase signal values are on the abscissa. 
Note the very low R-squared value (0.049), displayed in the upper right-hand quadrant of the graph. Stat 
refers to stationary phase, log refers to late-log phase, and gDNA refers to genomic DNA. 
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FIG. 4. Distribution of genes differentially expressed at late-log growth phase compared to 
stationary phase associated in cluster of ortholog genes (COGs) functional categories. Functional 
classifications are as follow: A, DNA replication, recombination and repair; B, Transcription; C, 
Translation, ribosomal structure and biogenesis; D, Nucleotide metabolism; E, Carbohydrate metabolism; 
F, Lipid metabolism; G, Amino acid metabolism; H, Secondary metabolites biosynthesis, transport and 
metabolism; I, Energy production and conversion; J, Inorganic ion transport and metabolism; K, Cofactor 
transport and metabolism; L, Cell envelope, biogenesis and outer membrane; M, Membrane transport; N, 
Defense mechanism; O, Signal transduction; P, Post-translational modification and secretion, protein 
turnover and chaperones; Q, Cell division; R, Cell motility and chemotaxis; S, General function prediction 
only; T, Predicted by homology; U, Unknown function. Open bars, up-regulated genes; solid bars, down-
regulated genes. 
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metabolism of the Brucella cultures at late log phase of growth compared to cultures at 
stationary phase.   
The highest bacterial replication observed at late-log compare to stationary 
growth phase is coincident with the up-regulation of genes encoding for DNA 
replication such as DNA polymerase (BMEI1321, BMEI1942, BMEII0290), dnaA 
(BMEI1362), a single strand binding protein (BMEI0880), DNA helicase (BMEI1485) 
and DNAtopoisomerase (BMEII0676), genes involved in pyrimidine (BMEI0609, 
BMEI1639) and purine (BMEI1575/6, BMEII0088) metabolism, and cell division-
involved genes like ftsX (BMEI0073), parB (BMEI0010) and minE (BMEII0925).  
Transcriptional regulators allow bacteria to express certain genes in response to 
specific signals. Twenty-one genes encoded transcriptional regulators belonged to AraC, 
AsnC, BetI, DeoR, GntR, IclR, LysR, LuxR, MarR, MerR and RpiR families were up-
regulated in late-log B. melitensis cultures. Some families are known to be involved in 
positive regulation of gene expression (LuxR, AraC), others families are involved in 
repression (DeoR, MerR), while members of other families (IclR, LysR) could by 
activators or repressors of expression (187). Their role in Brucella internalization is still 
unknown. As expected, the locus encoding for the alternative sigma 32 factor 
(BMEI0280) that allows bacteria survive in general stress situations, was observed up-
regulated in stationary cultures, while the locus BMEI1789 encoding for a subunit of 
another alternative sigma 54 factor (rpoN), which generally allows transcription of those 
genes involved in utilization of nitrogen and carbon sources and energy metabolism, was 
up-regulated in late-log phase cultures. The role of rpoN in Brucella remains to be 
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elucidated (55). Altogether, these data highlight the importance of finding the target 
genes of these transcriptional regulators in order to better understanding the Brucella 
physiology and metabolism.  
A significant number of genes (26) directly involved in cell envelope/outer 
membrane biogenesis were differentially expressed at late-log compare to stationary 
phase of growth such as those encoding for outer membrane proteins (BMEI0402, 
BMEI0786), lipoproteins (BMEI0991, BMEI1079), LPS (BMEI0418, BMEI0586, 
BMEI0833, BMEI1414) and peptidoglycan biosynthesis (BMEI0271, BMEI0576). 
ORFs encoding membrane transport elements were the COGs functional category with 
more up-regulated expressed genes. Among them, genes encoding for amino acid 
(BMEI0263/4, BMEII0098/9, BMEII0861-4) carbohydrate (BMEI1580, BMEI1713, 
BMEII0621/2/4) and uncharacterized transports (BMEI1554, BMEII0481/3, 
BMEII0662) were the predominant up-regulated groups. Three genes encoding proteins 
for the virB operon-type IV secretion system (T4SS), such as virB1 (BMEII0025), virB3 
(BMEII0027) and virB10 (BMEII0034) were up-regulated, and one (BMEI0033) was 
down-regulated. Altogether, these data indicate an active conversion of metabolites to 
components of the cell envelope structure at late-log phase, which could influence in the 
initial Brucella:host cell interaction, facilitating attachment and entry into host cells.  
Other conclusive remarks arising from the evaluation of microarray data analysis 
are the up-regulation of 9 protein-encoding ORFs involved in defense mechanisms (most 
against acriflavin protein) and 5 genes implicated in flagellar apparatus expression such 
as fliC (BMEII0150), fliF (BMEII0151), fliN (BMEII1112), flhA (BMEII0166) and flgD 
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(BMEII0164). Besides, there were 100 genes, 84 up- and 16 down-regulated 
differentially expressed with uncharacterized function in late-log phase compare with the 
stationary phase of growth. They represent a 22% of the genes differentially expressed, 
and may encode transcripts with previously unrecognized roles in B. melitensis adhesion 
and internalization. 
Validation of microarray results. To confirm the microarray results, we 
randomly chose 18 differentially expressed genes (one from each COGs functional 
category) and conducted qRT-PCR. Based on qRT-PCR results, 15 of these genes (83%) 
were altered greater than 2.0-fold and in the same direction as was determined by 
microarray analysis, two other genes (BMEI0402 and BMEI0642) were determined to 
be differentially expressed and in the same direction of microarray analysis, but the fold 
change was lower than 2, and no significant difference in the expression level of 
BMEI0344 was observed using qRT-PCR (Fig. 5). 
Late-log B. melitensis genes follow a similar expression pattern. In order to 
identify groups of genes with similar expression patterns, we performed hierarchical 
clustering analysis using Spotfire DecisionSite 8.2. Specifically, we were interested in 
identifying patterns of gene expression between bacteria grown in F12K tissue culture 
medium at late-log and stationary phases. Clustering analysis was performed on 
normalized Cy3 (cDNA amplified from total RNA) signal intensity values from the four 
log phase samples and four stationary phase samples and generated the cluster shown in 
Figure 6. As shown, all four samples from the log phase of growth clustered together, 
apart from those collected at stationary phase. This indicated that these 136 co-clustered 
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FIG. 5. Validation of DNA microarray results by quantitative RT-PCR. cDNA was synthesized from 
the same RNA samples used for microarray hybridization. Eighteen randomly selected ORFs that were 
differentially expressed based on microarray analysis between late-log and stationary growth phase were 
validated by quantitative RT-PCR. Fold-changes were normalized to the expression of B. melitensis 16S 
rRNA and calculated using the ∆∆Ct method. Seventeen out of 18 ORFs tested showed fold-changes in the 
same direction by both methodologies and 15 of them were also altered greater than 2-fold. Functional 
classifications are as follow: A, DNA replication, recombination and repair; B, Transcription; C, 
Translation, ribosomal structure and biogenesis; D, Nucleotide metabolism; E, Carbohydrate metabolism; 
F, Lipid metabolism; G, Amino acid metabolism; H, Secondary metabolites biosynthesis, transport and 
metabolism; I, Energy production and conversion; J, Inorganic ion transport and metabolism; K, Cofactor 
transport and metabolism; L, Cell envelope, biogenesis and outer membrane; M, Membrane transport; N, 
Defense mechanism; O, Signal transduction; P, Post-translational modification and secretion, protein 
turnover and chaperones; Q, Cell division; R, Cell motility and chemotaxis. 
 
  
 
44
 
 
 
-0.913 1
1 136 2  2  2 
Stat 2 Stat 4 Stat 3 Stat 1 Log 2 Log 4 Log 3 Log 1  
 
 
FIG. 6. Hierarchical cluster of genes from B. melitensis grown to stationary and late-log phases. 
Hierarchical clustering was performed on normalized Cy3 (transcript) signal intensity values from 8 arrays 
using Spotfire DecisionSite 8.2 software. Stat 1 – Stat 4 represent the four stationary phase replicate 
bacterial samples, and Log 1 – Log 4 represent the four late-log phase replicate samples. Higher signal 
values are shown in red, and lower signal values are shown in green. 
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genes were indeed differentially expressed between the two growth conditions. 
Moreover, the majority of differentially expressed genes were up-regulated in log phase 
compared to stationary phase (bright red color), consistent with the statistical analysis 
results (Appendix A). Co-clustered B. melitensis genes that were up-regulated during 
late-log growth phase included those encoding proteins involved in energy production 
and conversion, synthesis of cell envelope structural constituents, motility, metabolite 
influx and drug efflux, and transcriptional regulation. Co-clustered genes that were 
down- regulated included those involved in transcription regulation and metabolism 
(data not shown). 
In order to visually characterize and compare genes induced during different 
phases of culture, we used Spotfire DecisionSite 8.2 to create profile charts for genes 
that were consistently up-regulated or down-regulated in late-log phase of B. melitensis 
cultures (Fig. 7A and B), compared to stationary phase bacterial cultures. The 20 spots, 
representing 10 genes that most closely resembled the pattern of expression shown in 
Figure 7A (i.e., up-regulated in late-log phase cultures, compared to stationary phase 
cultures) are presented in Table 3. Six of the 10 genes (denoted by asterisk in Table 3) 
were also expressed during stationary phase, although to a lesser extent. The 20 down-
regulated genes (Fig. 7B), on the other hand, all encode uncharacterized hypothetical 
proteins, and thus shed no light on potential patterns of down-regulation. Overall, the 
profiling results were similar to the fold-change data (Appendix A) and the clustering 
results (Fig. 6). 
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FIG. 7. Expression profile chart for genes most highly up-regulated or down-regulated in late-log 
phase cultures of B. melitensis compared to stationary phase bacterial cultures. (A) An expression 
profile chart of the most highly up-regulated genes during late-log phase, was created using Spotfire 
DecisionSite 8.2 software. The ordinate represents normalized signal intensity values for each spot (gene), 
and experiment number/type is indicated on the abscissa. Stat 1 – Stat 4 represent the four replicate 
bacterial culture samples collected at stationary phase, and Log 1 – Log 4 represent the four replicate 
bacterial culture samples collected at late-log phase. Genes represented in the profile chart are listed in 
Table 3 with functions. (B) An expression profile chart of the most highly down-regulated genes during 
late-log phase. 
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TABLE 3. Genes significantly up-regulated in B. melitensis cultures grown in F12K 
tissue medium to late-log phase, compared to bacteria at stationary phase  
 
Locus Gene product Function No. of Spots 
BMEI1977 1-acyl-sn-glycerol-3-phosphate acyltransferase* 
Cell envelope: Biosynthesis and 
degradation of surface 
polysaccharides and 
lipopolysaccharides 
2 
BMEII0249 Dihydrodipicolinate reductase* L-lysine synthesis 1 
BMEI1297 DNA-directed RNA polymerase omega subunit* Transcription regulation 1 
BMEI1622 Hypothetical protein Unknown 3 
BMEI0362 Hypothetical protein* Unknown 3 
BMEI2005 Phenylalanyl-tRNA synthetase alpha subunit* Protein biosynthesis 3 
BMEII1003 Putative O-antigen transporter Cell envelope metabolism transport of LPS components  3 
BMEII0529 Surface protein Unknown 2 
BMEII0962 Taurine transport permease protein TauC* 
ABC-type transport system 
required for uptake of aliphatic 
sulfonates 
1 
BMEII1065 Transcriptional regulatory protein, LysR family Transcription regulation 1 
 
No. of spots refers to the number of replicate spots (from Figure 7A) that represented each of the gene 
products shown. Asterisks denote genes that were also expressed during stationary phase, but to a much 
lesser extent. 
 
Application of principal components analysis to assess global trends in B. 
melitensis transcriptional responses and to functionally group bacterial growth 
phase-specific genes. In order to reduce the dimensions of the data and describe the 
general trend of gene expression changes induced in B. melitensis cultures when grown 
in F12K tissue culture medium, we performed principal component analysis (PCA) 
using Spotfire DecisionSite 8.2 software. Three components were sufficient to describe 
100% of the variability between treatments, with the three new axes (PC1, PC2, and 
PC3) accounting for 85.8%, 8.0% and 6.2% of the variability, respectively (Table 4).  
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TABLE 4. Eigenvalue for each principal component 
 
 
 
 
 
The three components are shown graphically in Figure 8. We interpreted the first 
principal component (PC1) to represent those genes that were not significantly expressed 
in B. melitensis cultures during either phases of growth. We interpreted PC2 to represent 
genes that were expressed during both late-log and stationary phases, although slightly 
higher or lower in the latter for some genes. We considered the third principal 
component (PC3) to primarily represent genes that were expressed only in late-log 
cultures (i.e., up-regulated during late-log phase of growth compared to the stationary 
phase). Overall, the PCA data corroborated the results obtained using GeneSpring, 
Spotfire, SAM, and which also suggested that the most significant difference between 
late-log and stationary phases was the induction of genes specifically in the log phase 
that were down-regulated upon entry into the stationary phase of growth.  
PCA has previously been shown to be a powerful tool for grouping similarly 
expressed genes into functional sets (44). We interpreted the PCA results (based on 
component loadings) in order to attach biological meaning to the components and 
organized the genes that were most highly correlated with PC2 and PC3 based on 
eigenvalue percentages, into two separate lists of 257 and 203 genes, respectively. In  
Principal 
Component Eigenvalue Eigenvalue (%)
Cumulative 
Eigenvalue (%) 
No. of 
genes 
PC1 16.381 85.808 85.808 2,769 
PC2 1.522 7.974 93.782 257 
PC3 1.187 6.218 100.000 203 
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FIG. 8. Principal component analysis (PCA) of gDNA and transcript levels in B. melitensis cultures 
collected at stationary and late-log phases of growth. PCA was performed using Spotfire DecisionSite 
8.2 software. Three components were sufficient to describe all the variation between sample types. Data 
reduction (from many dimensions down to 2 dimensions) results in a representation of the data (as shown 
graphically) that can be interpreted as a description of gene expression changes (compared to gDNA 
levels).  The three components, (PC1, red), (PC2, blue), and (PC3, yellow), can be viewed as groups of B. 
melitensis genes that behave similarly between the various conditions: not expressed in either stationary or 
late-log phases of growth (PC1), expressed in both phases of growth (PC2), expressed only during late-log 
phase (i.e., not during stationary phase) (PC3). gDNA represents the level of the gene in the bacterial 
genome, Stat represents the level of the gene transcript at stationary phase, and Log represents the level of 
the gene transcript at late-log phase.  
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other words, we grouped together those genes whose expression patterns most resembled 
that of PC2 and PC3, as depicted in Figure 8. The majority of genes highly loaded on 
component 2 (expressed during both phases of bacterial growth) were related to protein 
synthesis, sugar metabolism, electron transport, motility, and intermediary metabolism, 
as expected (data not shown). Of the 257 genes that most highly correlated with PC2, 
153 were also determined to be significantly expressed in both late-log and stationary 
phases of B. melitensis growth, based on GeneSpring, Spotfire, SAM, and ANOVA 
analyses (data not shown). Of the 203 genes most highly loaded on component 3 (PC3), 
118 were also included in the most statistically significant altered gene list (Appendix A) 
and coded for proteins involved in cell wall synthesis, energy metabolism and transport 
of metabolites, metals, and drugs. Overall, the results were similar to what was obtained 
using hierarchical clustering (Fig. 6). 
Phenotypic characterization of B. melitensis strains mutated in genes highly 
up-regulated in late-log growth phase in HeLa cells. The above results suggested the 
possibility that some of the 454 genes differentially expressed between late-log and 
stationary growth phases might influence the invasion process of B. melitensis in HeLa 
cells. To test this hypothesis, we evaluated in vitro the internalization performance of 8 
transposon interrupted mutants of B. melitensis 16M genes highly up-regulated in late-
log growth phase. The criterion for election of the mutants was based on magnitude of 
fold-change expression and availability of the mutant strain with transposon interruption 
in the locus expressed on our B. melitensis mutant bank. The transposon mutants tested 
(Table 1) were interrupted in the following loci (fold-change as shown in Appendix A 
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are indicated between parenthesis): BMEI1414 (> 133.4-fold), BMEI1416 (207.7-fold), 
BMEI1538 (> 146.3-fold), BMEI1707 (> 42.5-fold), BMEII0025 (> 9.0-fold), 
BMEII0034 (> 81.6-fold), BMEII0380 (267.76-fold) and BMEII0472 (> 86.7-fold). All 
mutant strains had growth curves similar to the wild type strain when grown in F12K 
tissue culture media supplemented with 10% HI-FBS (i.e. late-log cultures had 2x109 
CFU/ml). Cultures were inoculated directly onto confluent monolayer of HeLa cells, co-
incubated for 30 min and then washed and re-incubated 1 h with fresh media containing 
gentamicin for killing extracellular bacteria. After lysing infected cell cultures with 0.1% 
Triton X-100, invasive bacteria were assessed by plating a serial dilution on TSA 
supplemented with kanamycin and incubating at 37ºC with 5% CO2 for 4 days. The 
screening invasion assays revealed that 4 mutants BME5F3, BME8A6, QW70F8 and 
QW184B9, were statistically significantly deficient (p < 0.05) for internalization, 
compared to the parental strain. The invasiveness of these 4 mutants was re-evaluated in 
9 independent assays, being BME5F3 (BMEI1538::Tn5) and QW184B9 
(BMEII0380::Himar1) statistically significantly deficient for internalization compared to 
the wild type (p < 0.01) (Fig. 9). These results suggest that 25% (~ 100) of the most 
highly up-regulated genes in late-log phase may have influence in Brucella 
internalization in non-phagocytic cells. 
 
DISCUSSION  
The molecular mechanisms involved in the initial Brucella:non-phagocytic host 
cell interaction are not well characterized. HeLa cells have been used as a model for  
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FIG. 9. Internalization ability of B. melitensis transposon interrupted in genes highly up-regulated in 
late-log growth phase in HeLa cells. HeLa cells were infected at MOI 1,000:1 by adding B. melitensis 
16M grown to the late-log phase onto cells and spinning down for 10 min. After 30 min incubation, 
extracellular bacteria were killed by 1 h gentamicin-treatment. Infected cultures were washed 3 times with 
PBS before lysing, and the lysates were serially diluted and cultured on TSA (TSA supplemented with 
kanamycin for mutants) plates for quantitation of CFU. The invasiveness of B. melitensis 16M with 
transposon insertion in locus I1538 (BME5F3) and II0380 (QW184B9) were significantly different (* = p 
< 0.01) than the parental strain. Results are presented as the number of CFU from internalized bacteria 30 
min post-infection per every 106 inoculated. Means + SD (error bars) of 9 independent assays are shown.
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studying adhesion and internalization of Brucella sp. in non-professional phagocytic 
cells (31, 98). These studies found that brucellae bind to cellular receptors containing 
sialic acid residues and induce their own uptake by a local rearrangement of the host cell 
cytoskeleton around the invading organisms. The ability of the bacteria to adhere and 
penetrate eukaryotic cells is a very well orchestrated process that requires several 
factors/elements in order to be successful (42). To date, only a few Brucella elements 
involved in cell invasion have been identified (10, 32, 54, 216). This study was 
performed with the goals of characterizing the Brucella invasion-related transcriptome in 
non-phagocytic cells and identifying bacterial candidate genes involved in the invasion 
process. 
Successful establishment within the host requires facultative intracellular 
pathogens to rapidly adjust to different environmental conditions by a coordinated 
expression of a large number of genes necessary for the adaptation between the 
extracellular and intracellular phases of infection. To more efficiently identify invasive 
differences between cultures at different phases of growth and eliminate from 
consideration any elements that might be expressed as a consequence of bacterial pre-
infection manipulation (centrifugation, washes, transfer to fresh media) or host:agent 
interactions, we grew the bacteria directly in the infective media used to inoculate the 
HeLa cell cultures and allowed them to interact only for a short period of time (30 min). 
We also used a higher MOI (1,000:1) than other studies (32, 50), because B. melitensis 
was not highly internalized by epithelioid-like HeLa cells during the first 30 minutes 
post-infection at lower MOIs under our experimental conditions. 
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Our initial experiment found that cultures of B. melitensis at late-log growth 
phase were more invasive to non-phagocytic cells than cultures at early-log and 
stationary growth phases. Similar results were observed for other invasive pathogens, 
such as Salmonella spp. or Yersinia enterocolitica (143, 177). As we demonstrated here, 
the Brucella transcriptome, and consequently the virulence of the organism, are modified 
during the different stages of the growth curve. This modification may also be 
influenced by the media used (B. melitensis growth curve was different in tryptic soy 
broth (TSB); data not shown), therefore the growth curve and the highest rate of 
infection must be determined for each condition employed. 
The relationship between growth phase and invasiveness is dependent on the 
availability of bacterial virulence factors at any given time. For instance, Shigella 
flexneri is more invasive during the early phase of their exponential growth, because 
invasion proteins (Ipa) are secreted in higher amounts during this growth phase (162), 
while Salmonella enterica and Legionella pneumophila have their secretion systems 
assembled and effector proteins properly stored in the cytoplasm only at the late 
exponential and stationary growth phases, respectively (42, 85, 159). In order to 
understand why our system evoked greater invasiveness in B. melitensis cultures at late-
log phase, we conducted a global gene expression detection study using cDNA 
microarray technology. Microarray analysis revealed that 454 genes were significantly 
differentially expressed between the most and least invasive cultures (Appendix A); 
however the roles of most of these genes are not well defined in Brucella pathogenesis. 
The vast majority of the observed changes in gene expression were related to the 
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bacterial response to the increased growth conditions in tissue culture media. For 
instance the up-regulation of genes associated with transcription and translation, nutrient 
metabolism, transport, and energy production and conversion correspond to a more 
active metabolism of the cultures at late-log phase of growth, compared to cultures at 
stationary phase. As was expected, several cell division- and DNA synthesis-related 
genes were also up-regulated in late-log phase, when the bacterial population was still 
actively growing. On the other hand, genes down-regulated in late-log phase were more 
heterogeneous in nature, demonstrating no predominant functional category. In 
concordance with the literature, the increased expression of the locus BMEI0280 
encoding the alternative sigma 32 factor was observed in stationary cultures. Sigma 32 
factor regulates the transcription of heat shock genes, which allow the bacteria to survive 
not only an abrupt increase in temperature, but also general stress situations, such as 
nutrient limitations during stationary growth phase (244). 
In seeking to identify possible contributors to the increased invasiveness of B. 
melitensis at late-log phase, the conversion of metabolites to components that alter cell 
envelope structure must be considered. Altered outer membrane/cell wall topology 
would be expected to influence the initial bacteria:host cell interaction and might 
facilitate attachment and entry into host cells. In our study, a significant number of genes 
directly involved in cell envelope/outer membrane biogenesis were differentially 
expressed (Appendix A). One of the genes up-regulated at late-log growth phase was the 
locus BMEI0402. The product of this gene has not been characterized yet; however it 
presents high homology (63% sequence identity) to an immunogenic outer membrane 
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protein Omp31 (BMEII0844) (233). Omp31 is a haemin-binding protein (47), which 
binds to and extracts iron from the host. Iron has been identified as a required element 
for epithelial invasion in microbial pathogens (18, 81, 106), and the expression of this 
locus along with another iron-related genes in late-log cultures (BMEI0176-177, 
BMEII0536, BMEII0567, BMEII0583, BMEII0704, BMEII0883, BMEII1120, 
BMEII1122) may influence the internalization ability of brucellae. SP41 is another 
surface-exposed outer membrane protein recently reported to be important for Brucella 
adherence to and invasion of non-phagocytic cells (32). This protein is encoded by the 
ugpB gene (BMEII0625), which most likely belongs to an operon (BMEII0621-625) that 
encodes for a sn-glycerol-3-phosphate ABC transporter (http://www.tigr.org/tigr-
scripts/operons/operons.cgi). In our study, the transcripts predicted to encode for the 
transport system [ugpC (BMEII00621) (ATP-binding protein), ugpE (BMEII0622) and 
ugpA (BMEII0624) (permease proteins)] were highly up-regulated (> 50 fold) in late-log 
cultures when compared to stationary cultures. However, the transcript from the gene 
ugpB that encodes for the OMP was not differentially expressed, and the other ugpE 
gene (BMEII0623) was down-regulated. These and previous data strongly suggest an 
active role of the whole sn-glycerol-3-phosphate ABC transport system in Brucella:host 
initial interaction, which will require further confirmation in future studies.  
Two of the mutants tested had transposon-interrupted genes whose products 
influence cell envelope/outer membrane biogenesis, but none of them were found to 
have a role in invasion. The mutant BME5D1 has a disruption of the locus BMEI1414 
that encodes for perosamine synthetase. This enzyme is involved in the biosynthesis of 
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the O- side chain of Brucella LPS, and a mutant deficient for this gene was not found to 
be defective for internalization in bovine macrophages, compared to the parental strain 
(91). The other mutant (BME8A6) has a transposon inserted in the locus BMEI1707 that 
encodes for the enzyme mandelate racemase, which catalyzes the interconversion of the 
enantiomers of mandelate via an enol intermediate. No references in the literature were 
found to suggest that this enzyme is involved in bacterial invasion or virulence. Our 
results found a lower, albeit non-significant, invasive rate compared to the wild type 
strain in 9 independent assays. The possibility that this enzyme plays a dual role in 
metabolism and invasion or indirectly contributes to increased invasiveness in Brucella 
is not entirely unlikely, as the major glycolytic enzyme enolase was found to be surface-
expressed and secreted, facilitating immune cell migration and pathogenic bacterial 
dissemination via activation of plasminogen, in addition to its main role in metabolism 
(89, 174, 209).  
Rapid adaptive physiological response to multiple environmental and cellular 
signals in bacteria is mainly mediated by transcriptional regulators. Prokaryotic genes 
putatively coding for transcriptional regulators are grouped in families based on 
sequence similarity and functional criteria. Twenty-one transcripts, belonging to 11 
families of transcriptional regulators, were differentially expressed in our study 
(Appendix A). It was recently reported that B. melitensis mutants for 12 of these 21 
transcriptional regulators were not attenuated after one-week of  infection in mice (101). 
However, none of these transcriptional regulators have been tested for internalization 
ability in non-phagocytic cells. Therefore, contribution of these genes to invasion 
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remains unknown. A well-known family of transcriptional activators that regulates 
various functions in microbes is LuxR (61). There are 2 loci (BMEI1758 and 
BMEII1116) that encode transcripts belonging to this family of transcriptional regulators 
in the B. melitensis genome. One (vjbR, BMEII1116) has been identified as a major 
regulator of the virB operon and flagella genes (48), while the function of the other 
remains unknown. In spite of detecting some virB and flagella genes up-regulated in our 
study, the transcriptional regulator vjbR was not differentially expressed, which would 
suggest that other transcriptional regulator(s) may participate in the expressional control 
of both the flagella and T4SS, as was discussed by Delrue et al. (2005). However, the 
locus BMEI1758 that encodes a 238 aa protein only found in Brucella species (no 
homology to proteins from other microorganisms), was up-regulated 221-fold in the late-
log phase of growth. Determining the importance of this and other transcriptional 
regulators in late-log growth phase cultures in the initial host:agent interaction could be 
the first step to identifying the effectors gene(s) they regulate.  
Another form of microbial transcriptional gene control is the two-component 
regulatory system, which involves a cytoplasmic membrane-located sensor protein and a 
cytoplasmic response regulator protein (16). Eight ORFs encoding for two-component 
response regulators have been identified in the B. melitensis 16M genome (51). Of 
particular interest is the up-regulation of the locus BMEI2034 (sensor protein ChvG), 
which is located immediately downstream of the ChvI/ChvG two-component system 
(BMEI2036-35), a B. melitensis homolog of the well-characterized BvrR/BvrS 2-
component regulatory system that controls cell invasion and intracellular survival in B. 
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abortus (99, 216). Currently available data indicate that the locus BMEI2034 is located 
in the same operon as the sensor protein ChvG (locus BMEI2035) 
(http://www.tigr.org/tigr-scripts/operons/operons.cgi); however, only BMEI2034 (not 
BMEI2035), was detected as differentially expressed between late-log and stationary 
growth phases in this study. The role of ChvG/ChvI in B. melitensis virulence has not 
been studied, but their homology with other 2-component response regulators of other 
pathogens would suggest an important role in virulence regulation. On the other hand, 
the influence of the signal transduction systems differentially expressed in this study 
could not be evaluated due to the unknown molecular regulation of these response 
regulators in B. melitensis. Addressing these issues would be expected to enormously 
clarify B. melitensis virulence mechanisms.  
Several motility-related genes were more highly expressed at late-log phase 
compared to stationary phase, including kinesin-like protein, chemotaxis MotD protein 
and genes related to flagellum apparatus synthesis and functions, e.g. flagellin itself 
(96.6-fold). Flagellin has been well-characterized as a contributor to bacterial virulence 
through chemotaxis, adhesion to and invasion of host cells (186). The extent to which 
flagellar machinery participates in the invasive process seems to depend at least partly 
on the species of bacteria and/or the host cell type. For instance, flagellar-associated 
motility in Salmonella is not required but accelerates invasion of Caco-2 colonic 
epithelial cells (229) whereas the invasion of Acanthamoeba astronyxis by Bukrholderia 
pseudomallei absolutely requires an intact flagellum apparatus (114). In the case of B. 
melitensis, a previous study has demonstrated that flagella expression is growth curve 
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dependent and required for persistent disease in a mouse model but not for invasion in 
cellular models (84). In the previous study was reported that a functional flagellum was 
assembled in early-log growth phase cultures but not at later time points. In our study, 
we did not analyze gene expression at early time points, but our results clearly indicate 
flagellar genes expressed in late-log phase cultures but not in stationary cultures. The 
differences in flagellum gene expression between the previous study and ours could be 
attributed to evaluation of different steps of the process (protein expression versus gene 
expression), different culture media, or post-transcriptional regulation mechanisms. We 
were not able to evaluate the role of B. melitensis flagellar gene expression in invasion 
under our experimental conditions, but undoubtedly, the presence of flagellar machinery 
and other adhesion/motility factors in some phases of the growth curve and their exact 
contribution to the Brucella invasion process warrant further studies. 
Genes coding for specific or general transporters were differentially expressed in 
late-log growth phase cultures, compared to stationary phase cultures. Among those 
most frequently observed were the ABC transporters, which are used by bacteria to 
import or export different compounds such as ions, polypeptides or carbohydrates 
through their membranes (45) and those used in the transport of nutrients, the latter 
which is directly related to the physiological state of the bacteria (i.e. growth curve) and 
the environment (i.e. culture medium). Among the mutant strains tested was QW154H11 
that has a transposon-interrupted locus BMEI1416. This locus codes for an ATP binding 
protein of the O-antigen export system. Our initial assays suggested that this ABC 
transporter system plays little or no role in B. melitensis invasion, and no publications 
  
 
62
 
were found linking it with virulence in bacteria. Another up-regulated transporter was 
the acriflavin system. Acriflavin resistance pumps belong to a non-ABC multidrug-
resistance efflux pumps. They not only confer bacteria protection to antibiotics but also 
defend them from natural substances produced by the host and play a direct role in 
bacterial pathogenesis (178). In this study, 3 (AcrA, AcrB, AcrD) of 7 Acriflavin 
resistance proteins observed in B. melitensis genome (51) were up-regulated in late-log 
growth phase cultures. Medium and growth-phase were reported to play an important 
role in the expression of the tripartite system AcrAB-TolC efflux pump in E. coli (13). 
Moreover, previous in vitro and in vivo studies using plant and other animal pathogens 
have shown the participation of the AcrAB-TolC efflux pump in adherence to, invasion 
of and persistence (24, 25). Not surprisingly, under our experimental conditions the 
mutant QW184B9 with a transposon interrupted in the locus BMEI0380 that encodes 
AcrA had significantly decreased internalization when compared with the parental strain. 
Participation of this multidrug-resistance efflux pump in B. melitensis invasion of non-
phagocytic cells will require further clarification. Also, a B. melitensis strain QW73H12 
mutated in the membrane fusion protein MtrC, a homolog of HlyD secretion protein, 
was evaluated for invasiveness. Proteins from this family are anchored in the 
cytoplasmic membrane with a highly conserved large periplasmic domain and are an 
important part of the transport apparatus of type I secretion systems (108). The role of 
MtrC protein in Brucella physiology has not been addressed yet, but our data suggest 
that it would not likely play a role in adhesion and internalization in spite of being highly 
up-regulated in the most invasive cultures.  
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The virB operon has been reported to be essential for intracellular survival and 
multiplication of Brucella (22, 50, 169, 213), but its role in adherence and internalization 
is contradictory (39, 236). In our study, some genes from the operon (virB1, 3 and 10) 
were up-regulated in late-log growth phase cultures compared to the stationary phase of 
growth. Building on the concept that highly up-regulated genes influence the invasive 
process under our experimental conditions, we infected non-phagocytic cells with a B. 
melitensis transposon interrupted in virB1 and virB10 genes. However, none of the 
mutants demonstrated differential invasion rates in HeLa cells, compared to the WT 
strain, which is in agreement with other previous experiments that have shown that virB 
did not influence B. abortus internalization in non-phagocytic cells (39). 
Finally, genes up-regulated in late-log phase encoding hypothetical proteins 
whose function is unknown or barely predicted deserve some special consideration. This 
group of “hidden genes” may contain some of the heretofore unknown virulence factors 
utilized for B. melitensis to invade and infect the host. Here we found that a B. melitensis 
transposon interrupted in the locus BMEI1538 (BME5F3) that encodes for a 
hypothetical protein of 77aa with no detected homology, partially lost the capacity to be 
internalized by non-phagocytic cells. These preliminary data suggest that the product of 
this locus as well its role in B. melitensis invasion in non-phagocytic cells is deserving of 
special attention.  
In conclusion, our studies reveal that B. melitensis grown in cell culture media at 
late-log phase are more invasive in non-phagocytic cells than cultures grown at early-log 
or stationary growth phases. cDNA microarrays provide informative differential 
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transcription profiles of B.melitensis cultures grown at late-log vs. stationary growth 
phase. Using a few specific examples we were able to confirm that highly expressed 
genes at late-log growth phase were involved in the invasion phenotype of B. melitensis 
cultures in non-professional phagocytic cells. Future studies on Brucella invasion and 
virulence will be aimed at more precisely delineating the roles of the genes discovered in 
this study. 
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CHAPTER III 
 
HOST AND Brucella melitensis TEMPORAL GENE EXPRESSION PROFILES 
IN AN in vitro MODEL OF INFECTION 
 
INTRODUCTION  
Brucella infects hosts principally by penetrating mucosal surfaces from which it 
disseminates to the rest of the body (66). In vitro assays performed on cell lines or 
primary cultures are useful for understanding the details of host:agent interactions. The 
HeLa cell line has been used to understand adhesion, internalization, intracellular 
trafficking, survival, and replication of brucellae in non-professional phagocytic cells. 
These studies have shown that individual Brucella initially attach to non-professional 
phagocytic cells via receptor molecules containing sialic acid or sulphated residues (31) 
and within a few minutes are internalized by receptor–mediated phagocytosis (52, 53). 
After invasion, virulent Brucella transiently interact with an intracellular compartment 
related to the early endocytic network that is gradually transformed in a 
multimembranous autophagic vacuole. Subsequently, Brucella is delivered to rough 
endoplasmic reticulum-like compartment in the perinuclear area, where massive 
intracellular replication occurs (53, 179).  
Despite the published precise and detailed descriptions of Brucella 
internalization and intracellular trafficking in non-professional phagocytic cells, there is 
no global or temporal molecular characterization of these phenomena. The goals of this 
study were to characterize the transcriptome of Brucella and Brucella-infected host cells 
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during acute infection in order to understand the initial strategies employed for 
intracellular pathogen survival and replication and to identify perturbations of major 
gene(s) modulating critical cellular pathways during the initial infection.  
  
MATERIALS AND METHODS 
Bacterial strains, media and culture conditions. Smooth virulent Brucella 
melitensis 16M Biotype 1 (ATCC 23456) re-isolated from an aborted fetus goat, and its 
derivative a B. melitensis 16M II0027 virB3 homolog::Himar1 (virB mutant) (241) were 
maintained as frozen glycerol stocks. Saturated cultures of strains were sub-cultured into 
50 ml conical tubes filled with 10 ml of cell culture media [F12K medium (ATCC) 
supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS) (ATCC)] at a 
ratio of 1:200, and incubated at 37ºC with 5% CO2 overnight with shaking until they 
reached the late-log growth phase (OD 0.4). 
Kinetics of B. melitensis in HeLa cells. HeLa cell infection was conducted as 
explained in Chapter II. Briefly, the HeLa S3 cell line (ATCC CCL-2.2), between 
passages 8 and 15, was grown in F12K medium containing 10% HI-FBS at 37ºC with 
5% CO2. Twenty-four hours prior to infection, cells were cultured in 24 well plates 
(Corning) at a concentration of 1x105 cells/well and replaced in the incubator. Before 
infection, cells from 1 well were detached and counted. Infection with B. melitensis was 
done by replacing the medium overlying the HeLa monolayers with a bacterial inoculum 
grown in cell culture media, at a multiplicity of infection of 1,000 bacteria per cell (MOI 
1,000:1). Bacteria were centrifuged onto the cells at 800 X g for 10 min followed by 30 
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min of incubation at 37ºC. Then, cells were washed once with PBS to remove 
extracellular bacteria and re-incubated with F12K media supplemented with 100 µg ml-1 
of gentamicin solution (Sigma) for 1 hour. After antibiotic treatment, infected cultures 
were washed 3 times with PBS, 1 ml of cell culture media added and replaced in the 
incubator. To determine the kinetics of B. melitensis WT and the virB mutant in the first 
12 h, the viable number of intracellular bacteria was determined at 0, 4, 8 and 12 h post-
infection (PI) by lysing infected cultures with 0.1% Triton X-100 (Sigma). Lysates were 
serially diluted and cultured on TSA plates (supplemented with kamamycin as 
necessary) for quantitation of colony-forming units (CFU). Duplicate wells containing 
bacterial suspensions alone were used as a control for bacterial growth. 
Induction of RNAi in HeLa cells. The day before transfection, HeLa cells were 
cultured in 24 well plates at a concentration of 4x104 cells/well in 0.5 ml of cell culture 
medium and replaced in the incubator. The following day, 50 µl of serum-free cell 
growth medium (Invitrogen) was mixed in separate compartments with 30 nM and 100 
nM of Silencer® mitogen-activated protein kinase 1 (MAPK1) (ID 1449) and MAPK1 
(ID 1544) Validated siRNA (Ambion) for each 24 wells of cells to be transfected. 
Simultaneously, 1 µl of TransFecting lipid reagent (Bio-Rad, Hercules, CA) was diluted 
into 50 µl of serum-free cell growth medium for each 24-well culture to be transfected. 
The diluted siRNA was combined and gently mixed with the diluted transfecting 
reagent. After 20 min incubation at RT, the culture media was removed from the wells 
and replaced by 100 µl of the siRNA-TransFecting complexes, rocked for 1 min and 
then filled with 400 µl of F12K cell culture media supplemented with 10% HI-FBS. The 
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next day, the media in the wells was replaced for 0.5 ml of fresh cell culture medium. 
Forty-eight hours after transfection, HeLa cells were infected with B. melitensis 16M 
and invasion and survival of intracellular bacteria was determined as described above. 
Infection of non-transfected cells and HeLa cells transfected with 30 nM Silencer® 
negative control #1 siRNA (Ambion) were used as controls. For validation of RNAi 
efficiency, RNA from transfected cells was extracted at the same time of infection (i.e. 
48 h post-transfection) using RNeasy kit (Qiagen) and eluted in 50 µl of DEPC-treated 
water with 2% DTT and 1% RNase inhibitor (Promega). RNAs extracted from HeLa 
cells transfected with 30 nM of Silencer® GAPDH siRNA control and negative control 
#1 siRNA (Ambion) were used for validation of knocked down gene expression. 
Contaminant genomic DNA was removed by RNase-free DNase I treatment (Ambion) 
according to the manufacture’s instructions, and samples were stored at -80ºC until used. 
The concentration of RNA was quantitated by NanoDrop® ND-1000 (NanoDrop), and 
the quality RNA was assessed using the Agilent 2100 Bioanalyzer (Agilent). Target 
mRNA levels were measured by qRT-PCR as explained below using the following 
primers: MAPK1 (Forward 5’-TGGATTCCCTGGTTCTCTCTAAAG-3’, Reverse 5’- 
GGGTCTGTTTTCCGAGGATGA-3’), GAPDH (Forward 5’- 
AAAAACCTGCCAAATATGATGACA-3’, Reverse 5’- 
AGCTTGACAAAGTGGTCGTTGA-3’) and β-actin (Forward 5’- 
GCAAATGCTTCTAGGCGGACTA-3’, Reverse 5’-CTGTCACCTTCACCGTTCCA-
3’) (Sigma Genosys). 
Isolation of total RNA from HeLa cells. Total RNA from infected and non-
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infected cell cultures was extracted at 4 and 12 h PI by removing the culture media, 
washing with PBS and adding 1 ml of TRI-Reagent® (Ambion) onto each cell 
monolayer (5x106 cells cultivated in 25 cm2 tissue culture flasks). After 5 min at room 
temperature (RT), the suspension was transferred to a 1.5 ml vial and 200 µl of 
chloroform added and kept at RT for 10 min. Then, the tubes were centrifuged at 10,000 
X g at 4ºC for 15 min and the aqueous phase transferred to a fresh tube containing 0.5 ml 
of 100% isopropanol. After vortexing, the samples were kept at RT for 10 min and then 
centrifuged at 10,000 X g at 4ºC for 10 min, the supernatant discarded and the pellet 
washed in 75% ethanol. Following centrifugation at 10,000 X g at 4ºC for 5 min, the 
supernatant was discarded and the pellet re-suspended in DEPC-treated water with 2% 
DTT and 1% RNase inhibitor (Promega). Contaminant genomic DNA was removed by 
RNase-free DNase I treatment (Ambion) according to the manufacture’s instructions, 
and samples were stored at -80ºC until used. The concentration of RNA was quantitated 
by NanoDrop® ND-1000, and the quality of RNA was determined using the Agilent 
2100 Bioanalyzer. 
Enrichment and sense-strand amplification of B. melitensis total RNA from 
infected HeLa cell cultures. B. melitensis total RNA was initially enriched and then 
amplified from 50 µg of total RNA from B. melitensis-infected HeLa cells at 4 and 12 h 
PI. The enrichment procedure was performed using the MICROBEnrich® kit (Ambion) 
according to the manufacturer’s instructions. After enrichment, the RNA was 
precipitated in 100% ethanol at -20ºC for at least 1 h, centrifuged for 30 min at 10,000 X 
g at 4ºC, followed by two ice-cold 70% ethanol washes. After 5 min centrifugation at 
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10,000 X g at 4ºC, the RNA was re-suspended in 25 µl of DEPC-treated water and 
immediately amplified in a 3 step-protocol. This protocol enables amplification of sense-
stranded prokaryotic transcripts, which was essential for our downstream microarray 
studies. In the first step, the protocol utilizes genome-directed primers (GDP: see below) 
to bias the reverse transcription to bacterial transcripts and the overhang tailing activity 
of Moloney murine leukemia virus (MMLV) reverse transcriptase to add the T7 
promoter to cDNAs during reverse transcription. Then, the second-strand cDNA is 
synthesized and finally, in vitro transcription is carried out using a T7 polymerase. The 
protocol has been described in detail (141). Briefly, the total amount of RNA after the 
enrichment procedure was reverse transcribed to cDNA in a 50 µl reaction using 42 µM 
of B. melitensis genome-directed primers (BmGDP), 5 µl of 50X dNTPs (10mM each) 
(Invitrogen), 2.5 µl of PowerScript (Clontech, Palo Alto, CA), 2.5 µl of RNAsin 
(Promega), and 42 µM of T7 promoter-template switching primer (T7-TS) (5’-
CGAAATTAATACGACTCACTATAGGGAGAGTACGCGGG-3’) (Sigma Genosys). 
The BmGDP and the RNA were mixed and heated at 70ºC for 10 min before being 
placed on ice for > 3 min and addition of the T7-TS and the reverse transcription 
reagents. The first-strand and the template switching reaction were performed at 42ºC 
for 90 min in a thermocycler with a non-heated lid. In the next step, the second-strand 
cDNA was synthesized by adding 1X final concentration of 10X Advantage 2 
Polymerase buffer (Clontech), 1X final concentration of 50X dNTPs mix (10mM each) 
(Invitrogen), 2U of Rnase H (Roche) and 1X final concentration of 50X Advantage 2 
Polymerase mix (Clontech) to the final reaction volume of 150 µl. The components were 
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mixed and the reaction incubated in a heated-lid thermocycler with the following cycle: 
37ºC for 5 min, 94ºC for 2 min, 65ºC for 1 min and 75ºC for 60 min. Double-stranded 
cDNA was purified using PCR purification kit (Qiagen), eluted in 100 µl of nuclease-
free water and concentrated to 15 µl in a speed-vac with no heat. In the last step, the in 
vitro transcription, using the double-stranded cDNA as template and T7 Megascript kit 
(Ambion) in 40 µl reactions with an additional 400U of T7 polymerase (Ambion) and 
20U of Rnase inhibitor SUPERase-In (Ambion), was carried out at 37ºC for 16 h. RNA 
was cleaned and recovered using RNeasy kit (Qiagen) and eluted in 100 µl of nuclease-
free water with 40U of SUPERase-In. The concentration RNA was determined, and the 
samples were stored at -80ºC until used. 
Isolation of total RNA and gDNA from cultures of B. melitensis 16M. 
Intracellular B. melitensis gene expression was compared to the gene expression of the 
inoculum (i.e., cultures of B. melitensis 16M grown in F12K media supplemented with 
10% HI-FBS at late-log growth phase) and B. melitensis gDNA was used for 
normalization of the bacterial gene expression profile. Isolation of total RNA and gDNA 
from Brucella cultures was done as previously described (Chapter II).   
Design of B. melitensis genome-directed primers (BmGDP). The GDP-Finder 
is a computer-based algorithm (http://www.innovationsinmedicine.org/software/GDP/) 
that predicts the minimal number of primers to specifically anneal to all ORFs in a given 
genome (220). For the B. melitensis genome the algorithm predicts 89 reverse primers of 
8-mer oligonucleotides searching for the first 500 bp of each complementary sequence 
of each ORF anneal to the 3,198 ORFs (Table 5). Primers were commercially  
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TABLE 5. Brucella melitensis 16M genome-directed primers (BmGDP) 
Order 
 
Primers 
 
Unique No. 
of ORFs 
covered 
 
No. ORFs 
covered 
 
Percent 
complete 
 
1 CGGCAAGC 291 291 9.10 
2 CCAGCGCC 248 539 16.85 
3 CGCCGCGC 223 762 23.83 
4 CCTTGCCG 201 963 30.11 
5 GCGCGCGC 171 1134 35.46 
6 GCCGGAAA 161 1295 40.49 
7 CGCCGCCG 133 1428 44.65 
8 GGCGCGGC 122 1550 48.47 
9 GCGCCAGC 110 1660 51.90 
10 TTCCGGCA 97 1757 54.94 
11 GCTTGCGC 93 1850  
12 CGATCAGC 85 1935  
13 GCCGCCAT 76 2011  
14 TTCGGCAA 70 2081  
15 CCTTGCGG 68 2149  
16 CGATGATG 64 2213  
17 CCGCGCCG 56 2269  
18 CATCGGCA 53 2322  
19 CGGCGGCA 47 2369  
20 CCAGATCG 43 2412 75.42 
21 GCTTGCCG 40 2452  
22 CCAGAAGC 40 2492  
23 GCGATGCG 38 2530  
24 GCGCGCGG 33 2563  
25 CCTTCGGC 32 2595  
26 CATCGCGC 30 2625  
27 CGCCTTCA 28 2653  
28 TTCCAGCG 27 2680  
29 CTTCCTTG 27 2707  
30 AGGCCGAT 25 2732 85.43 
31 CCATGCCG 23 2755  
32 TTCCTGCG 22 2777  
33 AATGCCGC 20 2797  
34 GCGCGAAA 17 2814  
35 CCATTGCG 18 2832  
36 CCGCCAGC 18 2850  
37 TTCGGAAA 18 2868  
38 CAGCGCAT 15 2883  
39 GCCTTTTC 15 2898  
40 GGCGGAAA 15 2913 91.09 
41 GATGCGGC 14 2927  
42 GCCAAGCG 13 2940  
43 GCCTGCGC 12 2952  
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44 CGGCATCG 12 2964  
45 CGCCATCG 10 2974  
46 GCCAGAAC 11 2985  
47 TGAAGCGG 11 2996  
48 GCACCAGC 8 3004  
49 CGGCAGAT 10 3014  
50 CCGCCTTC 9 3023 94.53 
51 CTTGATGA 9 3032  
52 AAACCGGA 9 3041  
53 AAGCGGCA 8 3049  
54 GCGGCGCC 8 3057  
55 GCGCTCGC 6 3063  
56 CCGCTTTC 7 3070  
57 TCAATGGC 7 3077  
58 TCTTCAAA 7 3084  
59 ATGGCGGC 5 3089  
60 GCCGCCAA 6 3095 96.78 
61 TTTTCGCC 6 3101  
62 GAAATCAA 6 3107  
63 AAGCAAGG 6 3113  
64 TTCGGCCA 5 3118  
65 TTCATCGA 5 3123  
66 GCCGAGAA 3 3126  
67 GAAATCCG 5 3131  
68 CCAATGCA 5 3136  
69 GGCGGCGA 3 3139  
70 CGGCGATG 4 3143 98.28 
71 CGAGATCG 4 3147  
72 TTGCGCAG 4 3151  
73 AAGCCCGC 4 3155  
74 TCACGCCG 4 3159  
75 CGCAATAT 4 3163  
76 AATGGAAA 3 3166  
77 CATCGATG 3 3169  
78 GCGACAGC 3 3172  
79 CAGCCGGA 3 3175  
80 CCATATCC 3 3178 99.37 
81 CCCGCGCA 3 3181  
82 TGCTCATC 3 3184  
83 ACTGTTCC 3 3187  
84 GATGATCG 2 3189  
85 CGACCAGC 2 3191  
86 TGATATCG 2 3193  
87 AATTTCCG 2 3195  
88 CGCAATAA 2 3197  
89 GCATTGGC 1 3198 100.00 
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synthesized (Sigma Genosys) and used for reverse transcription during the first step of 
RNA amplification and for labeling the cDNA.  
Samples preparation and slide hybridization. The labeling and hybridization 
procedures are an adaptation of the protocol developed by The Institute for Genomic 
Research (105) and were extensively described in Chapter II. Briefly, 10 µg of total 
RNA from B. melitensis 16M or HeLa cells were reverse transcribed overnight to amino- 
allyl cDNA using 1.5 µg of BmGDP (samples to be hybridized on pathogen arrays) or 6 
mg of random hexamer primers (samples to be hybridized on host arrays) (Invitrogen), 
0.6 µl 50X dNTPs (Invitrogen) / aa-dUTP (Ambion) mix (2:3 aa- dUTP: dTTP) and 
400U Superscript III (Invitrogen). The reaction was stopped by incubating the samples 
with 1M NaOH at 65ºC for 15 min and neutralized by adding 1M HCl. Unincorporated 
aa-dUTPs and free amines were removed by column passage (Qiagen) and dried using a 
Speed-Vac. 
Dried samples were re-hydrated in 0.1M Na2CO3 buffer (pH 9.0) and labeled 
with Cy3-ester (experimental B. melitensis RNA and reference HeLa RNA) or Cy5-ester 
(experimental HeLa RNA) (Amersham Pharmacia Biosciences). After one hour 
incubation in the dark, uncoupled dye was removed using columns (Qiagen) and dye 
incorporation calculated by NanoDrop®. B. melitensis gDNA was labeled overnight by 
direct incorporation of Cy5-dCTP (Amersham Pharmacia Biosciences) during reverse 
transcription using random primers and Klenow fragment (see Chapter II for details). 
Dry, labeled cDNA samples to be hybridized on B. melitensis microarrays were 
resuspended in nuclease–free water and mixed with 0.5 µg of labeled B. melitensis 
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gDNA to the final volume of 35 µl. Samples were heated at 95ºC for 5 min and then kept 
at 42ºC until hybridization. Following incubation at 42ºC, 35 µl of 2X formamide-based 
hybridization buffer [50% formamide; 10X SSC; 0.2% SDS] was added to each sample, 
well mixed, and applied to a custom 3.2K B. melitensis oligo-array. The dried, labeled 
cDNA samples from experimental HeLa RNA and universal human reference RNA 
(Strategene, La Jolla, CA) were re-suspended in 20 µl of nuclease-free water 
(experimental RNA) or human genomic DNA Cot1 (Invitrogen) (reference RNA), mixed 
and heated at 95ºC for 10 min followed by 10 min at 60ºC and another 10 min at 25ºC. 
Samples were kept at 42ºC until hybridization. Following incubation at 42ºC and 
immediately before hybridization, 40 µl of 2X formamide-based hybridization buffer 
was added to each sample. The samples were then hybridized to a commercially 
available 10K human ESTs microarray (Microarray Center, Ontario, Canada). Slides 
were hybridized at 42ºC for ~20 h in a dark, humid chamber (Corning) and washed for 
10 min at 42ºC with low stringency buffer [1X SSC, 0.2% SDS] followed by two 5-min 
washes in a higher stringency buffer [0.1X SSC, 0.2% SDS and 0.1X SSC] at room 
temperature with agitation. Slides were dried by centrifugation at 800 X g for 2 min and 
immediately scanned. Prior to hybridization, microarrays were pre-treated by washing in 
0.2% SDS, followed by 3 washes in distilled water and kept in prehybridization buffer 
[5X SSC, 0.1% SDS; 1% BSA in 100ml of water] at 42ºC for at least 45 min. 
Immediately before hybridization, the slides were washed 4 times in distilled water, 
dipped in 100% isopropanol and dried by centrifugation. 
Data acquisition and microarray data analysis. Following the stringency 
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washes and centrifugation, the microarrays were scanned using a commercial laser 
scanner (GenePix 4100). The genes represented on the arrays were adjusted for 
background and normalized to internal controls using image analysis software 
(GenePixPro 6.0). Genes with fluorescent signal values below background were 
disregarded in all analyses. Pathogen arrays were normalized against B. melitensis 
genomic DNA as previously described (219). Data were analyzed using GeneSifter 
(VizX Labs, Seattle, WA). The signal values of every gene (triplicate spots in 4 arrays = 
12 spots) for each experiment (i.e. 4 and 12 h) were averaged, the fold-change 
calculated, and Student’s t test performed. At each time point, genes determined to be 
expressed at statistically significantly levels on pathogen arrays hybridized with probes 
generated from B. melitensis-infected cells (fold-change > 2 and p value < 0.05) were 
subtracted from the final list of differentially expressed genes.  
Only a few host genes were detected as differentially expressed between infected 
and control samples using traditional statistical methods; therefore, different criteria 
were used to identify those genes differentially expressed in the host. Host arrays were 
initially normalized against universal human reference RNA and resulting data analyzed 
using Seralogix’s suite of gene expression analysis and modeling tools 
(www.seralogix.com). Differentially expressed genes were found to be significant based 
on Seralogix’s Bayesian z-score method. With this method, genes are ranked and 
ordered according to their expression magnitudes. A Bayesian predicted average 
variance value is used in the z-score method. Actual measured variances associated with 
each gene are used to compute a Bayesian averaged predicted variance value for each of 
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the ordered genes. The Bayesian variance is determined using a sliding window 
algorithm that averages 50 variances directly on the ascending and descending ordered 
sides of each gene of interest. Significantly changed genes were determined with the 
Bayesian z-test (p < 0.05). 
For the identification of Biosignature Dynamic Bayesian Network modeling, 
mechanistic gene discovery and pattern/pathways recognition used a framework of 
integrated software tools (XManager, XConsole & XBuilder) and relational database 
storage specialized for management and analysis of biosignature data (Biosignature 
Analysis Framework) developed by Seralogix, Inc.  
Microarray results validation. Five randomly selected genes from B. melitensis 
and HeLa cells with differential expression at 4 and 12 h PI (n = 20) by microarray 
results were analyzed by quantitative RT-PCR (qRT-PCR). Two micrograms from the 
same RNA samples used for microarray hybridization were reverse transcribed using 
TaqMan® Reverse Transcription Reagents (Applied Biosystems). For relative 
quantitation of target cDNA, samples were run in individual tubes in SmartCycler II 
(Cepheid). One SmartMix bead (Cepheid) was used for 2 - 25 µl PCR reactions along 
with 20 ng of cDNA, 0.2X SYBR Green I dye (Invitrogen) and 0.3 µM forward and 
reverse primers (Sigma Genosys) designed by Primer Express Software v2.0 (Applied 
Biosystems) (Tables 6 and 7) to produce an amplicon length of about 180 bp. For each 
gene tested, the individual calculated threshold cycles (Ct) were averaged among each 
condition and normalized to the Ct of the GAPDH and gyrA genes for host and pathogen 
respectively, from the same cDNA samples before calculating the fold change using the 
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TABLE 6. Primers for Real-time PCR analysis of genes in B. melitensis samples 
 
Locus ID Gene product Forward primers  (5'-3') Reverse primers (5'-3') 
    
BMEI0371 RNA polymerase S70 AGGCATGGGCCAAGCA AGATCAAGCGTGCCATATTGC 
BMEI0583 Cell division protein FtsQ TCAAGGGTTTTGTGGACCAGAT TGTTTTTCCCGATCAAGCTTCT 
BMEI0884 Gyrase A AAGGCCTCGATGATCGAGAAG ACGAGGTCTGCAAAGGCGTATA 
BMEI1426 Putative undecaprenyl-phophate alpha TGCACTTATCATCGCAATCAATG GAACAGGGCAAAACCGAGAA 
BMEI1440 Thio:disulfide interchange protein DsbA CGAAATTGGCCGGTTTTACA CCCGACATCTCCTCAAACGA 
BMEI1645 Acriflavin resistance protein B CTGATCCGCCAGGAACTCA CACCTGAACCGGCAATCG 
BMEII0260 GTP-binding protein LepA AGGGCTATGCCTCGTTCGA ATATGTTGCGGGATCAGTTCCT 
BMEII0346a Transcriptional regulator, AsnC family GATCGCGAGATTCTGGCTATTC TCGCCCGGATGATATTGCT 
BMEII0346b Transcriptional regulator, AsnC family ATATCATCCGGGCGATGATACT GCCAAAACATCCCGCAAAC 
BMEII0974 Nitrous-oxide reductase TCAGTTGCCGAACCAGCATA GGCGACCTTCATCGTTTCAC 
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TABLE 7. Primers for Real-time PCR analysis of genes in HeLa cells samples 
 
GenBank 
accession # Gene symbol Gene product Forward primers (5'-3') Reverse primers (5'-3') 
     
NM_000623 BDKRB2 Bradykinin receptor, beta 2 TAACATGAAGTCGTTGTGAGGGTTA CCGGCTCCCAATACTGATTC 
NM_001735 C5 Complement component 5 TGTAGTTCACAAAACCAGTACCTCTGA CACCGCATGAGAGGATCCA 
NM_001511 CXCL1 Chemokine ligand 1 TTCACCCCAAGAACATCCAAA CTCCCTTCTGGTCAGTTGGATT 
NM_006116 MAP3K7IP1 
Mitogen-activated protein kinase kinase kinase 
7 interacting protein 1 GGCAGCTGAGATGAACTGTCTTT CCCGACCCTTCTCCTATGC 
NM_003246 THBS1 Trombospondin 1 GATCCCCACCCTTACTCATCAC AGCTGGTGCTCACTGAGATGGT 
NM_000212 ITGB3 Integrin, beta 3 GAGGATGTCTGGGCCACTCA TGAGGGTGTGGAATTAGGAGGTA 
NM_002745 MAPK1 Mitogen-activated protein kinase 1 TGGATTCCCTGGTTCTCTCTAAAG GGGTCTGTTTTCCGAGGATGA 
NM_002539 ODC1 Ornithine decarboxylase 1 TGTTGCTGCTGCCTCTACGT GTGGCGTTTCATCCCACTCT 
NM_006206 PDGFRA 
Platelet-derived growth factor receptor, alpha 
polypeptide ATATTCTTTAGTGGAGGCTGGATGTG CCGAAAACTGGCCGATCA 
NM_181523 PIK3R1 
Phosphoinositide-3-kinase, regulatory subunit, 
polypeptide 1 GGAAGCAGCAACCGAAACAA AGTTATAGGGCTCGGCAAAGC 
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∆∆Ct method (Applied Biosystems Prism SDS 7700 User Bulletin #2). For each primer 
pair, a negative control (water) and an RNA sample without reverse transcriptase (to 
determine genomic DNA contamination) were included as controls during cDNA 
quantitation. Brucella arrays data were considered valid if the fold-change of each gene 
tested by qRT-PCR was > 2.0 and in the same direction as determined by microarray 
analysis. Due to different microarray analysis conducted for HeLa cells gene expression 
detection (genes were differentially expressed based on z-score and not on fold-change), 
host array data were considered valid if the fold change of each gene tested by qRT-PCR 
was expressed in the same direction as determined by microarray analysis. 
 
RESULTS 
The intracellular replication of B. melitensis in HeLa cells begins after an 
initial adaptation period of 4h post-infection. Kinetics of B. melitensis 16M 
intracellular replication in non professional phagocytic cells was evaluated during the 
first 12 h PI. At 4 h PI, the number of intracellular Brucella recovered was not 
significantly different (p > 0.05) compared with the number recovered at invasion (T0).  
However the number of intracellular Brucella present between 4 and 12 h PI increase 
70% (p < 0.05) (Fig. 10). The number of B. melitensis CFU present in growth control 
wells increased almost twice at 4 h and ~1 log in the first 12 h compared with the 
original inoculum (data not shown). These results indicate that under these experimental 
conditions, the intracellular replication of B. melitensis in HeLa cells begins after an 
initial adaptation period of 4h PI. 
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FIG. 10. Kinetics of B. melitensis 16M intracellular replication in HeLa cells. HeLa cells were infected 
at MOI 1,000:1 by replacing the media overlying the cells by a culture of B. melitensis 16M at late-log 
growth phase. After 30 min-interaction, cells were washed with PBS and incubated 1 h with gentamicin to 
kill extracellular bacteria. Cells were lysed  at 0 (T0), 4 (T4), 8 (T8) and 12 (T12) hours PI and lysates 
serially diluted and cultured on TSA plates for quantitation of intracellular viable number of bacteria. The 
intracellular number of B. melitensis at 8 and 12 h PI was significantly different than those at T0 (* = p < 
0.05) indicating that the intracellular replication of B. melitensis in HeLa cells began after an initial 
adaptation period of 4 h PI. Results are presented as the % of CFU compared with the T0. Data presented 
are the mean + SD (error bars) of triplicate samples of 3 independent experiments and statistical 
significance of differences was determined using Student’s t test (p value < 0.05 was considered 
significant).
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Genome-directed primers (GDP) generate more sensitive and specific 
probes of B. melitensis transcripts than random hexamer primers (RHP). Talaat et 
al. (2000) demonstrated the potential usefulness of GDP for detection of pathogen gene 
expression in vivo. In a technical experiment designed to determine the usefulness of the 
GDP for generation of cDNA from B. melitensis RNA and subsequent hybridization to 
microarrays, a primer set generated from GDP-Finder software was compared with a 
commercially available set of RHP. Each method was used on two identical B. melitensis 
RNA samples isolated from late-log phase cultures and the resulting cDNA was labeled 
with Cy3 and co-hybridized with Cy5-labeled genomic DNA (gDNA) on two arrays for 
each primer type. For inter-array comparison, 63 (of 9,681) genes with signals values 
flagged “bad” by GenePix 6.0 were removed across all four data sets to make them 
comparable. The consistency of the signal from samples reverse transcribed with GDP 
was slightly higher (R2 = 0.7535) compared to RHP samples (0.7116) (Fig. 11A and B). 
Linear regression analysis also revealed a slightly higher advantage for GDP (p value of 
1.12 x 10-72, T statistic of 18.2) over RHP (p value of 1.0 x 10-14, T statistic of 7.7). 
Likewise, correlation analysis indicated that GDP (87%) was slightly more consistent 
than RHP (84%) and the consistency was greater when considering average signal 
intensity values (GDP = 1665 & 1724 vs. 1912 & 1492 of RHP), average standard 
deviation (490 vs. 540) and standard deviation of average intensities (41 vs. 297). We 
also compared the average ratio between experimental replicates (1.3 for GDP and 0.91 
for RHP), as well as the average signal log ratio between each experimental replicate and 
the co-hybridized gDNA (0.77 and 0.69 for GDP and 0.69 and 0.83 for RHP).
  
 
83
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG. 11. Inter-array comparison of signal consistency from B. melitensis RNA samples reverse 
transcribed with genome-directed primers (GDP) vs. random hexamer primers (RHP). The 
consistency of the signal generated from a Cy3-labeled B. melitensis cDNA using a primer sets predicted 
from GDP-Finder software (GDP) was compared with a Cy3-labeled B. melitensis cDNA made by a 
commercially available set of RHP. Each method was used on two sets of identical B. melitensis RNA 
samples isolated from late-log phase cultures and the resulting cDNA was labeled with Cy3 and co-
hybridized with Cy5-labeled genomic DNA (gDNA) to two B. melitensis oligoarrays for each primer type. 
Signal consistency from samples reverse transcribed with GDP was slightly higher (R2 = 0.7535) (A) 
compared to RHP samples (0.7116) (B). 
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While the average ratio between experimental samples was higher for GDP than for 
RHP, the standard deviation of signal log ratios, which is a more reliable measure of 
consistency between arrays, was lower (0.06 for GDP and 0.10 for RHP). These results 
indicate greater consistency between arrays hybridized with samples reverse transcribed 
using GDP rather than RHP. 
Then, we examined the consistency between replicate spots on each array (intra-
array comparison). To streamline the comparison, genes that were flagged as “bad” and 
any “matching” replicate spots, were removed across all arrays. Eighty one spots were 
eliminated which left 9,600 spots, representing 3,200 different genes (genes spotted in 
triplicate). The comparison of the average signal values (GDP = 1,668 & 1,726, RHP = 
1,915 & 1,494), their standard deviations (42 v 298) and the average standard deviation 
between replicate spots (GDP = 257 & 190, RHP = 296 & 290) essentially confirm a 
higher intra-array consistency for the GDP over the RHP samples. As a final measure of 
consistency/variability between arrays, we separated all of the replicate spots and treated 
them as replicate samples/arrays in order to gauge the trend of consistency across all 
replicate spots: two replicates (arrays) with triplicate spots for each, yields 6 “theoretical 
arrays” for each condition (GDP and RHP). The average R2 value was much higher for 
GDP (0.83) compared to RHP (0.74), despite similar standard deviations (0.10 for GDP 
and 0.09 for RHP). These results indicated that GDP replicate spots were more similar to 
one another than were RHP replicate spots. Altogether, these results indicate that the 
reverse transcription of B. melitensis RNA using GDP generates more specific and 
sensitive probes than those generated with RHP. 
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Enrichment and amplification (E&A) RNA methodology is useful for 
downstream microarray application. Characterization of the transcriptome of 
intracellular Brucella is challenging due to the difficulty in obtaining sufficient 
quantities of good quality, pathogen RNA that is free of contaminating eukaryotic host 
RNA for further studies. To address this issue, we developed a 2-step protocol in which 
Brucella RNA is first enriched from a host:pathogen mixed RNA sample, and the 
remaining RNA is amplified in three steps as described in the Materials and methods. 
Before applying the E&A protocol to an in vitro system of infection, we wanted to 
evaluate whether bias was introduced and the reproducibility of the protocol. To answer 
these questions, we spiked 2 different samples of 25 µg of total RNA extracted from 
HeLa cells culture with 200 ng of B. melitensis RNA extracted from a late-log culture 
(host:pathogen RNA = 125:1). The mixed RNA samples were initially enriched using 
MICROBEnrich® kit, which decreased the RNA concentration more than 88% (from 25 
µg to 2.55 and 3 µg of total RNA). Then, 0.1 volume of the remaining RNA (i.e. 0.25 
and 0.3 µg of total RNA) was amplified. One round of amplification yielded more than 
80 µg of amplified sense total RNA from each sample (> than 260-fold amplification). 
Two aliquots of 10 µg from every E&A RNA sample were indirectly labeled and co-
hybridized against a B. melitensis gDNA on B. melitensis microarrays (4 arrays). The 
degree of bias introduced by the enrichment and amplification was determined by 
evaluating the performance of the E&A RNA samples against identical labeling and 
hybridization protocol from non-treated B. melitensis RNA (i.e. RNA extracted from a 
late-log culture).  
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Prior to all analysis procedures, spots that were flagged as “bad” were removed 
leaving a total of 3,120 good spots (out of the original 3,227). We employed genomic 
normalization to improve data quality and to compare multiple samples in a minimum of 
experiments (219). To compare the consistency of gene expression for each sample type, 
the signal values for each slide were graphed pairwise and fitted with trend lines. The 
resulting R2 values (slopes) represented the level of consistency (similarity) between 
each slide, which was similar for biological and technical replicates (Table 8). The 
overall level of consistency for controls was less than for experimental replicates 
between slides. Also inter-slide variability was higher than intra-slide variability. E&A 
treatment decreased this variability, which suggests that some level of noise for the B. 
melitensis control slides might have been due to noise interference. We next examined 
the average signal values for B. melitensis control and for E&A mixed RNA. The results 
revealed higher signals in control samples (987.5 vs. 800.5), but the difference was small 
and indicates that amplification does not necessary correspond with higher signal.  
 
 
TABLE 8. Results of pairwise graphical comparisons  
 
Samples R2 value 
 Control (Cy5) Experimental (Cy3) 
Slides (inter)   
B. melitensis control 0.49 0.58 
HeLa:Bmel E&A 0.52 0.79 
Arrays (intra)   
B. melitensis control 0.88 0.86 
HeLa:Bmel E&A 0.86 0.97 
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In order to evaluate the bias introduced by the enrichment and amplification 
process and the reproducibility of the protocol, we first calculated the correlation (r) 
between the fluorescence intensity in E&A vs. control samples and then compared the 
expression profiles of hybridizations of 2 independently amplified RNA samples. Our 
results show a reasonable correlation (r = 0.5858) between the expression profile of the 
samples E&A against the control sample, and a high degree of correlation between 
independent replicates (r = 0.9063). Altogether, these results suggest that our protocol is 
highly reproducible with an acceptable level of maintenance of the original information. 
Considering other reports that underestimate the magnitude of the bias as long as it is 
highly reproducible (240), our results from preliminary experiments indicate that 
enrichment of the original RNA sample followed by the biased amplification of 
pathogen transcripts is sufficient to accurately characterize the transcriptome of 
intracellular pathogens in an in vitro or in vivo system of infection. 
Another variable we considered was that the enrichment protocol does not 
remove all of the eukaryotic RNA and the primers (GDP) used for reverse transcription 
(first step of amplification and labeling) do not exclusively anneal to Brucella 
transcripts. Therefore, there was the possibility that RNA molecules from HeLa cells 
overlapped with sequences of the B. melitensis transcripts, cross-hybridized with probes 
on B. melitensis oligoarrays. To identify the number of falsely detected genes due to 
contaminating eukaryotic RNA, total RNA isolated from HeLa cells culture was labeled 
and hybridized on B. melitensis microarrays under the same conditions as RNA isolated 
from Brucella cultures. Initially, we observed a reduced amount of cDNA generated (3.8 
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vs. 9 µg from 10 µg of HeLa RNA using GDP or RHP, respectively) which indicate 
some restriction of annealing of GDP to eukaryotic RNA. After hybridization, only 105 
of 3120 genes (3.3%) were consistently detected (raw signal values above 500 for all 6 
replicates -triplicate arrays on duplicate slides-) due to contaminating eukaryotic RNA 
vs. 34% of genes consistently detected when B. melitensis RNA was used. This 
experiment shows that although there is some cross-hybridization between cDNA 
generated from eukaryotic RNA and the oligonucleotides (oligospots) printed on 
pathogen arrays, overall, the E&A protocol is consistent and accurate for detecting 
intracellular B. melitensis gene expression in an in vitro and in vivo system of infection.  
The intracellular B. melitensis transcriptome indicates a stress response at 4 
h post-infection that is reversed at 12 h post-infection. The intracellular B. melitensis 
total RNA was initially enriched and then amplified from total RNA of B. melitensis-
infected HeLa cells at 4 and 12 h PI. Four biological replicates of experimentally 
enriched and amplified RNA from every time point were indirectly labeled and co-
hybridized against B. melitensis gDNA to a custom 3.2K B. melitensis oligo-array. As 
we discovered in our preliminary data, there was a possibility that some HeLa transcripts 
cross-hybridize with probes on B. melitensis microarrays. For that reason, the original 
total RNA from B. melitensis-infected HeLa cells were also co-hybridized against B. 
melitensis gDNA to B. melitensis oligo-arrays, and those oligospots with signal were 
considered non-specific and eliminated from all analysis to avoid false positive gene 
detection. The intracellular B. melitensis gene expression was compared to the gene 
expression of the inoculum (i.e. in vitro-grown cultures of B. melitensis at late-log phase 
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of growth). Based on this criterion, statistical analysis of microarray results revealed that 
161 B. melitensis genes were detected as differentially expressed (fold-change > 2 and p 
< 0.05) at 4 h PI (Appendix B) The relative changes in gene expression ranged from a 
142.5-fold induction of the narG gene (BMEII0949) to a 60.9-fold down-regulation 
(0.01643) of the locus BMEI0299 (hypothetical protein). The vast majority of the 
differentially expressed genes (126 genes, 78%) were down-regulated. In concordance 
with our kinetic studies of B. melitensis intracellular replication in HeLa cells, where 
very low bacterial replication was observed in the first 4 h PI, cell division genes ftsQ 
(BMEI0583) and ftsA (BMEI0584) were down-regulated as well as genes involved in 
DNA replication, transcription and translation, transport and intermediate metabolism, 
and cell envelope, biogenesis and outer membrane activities. Ultrastructural studies in 
HeLa cells have shown that virulent Brucella are located inside the stressful 
environment of autophagic vesicles at 4 h PI (179), and data from our microarrays agree 
with this finding. For example, the observed down-regulation of the ribosomal protein 
genes and RNA polymerase (BMEI0750) are signs of amino acid starvation, consistent 
with the poor nutritional intravacuole microenvironment found by Brucella (132). In 
addition ppx (BMEII0598) which encodes an exopolyphosphatase, the enzyme 
responsible for hydrolysis of the terminal phosphate of guanosine pentaphosphate 
(pppGpp) to form guanosine tetraphosphate (ppGpp), a major regulator of bacterial 
adjustment to stress (130) was significantly upregulated in our microarray data.  
The up-regulation of the gene czcD (BMEI1438) and the catalytic subunits of the 
denitrifying reductase genes (BMEII0949, BMEII0974 and BMEII0998) are also 
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consistent with growth within autophagic vesicles. Host cells deliver divalent cations 
from the cytosol to the phagosome compartment to kill invaders that are taken up by 
bacteria through constitutively expressed transporters. CzcD is an integral membrane 
protein and part of the Co/Zn/Cd efflux system component that reduces the intracellular 
concentration of toxic heavy metals via active cation efflux to the extracellular media. 
Conversely, the low oxygen level inside the phagosome, demands the pathogen to adapt 
from aerobic metabolism to microaerobic or anaerobic metabolism to survive. Analysis 
of our microarrays found up-regulation of genes encoding the catalytic subunits of 
enzymes involved in electron transport during nitrate respiration such as narG 
(BMEII0949), norB (BMEII0998) and nosZ (BMEII0974) that allow Brucella to survive 
under low-oxygen conditions by respiration of nitrate (100). In addition to its role in 
denitrification, the protein encoded by norB reduces nitric oxide (NO) to nitrous oxide 
(N2O). This could help decrease the presence of intravacuolar NO, an important host cell 
defense element in the autophagic vacuole, thereby increasing Brucella’s intracellular 
survival. Also down-regulated at 4 h PI, were B. melitensis genes that encoded an iron 
uptake protein (BMEI0375 and BMEII0844). Iron is an essential cofactor in various 
biosynthetic and bioenergetic pathways and is also important for bacterial growth. The 
down-regulation of BMEI0375 and BMEII0844 suggests further confirmation of the 
slow growth by Brucella melitensis during this initial intracellular phase. Curiously, one 
gene whose expression was enhanced in Brucella exposed to stressful situations, clpX 
(BMEI0875) (132), was down-regulated in our analysis. Overall, these results suggest 
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that after internalization, B. melitensis encounters a hostile environment that obliges 
them to adapt their metabolism to survive.  
At 12 h PI, 115 B. melitensis genes were detected as differentially expressed 
(fold-change > 2 and p < 0.05) (Appendix C). Like the results at 4 h PI, narG 
(BMEII0949) was the highest expressed gene (103.3) and the most down-regulated gene 
was ptsP (BMEI0190), whose product is involved in the regulation of carbon and 
nitrogen utilization, with -13.5-fold (0.0739). As opposed to the profile at 4 h PI, at 12 h 
PI the majority of the differentially expressed genes (86 genes, 75%) were up-regulated. 
The greatest number of transcriptional changes at 12 h PI occurred in genes whose 
products are associated with DNA replication, transcription, transport and intermediate 
metabolism, as well as energy production and conversion. This molecular information 
combined with the intracellular replication of B. melitensis observed in infected HeLa 
cells, collectively indicate that by 12 h PI the bacteria have adapted to the intracellular 
environment and are actively replicating. Only 3 transcripts for ribosomal proteins 
(BMEI0202, BMEI0759 and BMEI0823) had decreased expression at 12 h PI, compared 
to 17 at the earlier time point. Also at the 12 h PI, no translation factors or tRNA 
synthetases were observed to be down-regulated which is indicative of translation re-
activation. 
In our data at 12 h PI, seven transcriptional regulators had enhanced expression 
in intracellular Brucella. Consistent with our data, two of them (BMEI0169 and 
BMEI0320) were previously identified as necessary for intracellular Brucella melitensis 
survival and replication both in vivo and in cell culture models (101).  Another regulator 
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with enhanced expression at 12 h PI was nikR. In Helicobacter pylori, the product of this 
gene transcriptionally represses the expression of a nickel transport system, but induces 
urease expression by binding to the ureA promoter (67). In our study, ureA (BMEI0649) 
was highly up-regulated (10.57), therefore it is possible that nikR also transcriptional 
activates urease expression in Brucella. Experimental evidence indicates that urease 
likely does not play a role in the intracellular survival of Brucella (202) but further 
investigation is warranted.  
There were 4 genes differentially expressed with possible involvement in 
Brucella intracellular survival: acrB, motD, phoQ, and ftsQ. acrB (BMEI1645) encoding 
acriflavin-resistance protein B and is part of the efflux pumps, which protect the 
organism from antibiotics and other substances produced by the host, was up-regulated. 
The up-regulation of this transcript suggests the protein might be important in Brucella 
pathogenesis as it is in Salmonella (24). motD (BMEII0156) (or fliK) encodes a regulator 
of flagellar hook length in the alpha subgroup of the Proteobacteria (64) was up 
regulated, and its expression is essential for proper formation of bundles of the flagellum 
filaments. Previous work demonstrated the requirement of flagellum expression for 
persistence of Brucella in the mouse model of infection (84). phoQ, which encodes a 
sensor protein whose participation in Salmonella virulence is well established, was also 
up-regulated, but its regulatory role in Brucella virulence factors is unknown. Similar to 
the observations at the 4 h PI, ftsQ transcription was down-regulated; but to a lesser 
degree than it was in the other time point (-5.63 vs -10.25), possibly due to the 
intracellular replication of Brucella.  
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One iron transport system gene (frpB, BMEII0105) was up-regulated at 12h, 
consistent with the requirement in Brucella for this ion during replication. Also genes 
encoding transporters of carbohydrates, lipids and amino acids and as well as metabolic 
genes were up-regulated. Genes encoding for different components of amino acid ABC-
transport systems were the most extensively differentially expressed, with 5 being  
(BMEI1627, BMEI1728, BMEII0070, BMEII0196, BMEII0631) up-regulated and 1 
down-regulated (BMEII0038) suggesting either the need for amino acids in protein 
synthesis during this active growth period or possibly suggesting the use of amino acids 
as carbon sources. Together, these results indicate a reactivation of Brucella gene 
expression at 12 h PI (replicative period) compared with the earlier adaptation period. 
Considering the results from the growth kinetic studies with the microarray data, we 
conclude that there is a down-regulation of the pathogen transcriptome during the 
adaptation period which is reversed at the later time point, in concordance with Brucella 
intracellular replication.   
Analysis of our microarray data also identified the modification of genes 
encoding a group of 50 proteins with unknown, predicted or moderately known 
functions at the 4 h PI. Further, 45 transcripts whose encoded proteins have unknown or 
poorly characterized functions were also differentially expressed 12 h PI compared to 
the control sample. These novel findings may have implications for Brucella virulence 
or intracellular survival and warrant further study.   
B. melitensis-infected HeLa cells have a down-regulated expression profile at 
4 h transitioning to an activated transcriptional profile at 12 h post-infection. Four 
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biological replicates of RNA isolated from B. melitensis-infected HeLa cells from every 
time point were indirectly labeled and co-hybridized against human universal RNA 
reference to a commercial 10K human array. Gene expression was indirectly compared 
with RNA isolated from non-infected HeLa cells treated similarly. Due to the low 
infection rate (1 out of 10 cells or less), classical statistical analysis using commercially 
available software only detected 26 (13 up- and 13 down-regulated) and 13 (1 up- and 12 
down-regulated) genes differentially expressed (fold-change > 1.5, p value < 0.05) at 4 
and 12 h PI, respectively (data not shown). To increase the detection of differentially 
expressed genes, we applied a more sensitive analysis for host microarray results. Using 
the Bayesian z-test, 157 (48 up- and 109 down-regulated) and 957 (733 up- and 224 
down-regulated) host genes were differentially expressed at 4 and 12 h PI respectively 
(Appendixes D and E). At 4 h PI, we found that activities like DNA replication and 
repair, transcription, cell cycle progression/cell proliferation and differentiation, and 
intermediate metabolism are down-regulated. These findings reflect a scenario similar to 
the decreased replication and metabolic activity that Brucella undergo at this time point 
and suggests that both host cells and intracellular pathogen undergo a period of 
adaptation during the early stage of infection. Six genes involved in DNA replication 
and repair and 17 involved in regulation of transcription were down-regulated and only 2 
genes (EWSR1 and PGBP1) related to these functions were up-regulated. According to 
our microarray data, translation does not seem to be affected after 4 h PI. Only 4 genes 
from this category were differentially expressed. Conversely, the data indicate that the 
cell cycle arrests and cell proliferation is diminished as reflected by the 15 genes 
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involved in these functions that were down-regulated. Additionally 2 negative regulators 
of cell proliferation (AIM2 and CTBP1) were up-regulated. This transient down-
regulation of the cell cycle/cell division and proliferation during B. melitensis infection 
may permit the cell to check and repair internal processes before progressing. Two genes 
down-regulated from this group are important during pregnancy, the ultimate organ 
targeted by Brucella systemic infection. HPGD is a prostaglandin-inactiving enzyme, 
and it is down-regulated during term or prematurely delivery, associated with the high 
expression of prostaglandins (125). Intracellular Brucella may utilize prostaglandins for 
its own benefit, or alternatively and more likely, Brucella-induced HPGD down-
regulation could be partially responsible for any role of prostaglandins in Brucella 
abortion. The other down-regulated gene encodes PLGF (placental growth factor), which 
is important for placental permeability and vascularization. Brucella abortion is 
characterized by impaired placental function.  Brucella prevents delivery of oxygen and 
nutrients to the fetus and/or removal of waste products from the fetus (66). It is also 
possible that down-regulation of the PLFG in infected cells contributes to Brucella-
induced abortion.  
Previous investigations found that Brucella are able to inhibit programmed cell 
death on macrophages (96). In our study, it is unclear whether Brucella infection induces 
or inhibits apoptosis in HeLa cells at 4 h PI. Three anti-apoptotic genes (GSTP1, 
SERINC3 and GADD45) were down-regulated suggesting a pro-apoptotic profile. At the 
same time, 1 anti-apoptotic gene (PIWIL2) was up-regulated and 4 pro-apoptotic genes 
(TFPT, CASP8, BCAP31 and RUNX3) were down-regulated making interpretation 
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difficult. Additionally, SDCCAG3, which positively influences the presentation of 
Tumor Necrosis Factor (TNF)-receptor on the cell surface and makes the cells more 
vulnerable to TNF-mediated apoptosis, was up-regulated in infected cells 4 h PI, but 
TNF was not affected. 
Immune and inflammatory responses are key functions for control and 
elimination of infections. Our studies found that these functions are basically down-
regulated in Brucella-infected HeLa cells at 4 h PI. Expression of C5, a complement 
component with multiple functions in inflammatory response, including positive 
regulation of chemotaxis and part of the membrane attack complex (MAC) perforin 
system, was down-regulated 2.75 fold. Coincident with that MASP1, which has an 
important function in the immune response by recognizing the sugar residues on the 
pathogens surface and activates the classical pathway of the complement cascade (205), 
were also observed down-regulated. Further, CXCL1, a gene that encodes a chemokine 
implicated in many cellular functions besides immune response such as cell 
proliferation, chemotaxis and intracellular signaling, and one defensin gene (DEFB126) 
encoding an antimicrobial peptide, were down-regulated. These data suggest that the 
host fails to mount a local or a general defense response against the invading pathogen in 
the first 4 h PI. Collectively, our microarray results indicate that at four hours post 
infection, the physiologic and metabolic processes of non-phagocytic cells are disturbed 
by the presence of the pathogen.   
Contrary to events at 4 h PI, infected cells at 12 h PI predominantly had up-
regulation of most functions. Our analysis found 957 genes differentially expressed, 733 
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being up-regulated and 224 down-regulated (Appendix E). Functions, such as DNA 
replication, mRNA processing, transcription, cell cycle/cell division/cell proliferation, 
cell adhesion and intermediate metabolism which were down-regulated at 4 h PI, were 
clearly up-regulated at 12 h PI, indicating that HeLa cells had adapted to the intracellular 
presence of the Brucella and the replication of the pathogen seems not to interfere with 
their physiological pathways. 
Transcription in general was up-regulated in infected cells at this time point. Host 
microarray data revealed 773 genes (81%) with increased expression as compared to the 
control cells. However, this transcriptional activation does not seem to correlate with 
protein expression, since genes whose products are involved in translation (translation 
initiation factors, tRNA synthetase) and protein biosynthesis (ribosomal proteins) were   
down-regulated. It has been demonstrated that Brucella replicate within the endoplasmic 
reticulum, therefore it is possible that a down-regulation of host translation is a Brucella 
strategy for replication. Additionally, several host genes related to protein catabolism 
were up-regulated (GLS, PRSS1, UCHL1, USP15 and 32, and others). A possible 
interpretation may be that Brucella inhibit host translation but increase protein 
catabolism to provide amino acids for its own benefit.   
Cell-cell adhesion (cadherins, contactins) and cell-matrix adhesion (collagen, 
integrins) were also clearly up-regulated. Thirty-two genes encoding proteins involved in 
these activities were up-regulated and only 2 genes were down-regulated. This result 
may be a pathogen effect to prevent epithelium detachment, because in vivo Brucella 
pass through the mucosal epithelium to colonize deeper tissues, causing only minimal 
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tissue injury. To this end, the up-regulation of 17 cytoskeleton and cytoskeleton 
organization genes such as MAP1B, NEB, PFN2, VIL1 may be partially responsible for 
the increased adhesion response. 
Similar to our findings at the 4 h PI, it was unclear whether infected HeLa cells 
undergo apoptosis at 12 h. Seven pro-apoptotic genes were up-regulated (BNIP31, 
CD38, MDM4, MAGEH1, PRG1, TP53, TP53BP2) and 5 anti-apoptotic genes were 
down-regulated (BCL2L1, BIRC3, BAG1, CSE1L, TEGT), which could be interpreted 
as a host defensive mechanism to prevent Brucella from establishing an intracellular 
niche. However, 3 up-regulated strong, apoptosis-inhibition genes (BCL2, BIRC4, 
DAD1) and 2 down-regulated apoptosis-inductor genes (ANXA1 and CASP1) could 
also indicate a pathogen counterbalance to avoid being released to the extracellular 
media. Collectively, our data indicate that under our experimental conditions neither pro- 
nor anti-apoptotic profile could be clearly associated with B. melitensis-infected cells in 
the first 12 h PI. Microscopic observations from experimental infections disclosed that 
non-phagocytic cells infected with virulent Brucella do not activate their apoptotic 
program. Instead, extensive bacterial replication generates necrosis and Brucella are 
released to the extracellular media after 48 h PI (8, 53). In addition, our data indicate that 
infected cells have a higher transcriptional profile for cell division and proliferation than 
non-infected cells. It is possible that an enhanced rate of division of host cells allows 
Brucella to remain intracellular while the cells divide. 
The ability to mount an immune response recovered in the infected host cells at 
12 h PI. Three interleukin receptor genes were up-regulated; IL1R1 and IL1F5 are 
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agonist and antagonist receptors for IL1 family molecules, respectively. IL1R1 is an 
important mediator involved in cytokine induction of immune and inflammatory 
responses, while IL1F5 inhibits cytokine production through inhibition of NF-KB 
activation (164). The other interleukin-receptor gene encodes the interleukin-2 receptor 
gamma chain (IL-2R gamma), an essential component of high- and intermediate-affinity 
IL-2 receptors, and also a functional component of the IL-4 receptor which associates 
with the IL-7 receptor (197). It was reported that Brucella lipoproteins induce a 
cytokine-mediated inflammation through binding of IL2R (90), thus our findings 
confirm previous observations. Another up-regulated receptor molecule was IRF4, 
which activates the transcription of several cytokines, such as IL2, IL 4, IL10, IL13 and 
modulates T cell differentiation (112). Several other genes that encode transcripts for T 
and B cell activation (CD8B1, CD28, CD86, IRF4, ICOSLG, TNFRSF17) and 
inflammatory response (C5, CCL16, CMTM7) were also up-regulated. The increased 
activity of host defenses against the pathogen was also reflected in the up-regulation of 
genes involved in phagocytosis (AHSG), bacteria cell wall degradation (LYZ) and 
oxidative burst of neutrophils (NCF1). The up-regulation of complement and the 
formation of the membrane attack complex were also active as reflected by the up-
regulation of the complement components 2 and 5 (C2, C5) and the down-regulation of 2 
genes whose products inhibit complement activation (CD46 and CD59). Other immune 
function related genes that were up-regulated included the antigen processing and 
presenting class I and II (HLA-A, HLA-B, HLA-DQA1, HLA-DRB1). MHC-I is present 
in all nucleated cells of the body while MHC-II expression is restricted to the immune 
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cells. It has been observed in infected macrophages that Brucella LPS interferes with 
MHC-II presentation of peptides to specific CD4+ T cells but has no effect on MHC 
class I antigen presentation (138); but its role in Brucella-infected HeLa cells has not 
been studied. Among the down-regulated genes were 2 pro-inflammatory cytokines (IL8 
and IL18) and 4 interferon-induced genes. All these data indicate that host cells 
recovered immune and inflammatory responses by 12 h PI.  
Modified expression of host genes related to the nervous system occurred at 12 h 
post-Brucella infection. Thirty-two genes (5.8% of the genes with known function 
associated with neural system development (NES, NGFR), neuronal differentiation 
(CDK5RAP1, NRG3), synaptic transmission (CHRNA2, NPFF) or intracellular 
trafficking in neural cells (GDI1) were differentially expressed (30 up- and 2 down-
regulated). Understanding these data is challenging, but effects on these genes may be 
related to the neuro-modulation of the immune responses (94, 148). To summarize, the 
data indicate that at 12 h PI epithelial-like cells had a significantly up-regulated 
transcriptional profile and the intracellular presence of Brucella melitensis does not seem 
to interfere with normal physiologic and metabolic processes.       
Validation of microarray gene expression results. To confirm the microarray 
results, we randomly chose 10 B. melitensis and 10 infected HeLa cells differentially 
expressed genes (5 from each time point) and conducted qRT-PCR. Validation of B. 
melitensis microarray gene expression results was done using cDNA reverse transcripted 
from the same enriched and amplified RNA samples used for microarray hybridization. 
The quantity of cDNA for each target gene was normalized to the quantity of gyrase A 
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(gyrA, BMEI0884) cDNA in each sample. gyrA was determined to be a stable expressed 
housekeeping gene in our microarray experiments and also in other bacteria (23). 
Quantitative Real-time PCR results confirmed 90% of the Brucella genes tested to be 
greater than 2.0-fold up- or down-regulated and in the same direction as was determined 
by microarray analysis (Fig. 12A and B) and that the 100% of the host genes tested were 
altered in the same direction as determined by microarray analysis (Fig. 12C and D). The 
only gene that was not validated by qRT-PCR was BMEII0346 (Transcriptional 
regulator protein, AsnC family). No significant difference in the expression level was 
observed using 2 different sets of primers, indicating possible false positive detection by 
microarray analysis or suboptimal qRT-PCR conditions for this particular gene as well. 
Dynamic Bayesian modeling analysis of microarray data reveals host and 
pathogen biosignature mechanistic candidate genes. Mathematical modeling has great 
potential for discovering and understanding disease mechanisms and biological 
processes. A dynamic Bayesian modeling analysis was conducted to identify host and 
Brucella pathways, pathways subnets and candidate genes important for B. melitensis 
infection. The analysis identified 19 and 16 highly activated gene ontology (GO) 
biological processes (downloaded from TIGR Comprehensive Microbial Resources; 
http://cmr.tigr.org/CMR/Downloads) comprising 298 and 160 distinct mechanistic genes 
at 4 and 12 h PI, respectively in Brucella, and 69 and 77 highly activated biological 
process (downloaded from Gene Ontology Consortium Database; 
http://www.geneontology.org) with 49 and 50 distinct mechanistic genes at 4 and 12 h PI 
in HeLa cells (data not shown). Using the same bioinformatic platform, 15 and 13 top
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FIG. 12. Validation of Brucella melitensis and host microarray results by quantitative Real-time 
PCR. cDNA was synthesized from the same RNA samples used for microarray hybridization. Ten 
randomly selected ORFs differentially expressed as detected by microarrays in intracellular B. melitensis 
and in B. melitensis-infected HeLa cells at 4 and 12 h PI compared with the inoculum and control cells 
respectively, were validated by quantitative RT-PCR. Five of 5 B. melitensis ORFs (100%) tested at 4 h PI 
(A) and 4 of 5 ORFs (80%) tested at 12 h PI (B) had fold-change greater than 2-fold and in the same 
direction by both methodologies. Ten of 10 HeLa genes tested at 4 (C) and 12 (D) h PI had fold-change 
altered in the same direction by microarray and qRT-PCR. Open bars, microarray fold-change; dark gray 
bars, qRT-PCR fold-change. 
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scored pathways subnet from the 111 and 171 pathways associated with gene probes on 
the B. melitensis and human microarrays respectively, were selected and analyzed and 
the modeling disclosed mechanistic genes for each pathway determined. On the 
pathogen side (Table 9), pathways already known to be implicated in Brucella virulence, 
like flagellar assembly, LPS biosynthesis or T4SS, together with to-date-unknown 
pathways for virulence such as valine, leucine and isoleucine degradation or polyketide 
sugar unit biosynthesis pathways were scored on the top 15 list and predicted to have 
some implication in Brucella virulence. Interestingly, the top 15 pathways scored were 
similar at 4 and 12 h PI, and a high proportion of the genes (56%) was important for 
Brucella pathogenesis at both time points. In concordance with Brucella signaling 
pathways, the software not only predicted known host pathways involved in infectious 
disease response, like Toll-like receptor or cytokine-cytokine interaction signaling 
pathways but also others unknown such as axon guidance or GnRH signaling pathways 
(Table 10). The top 13 scored host pathways had broader temporal and integral 
differences than in the pathogen pathway analysis. For instance, 9 of 13 pathways 
overlap over time and only MAPK1 was predicted to be mechanistic at 4 h and 12 h PI. 
Another difference of the Brucella signaling pathways analysis was that some genes 
were predicted to be key regulators in different pathways at the same time point. For 
instance, MAPK1 had up in 6 of the top 12 pathways analyzed at 12 h PI. Overall, study 
of signaling pathways using dynamic Bayesian modeling analysis not only predicted 
some known host and pathogen pathways involved in Brucella virulence but also 
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TABLE 9. Top scored B. melitensis pathways subnet analyzed and discovered 
candidate mechanistic genes from modeling at 4 and 12 h PI 
Pathway Source Mechanistic genes 
  4 h 12 h 
ABC transporters bme 02010 
Ribosa ABC transporter (rbsA, rbsB, 
rbsC) and Oligopeptide ABC 
transporter (oppA, oppB, oppC, 
oppD, oppF) 
Oligopeptide ABC transporter 
(oppB, oppC, oppF) and 
Branched-chain amino acid ABC 
transporter (livF, livH, livM) 
Aminoacyl-tRNA 
biosynthesis bme 00970 BMEI0987 BMEI0987 
Fatty acid metabolism bme 00071 BMEI1746, BMEI1747, BMEII0124 BMEI1746, BMEII0141 
Flagellar assembly bme 02040 
BMEI0324, BMEII0150, BMEII0151, 
BMEII0159, BMEII0160, BMEII0161, 
BMEII0165, BMEII0166, BMEII0167, 
BMEII1087, BMEII1109  
BMEI0324, BMEII0150, 
BMEII0151, BMEII0160, 
BMEII0166, BMEII0167, 
BMEII1087, BMEII1109 
Glycolysis/ 
Gluconeogenesis bme 00010 BMEI1746, BMEII0241, BMEII0608 
BMEI0145, BMEI0854, BMEI0856, 
BMEI0857, BMEI0925, BMEI1746, 
BMEI1747, BMEII0060, 
BMEII0141, BMEII0242, 
BMEII0744, BMEII0745  
Lipopolysaccharide 
biosynthesis bme 00540 
BMEI0831, BMEI0833, BMEI0835, 
BMEI1115, BMEI1904, BMEII1028 
BMEI0831, BMEI1115, BMEI1904, 
BMEII1028, BMEII1029 
Novobiocin 
biosynthesis bme 00401 BMEI1308, BMEI1309 BMEI1308, BMEI1309 
Oxidative 
phosphorilation bme 00190 
BMEI0076, BMEI0248, BMEI0250, 
BMEI0251, BMEI1185, BMEI1205, 
BMEI1543, BMEI1544, BMEI1546 
BMEI0076, BMEI0248, BMEI0250, 
BMEI0251, BMEI1185, BMEI1544, 
BMEI1546 
Polyketide sugar unit 
biosynthesis  bme 00523 BMEII0830, BMEII0836 
BMEII0440, BMEII0830, 
BMEII0836 
Protein export bme 03060 
BMEI0121, BMEI0680, BMEI0743, 
BMEI0777, BMEI1076, BMEI1077, 
BMEI2055 
BMEI0680, BMEI0743, BMEI0777, 
BMEI1076, BMEI1077, BMEI2055 
Purine metabolism bme 00230 BMEI0647, BMEI0649, BMEI1430 BMEI0649, BMEI1430, BMEI1653 
Two-component 
system bme 02020 
BMEI0865, BMEI0866, BMEI0978, 
BMEI0979, BMEI1804, BMEII0523, 
BMEII0554, BMEII0971 
BMEI0866, BMEI0979, BMEI1582, 
BMEI1804, BMEII0523, 
BMEII0554 
Type IV secretion 
system bme 03080 
BMEII0026, BMEII0027, BMEII0028, 
BMEII0030, BMEII0033, BMEII0034 
BMEII0027, BMEII0028, 
BMEII0030, BMEII0033 
Tyrosine metabolism bme 00350 BMEI1125 BMEI1125, BMEI1882 
Valine, leucine and 
isoleucine 
degradation  
bme 00280 
BMEI0125, BMEI0158, BMEI0203, 
BMEI0204, BMEI0426, BMEI0456, 
BMEI0466, BMEI0736, BMEI1067, 
BMEI1858, BMEI1919, BMEI1924, 
BMEI1927, BMEI1928, BMEI1945, 
BMEII0497, BMEII0613, BMEII0748, 
BMEII1021, BMEII1101 
BMEI0125, BMEI0158, BMEI0203, 
BMEI0204, BMEI0426, BMEI0736, 
BMEI1919, BMEI1927, BMEI1928, 
BMEI1945, BMEII0002, 
BMEII0061, BMEII0497, 
BMEII0613, BMEII1021, 
BMEII1101 
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TABLE 10. Top scored host pathways subnet analyzed and discovered candidate 
mechanistic genes from modeling at 4 and 12 h PI 
 
Pathway Source Mechanistic 
  4 h 12 h 
Calcium signaling 
pathway hsa04020 PRKACB CD38, PDGFRA 
Complement and 
coagulation cascade hsa04610 MASP1, C5 FGA, F3, F7, SERPINA5 
Cytokine-cytokine 
receptor interaction hsa04060 IL1R1, CXCL1  
EMC-receptor 
interaction hsa04512 LAMC1, THBS1 ITGB3, ITGB5, SPP1 
GnRH signaling 
pathway hsa04912 PRKACB MAPK1 
Insulin signaling 
pathway hsa04910 PHKB MAPK1 
MAPK signaling 
pathway hsa04010 
MAP3K7IP1,  NR4A1,  JUND, 
MAPK1,  MAPK8,  MAPK11 STMN1, MAPK1 
Regulation of actin 
cytoskeleton hsa04810 BDKRB2 
FGF7, PDGFRA, MAPK1, 
PIK3CG 
Toll-like receptor 
signaling pathway hsa04620 MAP3K7IP1 PIK3CG, PIK3R1, CD86 
Urea cycle and 
metabolism of urea 
groups 
hsa00220 GTP ODC1 
Axon guidance hsa04360  MAPK1 
T-cells receptor 
signaling hsa04660  PIK3CG, PIK3R1 
VEGF signaling 
pathway hsa04370  MAPK1 
 
Pathways description was based on KEGG (http://www.genome.jp/kegg/pathway)  
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identified other possible underlying pathways whose involvement in Brucella infection 
will require further elucidation. 
virB operon influences Brucella intracellular survival and replication but not 
invasion of HeLa calls in the first 12 h post-infection. One of the pathways predicted 
in silico as mechanistic for Brucella intracellular survival is the type 4 secretion system 
(T4SS) (Table 9). Brucella strains mutated in the virB operon (which encodes a T4SS) 
were previously reported to be attenuated for virulence in cell culture and in the mouse 
model of infection (169, 213). However, the importance of virB in B. melitensis survival 
and replication in non-professional phagocytic cells during the first 12 h PI has not been 
studied. To evaluate the role of virB, we selected a B. melitensis transposon-interrupted 
in virB3 homolog locus (BMEII0027) from our B. melitensis mutant bank and its 
phenotype was compared in parallel with the isogenic B. melitensis WT treated equally. 
First, we analyzed the influence of virB in the internalization of B. melitensis in HeLa 
cells. There were no differences (p > 0.05) in the number of internalized B. melitensis 
WT or mutant (Fig. 13A), indicating that virB is not required for B. melitensis invasion 
in non-professional phagocytic cells. However at 4 and 12 h PI, the number of 
intracellular virB mutants recovered was significantly lower (p < 0.05) than the number 
of WT recovered (Fig. 13B), indicating that virB operon is important for intracellular 
survival and replication of B. melitensis in HeLa cells during the first 12 h PI. The CFU 
of B. melitensis WT and mutant in growth control wells increased at a similar rate 
(almost 1 log at 12 h) compared with the original inoculum (data not shown). These 
findings indicate that loss of virB was responsible for the intracellular growth repression
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FIG. 13. Invasion phenotype and intracellular survival and replication of B. melitensis virB3 mutant 
in HeLa cells.  HeLa cells were infected with B. melitensis virB3 mariner transposon Himar1-interrupted 
at MOI 1,000:1 as explained in Materials and methods. The invasive phenotype and the intracellular viable 
number of bacteria were determined at 0, 4 and 12 h PI. Results were compared with HeLa cell cultures 
infected with B. melitensis WT in parallel. (A) The invasive phenotype of the virB mutant was similar than 
the WT (p > 0.05). Results are presented as the number of CFU from internalized bacteria per every 106 
bacteria inoculated. (B) The intracellular viable number of B. melitensis virB mutant was significantly 
lower than the WT at 4 (* = p < 0.05) and 12 h (** = p < 0.01) post-infection. Brucella CFU at 4 and 12 h 
PI are presented as a percentage (%) of internalized bacteria. Data presented are the mean + SD (error 
bars) of 4 independent experiments done in triplicate and statistical significance of differences was 
determined using Student’s t test (p < 0.05 was considered significant). 
  
 
109
A 
  
0
10
20
30
40
50
60
70
80
90
WT virB3
B. melitensis  strains
In
tr
ac
el
lu
la
r 
B
. m
el
ite
ns
is
 (C
FU
/1
06
 
in
oc
ul
at
ed
)
 
 
B 
 
0
20
40
60
80
100
120
140
160
180
T0 T4 T12 
Time points (h)
%
 o
f i
nt
ra
ce
llu
la
r 
B
. m
el
ite
ns
is
 (C
FU
)
Wild type
virB mutant
* **
 
  
 
110
in the mutant strain but was not required for extracellular growth. These results are in 
consistent with the prediction from our mathematic modeling, and indicate that under 
these experimental conditions virB operon is essential for intracellular survival and 
replication, but not invasion, of B. melitensis in HeLa cells in the first 12 h PI. 
Host MAPK1 is important for intracellular survival of B. melitensis in HeLa 
cells. Mitogen-activated protein kinase 1 (MAPK1 or ERK 1/2) controls many biological 
functions (124). Statistical analysis of our microarray experiments (also confirmed by 
qRT-PCR) revealed that MAPK1 was up-regulated at 4 and 12 h PI (Appedixes D and 
E). Further computational analysis predicted that this gene is important in Brucella 
pathogenesis (Table 10). However, the computational prediction does not indicate if the 
expression of MAPK1 favors or inhibits pathogen infection. To experimentally test the 
role of MAPK1 in B. melitensis pathogenesis in our non-professional phagocytic cell 
model, HeLa cells were independently transfected with either of 2 different MAPK1-
validated siRNA molecules and 48 h later were infected with B. melitensis WT. The 
expression of MAPK1 measured by qRT-PCR in cell cultures transfected with either 
molecule of MAPK1-validated siRNA was knocked down more than 90% compared 
with the expression of the gene in non-transfected cells or cells transfected with negative 
and positive control siRNA molecules (siRNA molecules with no homology on 
eukaryotic genome, and GAPDH, respectively) (data not shown). The phenotype of B. 
melitensis-infected MAPK1-siRNA transfected HeLa cells was compared with the 
phenotype of B. melitensis-infected HeLa cells non-transfected and transfected with 
negative control siRNA (Fig. 14). HeLa cells tranfected with a negative control of 
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siRNA molecules were more permissive to Brucella invasion than the other cell cultures 
but there was no effect on the intracellular B. melitensis survival and replication. The 
viable number of Brucella recovered at T0 in HeLa cells transfected with MAPK1 (ID 
1449) - validated siRNA was only 40% of that recovered from non-transfected HeLa 
cells (control) (p < 0.01). Additionally, the intracellular replication of Brucella at 4 h PI 
was repressed in HeLa cell cultures transfected with siRNA-MAPK1 (ID 1449). To 
verify that MAPK1 was involved in Brucella invasion and intracellular replication after 
4 h PI, we evaluated a second MAPK1 (ID 1544)–validated siRNA molecule in parallel 
under the same experimental conditions. In this case the number of invasive organisms 
was similar to that from the non-transfected cells (p > 0.05), but the CFU of B. melitensis 
recovered at 12 h PI was lower than that recovered at 4 h. These results do not fully 
define the role of MAPK1 in Brucella invasion process, but in accord with our predictive 
algorithm, indicate its importance in Brucella survival in non-professional phagocytic 
cells after 4 h PI. 
 
DISCUSSION 
 Prior to this study, the Brucella and the host temporal transcriptomes during early 
interaction were unknown. Here, using cDNA microarray technology, we analyzed in 
parallel the transcriptional profile of both host and Brucella at 4 and 12 h PI. 
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FIG. 14. Phenotype of B. melitensis-infected HeLa cells transfected with MAPK1-validated siRNA 
molecules. HeLa cells were independently transfected with 2 different MAPK1-validated siRNA 
molecules (1449 –triangles- & 1554 – big squares-) and 48 h later infected with B. melitensis WT 
cultures. Non-transfected (diamonds) and cell cultures transfected with siRNA-negative control (small 
squares) were used as controls of infection. The expression of MAPK1 measure by qRT-PCR was 
knocked-down more than 90% in cells transfected with both MAPK1-siRNA molecules. Cell cultures 
were infected and treated as explained in Materials and methods. The results suggest the importance of 
MAPK1 in Brucella intracellular survival in non-professional phagocytic cells after 4 h post-infection. 
Data are presented as logarithmic scale and results are the mean + SD (error bars) of 5 independent 
experiments done in duplicate. 
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Based on our initial experiments, which revealed that late-log cultures of B. 
melitensis grown in cell culture media are more invasive to HeLa cells than early-log or 
stationary cultures (see Chapter II), we infected HeLa cells with cultures at the optimal 
phase of growth and analyzed their intracellular kinetics. Our results demonstrate that 
B.melitensis survive, but are unable to replicate in the first 4 h PI (adaptive period). 
Following this initial period, Brucella begin to replicate intracellularly (replicative 
period). The initial lag period is due to a host:agent interaction and not a bacteria growth 
deficiency since the bacteria cultures continued growing in a control wells. We interpret 
this initial “non-replicative” period as the time necessary for the pathogen to adapt from 
the extracellular life style to the intracellular environment. Previous studies found 
different kinetics of Brucella cultures in non-professional phagocytic cells in the first 12 
h PI. For instance, Detilleux et al. (1990a) reported intracellular replication of B. abortus 
cultures in the first 8 h PI, followed by a decreasing number of viable intracellular 
brucellae. Pizzarro-Cerdá et al. (1998a) and Delrue et al. (2001) observed that the B. 
abortus and B. melitensis lag period was two times longer than we report here. However 
O’Callaghan et al. (1999) and Sieira et al. (2000) reported a similar intracellular kinetic 
profile of B. suis and B. abortus in HeLa cells as in our study. It is possible that the 
differences in the length of the adaptive period were based on the cultures (growth 
phase, media), cell types (HeLa or Vero cells) or the infection conditions used (initial 
time of Brucella:host cell interaction). 
 To understand the molecular behavior of the host and pathogen during their first 
12 h PI, we studied their transcriptional profile at the adaptation (4 h PI) and at the 
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replicative phases (12 h PI). Modern technology has made the gene expression detection 
from mammalian systems straightforward and robust. However, the study of 
transcriptional profile of intracellular bacteria is challenging due to the difficulty of 
obtaining adequate high quality pathogen RNA free of eukaryotic-RNA for downstream 
applications. In order to address this problem, we initially demonstrated the usefulness 
of BmGDP for generating sensitive and specific probes of B. melitensis transcripts from 
an in vitro culture for gene expression profile studies using DNA microarray analysis. 
We also generated BmGDP probes from RNA isolated from non-infected HeLa cells 
(although in less amount than with random primers), and some cross-hybridization along 
with false positive detection was observed when those probes were hybridized on B. 
melitensis microarrays. These results indicate that the BmGDP primers set do not 
specifically anneal only to B. melitensis transcripts nor does hybridization to the 
Brucella arrays select against all eukaryotic transcripts. To reduce the interference of the 
host RNA from the heterogeneous population of RNA, we used a commercial kit 
(MICROBEnrich) to significantly reduce the eukaryotic RNA and enrich the Brucella 
RNA. However, some mammalian RNA was still present in the samples after treatment, 
which could interfere with pathogen gene expression detection. In addition, the 
enrichment procedure does not address the challenge of a small amount of Brucella 
RNA present in the initial material (B. melitensis-infected cells or tissues), which is 
about 1:1,000 or less (i.e. 10 ng in 10 µg of total RNA). This low level of pathogen RNA 
was insufficient for microarray studies. To increase the Brucella RNA concentration and 
simultaneously equilibrate the host:pathogen RNA ratio, we applied a linear 
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amplification of sense-stranded RNA protocol biased to pathogen transcripts in the 
previously enriched RNA sample. We then evaluated the reproducibility of the 
methodology by measuring the correlation between the gene expression detected in an 
original sample (non-enriched non-amplified B. melitensis RNA) vs. an E&A 
host:pathogen mixed RNA sample (i.e. B. melitensis RNA spiked with HeLa RNA 
1:125). Bearing in mind that the presence of contaminant eukaryotic RNA and the extra 
handling of the samples could introduce some degree of bias into the population of 
treated RNA (153), the analysis of our results yielded an acceptable correlation (r = 
0.58589) between these 2 samples with high reproducibility of the technique (correlation 
between independent replicates = 0.9063). Correlation studies of pathogen gene 
expression from treated mix host:pathogen RNA sample with the original pathogen RNA 
sample as we present here, have not been previously reported. Studies focused on 
validation of methodology for RNA amplification in the sense orientation have shown 
correlation between “pure” samples before and after amplification. Making the same 
comparison (i.e. unamplified vs. amplified B. melitensis RNA), our study yielded a 
higher correlation level compared to other studies (r = 0.81398 vs. 0.77, Lawson & 
Johnston, 2006, or 0.8009, Marko et al., 2005). Amplification of the mixed RNA 
samples without previous enrichment did not work well in our hands (the lowest 
correlation compare against the original B. melitensis RNA sample, r = 0.38296). These 
results differ from other studies that have found a more complete bacteria global 
expression profile applying a direct amplification on the host:pathogen mixed sample 
(142). A possible explanation may be that in their study the number of bacteria, and the 
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bacterial RNA, was much higher than in our experiment and as a consequence, the 
bacterial:host RNA ratio was lower, with less contaminant eukaryotic RNA. Given that 
the B. melitensis:eukaryotic RNA ratio from in vitro or in vivo-infected samples is at 
least 10 times lower than in our simulated system and the possibility that eukaryotic 
RNA may interfere with pathogen gene expression detection, our strategy was to 
hybridize in parallel with the E&A sample, the original (untreated) infected sample on 
the Brucella oligoarray and disregard from future analysis all those spots that produced a 
signal in the untreated sample. The concept for using the original RNA samples as a 
control for cross-hybridization as opposed to non-infected HeLa cells, was based upon 
the evidence that the transcriptional profile of the infected host cells changes due to 
infection and would have different levels of cross-hybridization. This novel alternative, 
which has not been reported in previous studies that have evaluated the in vivo or in vitro 
transcriptional profile of intracellular bacteria (37, 139, 221, 226), decreases the 
sensitivity but increases the specificity of the system (i.e. some true positive expressed 
pathogen genes might be disregarded from the analysis but detected genes will be 
unambiguously pathogen genes).  
 A general overview from the combined analysis of the results from the host and 
pathogen transcriptional profiles indicate that both non-phagocytic cells and Brucella 
undergo an adaptation period during the first 4 h PI but is overcome by 12 h PI 
permitting Brucella to replicate intracellularly while minimally effecting on host 
physiological processes. Our studies identify down-regulation in all of the functional 
groups analyzed in B. melitensis at 4 h PI, similar to that observed in HeLa cells at the 
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same time point. It is difficult to say if these transcriptional modifications occurred as a 
consequence of the interaction (i.e. pathogen on the host or vice versa), or if they are self 
regulated. It has been clearly demonstrated that bacteria can modify host responses (75, 
163, 210), but the opposite effect has not received the same attention. There are well 
defined examples of how Brucella influences the host response (19, 29, 79, 96, 166, 198, 
217), but all of these studies focused on phagocytic cells. In non-phagocytic cells, 
Brucella escapes from the endocytic pathway, exploits the autophagic machinery of the 
host cell and transits to the endoplasmic reticulum where multiplication occurs (179). 
Brucella itself is responsible for modifying intracellular trafficking, since attenuated 
strains follow a different pathway. A type IV secretion system, encoded by the virB 
operon, is essential for Brucella’s modification of intracellular trafficking in HeLa cells 
(39). The virB promoter is induced intracellularly in macrophages after internalization 
and reaches peak expression at 5 h PI (22, 212). In our study, the microarray technique 
was not able to identify virB differentially expressed in intracellular Brucella. One 
possibility could be that the virB expression inside non-phagocytic cells follows a 
different kinetic than in macrophages. Another potential reason may be that in our initial 
study of B. melitensis gene expression in culture media (see Chapter II), we detected 
some of the virB genes (B1, B3, B10) up-regulated at late-log phase of growth. In this 
study, intracellular gene expression was compared with the inoculum (i.e., B. melitensis 
culture at late-log phase). Our results reflect only genes at least 2 fold differentially 
expressed as compare with the control, therefore it is possible that the changes in the 
virB operon are present but do not meet the 2-fold cut-off criterion. Independently, the 
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T4SS was identified in further computational analysis, and confirmed later in the in vitro 
model of infection, as a key pathway for B. melitensis survival and replication in HeLa 
cells in the first 12 h PI. Similar observations were reported for B. abortus (213) and B. 
suis (169). Our computational prediction found that some but not all of the virB genes 
are mechanistic for survival and replication in the first 12 h PI (Table 9). virB genes are 
organized in one operon that is transcribed as a polycistronic mRNA (22, 213). Due to 
the size of the transposon used to create the mutant (~1.3 kb), it likely has a polar effect 
on downstream genes. To further characterize the role of every virB gene in the initial 
steps of the infection, we are in the process of making non-polar mutants for individual 
virB genes that will be later tested under the same experimental conditions. 
 Impairment of phago-lysosome fusion is a major mechanism that allows 
intracellular survival of Brucella. It has been shown that Brucella lipopolysaccharide 
(LPS) – O side chain is involved in the prevention of phago-lysosome fusion in the first 
few hours following phagocytosis, resulting in the rapid acidification to the Brucella-
containing vacuole and the expression of true virulence genes such as the virB operon 
(183, 184). However, virtually nothing is known about specific molecules and targets 
involved in Brucella phago-lysosomal membrane fusion inhibition. Our study provides 
an initial effort to further characterize the differentially expressed genes, particularly 
hypothetical proteins, in the early phase of infection to enhance our understanding of the 
molecular actions that impair phago-lysosomal fusion. 
In the past, only one study has been published describing Brucella genes 
expressed intracellularly (68). Using a differential fluorescence induction approach, the 
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authors identified 34 ORFs differentially activated within macrophages at 4 h PI. From 
these 34 ORF only 9 were identified based on similiarity with other bacterial sequences 
in GenBank. In agreement with our results, the Brucella genes identified were involved 
in adaptation to intracellular environmental conditions. Together, these two studies 
reflect that even in 2 different cell types, Brucella undergo adaptation in the first 4 h PI.   
Two studies using microarray technology have been published describing host 
response to Brucella infection (69, 104). There were 148 genes differentially transcribed 
in a murine macrophage cell line infected with B. abortus at 4 h PI (69). In general, 
genes associated with immune and inflammatory response were up-regulated, genes 
involved in cell cycle/cell division/proliferation and differentiation, and intracellular 
trafficking were down-regulated while genes involved in apoptosis were equally 
distributed. These data are consistent with our microarray results, except for the pattern 
of expression of genes involved in immune response. This difference could be related to 
the fact that macrophages are cells directly involved in the immune response while HeLa 
cells are not. In the other study (104), the authors evaluated the transcriptional profile of 
B. melitensis-infected murine macrophages at 4, 24 and 48 h PI, and they found that the 
most significant transcriptional changes happen early after infection (4 h) and return to 
normal in later time points (between 24 and 48 h). Even when the number of transcripts 
significantly differentially expressed was much higher than in our study (1,296 genes), 
the majority of them (81%) were down-regulated at the 4 h PI. Also consistent with our 
results, general cellular activities such as cell growth and maintenance, intermediate 
metabolism and biological process regulation were substantially suppressed. However, 
  
 
120
He et al. (2006) found that immune response was up-regulated and apoptosis was clearly 
down-regulated. This anti-apoptotic profile observed in infected macrophages was 
different from our results. We were not able to differentiate whether there was a pro- or 
anti-apoptotic profile in B. melitensis-infected HeLa cells at 4 h PI.  This could be due to 
the fact that macrophages are the primary resident cells for Brucella in natural 
infections, while epithelium is not colonized in vivo.  
A different scenario was observed at 12 h PI where both host and pathogen 
transcriptional profiles were clearly up-regulated. Our interpretation of these data is that 
Brucella finish the initial adaptation period as indicated by the phagosomal membrane 
modification, and then Brucella begin replicating virtually without interfering with the 
host physiological metabolism. Among the major transcriptional changes observed in 
infected cells as compared to the non-infected ones was the up-regulation of cell-cell and 
cell-matrix adhesion. The up-regulation of genes involved in cell-cell contact by 
Brucella was previously reported (98), but its interpretation is unclear. In vivo, Brucella 
pass throughout the mucosal epithelium to colonize deeper tissues with only minimal 
tissue injury, therefore we hypothesize that the up-regulation of cell-cell adhesion could 
be a pathogen effort to avoid epithelium detachment that would prevent establishment of 
the infection.  
During the last stage of in vitro infection in non-phagocytic cells, virulent 
Brucella is delivered to the perinuclear endoplasmic reticulum where actual bacterial 
multiplication occurs (179). This has been interpreted as an opportunity for Brucella to 
take advantage of the metabolites synthesized or translocated to this compartment to 
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supply their nutritional requirements for growth. For instance, Legionella pneumophila, 
another intracellular pathogen that impairs phago-lysosomal fusion and replicates inside 
macrophages similar to Brucella, scavenges host proteins and amino acids for nutrients 
(23). It has been demonstrated that de novo host protein synthesis is not required during 
intracellular Brucella replication (52). Our microarray data suggest that host cell protein 
biosynthesis process was down-regulated in infected cells 12 h PI, but the transcription 
of genes involved in translational processes in the pathogen is re-activated compared 
with 4 h PI. These results provide evidence to hypothesize that Brucella may inhibit, by 
an unknown mechanism, the host translational process to enhance amino acid 
availability for synthesizing their own proteins, or possibly to utilize the amino acids as a 
carbon source. 
The influence of the epithelium in the initiation of the immune response in 
Brucella infection has been inadequately studied. Salmonella typhimurium is known to 
stimulate the Toll-like receptor signaling pathway in intestinal epithelial cells resulting 
in IL8 secretion and a massive neutrophil influx in the intestinal lumen (107). Legionella 
pneumophila was also reported to be able to induce secretion of several cytokines from 
the lung epithelium after infection that contributes to the immune response in 
legionellosis (206). This study found several immune-related transcripts up-regulated in 
B. melitensis-infected cells compared with control cells such as interleukin receptors, 
transcriptional activators of cytokines and activators of B and T cells. Brucella do not 
generate an acute inflammatory response after invasion in vivo (1). The down-regulation 
of 2 potent pro-inflammatory cytokines transcripts (IL8 and IL18) seems to reaffirm this 
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idea, but there were also two potent chemoattractants (C5 and CXC16) up-regulated that 
would suggest the opposite effect. The up-regulation of immune-stimulatory transcripts 
like IFR4 together with CD28 and CD86 antigen molecules would further suggest that 
Brucella-infected epithelium-like cells initially induce a Th-2 immune response. 
Additionally, the up-regulation of other transcripts indicates cellular and humoral 
immune response activation (ICOSLG, CD8B1, CTLA4, CD24, TNFRSF17). This is the 
first time that transcripts involved in immune and inflammatory response generated from 
Brucella-infected non-phagocytic cells are reported. These data suggest some 
participation of the epithelium in the onset of immune response in brucellosis which will 
need to be further addressed. On the pathogen side, only one functional annotated gene 
(acrB) and some uncharacterized transport systems with possible implication in Brucella 
protection from deleterious host and environmental factor effects were observed to be 
up-regulated at 12 h PI. The role of these up-regulated defense-encoded genes in 
Brucella intracellular survival and how they interact with the host counterpart also 
deserve to be more carefully studied. 
MAPK1 was among many transcripts involved in signaling pathways up-
regulated in infected HeLa cells at 12 h PI. The MAPK signaling cascade, represented 
by 3 well characterized subfamilies of MAPKs (ERK1/2, JNK and p38), has been 
implicated in bacterial internalization (223) and intracellular survival and replication 
(107, 173, 207). Jimenez-Bagues et al. (2005) demonstrated the importance that the 
integrity of the MEK - MAPK - ERK 1/2 pathway has on the elimination of rough B. 
suis in macrophages (121). To identify the importance of this MAPK signaling pathway 
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in B. melitensis invasion and intracellular survival in HeLa cells, we used 2 different 
siRNA molecules to knock-down MAPK1 expression. Our results confirmed that the 
internalization of Brucella decreased more that 60% when the gene was knocked-down 
with one siRNA molecule (ID1449), but not with the other siRNA molecule (ID1544). 
The difference observed cannot be attributed to the MAPK1 gene expression, because 
qRT-PCR showed that the gene was more than 90% down-regulated compared with non-
transfected cells. Interestingly, negative control transfected cells had higher numbers of 
internalized bacteria than the control, an effect that can be attributed to the transfecting 
reagent. Therefore, if the transfecting reagent’s effect on the internalization process were 
subtracted, the number of invasive bacteria would be lower in both MAPK1 siRNA-
transfected cells. Previous studies have reported that pretreatment of HeLa cells with 
PD098059, a ERK1/2 pathway inhibitor, resulted in a 50% decrease in Brucella 
internalization (98). In the same study the participation of GTPases of the 
Rho/Rac/Cdc42 subfamily in B. abortus internalization in non phagocytic cells was 
demonstrated. MAPK1 is in a downstream pathway activated by these small GTPase 
subfamily proteins (208). It is reasonable to believe that disruption of this signaling 
pathway will affect the invasion process. Later in our experiment, we observed that 
Brucella replicate intracellularly during the first 4 h PI in both MAPK1-knocked down 
cell cultures (even at higher rate than in control or negative transfected cells) but not at 
the later time point. Two papers demonstrated that Brucella LPS is not potent in 
stimulating the MAPK signaling pathways in macrophages (117, 121), suggesting that 
this may be one of the many reasons why virulent smooth Brucella would survive 
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intracellularly. This suggests that the interruption of MAPK pathway does not affect the 
fate of smooth Brucella in macrophages. In our experiments, MAPK1 was 3.7 fold up-
regulated, but it has previously been shown that the magnitude of the expression 
response may not be the most useful indicator of biological significance of the gene 
(151). Contrary to those studies, we observed an interference in B. melitensis 
intracellular survival after 4 h PI, possibly because of the role of MAPK1 activation and 
its participation in bacterial virulence is different in phagocytic than in non-phagocytic 
cells. Alternatively, the inhibition of MAPK1 might enhance the activity of other 
transcriptional regulators of the MAPK pathway which may have increased inhibitory 
effects on the ability of Brucella to survive and replicate. Based on our data and the wide 
spectrum of cellular processes that MAPK1 participates, more experiments are needed to 
define the role of MAPK1 in Brucella pathogenesis. 
In summary, we have characterized in parallel the temporal transcriptional profile 
of the host and the Brucella melitensis for the first time in an in vitro system of infection. 
Our data provide specific genes and pathways to further elucidate how both host and 
Brucella interact during the early infectious process to the eventual benefit of the 
pathogen and to the detriment of the naïve host. The integrated results permit the 
establishment of new hypotheses regarding the initial molecular pathogenesis of 
Brucella.   
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CHAPTER IV 
 
TEMPORAL GLOBAL GENE EXPRESSION ANALYSIS OF THE in vivo 
INITIAL INTERACTIONS OF BOTH Brucella melitensis AND THE BOVINE 
HOST  
 
INTRODUCTION 
In vitro host:agent interaction studies are useful for generating initial hypotheses; 
however in vivo studies are required for a fuller understanding of the bacterial 
pathogenesis. Cattle are mainly infected by B. abortus, but are also infected by B. 
melitensis under specific epidemiological conditions, with similar clinical signs in both 
infectious processes (231). The alimentary tract is the major route of infection in the 
transmission of B. melitensis (2). Previous studies in cattle have isolated Brucella from 
different sections of the alimentary tract (30) and feces (46), revealing the possibility 
that brucellae survive in the varied environmental conditions of the gastrointestinal tract. 
The calf ligated ileal loop model is a useful model for the study of in vivo host:agent 
initial interaction (204), an area that has not been studied in brucellosis. The goal of this 
study was to characterize the morphological changes and the parallel temporal 
transcription profiles of B. melitensis and the bovine host during their initial interaction 
in an effort to understand how this interaction modulates the outcome of the initial 
infectious process. 
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MATERIALS AND METHODS 
Bacterial strain, media and culture conditions. Smooth virulent Brucella 
melitensis 16M Biotype 1 (ATCC 23456) re-isolated from an aborted goat fetus was 
maintained as frozen glycerol stocks. An aliquot of a saturated culture was inoculated in 
a 200 ml Erlenmeyer flask filled with 50 ml of cell culture media [F12K medium 
(ATCC) supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS) 
(ATCC)], and incubated at 37ºC with 5% CO2 overnight with shaking until the late-log 
growth phase (OD = 0.4) was reached. Heat-inactivated (H-I) B. melitensis was prepared 
by incubation overnight at 65ºC. Concentration of the inocula, purity, and efficacy of 
heat killing of the Brucella was confirmed by plating serial dilutions on tryptic soy agar 
(TSA) (BD) and incubating at 37ºC for 4 days. 
Animal handling and surgical procedures. Four 3-week-old brucellosis-free 
male calves were used in these experiments. Calves were fed with milk replacer twice 
daily up to 24 h and water ad libitum up to 12 h prior to the surgery. To minimize the 
possibility of interference from other enteropathogens on the host gene expression 
profile, calves were tested for fecal excretion of Salmonella spp. and Coccidium spp. 
oocysts twice and only negative animals were used. All animal experiments were 
approved by the Texas A&M University Institutional Animal Care and Research 
Advisory Committee. Surgeries were performed under biosecurity level III (BSL3) 
conditions in USDA inspected and CDC-approved isolation buildings at the 
experimental farm at Texas A&M University (College Station, TX). The surgical 
procedures were similar to those previously described (203). Briefly, anesthesia was 
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induced with IV propofol (Propoflo; Abbot Laboratories, Chicago, IL) followed by 
placement of an endotracheal tube; animals were maintained under general anesthesia 
with isoflurane (Isoflo; Abbott Laboratories) for the duration of the experiment. The 
abdominal wall was incised, the distal ileum containing the linear Peyer’s patch 
exteriorized, and 21 segments with length ranging from 6 to 8 cm were ligated with 
umbilical tape leaving 1-cm loops between them. The loops were intraluminally 
inoculated with of 3 ml of a suspension containing 1x109 CFU of B. melitensis 16M/ml 
either alive (infected loops) or heat-inactivated (H-I) loops. Sterile cell culture media 
(F12K media supplemented with 10% HI-FBS) was injected into the control loops. The 
segments were replaced into the abdominal cavity, the incision temporarily closed, and 
reopened for collecting samples beginning at 15 min and continuing through 12 h PI. 
Calves were euthanatized with an intravenous over dose of sodium pentobarbital at the 
end of the procedures and the carcass immediately incinerated. One infected, one heat 
killed inoculated and one control loop were collected at 7 time points (0.25, 0.5, 1, 2, 4, 
8 and 12 h post-inoculation) and samples were processed for quantitation of tissue-
associated bacteria, morphology, and both host and agent gene expression profiling. 
Samples from the surgery room were transported in triple containment to the BSL3 for 
immediate processing. 
Quantitation of tissue-associated B. melitensis. Two-6 mm biopsy punches (0.1 
g) of intestinal mucosa were extracted from every infected loop, intensely washed three 
times in PBS to minimize extracellular bacteria, homogenized, and diluted in 1 ml of 
PBS. Similar procedures were followed in H-I and control loops to identify viable 
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Brucella as a consequence of leakage of the loops, cross-contamination during material 
processing or Brucella migration via lymphatic or blood vessels. Samples from 
mesenteric lymph nodes and liver were collected after the animals were euthanatized. To 
determine the number of viable colony forming units (CFU) of B. melitensis in tissues, 
lysates were serially diluted and cultured on selective Farrell’s media [TSA (BD) 
supplemented with Brucella selective supplement (Oxoid Limited, Hampshire, UK) as 
manufacturer’s instructions] (7).  
Five ml of blood were collected by aseptic venipuncture of the jugular vein into 
0.75 ml of acid-citrate-dextrose (ACD) at T0 (pre-inoculation), 0.5, 1, 2, 4, 8 and 12 h 
time points. One ml of blood from every time point was cultured in selective bi-phasic 
media (7). Briefly, TSA (BD) + 1% agar (Difco, Lawrence, KS) was cooled after 
autoclaving to 56ºC before adding the Brucella selective supplement (Oxoid). The 
molten medium was well mixed and dispensed 20 ml into 75 cm2 cell culture flask 
(Corning). Flasks were placed to allow the media to solidify along one side. The 
following day tryptic soy broth (TSB) (BD) was autoclaved, cooled and Brucella 
selective supplement (Oxoid) added according to manufacturer’s instructions. Fifteen ml 
were dispensed aseptically in each flask already containing the solid phase, and the 
sterility of the media was checked by overnight incubation at 37ºC. Blood cultures were 
incubated for at least 1 month at 37ºC and checked twice a week.   
Morphologic studies. For morphologic analysis by light microscopy, full cross-
sections of each loop including the Peyer’s patch were fixed in formalin, processed 
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according to the standard procedures for paraffin embedding, sectioned at 5-µm 
thickness, and stained with hematoxylin and eosin. 
Isolation of total RNA from intestinal loops. Six to ten-6 mm biopsy punches 
were extracted from every loop. The mucosa of the samples were immediately dissected, 
minced into small pieces with a sterile scalpel, and placed in TRI-Reagent® (Ambion) (2 
biopsy punches / 1 ml of reagent) and further homogenized with a tissue grinder. RNA 
was extracted according to TRI-Reagent manufacturer’s instructions. The resultant RNA 
pellet was re-suspended in DEPC-treated water (Ambion) with 2% DTT and 1% RNase 
inhibitor (Promega). Contaminant genomic DNA was removed by RNase-free DNase I 
treatment (Ambion) according to the manufacturer’s instructions, and samples were 
stored at -80ºC until used. RNA concentration was quantitated by NanoDrop® ND-1000 
(NanoDrop) and the RNA quality was determined using an Agilent 2100 Bioanalyzer 
(Agilent). 
Enrichment and sense-strand amplification of B. melitensis total RNA from 
infected bovine Peyer’s patches. B. melitensis total RNA was initially enriched and 
then amplified from 30 µg of total RNA from B. melitensis-infected bovine Peyer’s 
patches at 0.25, 0.5, 1, 2 and 4 h post-infection. The enrichment procedure was 
performed using MICROBEnrich® kit (Ambion) according to the manufacturer’s 
instructions, and the remaining material immediately amplified, as it was previously 
described in Chapter III. The concentration of amplified RNA was quantitated by 
Nanodrop and samples stored at -80ºC until used. 
  
 
130
Isolation of total RNA and gDNA from cultures of B. melitensis 16M. The 
intracellular B. melitensis gene expression was compared to the gene expression of the 
inoculum (i.e., cultures of B. melitensis 16M grown in F12K media supplemented with 
10% HI-FBS at late-log growth phase) and B. melitensis gDNA was used for 
normalization of the bacterial gene expression profile. Isolation of total RNA and gDNA 
from Brucella cultures was done as previously described in Chapter II. 
Preparation of bovine reference RNA. Total RNA was isolated from Madin-
Darby bovine kidney (MDBK) and bovine B lymphocyte (BL-3) cell lines (ATCC) and 
fresh bovine brain, as explained above. Cell lines were grown in 150 cm2 cell culture 
flasks with minimum essential medium Eagle (MEME) (ATCC) supplemented with 10% 
HI-FBS. Bovine brain was harvested from cortex and cerebellum of a Holstein male calf 
immediately after euthanasia. The tissue was homogenized in ice-cold TRI-Reagent® 
(Ambion). RNA concentration from each sample was quantitated and bioanalyzed before 
and after pooling the samples. Total RNA isolated from three samples was pooled 
together in equal amounts, aliquoted and stored at -80ºC until needed.  
Construction of cDNA microarrays and annotation. Selective unique 70-mer 
oligonucleotide sets representing 13,257 cattle ORFs were obtained from normalized and 
subtracted cattle placenta and spleen cDNA libraries and based upon the earlier cDNA 
array platform GPL2864 (70) and subtracted cDNA libraries created from embryonic 
(day 36 and day 64) and extra-embryonic (day 14 to 25) tissues (NCBI libraries 15993, 
15993 and 17188). Positive controls included beta actin (ACTB), glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), and hypoxanthine phosphoribosyltransferase 
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(HPRT). Exogenous spiking controls were the soybean genes chlorophyll ab binding 
protein (CAB), Rubisco small chain 1 (RBS1), and major latex protein (MSG). Negative 
controls were Cot1 DNA, genomic DNA, spotting buffer, poly-A, and water. All 70-mer 
oligos were printed in 150 mM phosphate buffer at 20 uM concentration in duplicate on 
aminosilane-coated glass slides at the W. M. Keck Center (University of Illinois at 
Urbana-Champaign). The oligos were annotated based on the GenBank accession 
number, when available. 
Sample preparation and slides hybridization. The labeling and hybridization 
procedures for host and pathogen samples were explained in detail in the previous 
chapter (Chapter III). Bovine experimental samples (i.e. from infected, H-I and control 
loops) were co-hybridized against bovine reference RNA sample to a custom 13K 
bovine ESTs–70-mers oligoarray. Prior to hybridization, the microarrays were denatured 
by steam exposure, UV cross-linked and immersed in prehybridization buffer at 42ºC for 
a minimum of 45 min. This was followed by four washes in distilled water, immersion in 
100% isopropanol for 10 seconds, and drying by centrifugation. Slides were hybridized 
at 42ºC for ~40 h in a dark humid hybridization chamber (Corning), then washed for 10 
min at 42ºC with low stringency buffer [1X SSC, 0.2% SDS] followed by two 5-min 
washes in higher stringency buffers [0.1X SSC, 0.2% SDS and 0.1X SSC] at room 
temperature with agitation. 
Data acquisition and microarray data analysis. Immediately after washing, the 
slides were scanned using a commercial laser scanner (GenePix 4100). The genes 
represented as spots on the arrays were adjusted for background and normalized to 
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internal controls using image analysis software (GenePixPro 6.0). Genes with 
fluorescent signal values below background were disregarded in all analyses. Initially, 
pathogen and host arrays were normalized against B. melitensis genomic DNA as 
previously explained (219) and bovine reference RNA respectively. Resulting data was 
analyzed using Seralogix’s suite of gene expression analysis and modeling tools 
(www.seralogix.com). Genes were determined to be significantly differential expresssed 
based on Seralogix’s Bayesian z-score method. Using this method genes are ranked and 
ordered according to their expression magnitudes and gene variance is computed using a 
Bayesian predicted variance value. The Bayesian variance is determined by using a 
sliding window algorithm that averages 50 variances directly on the ascending and 
descending ordered sides of each gene of interest. This method is used to smooth the 
variances across the dynamic range of intensity values. Significantly changed genes 
were determined with the Bayesian z-test (p < 0.025). At each time point, genes 
determined to be statistically significantly expressed on pathogen arrays hybridized with 
probes generated from B. melitensis-infected bovine samples (z-score p < 0.025) were 
subtracted from the final list of differentially expressed genes. 
New computational tools developed by Seralogix were used for the identification 
of Biosignature Dynamic Bayesian Network modeling, mechanistic gene discovery and 
pattern/pathway recognition. Seralogix’s Biosignature Analysis Framework is comprised 
of an integrated suite of software tools (XManager, XConsole & XBuilder) and 
relational database storage specialized for management and analysis of biosignature data.  
Microarray results validation. Six randomly selected B. melitensis and 6 
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bovine genes with differential expression on microarray were analyzed by quantitative 
RT-PCR (qRT-PCR). Two micrograms of RNA from the same samples used for 
microarray hybridization were reverse transcribed into cDNA using TaqMan® (Applied 
Biosystems). For relative quantitation of target cDNA, samples were run in individual 
tubes in a SmartCycler II (Cepheid). One SmartMix bead (Cepheid) was used for 2 x 25 
µl PCR reactions along with 20 ng of cDNA, 0.2X SYBR Green I dye (Invitrogen) and 
0.3 µM forward and reverse primers (Sigma Genosys) designed by Primer Express 
Software v2.0 (Applied Biosystems) (Tables 11 and 12). For each gene tested, the 
individual calculated threshold cycles (Ct) were averaged among each condition and 
normalized to the Ct of the bovine GAPDH and 16S rRNA genes for host and pathogen 
respectively from the same cDNA samples before calculating the fold change using the 
∆∆Ct method (Applied Biosystems Prism SDS 7700 User Bulletin #2). For each primer 
pair, a negative control (water) and an RNA sample without reverse transcriptase (to 
determine genomic DNA contamination) were included as controls during cDNA 
quantitation. Because our analysis considered genes differentially expressed based on z-
score and not on fold-change, array data were considered valid if the fold change of each 
gene tested by qRT-PCR was expressed in the same direction as determined by 
microarray analysis. 
 
RESULTS 
Colonization of bovine Peyer’s patches and systemic invasion of B. melitensis 
after intraluminal inoculation. We assessed the kinetics of B. melitensis 16M infection 
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TABLE 11. Primers for Real-time PCR analysis of genes in bovine Peyer’s patch samples 
 
GenBank 
accession # 
Gene 
symbol Gene product Forward primers (5'-3') Reverse primers (5'-3') 
     
NM_173895 BPI Bactericidal/permeability-increasing protein CCTCCGAAACTCACCATGAAG TGTCCAATCTGAGCTCTCCAATAA 
NM_175793 MAPK1 Mitochondrial-activated protein kinase 1 GGCTTGGCCCGTGTTG GGAAGATGGGCCTGTTGGA 
NM_174006 CCL2 Chemokine (C-C motif) ligand 2 TCCTAAAGAGGCTGTGATTTTCAA AGGGAAAGCCGGAAGAACAC 
NM_173925 IL8 Interleukin 8 TGCTTTTTTGTTTTCGGTTTTTG AACAGGCACTCGGGAATCCT 
NM_174091 IL18 Interleukin 18 CTGGAATCAGATCACTTTGGCA CAGGCATATCCTCAAAGACAGG 
NM_001033608 MIF Macrophage migration inhibitory factor CTGCAGCCTGCACAGCAT TTCATGTCGCAGAAGTTGATGTAG 
NM_001034034 GAPDH Glyceraldehyde-3-phosphate dehydrogenase TTCTGGCAAAGTGGACATCGT GCCTTGACTGTGCCGTTGA 
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TABLE 12. Primers for Real-time PCR analysis of genes in B. melitensis samples 
 
Locus ID Gene product Forward primers (5'-3') Reverse primers (5'-3') 
    
BMEI0475 Cytochrome C1 GCTGCAGCGGCTAATAATGG CGGTCAAAAGCGAATGGATATAA 
BMEI0526 Carbamoyl-phosphate synthase small subunit CGGTCAGAAGGCGCAGAATA CTCGCCAAGGATGTCACCAT 
BMEI1384 Transcriptional regulator, AraC family CGCAGTTCACCAAGGCATT GCGTGTTCAGAGGCGATCTT 
BMEI1440 Thiol:disulfide interchange protein DsbA CGAAATTGGCCGGTTTTACA CCCGACATCTCCTCAAACGA 
BMEI1798 23S ribosomal RNA methyltransferase CATGGGCTCGGTCTTTTCC TGTTCATTGCCCATTATCAGGAT 
BMEII0033 Channel protein virB9 homolog CGATGCAGGTCGGCACTAAT TGGCTGTTCACGATGCTTTC 
AF220147 16S rRNA CCTTACGGGCTGGGCTACA TGATCCGCGATTACTAGCGATT 
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after intraluminal inoculation by calculating the CFU present in the Peyer’s patches at 
different time points. The intestinal loops were intraluminally inoculated with 3x109 
CFU of B. melitensis 16M and 0.1 g of Peyer’s patches collected beginning at 15 min 
and continuing through 12 h. Fifteen minutes post-inoculation, ~106 CFU/g of tissue 
were recovered (Fig. 15). The number of tissue-associated B. melitensis rose rapidly, 
reaching the peak (2x106 CFU/g of tissue) by 4 h post-inoculation, and decreasing at 
later time points. 
To address the possibility of Brucella systemic invasion, blood from the jugular 
vein was collected and cultured. Blood samples taken from the first calf were 
contaminated and not considered in the final analysis of the data. Blood from the second 
calf was collected as early as 1 h time point while samples from the two other animals 
were taken from 30 min PI through the end of the procedure. All blood samples before 
the inoculation (T0, control) were Brucella-free, but B. melitensis was isolated from all 
samples after inoculation. B. melitensis were also isolated from mesenteric lymph nodes 
and liver at the 12 h time point and also isolated from control loops and loops inoculated 
with B. melitensis H-I at 8 and 12 h time points (2x102 to 2x103 CFU of B. melitensis / g 
of Peyer’s patch) from 1 animal. These results indicate rapid penetration of B. melitensis 
through Peyer’s patches followed by systemic distribution and organ colonization via 
blood and lymphatic vessels.  
Morphologic findings of B. melitensis-infected bovine Peyer’s patches. No 
differences in histological features were observed between control samples and H-I B. 
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FIG. 15. Kinetics of infection with B. melitensis 16M. Ileal loops were intraluminally inoculated in 3 ml 
containing 1x109 CFU of B. melitensis 16M/ml. Tissue (Peyer’s patch) samples of 0.1 g of mucosal tissue 
were extracted at 0.25, 0.5, 1, 2, 4, 8 and 12 h PI from every infected loop, intensively washed 3 times in 
PBS, macerated and diluted in 1 ml of distilled water. To determine the kinetics of the infection, 
macerated samples were serially diluted and cultured on Farrell’s medium. Numbers of CFU recovered 
from bovine Peyer’s patches are the average of 4 calves. Bars represent standard deviation. 
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melitensis-inoculated or B. melitensis-infected Peyer’s patches or mesenteric lymph 
nodes in the first 12 h PI. 
Enrichment procedure is useful for analysis of B. melitensis RNA from 
infected bovine tissues. Before applying the enrichment and amplification protocol 
described in Chapter III for characterizing the transcriptome of intracellular Brucella, we 
wanted to determine if the enrichment procedure was useful for analysis of bacterial 
RNA from infected bovine tissues. To answer this question a sample of 25 µg of MDBK 
cell line (Madin-Darby bovine kidney; ATCC) total RNA was spiked with 2 µg of B. 
melitensis total RNA (host:pathogen RNA = 12.5:1) and the mixed samples treated with 
MICROBEnrich® kit (Ambion) according to the instruction manual. A sample of RNA 
from HeLa cells spiked with B. melitensis RNA in the same proportions was used as a 
positive control. The total RNA yielded after the treatment was 3.72 µg for the 
HeLa:Brucella mix and 4 µg for the MDBK:Brucella mix. The integrity and 
composition of the samples pre and post-treatment were evaluated by agarose gel 
electrophoresis and Bioanalyzer analysis (Fig. 16A and B). Our results found that the 
enrichment procedure effectively reduced bovine RNA concentration from mixed host 
and pathogen samples. 
In vivo transcriptional profiling of intracellular B. melitensis. The 
intracellular B. melitensis total RNA was initially enriched and then amplified from total 
RNA of B. melitensis-infected bovine Peyer’s patch samples at 0.25, 0.5, 1, 2 and 4 h 
post-infection. Four biological replicates of experimentally enriched and amplified RNA 
from every time point (n = 20) were indirectly labeled and co-hybridized against B. 
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FIG. 16. Integrity and composition of the host:pathogen RNA samples pre- and post-enrichment 
treatment. Twenty-five (25) µg total eukaryotic RNA from human (HeLa S3) and bovine (MDBK) cell 
lines were mixed with 2 µg of Brucella melitensis 16M RNA (ratio 12.5:1) and treated with 
MICROBEnrich® (Ambion) according to the instruction manual. The eukaryote:prokaryote RNA ratio of 
the original sample was 12.5:1 and decreased to 1:1 after the treatment. (A) Agarose gel electrophoresis 
image. Lines 1 and 2: HeLa:B.melitensis 16M RNA mix; lines 3 and 4: MDBK:B.melitensis 16M RNA 
mix; pre- and post-treatment respectively. (B) Comparison of RNA composition from a sample of 
MDBK:B. melitensis 16M pre- and post-treatment with MICROBEnrich® (Ambion) and examined on an 
Agilent 2100 Bioanalyzer. Ribosomal RNA subunits are indicated. 
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melitensis gDNA to a custom 3.2K B. melitensis oligo-array. In preliminary experiments, 
we observed (data not shown) that some bovine transcripts cross-hybridize with probes 
on B. melitensis microarrays. To account for the possibility of this cross-hybridization in 
the surgery samples, the original total RNA from B. melitensis-infected bovine Peyer’s 
patches (i.e. non-enriched non-amplified) (n = 20) were also hybridized against B. 
melitensis gDNA on the B. melitensis oligo-arrays, and those oligospots with signal were 
considered non-specific and eliminated from all analyses to avoid false positive 
pathogen gene detection. The intracellular B. melitensis gene expression at every time 
point was compared to the gene expression of the inoculum (i.e. in vitro-grown cultures 
of B. melitensis at late-log phase of growth) (n = 4). Based on these criteria, statistical 
analysis of microarray results reveal that between 720 and 822 B. melitensis genes were 
detected as differentially expressed (z-score p < 0.025) between 15 min and 4 h post-
infection (Table 13). The ratio between up- and down-regulated genes varied from 1.1:1 
to 1.4:1, and none of the genes inversed its transcriptional expression during these first 4 
h PI. A group of 618 genes (19.3% of B. melitensis genome) that were differentially 
expressed in at least 4 out of 5 time points was considered the core set of genes that 
reflect the major changes in B. melitensis gene expression during the early in vivo bovine 
Peyer’s patch infection and therefore important in understanding key events in the 
modulation of host response. From this set of 618 differentially expressed genes, 365 
(59%) were up-regulated and 253 (41%) were down-regulated compared with the in 
vitro grown culture (Appendix F). Differentially expressed genes with predicted or 
 
  
 
142
TABLE 13. Number of genes differentially expressed by intracellular B. melitensis 
from 15 minutes to 4 h post-infection 
Time point No. genes up-regulated 
No. genes down-
regulated 
Total No. of genes 
differentially 
expressed 
15 min 431 385 816 
30 min 419 357 776 
1 h 465 357 822 
2 h 398 322 720 
4 h 470 343 813 
 
 
annotated functions were assigned to clusters of orthologous genes (COGs) functional 
categories according to the NCBI Brucella melitensis 16M genome project web page 
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=genomeprj&cmd=Retrieve&dopt=O
verview&list_uids=180). The COGs in which the greatest number of transcriptional 
changes occurred included, transcription, translation, amino acid transport and 
metabolism, energy production and conversion, and cell wall and membrane biogenesis 
(Fig. 17). In most of the COG categories, most genes were up-regulated except for 
transcription, defense, cell motility and intracellular trafficking and secretion groups, in 
which the opposite effect was observed. Genes assigned to nucleotide, lipid and 
inorganic ion transport and metabolism groups were equally distributed between those 
that were up- and down-regulated. There were 65 (10.5%) and 168 (27%) of the core 
genes differentially expressed in the first 4 h PI that had only a general predicted
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FIG. 17. Distribution of genes differentially expressed in intracellular B. melitensis between 15 min 
and 4 h post-infection categorized by COGs functional categories. Genes differentially expressed with 
predicted or annotated functions were assigned to clusters of orthologous genes (COG) functional 
categories. Functional classification is as follows: A, DNA replication, recombination and repair; B, 
Transcription; C, Translation, ribosomal structure and biogenesis; D, Post-translational modification and 
secretion, protein turnover and chaperones; E, Amino acid transport and metabolism; F, Nucleotide 
transport and metabolism; G, Carbohydrate transport and metabolism; H, Lipid transport and metabolism; 
I, Energy production and conversion; J, Coenzyme transport and metabolism; K, Inorganic ion transport 
and metabolism; L, Defense mechanisms; M, Signal transduction; N, Cell wall/membrane biogenesis; O, 
Cell division; P, Cell motility; Q, Intracellular trafficking and secretion; R, General function prediction 
only. There were 168 (81 up- and 87 down-regulated) differentially expressed genes with unknown 
function that are not included in the figure. Solid bars, up-regulated genes; open bars, down-regulated 
genes. 
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function or unknown function, respectively. This represents 37.5% of the genes 
differentially expressed, and may contain pathways with previously unrecognized roles 
in B. melitensis early pathogenesis.  
An overview analysis of the core set of differentially expressed genes disclosed 
that Brucella actively express not only genes involved in survival under stress conditions 
but also genes required for intracellular multiplication during the first 4 h PI in vivo. The 
first of these activities is reflected by the up-regulation of some stress-indicator genes 
including a gene encoding a protein involved in DNA protection during starvation 
(BMEI1980), and genes encoding heat shock and chaperone proteins such as DnaJ 
(BMEI0047, BMEI1513), HspA (BMEI1784) and GrpE (BMEI1777). Enhanced 
transcription of exopolyphosphatase (BMEI0598), a regulator of adjustment to stress in 
E. coli (130), and hfq (BMEI0872), a gene encoding an RNA-binding protein (Host 
Factor I) that increase Brucella resistance under stress conditions (193) was also 
observed. Additionally, genes encoding DNA replication, cell division, translation, 
amino acid metabolism, and cell wall and membrane biogenesis, all of which are 
molecular indicators of B. melitensis active growth, were up-regulated. Specifically, 
genes whose products are involved in DNA replication like DNA polymerase 
(BMEI1876), chromosomal replication initiation protein (BMEI1943), DNA helicase 
(BMEI1485) and the single-strand binding protein (BMEI880), were also up-regulated. 
Moreover, four genes actively involved in control of cell division were up-regulated: 
parB (BMEI0010), ftsA (BMEI0584), minC (BMEII0927) and BMEI0213. Amino acids 
are not available inside intracellular vacuoles, where Brucella reside (132), however 
  
 
145
amino acid biosynthesis is absolutely necessary for bacterial growth and multiplication 
inside intracellular vacuoles. Transcripts for proteins implicated in amino acid 
biosynthesis such as ilvCDI, carA and trpB-D, among others, were enhanced compared 
with the control. In addition, 58 genes that encode proteins required in translation and 
ribosomal structure were up-regulated, suggesting increased production of protein 
synthesis machinery in the first 4 h PI. Overall, these Brucella gene expression data are 
in accordance with the bacteriological studies, in which an increasing number of 
Brucella were isolated from 15 minutes to 4 h PI.   
Twenty-three transcripts involved in cell wall and membrane biogenesis were 
also up-regulated. Among them were ORFs encoding genes involved in LPS 
biosynthesis (BMEI0831/0833, BMEI1037, BMEI1404, BMEI1418, BMEI1602). LPS 
is a well characterized Brucella virulence factor that participates in the inhibition of the 
early fusion of phagolysosome membranes and facilitates Brucella to survive 
intracellularly (184). Another major virulence element required in initial Brucella 
pathogenesis in vitro is virB, a type IV secretion system (T4SS) gene (169). In our 
experiment, 2 of the 11 genes of the T4SS (virB5 and 11) were significantly down-
regulated in 4 or more time points. Another ORF (BMEI1538) encoding a hypothetical 
protein that was identified as important for B. melitensis internalization in non-
phagocytic cells (Chapter II), was up-regulated from 15 min to 4 h post-infection. In 
general, these data confirm that recognized virulence factors were differentially 
expressed in the in vivo system of infection. 
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Transcriptional profile of host bovine Peyer’s patches inoculated with B. 
melitensis. RNA isolated from the mucosa of the intestinal Peyer’s patches inoculated 
with viable B. melitensis, H-I B. melitensis or culture medium (control) from 4 different 
animals at 0.25, 0.5, 1, 2 and 4 h PI (n = 60) was indirectly labeled and co-hybridized 
against bovine reference RNA on a custom 13.2K bovine oligoarray. Bioanalysis 
determined that RNA from the experimental samples and the reference was of good 
quality (RIN > 7.0, 28S/18S ratio > 1.4, OD260/280 > 2.0, OD260/230 > 1.8 for experimental 
samples; and RIN = 9.7, 28S/18S ratio = 2.1, OD260/280 = 2.01, OD260/230 = 1.85 for 
reference RNA). When hybridized on the arrays, the reference bovine RNA generated a 
readable signal intensity on more than 85% of the spots on the microarray (SNR > 3SD 
above background) and co-hybridization with experimental samples allowing 
comparison of bovine gene expression profiles across all treatments and time points.  
Microarray analysis revealed that 1,387 bovine genes were detected as 
differentially expressed (z-score p < 0.025) in loops inoculated with virulent B. 
melitensis 16M compared with controls between 15 min and 4 h post-infection (Table 
14). From these 1,387 genes, 646 (46.5%) were up- and 741 (53.5%) were down-
regulated. Two different expression profiles could be distinguished in B. melitensis-
infected host in the first 4 h post-infection. The initial expression profile, which we 
termed the “very early” expression profile, was characterized by up-regulated gene 
expression that extended from 15 min to 1 h PI, followed by a down-regulated (termed 
“early”) transcriptional profile from 1 through 4 h PI. Of 224 differentially expressed  
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TABLE 14. Number of host genes differentially expressed in B. melitensis-infected 
bovine Peyer’s patch from 15 min to 4 h post-infection 
Time point No. genes up-regulated 
No. genes down-
regulated 
Total No. of genes 
differentially 
expressed 
15 min 107 20 127 
30 min 143 16 159 
1 h 561 612 1173 
2 h 65 300 365 
4 h 3 5 8 
 
 
genes in the “very early” host response, 196 (88%) were up- and 28 (12%) were down-
regulated (Appendix G). The greatest number of transcriptional changes occurred in the 
transcription regulation, cell cycle/cell differentiation and proliferation, and 
inflammation and immune response Gene Ontology (GO) processes. After 1 h post-
infection, a different set of 1,163 genes was expressed, 459 (39%) up- and 704 (61%) 
down-regulated (Appendix H). Genes encoding proteins implicated in transcription 
regulation, protein biosynthesis and protein degradation, cell cycle and cell proliferation, 
inflammation and immune response and general metabolism experienced the greatest 
transcriptional changes due to the B. melitensis infection (Fig. 18). Furthermore, 73 
(32%; 62 up- and 11 down-regulated) and 507 (44%; 174 up- and 333 down-regulated; 
not shown) of the differentially expressed genes before and after 1 hour PI respectively 
lacked of functional annotation. 
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FIG. 18. Distribution of host genes differentially expressed in B. melitensis-infected bovine Peyer’s 
patch after 1 h post-infection categorized by Gene Ontology. Functional classification is as follows: A, 
DNA replication and repair; B, Chromosome organization; C, RNA processing; D, Transcription 
regulation; E, Protein biosynthesis; F, Protein folding; G, Protein degradation; H, Cell cycle / cell 
proliferation and differentiation; I, Cell adhesion; J, Cell-cell communication; K, Cytoskeleton 
organization; L, Morphogenesis and development; M, Apoptosis; N, Inflammation and immune response; 
O, Pregnancy; P, Nervous system development and proliferation; Q, Metabolism; R, Electron transport; S, 
Signal transduction; T, Surface receptors; U, Transport; V, Endocytosis and intracellular trafficking; W, 
Other functions. Solid bars, up-regulated genes; open bars, down-regulated genes. 
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Inflammatory and innate immune responses are key elements in avoiding 
infectious disease in naïve hosts. The very early expression profile of bovine Peyer’s 
patches infected with B. melitensis had a clear up-regulation of these functions that was 
slightly reversed later. Genes encoding proteins important in neutrophil function and NK 
cell bactericidal elements were initially up-regulated. For instance, 3 genes encoding 
neutrophil lysosomal granules such as BPI (bactericidal/permeability increasing-
protein), one locus (Bt.78164) encoding a protein strongly similar to myeloperoxidase, 
and another locus (Bt.24637) encoding a product similar to azurocidin 1 were up-
regulated. Also a gene (Bt.11022) whose product is involved in increasing neutrophil 
exocytosis and phagocytosis - induced respiratory burst activity (43) was up-regulated, 
as well as two other protein-encoding genes involved in NK cell activation (TYROBP) 
and dendritic cell - NK cells cross-talk (NCR3) (136, 232). NK cells were reported to be 
early participants in the impairment of intramacrophagic Brucella replication in vitro 
(57). Other anti-inflammatory and immune-modulator genes were differentially 
expressed after 1 h PI. TLR6, which mediates cellular response to bacterial lipoproteins, 
was down-regulated. Genes encoding pro-inflammatory cytokines which mediate 
neutrophil or eosinophil migration or their receptors such as IL8, IL18, SDF1, SYK, 
eotaxin and CCR3 were down-regulated. One monocyte chemotaxis gene (CCL2) and 
one cellular receptor for chemoattractant molecules (CCR1) were also down-regulated. 
Moreover, SOCS3, a gene encoding a protein involved in suppression of intracellular 
cytokine signals, was down-regulated. Two genes, one encoding the enhanced killer of 
intracellular pathogens MIF and the other one encoding its cellular receptor (CD74), 
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were up-regulated after 1 h post-infection as well as iNOS2A, which encodes a potent 
protein involved in the defense response to intracellular bacteria. Genes involved in T 
lymphocyte attraction and activation were also differentially expressed in the host 
response to Brucella. Two genes encoding T cell-attractant and activating proteins such 
as CD2 and a locus (Bt.37553) moderately similar to CXCL9, and 3 other genes such as 
IL16, linker for activation of T cells (Bt.26847) and a gene with some similarity to 
CXCL11 (Bt.18368), were up-regulated in the very early and in the early host response, 
respectively. The chemokine CXCL13, important for the development of B cell areas of 
secondary lymphoid tissues (144) and predominantly a B cell chemoattractant, was 
down-regulated. In summary these data indicate that the bovine host responds to very 
early Brucella infection with an up-regulation of genes that encode lysosomal 
bactericidal enzymes and later turns on an anti-polymorphonuclear and anti-monocyte, 
but not antiT lymphocyte, chemoattractant response. 
The activation of the complement system is another important non-specific host 
response to bacterial infection. In the very early PI response, three genes encoding 
components of the complement system were up-regulated. Two of them are participants 
of the membrane attack complex (MAC), a perforin bacterial membrane system and final 
product of the complement activation. Later, three genes encoding complement 
activation elements (DF, C1R and Bt.76479) were up-regulated, while the complement 
component 1qa was down-regulated. 
Differential expression of genes coding for antigen processing and presentation 
molecules MHC I & II were observed in the “early”, but not in the “very early”, host 
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response. Two different probes on the array for the classical major histocompatibility 
class I antigens (BOLA) had lower signal in infected than in control samples, as did the 
B2M gene, a necessary element for MHCI expression (9). Alternatively, two genes 
(BOLA-DRB3 and BOLA-DOB) which encode components of the major 
histocompatibility class II antigen were up-regulated while another one (BOLA-DRA) 
was down-regulated.  
The inhibition of host cell apoptosis by intracellular pathogens was interpreted as 
a protective mechanism that prevents the bacteria from being recognized and eliminated 
by the host immune system. In our study, four pro-apoptotic genes (CIDEB, PTGES, one 
transcribed locus with moderate similarity to caspase recruitment domain [Bt.687] and 
another transcribed locus strongly similar to an apoptotic chromatin condensation 
inducer in the nucleus [Bt.9054]) were up-regulated in the very early response, and 
another eight pro-apoptotic genes (TP53, BID, GRIM19, WWOX, DEDD2, a gene 
similar to PLAIDD [Bt.30544], a gene similar to BCL2/adenovirus E1B 19-kDa protein-
interacting protein 3 [Bt.1411], and a transcript locus moderately similar to necrosis 
factor receptor superfamily, member 12a [Bt.20111]) were up-regulated after 1 h of B. 
melitensis infection. Simultaneously, four anti-apoptotic genes (BCL2A1, a gene similar 
to TM2 domain containing 2 [Bt.13981], and 2 transcripts moderate similar to cell death 
regulator Aven [Bt.1793] and IAP repeat-containing 2 [Bt.64777]) were down-regulated 
in the early infection response. These data suggest that early in the infection, the host 
induces a cell death program to avoid Brucella intracellular survival and persistence.  
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Abortion is the principal clinical symptom of brucellosis in pregnant animals 
(171). Pregnancy is maintained by a delicate hormonal equilibrium involving 
progesterone (a pregnancy-stimulatory hormone) and prostaglandins (a delivery-inductor 
hormone) as the two major participants (118). In our microarray-based expression 
analysis a delivery-induced transcriptional profile was observed. For instance, a gene 
encoding for a pregnancy-associated glycoprotein 7 (PAG7), a protein found to be 
expressed in early bovine pregnancy (115), was down-regulated in the very early 
Brucella:host interaction, while 20-beta-hydroxysteroid dehydrogenase-like gene 
(Bt.28223) involved in prostaglandin E2 to PGF2α conversion, was up-regulated. After 1 
h PI, a gene involved in progesterone biosynthesis (ADAM), one progesterone receptor 
(PGRMC2) and one inhibitor of prostaglandin effects (PGDH), were down-regulated. 
Summarizing, these data indicates an early pro-abortive transcriptional response in a 
Brucella-infected host.    
Other observations arising from the evaluation of microarray data analysis after 1 
h PI include the transcriptional arrest of the cell cycle and inhibition of cell proliferation 
and differentiation (TP53, CCNE2, CDK10), and the enhanced expression of cell-cell 
adhesion (ITG, IGAL1, ZO3) and cell-cell communication (GJB1 and 6) related genes. 
A much lower number of host genes were expressed in intestinal loops 
inoculated with heat-killed B. melitensis 16M. A total of 140 genes were differentially 
expressed in the first 4 h post-inoculation, being 78 (56%) up- and 62 (44%) down-
regulated (Appendix I). Sixty-nine (49%) of the differentially expressed genes did not 
have a functional characterization and 25 of 71 of the expressed genes with known 
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functions in killed Brucella-inoculated tissues were also observed differentially 
expressed in viable B. melitensis-infected tissues. More genes encoding inflammatory 
and immune responses were differentially transcribed than any other functional category. 
Interestingly, 4 up-regulated genes in live Brucella-infected tissues from this category 
(BPI, NCR3, a gene similar to complement component C9 precursor [Bt.14139] and a 
gene with some similarity to CXCL9 [Bt.37553]), encoding NK cell and complement 
activation and lysosomal enzymes, were down-regulated in killed Brucella-inoculated 
Peyer’s patches. Simultaneously, 2 leukocyte-chemoattractant genes, CCL5 (RANTES) 
and CCL8, were up-regulated in tissues inoculated with heat-inactivated pathogen. 
Overall, these data suggest a pro-inflammatory expression profile in heat-killed 
Brucella-inoculated tissues, which is the opposite of that which was observed in live B. 
melitensis–infected tissues in the first 4 h post-infection. Similar to the pro-apoptotic 
expression profile observed with live B. melitensis infection, up-regulation of a pro-
apoptotic gene similar to Death Associated Transcription Factor 1 (Bt.14503), down-
regulation of the anti-apoptotic gene BCL2A1, and down-regulation of protein 
biosynthesis-involved genes could be observed in tissues inoculated with heat-killed 
Brucella. Aside from this, no other apparent biological patterns could be identified 
among the other 52 functional genes expressed as a consequence of the H-I pathogen 
inoculation during the first 4 h post-inoculation, as the remaining genes were randomly 
distributed among different GO processes.  
Validation of microarray gene expression results by qRT-PCR. To confirm 
the microarray results we randomly chose 6 B. melitensis and 6 bovine genes 
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differentially expressed in the first 4 h post-infection and conducted qRT-PCR at every 
time point, (i.e. 60 data points). Validation of B. melitensis microarray results was done 
using cDNA reverse transcribed from the same enriched and amplified RNA samples 
used for microarray hybridization. Fold change relative to the inoculum and control 
loops was used for measuring the intracellular B. melitensis and bovine gene expression, 
respectively. Quantitative Real-time PCR results confirmed that all of the Brucella and 
host genes tested were altered in the same direction as was determined by microarray 
analysis (Figs. 19 and 20). 
Dynamic Bayesian modeling analysis of host and pathogen microarray 
results reveal biosignature candidate genes. To further identify specific B. melitensis 
and bovine biological processes, pathways and gene targets for blocking B. melitensis 
early infection, a mathematical model of predictive analysis was conducted. The analysis 
identified 31 to 54 candidate genes important for Brucella early pathogenesis (Appendix 
J). Genes encoding proteins involved in transcription and amino acid metabolism were 
identified as important throughout the evaluated period (i.e. first 4 h PI), while others 
were only identified as essential at a specific time point. Several genes with predicted or 
uncharacterized function were also marked as necessary for initial Brucella pathogenesis 
in bovine Peyer’s patches. This analysis suggests that Brucella host invasion is sustained 
in different biological processes, whose importance varies during the course of infection. 
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FIG. 19. Validation of B. melitensis microarray results by quantitative Real-time PCR. cDNA was 
synthesized from the same enriched and amplified RNA samples used for microarray hybridization. Six 
randomly selected ORFs that were differentially expressed by microarrays in intracellular B. melitensis 
between 15 min and 4 h PI as compared to the inoculum were validated by quantitative RT-PCR. Fold-
change was normalized to the expression of B. melitensis 16S rRNA and calculated using the ∆∆Ct 
method. All tested genes at all time points had fold-changes altered in the same direction as microarray. 
Open bars represent fold-change by microarray, solid bars represent fold-change by qRT-PCR.
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FIG. 20. Validation of bovine microarray results by quantitative Real-time PCR. cDNA was 
synthesized from the same RNA samples used for microarray hybridization. Six randomly selected genes 
that were differentially expressed by microarrays in B. melitensis-infected bovine Peyer’s patch between 
15 min and 4 h PI as compared to non-infected tissues (control) extracted at the same time points were 
validated by quantitative RT-PCR. Fold-change was normalized to the expression of GAPDH and 
calculated using the ∆∆Ct method. All tested genes at all time points had fold-changes altered in the same 
direction in microarray and qRT-PCR. Open bars represent fold-change by microarray, solid bars 
represent fold-change by qRT-PCR. 
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Similarly, we conducted an in silico predictive mathematical model using the 
host gene expression data. The analysis identified 47 highly activated gene ontology 
(GO) biological processes (downloaded from Gene Ontology Consortium Database; 
http://www.geneontology.org) comprising 37 distinct mechanistic genes: 6 for “very 
early” and 31 for “early” infection (Table 15). Using the same bioinformatic platform, 
NK cell mediated cytotoxicity (hsa04650), leukocyte transendothelial migration 
(hsa04670), cell adhesion molecules (hsa04514), gap junction (hsa04540) and MAPK 
signaling (has04010) were identified among the top five pathways important for initial 
Brucella pathogenesis in bovine Peyer’s patches. Furthermore, genes such as TP53 
(apoptosis and Wnt signaling pathways), ITGA4, ITGAL and VCAM1 (cell adhesion 
molecules, leukocyte transendothelial migration and NK cell mediated cytotoxicity 
pathways), MAPK1 (MAPK signaling, NK cell mediated cytotoxicity and insulin 
signaling pathways), ADCY1 and ADRB1 (gap junction and calcium signaling 
pathways), SYK (NK cells mediated cytotoxicity) and IL8 and CCL2 (cytokine-cytokine 
receptor interaction signaling pathway) were the top 10 candidate genes that influence 
the outcomes of Brucella:host initial interaction. In summary, these data provide an 
important starting point for further analysis of important host biological processes, 
pathways and genes in Brucella pathogenesis. 
  
DISCUSSION 
In this study, we analyzed the kinetics of Brucella invasion and the global gene 
expression of the Brucella melitensis:bovine host interaction in the first 12 h post-
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TABLE 15. Set of host candidate genes identified in silico as important for infection 
of bovine Peyer’s patch in the first 4 hours of Brucella:host interaction 
Unigene 
ID Symbol Gene product Expression 
    
Mechanistic genes at “very early” host response 
    
Bt.4689 UCHL5 Ubiquitin carboxyl-terminal hydrolase L5 Up 
Bt.336 TPSB1 Tryptase beta 1 Up 
Bt.1354 MYO1A Myosin IA Up 
Bt.45674 CD2 CD2 antigen Up 
Bt.20121 CTSD Cathepsin D (lysosomal aspartyl protease) Up 
Bt.20296 SFXN2 Sideroflexin 2 Up 
    
Mechanistic genes at “early” host response 
    
Bt.15513 SSB Sjogren syndrome antigen B (autoantigen La) Down 
Bt.18504 MMP3 Metalloproteinase 3 receptor Up 
Bt.4902 CTSZ CTSZ protein Up 
Bt.8282 DPP4 Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2) Down 
Bt.7938 CTSS Cathepsin S Down 
Bt.1613 PRSS11 Protease, serine, 11 [IGF binding] Down 
Bt.24017 PSMC2 Proteasome (prosome, macropain) 26S subunit, ATPase 2 Down 
Bt.7181 CAPNS1 Calpain, small subunit 1 Up 
Bt.12473 CDC37 CDC37 homolog Down 
Bt.11942 COL18a1 Collagen, type XVIII, alpha 1 Up 
Bt.52428 CFL1 Cofilin 1 (non-muscle) Up 
Bt.45570 EPAS1 Endothelial PAS domain protein 1 Down 
Bt.4908 RBBP7 Retinoblastoma binding protein 7 Down 
Bt.7776 TPT1 Tumor protein, translationally-controlled 1 Up 
Bt.8140 FCER1G Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide Up 
Bt.44261 TNFRSF8 Tumor necrosis factor receptor superfamily, member 8 Up 
Bt.15528 MIF Macrophage migration inhibitory factor (glycosylation-inhibiting factor) Up 
Bt.62596 CCR1 Chemokine C-C motif receptor 1 Down 
Bt.2408 CCL2 Chemokine (C-C motif) ligand 2 Down 
Bt.42359 PLA2G7 Phospholipase A2, group VII  Down 
Bt.2047 ADM Adrenomedullin Down 
Bt.4990 ACVR2B Activin A receptor, type IIB Up 
Bt.16889 LTB4R Leukotriene B4 receptor Up 
Bt.167 MAPK1 Mitogen-activated protein kinase 1 Up 
Bt.52357 HRMT1L2 HMT1 hnRNP methyltransferase-like 2 Up 
Bt.4269 OTC Ornithine carbamoyltransferase Down 
Bt.24449 SDHA Succinate dehydrogenase flavoprotein subunit A Up 
Bt.23164 UQCRC1 UQCRC1 protein Up 
Bt.4001 HMOX1 Heme oxygenase (decyclizing) 1 Up 
Bt.2689 PRDX2 Peroxiredoxin 2 Up 
Bt.12916 GPX3 Glutathione peroxidase 3 (plasma) Up 
Bt.28278 ACE2 Angiotensin I converting enzyme 2 precursor Down 
Bt.32810 PDLIM1 PDZ and LIM domain 1 (elfin) Down 
Bt.64560  Transcribed locus Up 
Bt.43664  Transcribed locus Up 
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infection using a ileal-loop model of infection. Initially, we evaluated the kinetics of 
invasion by B. melitensis in bovine Peyer’s patches. The alimentary tract is the main 
route of invasion for B. abortus and B. melitensis (2, 171) however the portal(s) of entry 
is incompletely characterized. B. abortus was isolated from the small intestine of calves 
5 h after being fed infected milk (30) and from feces of coyotes orally infected (46), 
which suggest that in natural conditions viable Brucella are able to reach the intestinal 
Peyer’s patches. In our experiment, Brucella were recovered from intestinal tissue as 
early as 15 min post-infection, and the number of tissue-associated bacteria was maximal 
at 4 h PI (2x106 Brucella / g of tissue) and decreased later. The inverse relation between 
Brucella invasion and time post-infection was also observed in B. abortus S19-infected 
bovine ileal loops (1). The decreasing uptake through time was apparently related to the 
degeneration of Brucella in the intestinal lumen and consequent lack of adhesion due to 
surface modification. Another possibility might be the saturation of Brucella receptors in 
the epithelium, as was reported in Salmonella infection (21). A third reason for the 
decreased number of tissue-associated Brucella during the experiment could be the quick 
passage from the lumen through the tissue to the blood and lymphatic circulation. In this 
study, we isolated B. melitensis from general circulation, beginning as soon as 30 
minutes after inoculation. Other bacterial pathogens such as Salmonella, Yersinia and 
Shigella also colonize and invade the host through the Peyer’s patches at even higher 
numbers than we observed in this study (97, 235, 237), but their almost immediate 
presence in systemic blood after inoculation has not been reported. This data were 
unexpected as B. melitensis, thus the elucidation of the host and Brucella elements 
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responsible for this quick invasion and translocation will contribute to unraveling one of 
the most valuable secrets of the initial Brucella:host interaction. 
No significant histologic differences were observed in samples taken from ileal 
loops inoculated with culture media (control), H-K Brucella or fully virulent B. 
melitensis at any of the 7 time points evaluated. Similar to these results, Mense et al. 
(2001) did not detect substantial histologic changes or inflammatory responses in the 
respiratory tract in mice after 1 day of intranasal inoculation of B. melitensis (157). In 
contrast a mild acute inflammation at 4, 6 and 10 h after B. abortus S19 inoculation was 
observed in another study using the ileal loop model (1). These differences could due to 
differences in the Brucella species inoculated or to a host response to a larger inoculum 
(6x1011 vs. 3x109 CFU used in our study).  
Brucellosis is a chronic infectious disease and most of the current research has 
been focused on persistence (74, 109, 248). There is little knowledge of the virulence 
factors that influence the establishment of infection. One of the major virulence factors 
described in Brucella spp. is the virB operon which encodes a T4SS. Results from in 
vitro system of infection found that virB is not required for cellular invasion, but its 
expression, which begins 15 min after the bacteria is phagocytized and reaches maximal 
expression at 5 h PI (212), is indispensable for intracellular survival of Brucella (Chapter 
II and III of this dissertation, (48, 169, 213)). In our in vivo experiment, genes from virB 
operon were down regulated. Besides virB5 and virB11 (Appendix F), virB6, virB9 and 
virB10 were also down-regulated although they are not displayed in appendix F because 
they were not differentially expressed in more than three time points. The down 
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regulation of virB9 was also verified by qRT-PCR, confirming that the type IV secretion 
system was down-regulated. In addition, the transcriptional regulator vjbR (BMEII1116) 
that positively regulates the expression of the B. melitensis virB operon (48) was not 
differentially expressed in our microarray results. These data indicate that the T4SS was 
down-regulated in our in vivo model during the first 4 h PI. These results, in addition to 
those reported by Roux et al. who did not see differences in the number of B. abortus 
and B. melitensis WT and virB mutant recovered from mouse spleens in the first 3 days 
PI (196), suggest that virB apparently plays a minimal role in the initial in vivo Brucella 
pathogenesis. There may be environmental signals in vivo that affect the expression of 
the virB operon differently than in in vitro systems of infection. Identification of the host 
molecular targets of the T4SS will help characterize its expression in vivo. 
The unconventional lipopolysaccharide (LPS) component of the external 
membrane is another well-characterized virulence factor in Brucella (138, 227). LPS 
was shown to be active in inhibition of the early fusion of the Brucella-containing 
phagosomes and lysosomes (184) and directly involved in deficient CD4+ T cell 
activation (79). In our study, several genes encoding LPS biosynthesis were up-
regulated, suggesting active LPS participation during the initial Brucella:host 
interaction. It was hypothesized that LPS released during  intracellular replication and 
death of brucellae is integrated in lipid rafts that are recycled to the cell surface, where 
they form macrodomains in association with MHC class II (80, 137). The segregation of 
MHC class II molecules in macrodomains was postulated to be a possible mechanism 
responsible for the down-regulation of antigen presentation following Brucella infection 
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(79, 137). In our study 2 genes encoding MHC class II antigen presentation and several 
others whose products are involved in T cell activation were up-regulated, which would 
suggest early development of a T cell immune response. The up-regulation of MHC 
class II molecules was observed on the cell surface of mouse macrophages recovered 
from B. abortus LPS-inoculated mice (79). Altogether the previous data reaffirm that the 
down regulation of T cell activation in brucellosis is not a transcriptional regulation 
mechanism such as that described for another intracellular pathogen causing 
leishmaniasis (135) nor a direct suppressive effect on T cells, but instead an antigen 
presenting cell surface membrane modification that impairs efficient antigen 
presentation (137). 
Smooth brucellae were found to impair apoptosis in mononuclear cells, which 
was interpreted as a pathogen strategy to avoid being recognized and eliminated by the 
immune system (73, 86, 96). In our study, the molecular response of the host in the first 
4 h PI had an apoptotic profile. Interestingly, BCL2A1 was down-regulated in the first 4 
h PI in our study in both infected tissue and tissues inoculated with H-I B. melitensis, but 
the human homolog was observed up-regulated in B. suis-infected human monocytes at 
the same time point (96). The differences observed could be due to the complexity of our 
model system which includes the multiple cell types present in the intestinal tract as 
opposed to monocytes in in vitro culture.  Moreover, it could be interpreted as host 
innate immune response to prevent the establishment of persistent infection before 
Brucella interfere with the host gene expression. 
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A mathematical prediction model identified Brucella “mechanistic” candidate 
genes important for infection of bovine Peyer’s patches (Appendix J). Some of the 
candidate genes were identified as important during the whole period, while others were 
only identified as candidates for specific time points. Some of these genes do not occur 
among the core set of genes differentially expressed in the first 4 h PI because they were 
not detected differentially expressed in more than three time points. Among them we 
identified aroC (BMEI1506) which is necessary for biosynthesis of aromatic amino 
acids, and which is absolutely required for intracellular replication of Brucella, 
Salmonella and Shigella (35, 60, 82), and lon (BMEI0876), a stress response protease 
required for initial in vivo infection in a mouse model of brucellosis (192). Some of the 
mechanistic candidate genes were down-regulated, which could be interpreted in that 
their expression is deleterious for the pathogen’s early survival in vivo. These data need 
to be experimentally corroborated, but they suggest potential pathways for future 
research. 
In this study, we observed that the naïve bovine host immediately responded to 
Brucella infection by enhancing the transcriptional profile that is followed by a 
transcriptional down-regulation. The innate immune response has been recognized as a 
central defense mechanism that influences the development of adaptive immunity and is 
a critical component of local immunity in mammals (77). “Very early” post-infection, 
our study found that genes encoding proteins involved in the innate immune response 
such as complement components, bactericidal oxygen and nitrogen intermediates and 
neutrophil lysosomal enzymes were up-regulated. However, the role that these gene 
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products play in vivo in the early host protection against Brucella infection needs to be 
evaluated, as previous in vitro studies have demonstrated that smooth brucellae are not 
only resistant to complement-mediating killing (72) but also inhibit neutrophil 
degranulation (19, 172), NK cell activity (198) and are poor inducers of the respiratory 
burst (188) and bactericidal nitrogen intermediates (121, 150). In contrast, some of these 
genes were down-regulated in H-I B. melitensis-inoculated Peyer’s patches, which 
suggest that the host recognizes the pathogen as an inert element that does not need to be 
killed. 
Elicitation of the host immune response by Brucella spp. was reported earlier 
(29, 239). In this study, down-regulation of the genes encoding the pro-inflammatory 
cytokines IL8 and IL18 (both confirmed by qRT-PCR) were observed after 1 h PI. The 
same two cytokines were also down-regulated in B. melitensis-infected HeLa cells at 12 
h PI (Chapter III). However, IL8 mRNA expression was detected in a human 
macrophage cell line infected with B. suis in the first 5 h PI (56). This would suggest that 
the down-regulated expression of these 2 cytokines primarily originates in the 
epithelium, which supports our previous hypothesis about the active role of the 
epithelium in the early immune response to Brucella infection (Chapter III). IL8, but not 
IL18, is the major neutrophil chemoattractant in in vivo pathogenesis of S. typhimurium-
induced enteritis (204), and its down-regulation may be one of the primary reasons why 
PMN infiltration is not observed in Brucella-infected tissues. Moreover, IL18 is also a 
pro-inflammatory cytokine with broader biological functions, i.e. NK cell proliferation 
(83), apoptosis (123), Th1/Th2 response (110), and activation of T cell proliferation 
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(158); its role in the onset of brucellae infection needs to be defined, being apparently 
dispensable for persistence (239). Eosinophils are also absent in response to Brucella 
infection. The down-regulation of the eosinophil chemoattractant, eotaxin, and its 
receptor CCR3 (182) could contribute to the lack of eosinophil infiltration in Brucella-
infected tissues. Brucella LPS and outer membrane proteins (OMPs) were identified as 
responsible for disrupting the host immune response (90, 127). In our study, several 
previous uncharacterized OMPs were distinguished in silico as candidate genes 
important for early B. melitensis virulence (Appendix J) that must be experimentally 
corroborated. 
Monocyte migration inhibitory factor (MIF) is not only an important regulator of 
innate and adaptive immunity but also a positive regulator of other cellular activities. For 
instance, MIF is a chemoattractant for monocytes/macrophages in injured tissues 
through activation of CCL2 (95). In our study MIF was up-regulated after 1 h PI, but 
CCL2 was simultaneously down-regulated (both confirmed by qRT-PCR), which may 
explain the absence of monocyte infiltration in early Brucella infection. Furthermore, 
MIF binds CD74 and induces the activation of the ERK1/2 MAPK cascade and PGE2 
production (145). ERK1/2 (or MAPK1) is mainly involved in cell proliferation, 
differentiation and development (124). Dynamic Bayesian modeling analysis indicates 
that MIF and MAPK1 are candidate genes important for Brucella survival in the first 4 h 
post-infection of the bovine Peyer’s patch (Table 14). The influence of the genes and the 
relevance of the pathway in vivo must wait further experimental testing.  
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MIF also induces prostaglandin E2 (PGE2) production (145). PGE2, together with 
PGF2α are potent stimulators of myometrial contraction and cervical smooth muscle 
relaxation, playing a major role in parturition and abortion (63, 111). In our study, not 
only MIF was up-regulated, but also PTGES, which converts PGH2 to PGE2 (116), and 
20-beta-hydroxysteroid dehydrogenase-like gene (Bt.28223) involved in PGE2 to PGF2α 
conversion. The gene PGDH, which encodes a prostaglandin-inactivating enzyme, was 
down-regulated, and its down-regulation was observed during term or premature 
delivery (125). Interestingly, the human homolog gene was also observed down-
regulated in B. melitensis-infected HeLa cells at 12 h PI (Chapter III). The enhanced 
presence of FGL2 and the decreased activity of IL8 (genes encoding these proteins were 
up- and down-regulated in this study, respectively) were also implicated in abortion (38, 
211). The individual contribution of these genes in Brucella-induced abortion is 
unknown, but together they indicate an early pro-abortive transcriptional profile in the B. 
melitensis-infected host that deserves future study. 
In summary, we characterized several phenomena during the first 4 h of the B. 
melitensis: bovine host interaction. Our results demonstrate that Brucella are able to 
invade the host via intestinal Peyer’s patches and are present in systemic blood by 30 
min post-infection. A common set of genes was identified as differentially expressed in 
Brucella, while two different transcriptional profiles were observed in the bovine host 
early in the infection. The accesisibility to new techniques such as laser capture 
microdissection (LCM) will allow study of the temporal expression profile of both 
Brucella and host more accurately, allowing determination of how Brucella modify their 
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transcriptome inside different cell types and how these cells respond to Brucella 
infection. Increasingly powerful software and modeling approaches will facilitate the 
connectivity of Brucella effectors with host targets for better understanding of the 
Brucella:host interaction for subsequent therapeutic and vaccine research. 
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CHAPTER V 
CONCLUSIONS 
 
 Brucella spp. are the etiologic agents of brucellosis, causing world-wide zoonotic 
infectious disease that results in abortion and infertility in animals and a chronic 
debilitating illness in humans. Brucella melitensis is one of the six species of the genus 
Brucella and considered potential bioterrorist agent due to its high virulence to humans. 
The objective of this study was to elucidate the molecular pathogenesis of brucellosis by 
by characterizing the alterations in the transcriptome of the host and B. melitensis during 
their early interactions. The hypothesis was that the dynamics of Brucella:host 
interactions modifies gene expression levels in both genomes during the early infectious 
process lead to the eventual benefit of the pathogen and to the detriment of the naïve 
host. 
 To test the hypothesis and accomplish the overall objective, specific goals were 
elaborated. Initially, the Brucella invasion–associated transcriptome was characterized 
and relevant genes for Brucella invasion in non-professional phagocytic cells were 
identified. In these experiments, B. melitensis invasiveness and gene expression were 
found to be associated with the phase of in vitro growth, as illustrated phenotypically by 
HeLa cell internalization, and molecularly by 454 differentially expressed genes 
identified by cDNA microarray technology. Two of eight differentially expressed genes 
were confirmed to be important for internalization in non-phagocytic cells which may 
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indicate that approximately 25% (or about 115 genes) of the differentially expressed 
detected genes may participate in the invasion process.  
The next specific goal was to characterize the transcriptome of B. melitensis and 
the epithelial-like HeLa cell line to identify initial strategies of the pathogen for 
intracellular survival and replication, and perturbations of major gene(s) modulating 
critical cellular pathways in the host during the initial Brucella infectious process. 
Microarray-based studies revealed that both host and pathogen had initial down-
regulated expression profiles at 4 h PI that were reversed at 12 h PI. Very little is known 
about which effectors are utilized by Brucella to survive intracellularly nor which host 
molecules are targeted to benefit the pathogen in detriment of the naïve host. These 
experiments revealed numerous specific genes and pathways, thus further elucidating 
interactive mechanisms during the early infectious process. Two of the in silico 
identified genes were confirmed to be critical for the intracellular life style of Brucella in 
non-phagocytic cells in the first 12 h PI, validating in silico generated data as a powerful 
tool to identify invasion and survival mechanisms of Brucella. Future investigations 
should explore other specific in silico identified host and pathogen biological processes, 
pathways or genes to further characterize the initial molecular host:Brucella intracellular 
interactions. 
Finally, the morphological changes and the temporal transcription profiles of 
both B. melitensis and the bovine host were investigated during their initial interactions 
to expand our understanding of how this interaction modulates the outcome of the 
infectious process. Host invasion of Peyer’s patches by B. melitensis and the presence of 
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Brucella in systemic blood within 30 minutes was confirmed, and the in vivo 
transcriptional profiles of both B. melitensis and bovine host were characterized at 
multiple times during the first 4 h PI. These in vivo experiments generated data that 
conflicts with previously published in vitro findings. For instance, the virB operon was 
down-regulated providing evidence that it may not be essential for in vivo B. melitensis 
invasion. Also pro-apoptotic and anti-inflammatory expression profiles were identified 
in the host during the first 4 h PI, and genes encoding proteins related with interruption 
of pregnancy and abortion were differentially expressed. These findings can be extended 
by using laser capture micro dissection (LCM) to further the define pathways and genes 
expressed by Brucella in specific cell types and identify host responsive genes. By 
combining gene deletion mutants of Brucella with specific host genes knocked down by 
siRNA the in vivo host:Brucella interactions can be more effectively understood. As 
more powerful bioinformatics are developed, these new tools will connect Brucella 
effector genes with host targets for a clearer understanding of the Brucella:host 
interactions for application to improved therapeutics and vaccines.  
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APPENDIX A 
TABLE A.1. Genes significantly altered in B. melitensis grown in F12K tissue 
culture medium to late-log phase, compared to stationary phase under the same 
conditions 
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
 
DNA replication, recombination and repair 
BMEI0453 MutT/NUDIX family protein 5.2 69.1 60.8 0.007082 
BMEI0462 Phosphohydrolase (MutT/NUDIX family protein) 37.8 122.2 132.0 0.01818 
BMEI0880 Single-strand binding protein 2.9 124.0 124.9 0.029169 
BMEI0901 Resolvase 2.5 2.8 2.8 0.005101 
BMEI1321 DNA polymerase, bacteriophage-type 3.1 3.8 3.9 0.008698 
BMEI1362 Chromosomal replication initiator protein DnaA 3.8 300.9 449.2 0.029257 
BMEI1409 Transposase  11.7 201.6 264.4 0.013443 
BMEI1420 Transposase  123.0 123.0 123.0 0.009518 
BMEI1422 Transposase  75.6 94.8 95.0 0.005182 
BMEI1485 Replicative DNA helicase 15.2 66.6 60.5 0.024788 
BMEI1815 Transposase  6.2 80.0 70.3 0.037454 
BMEI1910 Recombination protein RecR 4.3 88.2 77.7 0.028354 
BMEI1942 DNA polymerase III subunit beta 5.95 160.0 170.9 0.040039 
BMEII0183 Transposase  5.8 8.7 9.8 0.011806 
BMEII0290 DNA polymerase III subunit epsilon 4.0 55.4 76.8 0.027906 
BMEII0447 Transporter  2.5 4.9 5.3 0.00539 
BMEII0527 Exodeoxyribonuclease VII large subunit 4.0 112.5 111.0 0.001261 
BMEII0663 Phosphohydrolase (MutT/NUDIX family protein) 98.8 141.2 152.2 0.025194 
BMEII0676 DNA topoisomerase IV subunit B 2.53 2.8 2.9 0.014043 
BMEII0713 Transposase  174.2 311.0 324.6 0.000368 
BMEII0716 Transposase  6.4 67.6 63.1 0.041021 
      
Transcription 
BMEI0280 RNA polymerase sigma 32 factor -5.0 -10.0 -4.3 0.004316 
BMEI0510 Leucine-responsive regulatory protein 59.4 87.2 76.0 0.004841 
BMEI1098 Transcriptional regulatory protein, AsnC family 4.3 10.7 10.1 0.032585 
BMEI1379 Transcriptional regulator BetI 6.0 155.2 169.8 0.008584 
BMEI1384 Transcriptional regulator, AraC family  -20.0 -20.7 -17.0 0.005425 
BMEI1717 Transcriptional regulator, IclR  4.3 12.2 13.3 0.006167 
BMEI1758 Transcriptional activator, LuxR family  221.6 221.6 221.6 0.011148 
BMEI1789 DNA-directed RNA polymerase subunit N (sigma-54 factor rpon) 7.56 113.6 92.1 0.017962 
BMEI1845 Transcriptional regulatory protein, AsnC family  100.0 100.0 100.0 0.018725 
BMEII0092 Replication protein B 54.4 74.6 71.5 0.017128 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII0127 Acetate operon repressor 2.6 34.9 41.4 0.018305 
BMEII0143 Transcriptional regulator, AraC family 13.1 120.6 110.8 0.011801 
BMEII0346 Transcriptional regulatory protein, AsnC family 39.3 39.1 39.1 0.00386 
BMEII0372 Transcriptional regulator, MerR family  3.9 91.5 64.7 0.039435 
BMEII0383 Transcriptional regulator, GntR family  37.4 37.4 37.4 0.026822 
BMEII0426 Transcriptional regulator, DeoR family  44.9 44.9 44.9 0.005492 
BMEII0436 Transcriptional regulator, DeoR family  8.8 94.1 98.6 2.60E-03 
BMEII0467 Transcriptional regulator, MerR family  37.0 88.1 86.1 0.021261 
BMEII0520 Transcriptional regulator, MarR family  -7.2 -7.4 -6.4 0.009266 
BMEII0573 Transcriptional regulator, RpiR family  56.5 103.4 109.5 0.026452 
BMEII0721 Transcriptional regulator, AraC family  13.7 107.2 98.6 0.013143 
BMEII0807 Transcriptional regulator, GntR family  4.4 219.3 202.1 0.007073 
BMEII0902 Transcriptional regulator protein, LysR family  34.2 34.2 34.2 0.007487 
BMEII1007 Transcriptional regulator, GntR family  7.0 61.0 508.9 0.001131 
BMEII1077 Transcriptional regulator protein, LysR family  3.2 55.4 72.3 0.0216 
BMEII1093 Glycerol-3-phosphate regulon repressor  386.5 386.5 386.5 0.004118 
BMEII1135 Transcriptional regulator protein, LysR family  2.3 3.1 3.1 0.008648 
      
Translation, ribosomal structure and biogenesis 
BMEI0277 Heat shock protein 15 2.4 3.3 3.2 0.008141 
BMEI0616 tRNA delta(2)-isopentenylpyrophosphate transferase 9.4 73.7 69.1 0.005714 
BMEI0890 Queuine tRNA-ribosyltransferase 5.8 174.1 212.4 0.011321 
BMEI0934 ATP-dependent RNA helicase RhlE 3.4 46.4 36.4 0.032457 
BMEI1671 Translation initiation factor IF-1 2.4 4.3 4.8 0.031672 
BMEI1798 23S ribosomal RNA methyltransferase 164.3 171.4 172.6 0.005135 
BMEI1959 Methyltransferase 213.5 213.5 213.5 0.004073 
BMEI1960 Methyltransferase 8.1 85.8 89.3 0.021941 
BMEII0276 Ribonuclease P 6.4 274.5 226.0 0.008062 
BMEII0278 Translation initiation inhibitor  4.4 8.1 7.2 0.004336 
BMEII0597 23S ribosomal RNA methyltransferase 4.4 7.8 8.4 0.012347 
BMEII0890 16S ribosomal RNA m(5)C 967 methyltransferase 30.7 88.8 77.7 0.02906 
      
Nucleotide metabolism 
BMEI0358 Deoxyuridine 5'-triphosphate nucleotidohydrolase 6.95 114.4 100.3 3.90E-05 
BMEI0608 Thymidylate synthase 91.7 91.7 91.7 0.012037 
BMEI1281 Dihydroorotase 2.3 2.5 2.5 0.002812 
BMEI1571 Guanine deaminase -5.1 -11.4 -4.9 0.011304 
BMEI1575 Xanthine dehydrogenase  2.9 76.7 79.6 0.021288 
BMEI1576 Xanthine dehydrogenase  68.3 257.3 254.9 0.000524 
BMEI1639 Dihydropyrimidine dehydrogenase 94.7 123.0 122.3 0.014601 
BMEII0088 Inosine-uridine preferring nucleoside hydrolase 10.5 785.5 1058.8 0.021628 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII0627 Probable adenine deaminase  3.4 177.2 223.8 0.013583 
      
Carbohydrate metabolism 
BMEI0344 
Phosphoglucosamine 
mutase/phosphoacetylglucosamine 
mutase/phosphomannomutase 
51.3 84.9 76.9 0.010824 
BMEI0921 UDP-glucose 4-epimerase -7.6 -11.6 -6.7 0.005944 
BMEI0974 Ribose-5-phosphate isomerase A 97.5 158.0 157.0 0.008367 
BMEI1237 UDP-glucose 4-epimerase 2.6 2.6 2.8 0.039446 
BMEI1436 Pyruvate phosphate dikinase 5.5 67.3 58.8 0.029235 
BMEI1570 Putative hydroxypyruvate reductase  3.7 116.9 114.9 0.040269 
BMEII0355 D-galactose 1-dehydrogenase  4.3 85.1 111.2 0.020829 
BMEII0430 Erythritol kinase  3.5 103.2 118.8 0.03274 
BMEII0476 Uronate isomerase 55.8 55.8 55.8 0.017535 
BMEII0568 Myo-inositol-1(or 4)-monophosphatase  2.7 4.7 4.6 0.023251 
BMEII0574 Myo-inositol 2-dehydrogenase  154.3 154.3 154.3 0.023522 
BMEII0724 Endoglucanase H 3.7 208.4 206.4 0.013526 
BMEII0823 Glycerol kinase 58.9 58.9 58.9 0.005347 
BMEII0850 GDP-fucose synthetase  6.5 285.5 453.3 0.032125 
BMEII1095 L-fuculose phosphate aldolase  5.5 164.6 194.1 0.010794 
      
Lipid metabolism 
BMEI0099 3-hydroxybutyryl-CoA dehydrogenase 3.1 10.9 11.5 0.03388 
BMEI0166 Acyl-CoA thioesterase II 3.85 76.7 81.4 0.032527 
BMEI0477 Monoamine oxidase regulatory protein, putative  41.3 64.1 63.4 0.035528 
BMEI0688 3-hydroxyisobutyrate dehydrogenase 81.9 82.0 81.9 0.020739 
BMEI0897 Glutaryl-CoA dehydrogenase 2.7 68.1 66.2 0.021585 
BMEI1024 3-hydroxyisobutyrate dehydrogenase 8.8 177.8 185.3 0.018569 
BMEI1235 Short-chain dehydrogenase 49.2 49.2 49.2 0.010489 
BMEI1473 3-oxoacyl-(acyl carrier protein) synthase 2.3 2.4 2.4 0.003662 
BMEI1478 Acyl-carrier-protein S-malonyltransferase 9.1 62.1 49.2 0.023269 
BMEI1709 Oxidoreductase UcpA 2.7 3.8 3.4 0.028269 
BMEI1861 Arylesterase precursor  5.2 134.7 154.4 0.029325 
BMEII0047 Lysophospholipase L2 47.2 47.2 47.2 0.008023 
BMEII0239 Cardiolipin synthetase  14.4 170.8 182.4 0.017839 
BMEII0514 3-ketoacyl (acyl-carrier-protein) reductase 4.5 139.2 197.5 0.033898 
BMEII1103 Phosphatidylglycerophosphatase B 3.6 148.1 143.9 0.02058 
      
Amino acid metabolism 
BMEI0028 L-sorbose dehydrogenase [FAD] 13.1 76.2 63.6 0.027971 
BMEI0559 5,10-methylenetetrahydrofolate reductase  2.7 3.0 2.9 0.017735 
BMEI0591 Xaa-Pro aminopeptidase 94.4 144.8 134.7 0.01548 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEI0617 Acetolactate synthase III large subunit 54.4 146.4 125.8 0.014389 
BMEI0647 Urease alpha subunit 42.7 42.7 42.7 0.021861 
BMEI0706 CobC protein 46.8 46.8 46.8 0.016867 
BMEI0730 Lactoylglutathione lyase 163.9 163.9 163.9 0.011144 
BMEI1365 Protease II 88.2 260.5 308.2 0.015829 
BMEI1380 Choline dehydrogenase 6.2 295.9 360.4 0.025683 
BMEI1617 O-succinylhomoserine sulfhydrylase -18.6 -136.3 -14.6 0.006793 
BMEI1719 Sarcosine oxidase gamma subunit  4.0 27.3 10.5 0.005638 
BMEI1720 Sarcosine oxidase alpha subunit  24.0 64.0 64.1 0.021308 
BMEI1781 Carbamoyl-phosphate synthase large chain  22.8 124.4 148.7 0.009883 
BMEI1905 Prephenate dehydratase 4.7 154.1 118.3 0.033418 
BMEII0012 Oligoendopeptidase F 41.9 96.1 100.6 0.021343 
BMEII0040 Glutamate synthase [NADPH] large chain 14.8 92.1 90.6 0.024754 
BMEII0049 N-formylglutamate deformylase 8.6 69.6 73.0 0.020268 
BMEII0134 5-carboxymethyl-2-hydroxymuconate delta-isomerase  234.53 298.8 302.4 0.002041 
BMEII0135 5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase 3.16 9.7 10.3 0.037007 
BMEII0136 Homoprotocatechuate 2,3-dioxygenase 23.7 170.7 164.3 0.026465 
BMEII0404 3-isopropylmalate dehydrogenase 5.0 103.4 89.7 0.01957 
BMEII0546 Metal-activated pyridoxal enzyme  2.5 2.6 2.6 0.004646 
BMEII0582 Sarcosine oxidase beta subunit  77.9 147.5 151.7 0.002203 
BMEII0756 N-acetylglucosamine kinase  13.7 147.8 107.9 0.018282 
BMEII0907 Glutaminase  4.6 152.4 128.0 0.03523 
BMEII0910 Glutamate decarboxylase beta  3.1 136.3 113.9 0.041125 
BMEII0964 Asparagine synthetase B (glutamine-hydrolyzing) 14.4 331.3 323.2 0.00443 
BMEII1054 ATP phosphoribosyltransferase 2.3 2.4 2.3 0.002473 
BMEII1055 ATP phosphoribosyltransferase regulatory subunit 5.8 251.7 103.8 0.038745 
      
Secondary metabolite biosynthesis, transport and metabolism 
BMEI1560 Salicylaldehyde dehydrogenase  3.9 81.9 68.3 0.023819 
BMEI1860 Hypothetical transmembrane oxidoreductase 2.4 2.7 2.5 0.018287 
BMEII0078 2,3-dihydroxybenzoate-AMP ligase 221.0 221.0 221.0 0.015707 
BMEII0079 Isochorismatase 55.6 105.4 92.1 0.010724 
BMEII0580 Probable blue-copper protein YacK precursor  2.7 6.8 7.7 0.019374 
      
Energy production and conversion 
BMEI0475 Cytochrome C1 15.13 180.3 164.8 0.016951 
BMEI0548 Flavohemoprotein 99.2 99.2 99.2 0.004279 
BMEI0836 Citrate synthase -3.7 -5.0 -3.3 0.008278 
BMEI0898 Predicted acyl-CoA transferase/Carnitine dehydratase 2.8 3.7 4.1 0.017818 
BMEI1462 Cytochrome C oxidase polypeptide III 5.6 152.0 114.1 0.008024 
BMEI1465 Cytochrome C oxidase polypeptide I  2.85 3.3 3.2 0.0006 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEI1591 Ferredoxin-NADP reductase 49.2 72.7 72.4 0.009468 
BMEI2037 Phosphoenolpyruvate carboxykinase 113.9 155.7 158.2 0.021717 
BMEII0135 5-carboxymethyl-2-hydroxymuconate semialdehyde dehydrogenase  3.16 9.7 10.3 0.037007 
BMEII0141 Aldehyde dehydrogenase 137.2 166.5 169.7 0.004314 
BMEII0241 Coniferyl-aldehyde dehydrogenase 35.8 71.0 71.6 0.024943 
BMEII0246 Nitroreductase  78.7 78.7 78.7 0.000402 
BMEII0255 Iron-sulfur cluster-binding protein 3.6 75.5 83.5 0.026113 
BMEII0378 Formate dehydrogenase alpha chain  214.2 214.2 214.2 0.005487 
BMEII0388 Piperideine-6-carboxylate dehydrogenase 5.5 106.7 101.4 0.007737 
BMEII0553 Alcohol dehydrogenase -5.3 -6.6 -4.8 0.005386 
BMEII0588 Formate dehydrogenase accessory protein 11.5 66.6 56.3 0.028185 
BMEII0771 Hydroxyacylglutathione hydrolase  23.4 23.4 23.4 0.000994 
BMEII0876 Quinone oxidoreductase  51.5 99.7 97.6 0.005751 
BMEII0950 Nitrate reductase alpha chain  193.9 282.4 290.3 0.016923 
BMEII0951 Nitrate reductase beta chain  4.1 408.9 512.2 0.019189 
BMEII0965 Pseudoazurin  3.8 41.8 44.0 0.016079 
BMEII0973 Nitrous-oxide reductase precurser 24.8 43.0 42.2 0.03814 
BMEII1005 Malate dehydrogenase  4.9 144.5 103.8 0.01867 
BMEII1019 Alpha-methylacyl-CoA racemase  3.0 173.7 194.3 0.029976 
BMEII1073 Cytochrome b561 31.9 31.9 31.9 0.009619 
      
Inorganic ion transport and metabolism 
BMEI0317 Integral membrane protein 72.2 97.4 95.2 0.017047 
BMEI0450 Cobalt-Zinc-Cadmium resistance protein CzcD 5.3 8.2 7.0 0.009439 
BMEI0511 TRK system potassium uptake protein TrkH 7.2 67.7 49.0 0.031708 
BMEI0639 CbiM protein 124.1 275.3 278.9 0.003432 
BMEI0640 CbiM protein -2.6 -3.0 -2.7 0.001693 
BMEI0660 Metal chelate transport ATP-binding protein 2.4 2.5 2.5 0.007193 
BMEI1988 Phosphate transport system permease protein PstC  -3.9 -3.9 -3.7 0.001835 
BMEII0338 ABC transporter substrate binding protein 4.9 98.6 96.6 0.001187 
BMEII0487 Nickel-binding periplasmic protein precursor 10.2 106.7 61.5 0.029493 
BMEII0488 Nickel transport system permease protein NikB 10.0 88.4 73.1 0.006553 
BMEII0536 Iron(III) dicitrate transport system permease protein FecD  4.2 105.8 126.6 0.013862 
BMEII0567 Iron(III)-transport ATP-binding protein SfuC  7.5 383.3 497.7 0.022023 
BMEII0581 Superoxide dismutase (Cu-Zn) 7.4 99.2 80.5 0.010658 
BMEII0704 Bacterioferritin  3.2 3.5 4.0 0.032068 
BMEII0765 Potassium efflux system protein PhaG  26.9 138.0 129.4 0.022215 
BMEII0767 Potassium efflux system protein PhaE  5.3 92.0 76.3 0.024117 
BMEII0883 High-affinity iron permease 13.0 151.4 64.8 0.039901 
BMEII1011 Sulfite reductase (NADPH) flavoprotein alpha-component  19.9 200.1 214.6 0.010442 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII1120 Iron(III)-binding periplasmic protein precursor  20.8 131.3 137.1 0.016841 
      
Cofactor transport and metabolism 
BMEI0176 Porphobilinogen deaminase 4.1 33.0 41.5 0.006669 
BMEI0177 Uroporphyrinogen-III synthetase 2.3 2.9 2.9 0.02117 
BMEI0690 Cobyric acid synthase 215.6 279.7 296.5 0.020047 
BMEI0700 Precorrin-3B C17-methyltransferase 2.4 2.9 2.6 0.03227 
BMEI0841 Molybdopterin biosynthesis MoeA protein -3.0 -3.2 -2.7 0.00438 
BMEI0842 Molybdenum cofactor biosynthesis protein C -5.1 -6.7 -4.5 0.007319 
BMEI0886 Phosphopantetheine adenylyltransferase 73.1 73.3 73.5 0.010854 
BMEI0954 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase 2.3 2.5 2.4 0.025565 
BMEI1187 Riboflavin synthase subunit beta 4.1 57.9 61.1 0.017448 
BMEI1517 Pyridoxamine 5'-phosphate oxidase 4.4 6.0 7.8 0.04036 
BMEI1592 3-methyl-2-oxobutanoate hydroxymethyltransferase 2.5 2.6 2.6 0.023893 
BMEI1735 Thiazole synthase 2.7 78.3 84.1 0.038439 
BMEI1902 Molybdopterin biosynthesis enzyme 6.8 26.0 40.9 0.034044 
BMEII0077 Isochorismate synthase DhbC 17.1 70.5 58.8 0.02942 
BMEII0775 Biotin synthase  18.5 97.3 106.1 0.007341 
BMEII0834 Glutamate-1-semialdehyde 2,1-aminomutase 2.7 4.2 4.4 0.019027 
BMEII1010 Thiamine biosynthesis lipoprotein ApbE precursor  3.2 85.8 105.2 0.028487 
BMEII1044 Rivoflavin kinase/FMN adenylyltransferase 5.3 139.8 147.3 0.00776 
      
Cell envelope, biogenesis and outer membrane 
BMEI0271 Monofunctional biosynthetic peptidoglycan transglycosylase 7.5 75.9 56.6 0.028509 
BMEI0402 31 kDa outer-membrane immunogenic protein precursor 4.2 4.9 4.5 0.017121 
BMEI0418 Lipooligosaccharide biosynthesis protein Lic2B 23.0 62.7 56.2 0.018425 
BMEI0566 Soluble lytic murein transglycosylase  -3.6 -4.8 -3.5 0.001835 
BMEI0586 UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase 21.1 419.8 394.4 0.001476 
BMEI0786 Outer membrane protein 11.6 141.4 133.5 0.033327 
BMEI0814 Penicillin-binding protein 6 (D-alanyl-D-alanine carboxypeptidase fraction C)  99.9 151.9 141.9 0.032178 
BMEI0833 UDP-N-acetylglucosamine acyltransferase 70.6 145.1 156.5 0.00953 
BMEI0991 RarE lipoprotein A 3.8 6.1 6.5 0.00441 
BMEI1079 Lipoprotein NlpD 16.2 250.2 173.5 0.043447 
BMEI1175 Putative capsule polysaccharide export protein precursor  6.5 193.0 176.1 0.020777 
BMEI1414 Perosamine synthetase 133.4 156.9 161.9 0.027191 
BMEI1493 Peptidoglycan binding protein (LysM domain) 3.3 55.1 61.3 0.036401 
BMEI1626 N-acetylglucosaminyltransferase  4.2 89.4 92.6 0.012732 
BMEI1707 Mandelate racemase 42.5 265.7 298.4 0.010775 
BMEII0083 Basic membrane protein A precursor  255.3 255.3 255.3 0.000461 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII0084 Basic membrane protein A precursor  156.3 156.3 156.3 0.006337 
BMEII0157 Hypothetical protein 69.7 99.9 99.0 0.011761 
BMEII0376 Heat resistant agglutinin 1 precursor  100.2 100.2 100.2 0.023267 
BMEII0472 Membrane fusion protein MtrC  86.7 185.5 185.5 0.012122 
BMEII0727 UDP-glucose 6-dehydrogenase  36.1 248.0 218.4 0.011001 
BMEII0729 Cellulose synthase catalytic subunit (UDP-forming) 89.1 106.0 109.3 0.002611 
BMEII0731 dTDP-glucose 4-6-dehydratase 62.1 87.4 88.3 0.001361 
BMEII0836 dTDP-4-dehydrorhamnose 3,5-epimerase  53.2 53.2 53.2 0.026117 
BMEII1101 Bactroprenol glucosyl transferase/Bactoprenol apolipoprotein N-acyltransferase  4.3 190.3 160.5 0.026543 
BMEII1128 Succinoglycan biosynthesis protein ExoM 3.6 55.8 50.1 0.00868 
BMEII1130 Probable UDP-N-acetyl-D-mannosaminuronic acid transferasa  76.9 83.3 83.1 0.002959 
      
Membrane transport 
BMEI0113 Asparagine transport system permease protein 73.4 73.4 73.4 0.003179 
BMEI0263 Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein precursor 3.1 10.6 10.1 0.01319 
BMEI0264 Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein precursor 10.3 234.4 181.7 0.017178 
BMEI0642 Urea transporter 94.4 94.4 94.4 0.003138 
BMEI0654 ABC transporter ATP-binding protein 23.7 346.4 384.7 0.004751 
BMEI0797 Transporter 6.9 478.8 464.2 0.010229 
BMEI1022 Arginine/Ornithine-binding periplasmic protein precursor 4.2 244.4 209.7 0.017741 
BMEI1041 ABC transporter ATP-binding protein -5.0 -5.5 -3.9 0.010444 
BMEI1416 O-antigen export system ATP-binding protein RfbB 207.7 207.7 207.7 0.015649 
BMEI1554 Transporter, MFS superfamily 87.2 87.2 87.2 0.015542 
BMEI1580 Mannitol transporter, large subunit  3.5 69.6 72.8 0.017358 
BMEI1713 Maltose/maltodextrin transport ATP-binding protein MalK  234.4 437.5 458.8 0.005988 
BMEI1912 Sugar transporter 44.3 89.7 87.9 0.015466 
BMEII0025 Attachment mediating protein VirB1 homolog  9.0 115.3 109.3 0.010999 
BMEII0027 Channel protein VirB3 homolog 2.2 165.3 141.1 0.042572 
BMEII0034 Channel protein VirB10 homolog 81.6 81.6 81.6 0.025033 
BMEII0038 D-serine/D-alanine/glycine transporter 35.03 236.2 243.8 0.003534 
BMEII0066 High affinity branched-chain amino acid transport ATP-binding protein LivG 11.7 85.3 90.2 0.012414 
BMEII0087 Sugar ABC transporter, permease protein  40.3 151.7 134.9 0.033397 
BMEII0098 High affinity branched-chain amino acid transport ATP-binding protein LivF 5.6 135.9 137.1 0.014354 
BMEII0099 High affinity branched-chain amino acid transport ATP-binding protein LivG 86.2 86.2 86.2 0.016303 
BMEII0102 High affinity branched-chain amino acid transport system permease protein LivH 13.7 123.2 113.2 0.003106 
BMEII0103 Leu/ile/val-binding protein precursor 10.2 154.4 159.9 0.008315 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII0114 Sn-glycerol-3-phosphate transport system permease protein UgpE 5.9 55.6 40.7 0.008082 
BMEII0144 Xylose transport system permease protein XylH  84.1 84.1 84.1 0.011375 
BMEII0196 Spermidine/putrescine-binding periplasmic protein  7.7 65.8 66.1 0.02712 
BMEII0200 Oligopeptide transport ATP-binding protein OppD  5.8 40.8 35.4 0.046728 
BMEII0223 Oligopeptide transport ATP-binding protein OppF  69.4 69.4 69.4 0.020388 
BMEII0284 Periplasmic dipeptide transport protein precursor  2.8 49.2 39.9 0.025605 
BMEII0285 Dipeptide transport system permease protein DppB  6.6 262.1 306.1 0.019232 
BMEII0302 Ribose transport system permease protein RbsC 3.4 44.7 25.4 0.028921 
BMEII0340 High affinity branched-chain amino acid transport system permease protein LivM 4.2 4.7 4.7 1.00E-04 
BMEII0342 High affinity branched-chain amino acid transport ATP-binding protein LivF 67.6 100.6 91.8 0.005617 
BMEII0481 ABC transporter ATP-binding protein 6.0 303.9 289.7 0.016367 
BMEII0483 ABC transporter integral membrane protein 3.0 19.3 22.0 0.01803 
BMEII0517 Branched-chain amino acid transport protein AzlC  14.7 169.0 154.7 0.00594 
BMEII0548 Glycine betaine/L-proline transport ATP-binding protein ProV  4.1 101.4 120.6 0.025865 
BMEII0583 Iron(III)-transport ATP-binding protein SfuC  102.3 102.3 102.3 0.004557 
BMEII0596 Methylenomycin A resistance protein  8.1 97.8 76.0 0.023565 
BMEII0618 Xanthine/uracil permease  5.7 193.7 206.2 0.02544 
BMEII0621 Sn-glycerol-3-phosphate transport system permease protein UgpC 81.4 81.4 81.4 0.02135 
BMEII0622 Sn-glycerol-3-phosphate transport system permease protein UgpE 158.6 185.6 176.9 0.015793 
BMEII0623 Sn-glycerol-3-phosphate transport system permease protein UgpE -16.2 -18.0 -13.9 0.006297 
BMEII0624 Sn-glycerol-3-phosphate transport system permease protein UgpA 58.3 102.1 105.0 0.014122 
BMEII0628 High affinity branched-chain amino acid transport ATP-binding protein LivF 9.0 87.8 68.7 0.013577 
BMEII0662 Transporter, Msf superfamily 55.2 109.0 104.0 0.015113 
BMEII0691 Periplasmic oligopeptide-binding protein precursor  4.0 74.9 63.7 0.031048 
BMEII0737 Oligopeptide transport system permease proteinOppC 3.0 88.3 70.2 0.012229 
BMEII0753 Sorbitol/mannitol transport inner membrane protein  3.4 42.2 45.3 0.039989 
BMEII0755 Sugar-binding protein  2.8 9.0 8.6 0.036941 
BMEII0845 Lipopolysaccharide N-acetylglucosaminyltransferase -2.8 -3.5 -2.6 0.014534 
BMEII0851 Exopolysaccharide production protein ExoF precursor  14.3 344.7 451.8 0.020084 
BMEII0861 Oligopeptide transport system permease protein AppC  5.6 375.3 490.0 0.018617 
BMEII0863 Oligopeptide transport ATP-binding protein AppD  8.3 128.5 79.9 0.029032 
BMEII0864 Oligopeptide transport ATP-binding protein AppF  45.4 44.0 44.0 0.02127 
BMEII0868 Leucine-specific binding protein precursor  235.6 396.7 402.3 0.000378 
BMEII0875 Leucine-specific binding protein precursor  3.7 7.6 6.5 0.023208 
BMEII0922 Spermidine/putrescine transport ATP-binding protein PotA  9.2 86.1 83.4 0.004857 
BMEII1122 Iron(III)-transport system permease protein SfuB  71.7 71.7 71.7 0.003809 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
Defense mechanisms 
BMEI0403 Multiple antibiotic resistance protein MarC 163.0 262.8 256.8 0.012425 
BMEI0656 Daunorubicin resistance transmembrane protein  98.95 98.95 98.95 0.0151 
BMEI0893 Acriflavin resistance protein B 10.46 12.4 9.8 0.00035 
BMEII0380 Acriflavin resistance protein A precursor 267.76 267.76 267.76 0.009676 
BMEII0382 Acriflavin resistance protein D 94.95 175.5 161.3 0.008164 
BMEII0451 Type I restriction-modification system methylation   -3.6 -3.9 -3.2 0.007363 
BMEII0533 Fusaric acid resistance protein FusE  15.6 145.4 161.5 0.027832 
BMEII0801 Daunorubicin resistance transmembrane protein  3.2 160.2 136.7 0.021329 
BMEII0914 Acriflavin resistance protein A precursor 5.4 130.8 161.9 0.030513 
BMEII0916 Acriflavin resistance protein D 78.66 78.66 78.66 0.020278 
      
Signal transduction 
BMEI0067 cAMP-dependent protein kinase regulatory subunit 2.3 2.9 2.9 0.00272 
BMEI0372 Sensory transduction regulatory protein -6.2 -7.3 -5.1 0.00684 
BMEI0374 Sensory transduction histidine kinase -3.8 -4.4 -3.6 0.003242 
BMEI1328 Sensory transduction histidine kinase 3.3 131.0 122.6 0.030607 
BMEI1582 Transcriptional regulatory protein DegU  37.7 46.7 43.8 0.003334 
BMEI1606 Sensory transduction histidine kinase 2.8 3.3 3.0 0.023505 
BMEI2034 Sensor protein ChvG 3.8 36.9 38.5 0.003834 
BMEII0292 Response regulator protein  2.9 3.6 3.5 0.001663 
BMEII1027 Hypothetical protein 2.4 4.1 3.9 0.011999 
      
Post-translational modification and secretion, protein turnover and chaperones 
BMEI0643 Urease accessory protein UreD 32.4 32.4 32.4 0.012636 
BMEI0644 Urease accessory protein UreG 9.3 202.1 196.6 0.029832 
BMEI0645 Urease accessory protein UreF 70.1 70.1 70.1 0.026077 
BMEI0646 Urease accessory protein UreE 49.7 49.7 49.7 0.001821 
BMEI0783 Protease DO 49.6 188.8 162.3 0.011156 
BMEI1080 Protein-L-isoaspartate O-methyltransferase -16.3 -17.0 -15.7 0.000502 
BMEI1331 Cytochrome C-type biogenesis protein CycL  4.1 158.5 164.5 0.005198 
BMEI1574 XdhC protein (assists in molybdopterin insertion into xanthine dehydrogenase) 4.6 110.5 107.5 0.000469 
BMEI1655 Urease accessory protein UreD 15.1 371.3 391.2 0.037834 
BMEI1793 Putative protease IV -2.5 -2.5 -2.2 0.00705 
BMEI1799 Lipoprotein signal peptidase  201.8 271.9 271.6 0.00713 
      
Cell division 
BMEI0008 Glucose-inhibited division protein B 8.8 291.7 360.0 0.017072 
BMEI0010 Chromosome partitioning protein ParB 8.0 116.3 106.8 0.000631 
BMEI0073 Cell division protein FtsX 7.0 208.3 260.8 4.83E-04 
BMEII0470 Integral membrane protein 71.7 93.4 89.1 0.011569 
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Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEII0925 Cell division topological specificity factor MinE 3.5 80.7 87.7 0.039051 
      
Cell motility and chemotaxis 
BMEI0961 Kinesin-like protein 8.8 69.1 76.0 0.019508 
BMEII0150 Flagellin 96.6 96.6 96.6 0.007312 
BMEII0151 Flagellar M-ring protein FliF 3.1 3.7 3.3 0.030285 
BMEII0156 Chemotaxis MotD protein 3.0 4.1 4.0 0.000409 
BMEII0164 Flagellar basal body rod modification protein 2.1 2.4 2.5 0.018005 
BMEII0166 Flagellar biosynthetic protein FlhA 5.4 104.9 97.7 0.034612 
BMEII1112 Flagellar motor switch protein FliN 10.3 139.2 130.1 0.003866 
      
General function prediction only 
BMEI0158 Acetyltransferase 48.95 77.0 78.9 0.023737 
BMEI0346 Sodium/bile acid cotransporter homolog, sbf family 334.6 334.6 334.6 0.004413 
BMEI0350 Acetyltransferase 3.8 50.6 29.4 0.013507 
BMEI0594 Chloramphenicol acetyltransferase 191.2 191.2 191.2 0.001931 
BMEI0720 Sugar fermentation stimulation protein 5.4 76.5 67.1 0.026151 
BMEI0736 Ferripyochelin binding protein 4.8 200.1 195.5 0.022678 
BMEI0740 Inosine-5'-monophosphate dehydrogenase -7.4 -8.3 -6.3 0.008082 
BMEI0946 NAD(FAD)-utilizing dehydrogenase 4.2 15.0 15.2 0.004063 
BMEI0962 Membrane lipoprotein lipid attachment SitE containing protein -20.7 -267.3 -16.9 0.004775 
BMEI1269 Chloramphenicol-sensitive protein RarD 2.4 2.9 3.0 0.004112 
BMEI1370 ATPase 3.9 57.0 61.9 0.025749 
BMEI1388 Oxidoreductase 4.1 88.9 75.6 0.018948 
BMEI1437 Putative hydroxilase 36.7 51.8 49.4 0.022621 
BMEI1443 2-Haloalkanoic acid dehalogenase I 2.3 2.7 2.8 0.009551 
BMEI1487 Colicin V production protein  4.25 109.6 136.5 0.039396 
BMEI1534 Methyltransferase  -5.0 -5.2 -4.5 0.005094 
BMEI1634 Phosphoglycolate phosphatase  30.2 83.5 93.0 0.02468 
BMEI1822 S-formylglutathione hydrolase  2.7 3.0 3.0 0.011448 
BMEI2011 2-hydroxymuconic semialdehyde hydrolase  10.3 151.7 145.9 0.006432 
BMEII0327 Phosphoglycolate phosphatase  70.5 291.1 363.5 0.043366 
BMEII0829 Possible S-adenosylmethionine-dependent methyltransferase  20.0 47.3 55.5 0.036531 
BMEII0838 Succinoglycan biosynthesis transport protein ExoT  12.2 84.9 91.5 0.011502 
BMEII1003 Putative O-antigen transporter  2.4 2.6 2.5 0.035181 
BMEII1016 Protease I 66.5 66.5 66.5 0.018129 
BMEII1019 Alpha-methylacyl CoA racemase 3.0 173.7 194.3 0.029976 
BMEII1052 Transporter 3.3 114.5 123.0 0.020979 
BMEII1060 2,5-diketo-D-glucuronic acid reductase  7.0 237.9 189.0 0.01192 
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      FC   (p) 
      
Predicted by homology 
BMEI0804 Hypothetical cytosolic protein -6.5 -9.0 -5.4 0.019652 
BMEI1319 Hypothetical membrane spanning protein 2.9 132.1 136.8 0.020961 
BMEII0261 Hypothetical cytosolic protein 30.8 31.7 31.7 0.023401 
BMEII0522 Hypothetical protein 8.1 275.0 346.4 0.03065 
      
Unknown function 
BMEI0002 Cytochrome functioning/assembly related protein 3.75 218.6 242.6 0.026103 
BMEI0016 Hypothetical protein 3.0 7.4 9.2 0.035575 
BMEI0018 Hypothetical cytosolic protein 2.8 3.9 3.9 0.001061 
BMEI0051 Hypothetical protein 29.4 29.4 29.4 0.010789 
BMEI0057 Hypothetical membrane spanning protein 2.3 2.4 2.4 0.014254 
BMEI0059 Hypothetical protein 13.2 66.2 60.8 0.018855 
BMEI0063 Hypothetical membrane spanning protein 4.5 108.7 102.9 0.030677 
BMEI0064 Hypothetical protein 7.8 209.0 237.5 0.02241 
BMEI0152 Hypothetical cytosolic protein 3.3 113.4 166.3 0.027048 
BMEI0153 Hypothetical protein 3.3 108.2 104.6 0.008451 
BMEI0179 Hypothetical protein 6.3 83.2 61.1 0.0013685 
BMEI0217 Hypothetical protein 6.9 218.1 235.6 0.009073 
BMEI0262 Hypothetical protein 2.9 106.8 126.6 0.026445 
BMEI0366 Hypothetical protein -3.9 -4.4 -3.5 0.00797 
BMEI0373 Hypothetical protein -3.5 -3.8 -3.3 0.005577 
BMEI0422 Hypothetical protein 3.4 14.7 10.9 0.00701 
BMEI0425 Hypothetical protein 4.0 41.8 29.3 0.00842 
BMEI0431 Hypothetical protein 18.9 43.3 46.6 0.034105 
BMEI0442 Hypothetical protein 112.1 222.9 214.6 0.005347 
BMEI0448 Hypothetical protein 68.1 83.6 86.3 0.02205 
BMEI0458 Hypothetical membrane spanning protein 26.3 195.3 182.2 0.007626 
BMEI0498 Cold shock protein CspA 3.2 3.6 4.0 0.031073 
BMEI0542 Hypothetical protein 3.7 68.1 60.6 0.015161 
BMEI0550 Hypothetical protein 231.3 231.3 231.3 2.70E-05 
BMEI0590 Hypothetical protein 72.3 250.8 259.7 0.005759 
BMEI0600 Hypothetical membrane spanning protein 3.6 83.5 76.9 0.012201 
BMEI0601 Hypothetical protein 5.7 100.2 80.3 0.039441 
BMEI0607 Hypothetical cytosolic protein 4.5 73.8 55.8 0.034613 
BMEI0620 Hypothetical protein -6.5 -7.6 -4.7 0.01773 
BMEI0638 Hypothetical protein 32.6 237.6 217.3 0.008528 
BMEI0678 Low pH-induced protein A -4.1 -6.0 -3.3 0.012169 
BMEI0692 Hypothetical protein 8.9 390.0 383.9 0.000643 
BMEI0798 Hypothetical protein -15.4 -18.0 -15.4 0.001644 
BMEI0805 Hypothetical protein -36.4 -56.4 -26.5 0.003588 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEI0813 Hypothetical protein -9.2 -11.1 -8.5 0.001088 
BMEI0903 Hypothetical protein 4.5 93.7 84.9 0.019457 
BMEI1026 Outer membrane protein E 2.8 3.7 3.9 0.023952 
BMEI1028 Hypothetical protein 8.1 186.3 227.3 0.024455 
BMEI1072 Hypothetical protein -25.8 -29.3 -17.8 0.007248 
BMEI1086 Hypothetical cytosolic protein 2.9 4.2 4.2 0.021914 
BMEI1165 Hypothetical membrane spanning protein 28.6 30.2 30.2 0.004184 
BMEI1173 Hypothetical membrane spanning protein -2.8 -3.0 -2.8 1.92E-04 
BMEI1214 Hypothetical protein -5.4 -5.5 -4.9 0.009011 
BMEI1219 Hypothetical protein 5.0 467.0 572.7 0.024323 
BMEI1242 Hypothetical membrane spanning protein -7.6 -10.9 -5.7 0.009799 
BMEI1275 Hypothetical protein 3.0 37.2 35.4 1.10E-02 
BMEI1298 Hypothetical cytosolic protein 11.8 199.6 187.5 0.008254 
BMEI1317 Hypothetical protein 23.0 116.3 130.9 0.013377 
BMEI1358 Hypothetical cytosolic protein 121.1 121.1 121.1 0.005318 
BMEI1361 Hypothetical cytosolic protein 12.9 177.6 168.0 0.020648 
BMEI1371 Hypothetical protein 4.8 148.3 119.3 0.041039 
BMEI1417 Perosamine synthetase WbkB 225.2 338.0 140.2 0.017503 
BMEI1428 Ribonuclease III 3.1 156.8 172.5 0.031964 
BMEI1431 BioY protein 19.2 19.2 19.2 0.008123 
BMEI1461 Zinc-finger protein  79.4 79.4 79.4 0.015544 
BMEI1474 Hypothetical protein 2.8 2.9 2.8 0.022541 
BMEI1507 Hypothetical protein -4.6 -5.3 -4.7 0.000656 
BMEI1508 Putative lipoprotein 2.5 99.7 94.9 0.041956 
BMEI1509 Hypothetical protein 3.1 95.9 91.2 0.03679 
BMEI1516 Hypothetical protein 20.4 20.4 20.4 1.18E-02 
BMEI1538 Hypothetical protein 146.3 157.0 157.6 0.001598 
BMEI1572 Hypothetical membrane spanning protein 49.1 87.2 70.7 0.014322 
BMEI1665 Hypothetical protein 47.1 62.9 62.9 0.018253 
BMEI1673 Zinc-binding protein 4.7 158.4 176.8 0.00935 
BMEI1681 Hypothetical protein 2.7 86.9 108.5 0.017799 
BMEI1699 Hypothetical protein 5.9 119.7 105.4 0.014791 
BMEI1711 Hypothetical protein 187.0 187.0 187.0 0.008656 
BMEI1761 Hypothetical protein 11.4 164.2 155.7 0.001759 
BMEI1767 Hypothetical protein 3.3 22.3 21.0 0.04257 
BMEI1785 Hypothetical protein -4.6 -7.9 -4.3 0.004907 
BMEI1795 Hypothetical protein 4.8 199.7 268.0 0.02577 
BMEI1857 Hypothetical cytosolic protein 4.4 137.1 153.5 0.0001582 
BMEI1866 Hypothetical protein 5.1 98.2 97.9 0.035802 
BMEI1893 Protein YbiS precursor  148.6 148.6 148.6 0.010974 
BMEI1993 Hypothetical exported protein 23.2 190.5 174.4 0.023201 
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TABLE A.1. (continued) 
      
Locus ID Gene product SAM Spotfire GSpring ANOVA 
      FC   (p) 
      
BMEI2044 Hypothetical membrane spanning protein -2.3 -2.3 -2.1 0.006975 
BMEI2049 Hypothetical protein 12.5 151.5 135.2 0.036594 
BMEII0043 Hypothetical protein 38.6 102.5 81.5 0.030811 
BMEII0082 Hypothetical protein 201.8 201.8 201.8 0.001519 
BMEII0090 Hypothetical protein 32.8 32.8 32.8 0.018867 
BMEII0094 Hypothetical protein 7.2 310.1 306.7 0.006073 
BMEII0231 SlyX protein 6.9 510.9 649.5 0.016558 
BMEII0237 Hypothetical protein 82.3 86.6 82.2 0.026051 
BMEII0296 Hypothetical protein 26.6 158.7 145.5 0.000888 
BMEII0399 Hypothetical protein 69.2 90.9 91.9 0.005163 
BMEII0529 Surface protein 2.5 3.0 3.5 0.039543 
BMEII0615 Hypothetical protein -60.5 -70.5 -43.9 0.010396 
BMEII0658 Hypothetical protein 15.3 193.4 179.1 0.004162 
BMEII0668 Putative integral membrane protein 4.3 103.3 129.3 0.022889 
BMEII0682 Oxacillin resistance-associated protein FmtC  4.7 49.2 43.4 0.027366 
BMEII0733 Hypothetical protein 2.3 3.2 3.1 0.039316 
BMEII0805 Hypothetical protein 4.0 140.1 116.1 0.025098 
BMEII0905 Hypothetical protein 224.3 224.3 224.3 0.00956 
BMEII0935 Nickel resistance protein  2.7 8.2 10.1 0.021854 
BMEII0993 Hypothetical protein 30.3 30.0 30.0 0.033095 
BMEII0994 Hypothetical protein 3.3 12.1 9.0 0.011808 
BMEII0995 Hypothetical protein 3.1 360.2 290.1 0.023106 
BMEII1013 Hypothetical cytosolic protein 5.8 243.9 262.2 0.008494 
BMEII1091 Hypothetical pyridoxal phosphate biosynthesis protein 108.1 206.2 175.9 0.01675 
            
 
 
FC = Fold-change 
Negative sign (-) before the number indicates down-regulation of the gene 
GSpring = GeneSpring software 
SAM = Significance Analysis of Microarrays software 
Spotfire = Spotfire DecisionSite 8.2 software 
ANOVA = Analysis of variance 
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APPENDIX B 
TABLE B.1. Genes significantly altered by intracellular B. melitensis at 4 h PI of 
HeLa cells, compared to the inoculum 
 
Locus ID Symbol Gene product Fold-change p value 
     
 
DNA replication, recombination and repair 
BMEI0986 tatD SEC-independent protein TatD  2.48 2.24E-02 
BMEII1026 mutL DNA mismatch repair protein 5.27 1.51E-02 
BMEI0596 uvrD DNA helicase II 0.30395 9.74E-03 
BMEI1946 mutM Formamidopyrimidine-DNA glycosylase  0.3125 1.25E-04 
     
Transcription 
BMEI0685  Transcriptional regulator, AraC family 3.72 2.95E-03 
BMEII0226  NTA operon transcriptional regulator  5.91 2.01E-03 
BMEII0642  PCA regulon regulatory protein  4.68 1.87E-03 
BMEI0371 sigH Regulatory factor VirF homolog  0.08425 2.55E-03 
BMEI0447 lrp Leucine-responsive regulatory protein  0.41667 3.91E-03 
BMEI0493 ompR Transcriptional regulator OmpR 0.22936 9.19E-03 
BMEI0686  Transcriptional regulator, LysR family 0.2924 4.34E-03 
BMEI0744 nusG Transcription antitermination protein NusG 0.20284 1.09E-02 
BMEI0750 rpoC DNA-directed RNA polymerase, beta chain 0.20161 9.24E-03 
BMEI1035 rhlE-2 ATP-dependent RNA helicase DEAD  0.36101 8.68E-03 
BMEII0281  Transcriptional regulator, GntR family   0.32787 9.93E-03 
     
Translation 
BMEI1073  Glucose-inhibited division protein A 3.65 2.46E-03 
BMEII0260  GTP-binding protein LepA 10.01 5.11E-04 
BMEI0056 rpmB LSU ribosomal protein L28P 0.1938 6.04E-05 
BMEI0148 rimM 16S ribosomal RNA processing protein RimM 0.29412 9.28E-04 
BMEI0156 rplS LSU ribosomal protein L19P 0.1007 1.12E-02 
BMEI0191 prfA Bacterial Peptide Chain Release Factor 1 (RF-1) 0.2849 8.52E-05 
BMEI0201 rplU LSU ribosomal protein L21P 0.29155 8.35E-03 
BMEI0202 rpmA LSU ribosomal protein L27P 0.23641 9.80E-03 
BMEI0481  LSU ribosomal protein L25P 0.26178 8.32E-04 
BMEI0491 csaA Protein secretion chaperonin CsaA 0.16287 4.37E-04 
BMEI0742 tuf Protein Translation Elongation Factor Tu (EF-TU) 0.1297 1.27E-02 
BMEI0746 rplA LSU ribosomal protein L1P 0.28736 1.16E-02 
BMEI0747 rplJ LSU ribosomal protein L10P 0.28818 2.40E-03 
BMEI0756 rpsJ SSU ribosomal protein S10P 0.21834 1.00E-02 
BMEI0757 rplC LSU ribosomal protein L3P 0.18727 5.88E-03 
BMEI0759 rplW LSU ribosomal protein L23P 0.17123 3.58E-03 
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TABLE B.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
     
BMEI0774 rpsE SSU ribosomal protein S5P 0.06623 1.83E-03 
BMEI0776 rplO LSU ribosomal protein L15P 0.23148 4.35E-03 
BMEI0780 rpsK SSU ribosomal protein S11P 0.15674 6.53E-03 
BMEI0782 rplQ LSU ribosomal protein L17P 0.12723 3.18E-04 
BMEI0826 frr Ribosome recycling factor (RRF) 0.25253 7.81E-04 
BMEI0915 thrS Threonyl-tRNA synthetase 0.28818 6.59E-04 
BMEI0987 metG Methionyl-tRNA synthetase 0.16949 6.30E-03 
BMEI1168 rplM LSU ribosomal protein L13P 0.31348 9.90E-03 
BMEI1272 cysS Cysteinyl-tRNA synthetase 0.34247 7.37E-03 
BMEI1418  GDP-mannose 4,6-dehydratase / GDP-4-amino-4,6-dideoxy-D-mannose formyltransferase 0.37879 1.87E-03 
BMEI1480 rpsF SSU ribosomal protein S6P 0.27174 1.47E-02 
BMEI2038  Peptidyl-tRNA hydrolase 0.26042 9.70E-03 
     
Signal transduction mechanisms 
BMEI0102 uspA Universal stress protein family 0.13298 9.43E-03 
BMEI1128  BolA protein family 0.16 1.06E-02 
BMEI1328  Sensory transduction histidine kinase 0.37175 1.11E-04 
BMEI2036  Transcriptional regulatory protein ChvI 0.28409 2.47E-04 
     
Carbohydrate transport and metabolism 
BMEII0474  Mannonate dehydratase 3.75 8.46E-03 
BMEII0941  Maltose/Maltodextrin transport ATP-binding protein MalK 11.32 7.80E-03 
BMEI0393  D-Ribose-binding periplasmic protein precursor 0.31847 3.45E-04 
BMEI0399  Dihydroxyacetone kinase 0.23256 2.55E-02 
BMEI0977  Putative sugar kinase 0.3413 6.73E-03 
BMEI1997  Gluconolactonase 0.369 1.36E-02 
BMEII0435  D-ribose-binding periplasmic protein precursor 0.25063 2.40E-03 
BMEII0590  Sugar-binding protein 0.18868 1.58E-03 
     
Aminoacid transport and metabolism 
BMEI0084 lysA Diaminopimelate decarboxylase 2.2 1.98E-02 
BMEI0256  D-amino acid dehydrogenase, small subunit 2.91 1.05E-02 
BMEII0207  Dipeptide transport system permease protein DppC 6.74 5.63E-03 
BMEII0909  Glutamate/gamma-aminobutyrate antiporter 3.66 1.69E-02 
BMEII0922  Spermidine/Putrescine transport ATP-binding protein PotA 3.16 1.56E-02 
BMEI0207 proB Gamma-glutamyl kinase 0.29586 9.11E-03 
BMEI0433 sapA Periplasmic dipeptide transport protein precursor  0.19685 4.83E-03 
BMEI0559 metF 5,10-methylenetetrahydrofolate reductase 0.26596 7.20E-03 
BMEI0618 ilvN Acetolactate synthase, small subunit 0.30211 7.87E-03 
BMEI0734 cysE Serine acetyltransferase 0.38462 1.31E-02 
BMEI0844  Anthranilate phosphoribosyltransferase 0.26385 5.71E-03 
  
 
228
TABLE B.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
     
BMEI1380 betA Choline dehydrogenase 0.36364 9.73E-03 
BMEII0012 pepF Oligoendopeptidase F 0.27855 3.78E-03 
BMEII0284  Periplasmic dipeptide transport protein precursor  0.34247 5.12E-03 
BMEII0295  Biphenyl-2,3-diol 1,2-dioxygenase III 0.34483 1.85E-03 
 
Nucleotide transport and metabolism 
BMEII0598  Exopolyphosphatase  7.84 7.13E-03 
BMEII0931  NrdI protein 3.13 1.60E-02 
BMEI0778 adk Adenylate kinase 0.31348 1.85E-03 
     
Lipid transport and metabolism 
BMEI0861  Glucose 1-dehydrogenase II  0.25253 1.14E-02 
BMEII0958  Sterol binding protein 0.4065 2.12E-03 
     
Coenzyme and inorganic ion transport and metabolism 
BMEI1438 czcD Cobalt-zinc-cadmium resistance protein CzcD  3.09 1.18E-02 
BMEII0998 norB Nitric-oxide reductase subunit B  3.74 2.67E-03 
BMEI1207  Salicylate hydroxylase 3.94 1.78E-02 
BMEII0640  4-hydroxybenzoate-3-monooxygenase 22.89 6.84E-04 
BMEI0050  CobT protein 0.32051 2.13E-03 
BMEI0375 fur Ferric uptake regulation protein 0.37594 5.58E-03 
BMEI0547 phnA PhnA protein 0.27933 4.92E-03 
BMEI0931  Putative thiosulfate sulfurtransferase   0.04943 5.98E-03 
BMEI1021  Molybdopterin-guanine dinucleotide biosynthesis protein B 0.40486 4.30E-03 
BMEI1557  Arsenate reductase 0.29326 7.78E-03 
BMEI1757  Omega-amino acid-pyruvate aminotransferase 0.31546 8.25E-03 
BMEII0844  31 kDa outer-membrane immunogenic protein precursor 0.25575 7.59E-03 
     
Post-translational modifications 
BMEI1440  Thiol:Disulfide interchange protein DbsA 6.57 2.61E-02 
BMEI0512 trxB Thioredoxin reductase 0.21097 3.21E-03 
BMEI0845  Peptidyl-prolyl cis-trans isomerase D  0.36496 1.58E-03 
BMEI0875 clpX ATP-dependent Clp protease, ATP-binding subunit ClpX 0.2584 3.59E-03 
BMEI1455  Thio:disulfide interchange protein 0.35336 3.81E-05 
BMEI1649 ureG Urease accessory protein UreG 0.3367 1.08E-03 
BMEI1651 ureE Urease accessory protein UreE 0.35587 1.05E-03 
     
Energy production and conversion 
BMEII0949 narG Respiratory nitrate reductase 1 alpha chain 142.49 1.70E-03 
BMEII0974 nosZ Nitrous-oxide reductase  3.32 5.47E-03 
BMEI0140  2-oxoglutarate dehydrogenase E1 component 0.17857 6.13E-04 
BMEI0251 atpD ATP synthase beta chain  0.24631 2.36E-04 
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TABLE B.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
     
BMEI0791  Isocitrate dehydrogenase 0.2551 8.10E-03 
BMEI1152 nuoG NADH-quinone oxidoreductase chain G  0.19802 4.94E-03 
     
Secondary metabolites biosynthesis 
BMEI0394  2-deoxy-D-glucose-3-dehydrogenase 0.40161 8.42E-03 
BMEI1708  2- hydroxyhepta-2,4-diene-1,7-dioate isomerase / 5-carboxymethyl-2-oxo-hex-3-ene-1,7-dioate decarboxylase  0.1634 3.14E-04 
     
Cell wall/membrane biogenesis 
BMEII0852  Succinoglycan biosynthesis transport protein ExoP 4.42 1.31E-02 
BMEI0340  Peptidoglycan-associated lipoprotein  0.21645 1.19E-02 
BMEI0454 ompW Outer membrane protein W precursor 0.22831 9.75E-03 
BMEI0566  Soluble lytic murein transglycosylase  0.22883 2.22E-03 
BMEI0786  Outer membrane protein   0.37037 5.57E-04 
BMEI1193  Cell wall degradation protein 0.28986 1.92E-02 
BMEI1992 rlpA Rare lipoprotein A 0.31646 3.14E-03 
     
Cell division 
BMEI0583 ftsQ Cell division protein FtsQ 0.09756 1.20E-02 
BMEI0584 ftsA Cell division protein FtsA 0.18149 4.60E-05 
     
General function prediction only 
BMEI0593  SCO2 protein 2.34 2.16E-02 
BMEI1458 thrB Homoserine kinase 3.23 8.45E-03 
BMEII0123  Exoenzymes regulatory protein AepA precursor 3.54 6.82E-03 
BMEII0179  Low affinity zinc transport membrane protein  6.61 9.40E-04 
BMEII0638  3-oxodipate enol-lactonase 3.29 8.23E-03 
BMEI0792  Intracelular proteinase I 0.34483 9.68E-04 
BMEI0796  31 kDa immunogenic protein precursor 0.33557 1.04E-03 
BMEI1110  Secretion activator protein 0.21368 1.12E-02 
BMEI1495  Lysine decarboxylase 0.21322 4.88E-03 
BMEI1951  Putative hydrolase 0.23419 5.62E-03 
BMEII0479  ABC transporter substrate-binding protein   0.22075 2.10E-03 
BMEII0806  Putative transmembrane protein  0.33898 4.84E-04 
     
Unknown function 
BMEI0731  Cold shock protein 3.3 6.70E-03 
BMEI1454  Hypothetical protein 4.06 2.37E-03 
BMEI1539  Hypothetical protein 17.34 6.49E-04 
BMEI1896  Hypothetical membrane spanning protein 6.46 1.41E-02 
BMEII0262  Hypothetical protein 3.76 7.06E-03 
BMEII1131  Hypothetical protein 2.71 2.24E-02 
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TABLE B.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
     
BMEI0100  Hypothetical protein 0.14025 5.16E-03 
BMEI0119  Hypothetical protein 0.37879 8.81E-03 
BMEI0144  Hypothetical exported protein 0.21008 1.04E-03 
BMEI0222  Carbonic anhydrase 0.21834 1.13E-02 
BMEI0287  Hypothetical protein 0.38911 1.57E-03 
BMEI0299  Hypothetical protein 0.01643 2.03E-03 
BMEI0323  Probable transport ATP-binding protein MsbA  0.12063 6.89E-03 
BMEI0445  Oxalate/formate antiporter  0.03421 1.40E-02 
BMEI0497  Hypothetical membrane spanning protein 0.28736 6.59E-03 
BMEI0521  Hypothetical protein 0.25253 6.15E-03 
BMEI0535  Hypothetical protein 0.40161 6.69E-03 
BMEI0668  Calcium binding protein 0.29326 1.10E-02 
BMEI0724  Hypothetical protein 0.23981 4.46E-03 
BMEI0732  Hypothetical cytosolic protein 0.4329 7.06E-03 
BMEII0754  Sugar-binding protein 0.32154 4.73E-03 
BMEII0755  Sugar-binding protein 0.3861 8.90E-04 
BMEI0885  Hypothetical protein 0.2457 5.36E-03 
BMEI1031  Hypothetical protein 0.34843 2.49E-02 
BMEI1072  Hypothetical protein 0.19646 7.57E-03 
BMEI1226  Hypothetical cytosolic protein 0.33113 1.17E-02 
BMEI1242  Hypothetical membrane spanning protein 0.32051 2.81E-03 
BMEI1435  Polysaccharide deacetylase  0.45045 1.38E-02 
BMEI1745  Hypothetical protein 0.30864 1.21E-03 
BMEI1761  Hypothetical protein 0.1996 1.21E-02 
BMEI1893  Protein YbiS precursor 0.38168 1.43E-05 
BMEII0279  Hypothetical membrane spanning protein 0.2439 1.41E-02 
BMEII0335  Hypothetical protein 0.37037 3.86E-03 
BMEII0471  Hypothetical protein 0.35842 5.00E-03 
BMEII0581 sodC Superoxide dismutase (Cu-Zn) 0.08606 1.75E-02 
BMEII0609  Hypothetical protein 0.22422 7.44E-03 
BMEII0615  Hypothetical protein 0.29326 2.42E-02 
BMEII0991  Hypothetical membrane spanning protein 0.24331 1.16E-02 
     
 
 
Fold-change below 1 indicates down-regulation of the gene expression 
 
Genes were ordered in cluster of ortholog groups (COGs) functional categories (downloaded 
from NCBI/genome projects/bacteria/B. melitensis) with adaptations 
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APPENDIX C 
TABLE C.1. Genes significantly altered by intracellular B. melitensis at 12 h PI of 
HeLa cells, compared to the inoculum 
 
Locus ID Symbol Gene product Fold-change p value 
     
DNA replication, recombination and repair 
BMEI0988 holA DNA polymerase III, delta subunit 4.58 1.23E-02 
BMEI1818 hrpB ATP-dependent helicase HrpB 2.82 1.00E-02 
BMEI0332 ruvC Holliday junction resolvase 0.274 8.97E-04 
     
Transcription 
BMEI0169  Transcriptional regulator, GntR family/Aminotransferase Class-I 2.61 1.01E-02 
BMEI0320  Transcriptional regulator, GntR family 2.38 7.42E-03 
BMEI0604  Transcriptional regulator, tetR family 5.87 6.99E-03 
BMEII0299  Transcriptional regulator, IclR family  5.92 5.80E-03 
BMEII0346 asnC Transcriptional regulatory protein, AsnC family 3.31 4.42E-03 
BMEII0426 deoR Transcriptional regulator, DeoR family 3.34 2.22E-03 
BMEII0486 nikR Nickel-responsive regulator NikR 3.54 1.64E-02 
BMEI1949  Transcriptional regulator, MarR family  0.2882 1.40E-02 
     
Translation 
BMEI1953  Aspartyl-tRNA synthetase  2.74 4.01E-03 
BMEI1959  Methyltransferase  2.74 1.29E-02 
BMEI2005 pheS Phenylalanyl-tRNA synthetase, alpha chain 2.91 6.83E-03 
BMEI0202 rpmA LSU ribosomal protein L27P 0.1848 9.17E-03 
BMEI0759 rplW LSU ribosomal protein L23P 0.4202 3.10E-03 
BMEI0823 rpsB SSU ribosomal protein S2P 0.1721 6.09E-03 
BMEI1199  Arginyl-tRNA-protein transferase  0.216 1.48E-02 
BMEI1267 ksgA Dimethyladenosine transferase 0.1927 1.59E-02 
     
Defense mechanisms 
BMEI1645 AcrB Acriflavin resistance protein B  3.84 4.01E-03 
     
Signal transduction mechanisms 
BMEI1336 phoQ Sensor protein PhoQ  2.14 8.16E-03 
BMEI1582 degU Transcriptional regulatory protein DegU 4.79 1.47E-02 
BMEI0190 ptsP Phosphoenolpyruvate-protein phosphotransferase PtsP 0.0739 6.75E-03 
BMEI2027  Alkaline phosphatase synthesis sensor protein PhoR  0.2632 1.73E-03 
     
Cell wall / membrane biogenesis 
BMEI1304  Outer membrane Porin F precursor 3.51 3.91E-04 
BMEI1426  Putative undecaprenyl-phosphate alpha-N-acetylglucosaminyltransferase 3.74 3.60E-03 
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TABLE C.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
BMEI1556  Integral membrane protein  3.75 8.68E-03 
BMEII0376  Heat resistant agglutinin 1 protein 2.69 1.48E-02 
BMEII0728  Cellulose synthase catalytic subunit (UDP-forming) 5.48 1.44E-03 
BMEI0633  Integral membrane protein 0.33 4.51E-03 
     
Cell motility 
BMEII0156 motD Chemotaxis MotD protein 3.7 9.36E-03 
     
Cell division 
BMEI0583 ftsQ Cell division protein FtsQ 0.1776 5.10E-03 
     
Energy production and conversion 
BMEI0898  Predicted acyl-CoA transferases/carnitine dehydratase 2.32 8.98E-03 
BMEII0141  Aldehyde dehydrogenase 2.99 8.80E-03 
BMEII0185 dld D-lactate dehydrogenase  5.22 1.64E-02 
BMEII0786  NADH dehydrogenase 3 5.76E-03 
BMEII0949 narG Respiratory nitrate reductase 1, alpha chain 103.31 6.94E-03 
BMEII0974 nosZ Nitrous-oxide reductase  3.81 2.94E-04 
BMEII1062  (S)-2-hydroxy-acid oxidase subunit GlcE   2.52 1.18E-02 
BMEI0474 petB Cytochrome B 0.365 3.32E-03 
BMEI1152 nuoG NADH-quinone oxidoreductase chain G  0.1842 1.07E-02 
BMEI1157 nuoB NADH-quinone oxidoreductase chain B 0.1988 3.87E-03 
     
Carbohydrate transport and metabolism 
BMEII0106  Xylose repressor  6.25 8.57E-03 
BMEII0624 ugpA Sn-glycerol-3-phosphate transport system permease UgpA 3.48 1.49E-02 
BMEII0857  N-acetylmannosamine-6-phosphate 2-epimerase / N-acetylmannosamine kinase 2.63 4.62E-03 
BMEII1119  Multidrug resistance protein B  2.76 4.49E-03 
     
Amino acid transport and metabolism 
BMEI0124 argJ Bifunctional ornithine acetyltransferase/N-acetylglutamate synthase protein 3.6 6.13E-03 
BMEI0649 ureA Urease gamma subunit 10.57 8.57E-03 
BMEI1309  Histidinol-phosphate aminotransferase 3.66 1.05E-02 
BMEI1627  Arginine-binding periplasmic protein  4.55 8.73E-03 
BMEI1722  Sarcosine oxidase beta subunit 3.62 1.96E-02 
BMEI1728 proW Glycine betaine/L-proline transport system permease ProW 3.39 4.58E-03 
BMEII0070  Leucine-, isoleucine-, valine-, threonine-, and alanine-binding protein precursor 7.61 1.08E-02 
BMEII0196  Spermidine/putrescine-binding periplasmic protein  3.1 7.71E-03 
BMEII0249  Dihydrodipicolinate reductase 2.64 1.19E-02 
BMEII0631 livM High-affinity branched-chain amino acid transport system permease protein LivM 3.09 8.73E-03 
BMEI1166  O-acetylhomoserine sulfhydrase/O-acetylserine sulfhydrase 0.2083 7.58E-03 
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TABLE C.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
BMEII0038 cycA D-serine/D-alanine/glycine transporter  0.1905 9.93E-03 
     
Lipid transport and metabolism 
BMEI0022  3-hydroxybutyryl-CoA dehydratase  4.37 3.54E-03 
BMEI0552  Lysophospholipase L2  4.95 2.78E-03 
BMEI1521 acdA Acyl-CoA dehydrogenase 2.32 4.93E-03 
BMEI1922  Acetoacetyl-CoA synthetase 3.12 1.19E-02 
BMEII0062 fabG Probable carbonyl reductase (NADPH) 2.64 1.13E-02 
     
Coenzyme and inorganic ion transport and metabolism 
BMEI1438 czcD Cobalt-zinc-cadmium resistance protein CzcD  3.01 7.71E-03 
BMEI1517 pdxH Pyridoxamine 5-phosphate oxidase 4.8 1.06E-02 
BMEII0105 frpB Iron-regulated outer membrane protein FrpB 2.65 6.57E-03 
BMEII0580  Probable blue-copper protein Yack precursor  2.38 7.02E-04 
BMEII0776 bioF 8-amino-7-oxononanoate synthase 3.08 5.50E-03 
BMEII0798  Nitrate transport ATP-binding protein NrtC  3.64 4.17E-03 
BMEI0001 hemE Uroporphyrinogen decarboxylase 0.2604 6.33E-03 
BMEI0675 cysW Sulfate transport system permease protein CysW 0.2137 9.34E-03 
     
General function prediction only 
BMEI0361  ABC transporter ATP-binding protein/ABC transporter permease protein 3.93 5.05E-03 
BMEI0697  Transporter, DME family  3.95 1.20E-02 
BMEI0852  Methyltransferase  3.68 1.05E-03 
BMEI0981  Phosphoglycolate phosphatase  3.52 9.27E-03 
BMEI1284  Hypothetical protein-tyrosine phosphatase 2.59 1.78E-02 
BMEI1323  Transporter, DME family  3.61 5.30E-04 
BMEI1578  Glyoxylate induced protein 2.93 1.28E-02 
BMEI1743  ABC transporter ATP-binding protein 4.81 5.54E-04 
BMEII0618  Xanthine/uracil permease 3.03 8.02E-04 
BMEI0335  4-hydroxybenzoyl-CoA thioesterase family active site 0.2062 2.45E-03 
BMEII0554  Glutamine synthetase 0.369 1.09E-02 
BMEII0806  Putative transmembrane protein  0.4132 1.24E-02 
     
Unknown function 
BMEI0304  Hypothetical cytosolic protein 7.22 1.66E-03 
BMEI0903  Hypothetical protein 2.77 8.20E-03 
BMEI0907  Hypothetical protein 5.47 1.10E-02 
BMEI1470  Protein YicC 5.54 1.51E-03 
BMEI1472  Hypothetical protein 2.38 2.31E-03 
BMEI1562  Hypothetical protein 2.63 6.11E-03 
BMEI1711  Hypothetical protein 3.52 4.24E-03 
BMEI1854  Hypothetical protein 5.01 2.88E-03 
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TABLE C.1. (continued) 
     
Locus ID Symbol Gene product Fold-change p value 
     
BMEI1856  Hypothetical exported protein 3.46 1.04E-02 
BMEI1860  Hypothetical transmembrane oxidoreductase 3.27 2.10E-03 
BMEII0147  Putative integral membrane protein  3.66 3.12E-03 
BMEII0149  Extracellular serine protease  3.02 7.18E-03 
BMEII0191  Hypothetical protein 5.52 3.38E-03 
BMEII0197 pncA Glu/asp-tRNAamidotransferase subunit A  2.99 6.37E-03 
BMEII0357  2-dehydro-3-deoxygalactonokinase  2.61 6.32E-03 
BMEII0403  Conserved cytosolic protein 3.09 8.65E-04 
BMEII0459  Hypothetical protein 4.46 7.73E-03 
BMEII0693  Hypothetical cytosolic protein 3.25 6.98E-03 
BMEII0725  Hypothetical protein 3.42 6.32E-03 
BMEII0917  Hypothetical protein 4.05 4.45E-03 
BMEII0955  Hypothetical protein 5.08 7.98E-03 
BMEII0967 nosX NosX 2.52 3.66E-03 
BMEII1046  Hypothetical protein 13.95 1.44E-02 
BMEII1072  Hypothetical protein 3.08 1.30E-02 
BMEI0331  Hypothetical protein 0.2375 1.14E-03 
BMEI0495  Hypothetical protein 0.116 4.56E-03 
BMEI0536  Periplasmic immunogenic protein  0.2488 9.79E-03 
BMEI1221  Hypothetical cytosolic protein 0.266 3.37E-03 
BMEI1261  Leucyl aminopeptidase 0.112 6.22E-03 
BMEI1509  Hypothetical protein 0.3597 8.59E-03 
BMEII0015  Homospermidine synthase  0.2717 7.14E-03 
BMEII0417  Hypothetical protein 0.3257 6.75E-03 
     
 
 
Fold-change below 1 indicates down-regulation of the gene expression 
 
Genes were ordered in cluster of ortholog groups (COGs) functional categories (downloaded 
from NCBI/genome projects/bacteria/B. melitensis) with adaptations 
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APPENDIX D 
TABLE D.1. Host genes significantly altered in B. melitensis-infected HeLa cells at 
4 h PI, compared to non-infected cells 
 
Symbol Gene product Fold- change z-score 
    
DNA replication and repair 
ORC5L Origin recognition complex, subunit 5 0.66221 -3.468948 
POLD3 Polymerase, delta 3 0.77873 -2.428154 
TOP2B Topoisomerase (DNA) II beta 0.73286 -2.756899 
ERCC5 Excision repair cross-complementing rodent repair deficiency, 0.73272 -2.51055 
GADD45G Growth arrest and DNA-damage-inducible, gamma 0.78274 -2.32859 
H2AFJ H2A histona family, member J 0.71104 -3.294313 
    
Transcription regulation 
EWSR1 Ewing sarcoma breakpoint region 1 1.2874 2.2920873 
PGBP1 Polyglutamine binding protein 1 1.44462 3.3070653 
CXXC5 CXXC finger 5 0.73896 -2.725255 
ETV1 ETS translocation variant 1 0.76232 -2.406796 
EBF2 Early B-cell factor 2 0.77475 -2.369549 
EN2 Engrailed 2 0.76205 -2.30452 
HOXB9 Homeo box B9 0.75307 -2.408951 
JMJD2A Jumonji domain containing 2A 0.75587 -2.385624 
MEF2B Monocyte-specific enhancer factor 2B 0.65713 -3.849618 
MLL5 Mixed-lineage leukemia protein 5 (Drosophila) 0.77121 -2.377747 
NR4A1 Nuclear receptor subfamily 4, group A, member 1 0.55428 -5.284012 
RFX3 Regulatory factor X 3 0.76687 -2.375122 
TBX3 T-box 3 0.77082 -2.245508 
THRAP5 Thyroid hormone receptor associated protein 5 0.74269 -2.357621 
SOX10 Sex determining region Y, box 10 0.77109 -2.344628 
ZNF134 Zinc finger protein 134 0.76556 -2.362746 
ZNF189 Zinc finger protein 189 0.76975 -2.269084 
ZNF202 Zinc finger protein 202 0.76388 -2.420872 
ZNF257 Zinc finger protein 257 0.75757 -2.591762 
    
RNA processing 
CPSF2 Cleavage and polyadenylation specific factor 2 1.31753 2.3680842 
SNRPF Small nuclear ribonucleoprotein F 1.37152 3.036003 
U2AF1 U2 small nuclear RNA auxiliary factor 1 1.33886 2.6185748 
DHX36 DEAH (Asp-Glu-Ala-His) box polypeptide 36 0.44245 -7.318729 
    
Protein biosynthesis 
EIF5 Eukaryotic translation initiation factor 5 1.26522 2.4960049 
MTIF2 Mitochondrial translation initiation factor  0.77088 -2.434161 
RPL6 Ribosomal protein L6 0.76423 -2.577655 
RPL41 Ribosomal protein L41 0.76695 -2.468626 
    
Cell cycle / cell proliferation 
AIM2 Absent in melanoma 2 (Interferon inducible protein AIM2) 1.30578 2.4723298 
CDK4 Cyclin-dependent kinase 4 1.29321 2.2839838 
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TABLE D.1. (continued) 
    
Symbol Gene product Fold- change z-score 
    
EVI2B Ectopic viral integration site 2B protein 1.60363 3.6896678 
JUND Jun D proto-oncogen 1.65212 4.3907758 
LRP16 LRP 16 protein 1.588 3.8477827 
PIWIL2 Piwi-like 2 (Drosophila) 1.31844 2.2969718 
CTBP1 C-terminal binding protein 1 1.47444 3.8582533 
ABL1 v-abl Abelson murine leukemia viral oncogene homolog 1 0.73293 -2.855903 
MYB v-myb myeloblastosis viral oncogene homolog (avian) 0.66196 -3.522326 
DCX Doublecortex 0.76191 -2.298506 
EMP2 Epithelial membrane protein 2 0.78335 -2.252619 
EPS8 Epidermal growth factor receptor kinase substrate EPS8 0.64176 -3.723731 
HPGD Hydroxyprostaglandin dehydrogenase 15 (NAD) 0.74688 -2.456055 
IGF2 Insulin-like growth factor II 0.75238 -2.548235 
NDRG1 N-myc downstream regulated gene 1 0.76004 -2.300189 
PLGF Placenta growth factor 0.70274 -3.097604 
RBBP4 Retinoblastome-binding protein 4 0.72108 -2.927198 
RUNX3 Runt-related transcription factor 3 0.77929 -2.286013 
THRA Thyroid hormone receptor alpha 0.74799 -2.456245 
TIMP1 TIMP metallopeptidase inhibitor 1 0.75154 -2.517132 
TPD52 Tumor protein D52 0.76654 -2.548088 
ZNF36I2 Zinc finger protein 36, C3H type-like 2 0.75922 -2.282861 
    
Cell adhesion 
CD34 Hemopoietic progenitor cell antigen CD34 1.44534 3.4986467 
CD47 CD47 antigen 1.32438 2.2968414 
THBS1 Thrombospondin 1 1.62538 4.7191228 
LAMC1 Laminin, gamma 1 0.69363 -3.198841 
    
Apoptosis 
TFPT TCF3 (E2A) fusion partner 0.76716 -2.324711 
CASP8 Caspase 8 0.77249 -2.261711 
BCAP31 B-cell receptor-associated protein 31 0.75787 -2.501483 
RUNX3 Runt-related transcription factor 3 0.77929 -2.286013 
SERINC3 Serine incorporator 3 0.74665 -2.576057 
    
Immune and inflammatory response 
BDKRB2 Bradykinin receptor B2 1.58372 4.2821552 
F3 Coagulation factor III  1.3538 2.4746753 
C5 Complement component 5 0.77757 -2.309976 
CD24 CD 24 molecule 0.69982 -3.106687 
CD46 CD 46 molecule 0.75207 -2.54949 
CXCL1 Chemokine (C-X-C motif) ligand 1 0.6915 -3.16797 
DEFB126  Defensin b 126 0.76296 -2.301419 
IFITM3 Interferon induced transmembrane protein 3 0.74363 -2.699258 
MASP1 Mannan-binding lectin serine protease 1 0.7236 -2.626426 
    
Intracellular trafficking 
SDCCAG3 Serologically defined colon cancer antigen 3 1.30104 2.4627789 
AAAS Achalasia, adrenocortical insufficiency, alacrimia 0.76584 -2.424322 
GOLGA2 Golgi autoantigen, subfamily A2 0.75279 -2.473068 
RAB11FIP2 RAB 11 family interacting protein 2 0.76208 -2.405119 
EEA1 Early endosome antigen 1 0.74407 -2.462189 
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TABLE D.1. (continued) 
    
Symbol Gene product Fold- change z-score 
    
Signal transduction 
FARP2 FERM, RhoGEF and pleckstrin domain protein 2 0.74497 -2.465998 
AVPI1 Arginine vasopressin-induced 1 0.7752 -2.306763 
MAP3K7IP1 Mitogen-activated protein kinase kinase kinase 7 interating protein 1 0.76936 -2.313994 
GNAI2 
Guanine nucleotide binding protein (G protein), alpha inhibiting activity 
polypeptide 2 0.76428 -2.549902 
GKAP1 G kinase anchoring protein 1 0.77107 -2.297608 
RICS Rho GTPase-activating protein 0.76216 -2.242356 
    
Metabolism 
HYAL1 Hyaluronoglucosaminidase 6.57069 15.496092 
MMP11 Matrix metalloproteinase 11 1.30574 2.4432546 
HEXA Hexosaminidase A (alpha polypeptide) 0.71608 -3.026842 
APOA2  Apolipoprotein A-II 0.7216 -2.843429 
GPT Glutamic-pyruvate transaminase 0.75646 -2.36531 
HMGCR 3-hydroxy-3-methylglutaryl-coenzyme A reductase  0.74266 -2.534719 
LDLR Low density lipoprotein receptor 0.78663 -2.327002 
LPIN1 Lipin 1 0.76441 -2.348436 
CPE Carboxypeptidase E 0.76493 -2.356092 
POMGNT1 Protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase  0.75945 -2.413648 
STK23 Serine/threonine kinase 23 0.75774 -2.24361 
TDO2 Tryptophan 2,3-dioxygenase 0.68774 -3.478427 
DPH1 DPH1 homolog (S. cerevisiae) 0.75977 -2.323451 
    
Cytoskeleton organization 
ACTC Actin, alpha 1.3233 2.5042674 
ALPL Alkaline phosphatase, liver 1.50242 3.3968313 
WFDC2 WAP four-disulfide core domain 2 1.38431 3.0092823 
EPB41 Erithrocyte membrane protein band 4.1 0.73614 -2.797787 
KRT1 Keratin 1 0.74833 -2.905533 
PFN1 Profilin 1 0.79711 -2.358022 
    
Other functions 
COMT Catechol-O-methyltransferase 0.73715 -2.844418 
GSTP1 Glutathione S-transferase pi 0.66415 -3.53081 
KCND1 Potassium voltage-gated channel, member 1 0.64367 -3.630932 
SFXN4 Sideroflexin 4 0.78375 -2.429203 
CP Ceruloplasmin 0.71908 -2.770096 
CHGA Chromogranin A 0.74525 -2.399948 
FGA Fibrinogen, A alpha polypeptide 0.68628 -3.100724 
AGGF1 Angiogenic factor with G patch and FHA domains 1 0.73601 -2.758494 
DKK3 Dickkopf homolog 3 (Xenopus laevis) 0.71877 -2.760573 
EXT2 Exostoses (multiple) 2 0.76486 -2.310001 
SPANXA1 Sperm protein associated with the nucleus, X-linked, family member A1 0.66837 -3.450173 
ITIH4 Inter-alpha (globulin) inhibitor H4  0.62762 -4.345992 
CCDC91  Coil-coil domain containing 91 1.27627 2.3041053 
TRIM31 Tripartite motif-containing 31 1.63875 4.2126431 
KLHL9 Kelch-like 9 (Drosophila) 0.6772 -3.211075 
SDCCAG10 Serologically defined colon cancer antigen 10 0.72702 -2.735052 
STAMBPL1 STAM binding protein-like 1 0.76121 -2.390359 
TULP1 Tubby-like protein 1 1.26614 2.3308962 
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TABLE D.1. (continued) 
    
Symbol Gene product 
Fold- 
change z-score 
    
PROM1 Prominin 1 0.77602 -2.246849 
PDE6D Phosphodiesterase 6D 0.76868 -2.334084 
    
Unknown function 
HSPC135 Transcribed locus 1.459 3.2731334 
Hs 153687       Transcribed locus 1.60324 3.4042936 
Hs 155566       Transcribed locus 5.86847 14.652094 
Hs 157441       Transcribed locus 1.53434 3.6155001 
Hs 197081       Transcribed locus 1.30886 2.4470698 
Hs 24087 Transcribed locus 1.60473 4.2862217 
Hs 356537       Transcribed locus 1.38542 3.0144897 
Hs 405564       Transcribed locus 1.24741 2.2522462 
Hs 408576       Transcribed locus 1.32242 2.3248019 
Hs 415220       Transcribed locus 1.55965 4.1941278 
Hs 448968       Transcribed locus 1.34355 2.3754105 
Hs 512640       Transcribed locus 1.44503 3.5539992 
MGC16121 Hypothetical protein MGC16121 1.56738 3.8964986 
MGC50853 Hypothetical protein MGC50853 1.32824 2.355143 
MT1M Metallothionein 1M 1.33285 2.5995546 
NICN1 Nicolin 1 1.31822 2.2914136 
gb:AI025496    Transcribed locus 1.32677 2.4950966 
gb:H46666       Transcribed locus 1.35682 2.4532232 
gb:R52934       Transcribed locus 1.39486 2.7219361 
gb:W51760 Similar to Heparin-binding growth factor precursor 2 1.649 4.3171207 
ACBD5 Acyl-Coenzyme A binding domain containing 5 0.74403 -2.432968 
C14orf147 Transcribed locus 0.75143 -2.687003 
C20orf62 Transcribed locus 0.7356 -2.897555 
FLJ 20097       Transcribed locus 0.73823 -2.513384 
FLJ37478 Transcribed locus 0.55793 -5.503183 
Hs 108338       Transcribed locus 0.74758 -2.675371 
Hs 1987 Transcribed locus 0.70571 -2.822536 
Hs 83341 Transcribed locus 0.76519 -2.535004 
KIAA0664 Transcribed locus 0.74777 -2.470381 
TMEM140 Transmembrane protein 140 0.77583 -2.323219 
gb:AA775845   Transcribed locus 0.77458 -2.387821 
gb:AI190209    Transcribed locus 0.74974 -2.556592 
gb:BE874451   Transcribed locus 0.66936 -3.788126 
gb:H62594 Similar to contains Alu repetitive elements 0.76084 -2.700185 
    
 
 
Negative sign (-) before the z-score numbers and fold-change below 1 indicate down-regulation 
of the gene expression 
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APPENDIX E 
TABLE E.1. Host genes significantly altered in B. melitensis-infected HeLa cells at 
12 h PI, compared to non-infected cells 
 
Symbol Gene product Fold-change z-score 
    
    
DNA replication and repair 
ARID1A AT rich interactive domain A1 1.53432145 3.45093586 
POLK Polymerase kappa 1.36535226 2.50694601 
RAD51L1 Rad51-like 1 (S. cerevisiae) 1.34005034 2.31790911 
RAD9B RAD9 homolog B (S. cerevisiae) 1.31959503 2.53651239 
TDP1 Tyrosyl-DNA phosphodiesterase/alkaline phosphatase D 1.33670838 2.38178397 
POLE3 Polymerase, epsilon 3 0.65504295 -3.03419011 
    
RNA processing 
CPEB2 Cytoplasmic polyadenylation element binding protein 2 1.41515313 2.98643844 
CPSF2 Cleavage and polyadenylation specific factor 2 1.50438478 3.51843933 
DDX12 DEAD/H box polypeptide 12  1.4437683 3.07058803 
DHX15 DEAD box polypeptide 15 1.42903951 3.10560287 
HNRPM Heterogeneous nuclear ribonucleoprotein M 1.39416622 2.60652989 
RNASE4 Ribonuclease 4 2.26949857 6.55731176 
SNRPE Small nuclear ribonucleoprotein E 1.50133566 3.26020646 
SPOP Speckle-type POZ protein 1.66683916 4.24989545 
SFRS11 Splicing factor, arginine/serine-rich 11 1.41167802 2.54044576 
XRN2 5'-3' exoribonuclease 2 1.38551554 2.77519719 
DDX3Y DEAD box protein 3, Y-chromosomal 0.7306879 -2.24863398 
DDX1 DEAD box polypeptide 1 0.66094854 -3.29437546 
DHX36 DEAD box polypeptide 36 0.57712856 -4.44245846 
LSM3 LSM3 homolog U6 small nuclear RAN associated (S. cerevisiae) 0.65127981 -2.97093082 
SNRPF Small nuclear ribonucleoprotein F 0.63368679 -3.24226412 
NOLA2 Nucleolar protein family A, member 2 0.65828881 -2.52074599 
    
Transcription regulation 
ATF2 Activating transcription factor 2 1.43924458 3.04524649 
AFF4 AF4/FMR2 family, member 4 1.36337646 2.68183479 
CRSP3 Cofactor required for Sp1 transcriptional activation, subunit 3 1.36166754 2.78728324 
CXXC5 CXXC finger 5 1.39493444 2.65395049 
ETV1 EST translocation variant 1 1.5087615 3.20185387 
ETV5 EST translocation variant 5 1.48650053 3.09294328 
EWSR1 Ewing sarcoma breakpoint region 1 1.38353697 2.60823252 
FOXJ1 Forkhead fox J1 1.40614468 2.95790085 
FOXA3 Forkhead box A3 1.3879332 2.5191127 
FOXI1 Forkhead box I1 1.32758513 2.5839967 
HDAC6 Histone deacetylase 6 1.28801616 2.34362069 
HES1 Hairy and enhancer of split 1 (Drosophila) 1.65541258 3.29231548 
HSF4 Heat shock transcription factor 4 1.4143357 2.76784744 
KLF12 Kruppel-like factor 12 1.31467392 2.64400586 
KLF6 Kruppel-like factor 6 1.62447841 4.2310962 
KLF9 Kruppel-like factor 9 1.58421741 3.86748496 
NCOR2 Nuclear receptor corepressor 2 1.35875196 2.44483547 
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TABLE E.1. (continued) 
    
Symbol Gene product Fold-change z-score 
    
    
NRIP1 Nuclear receptor interacting protein 1 1.58573658 3.53376861 
PWP1 PWP1 homolog (S. cerevisiae) 1.65195601 4.3407906 
RUNX1 Runt-related transcription factor 1 1.36609236 2.77118801 
SOX4 SRY-box containing gene 4 1.36844765 2.62059973 
TCF7 Transcription factor 7 1.47637634 3.51251753 
TCFL5 Transcription factor-like 5 1.53719257 3.44044927 
TFAP4 Transcription factor AP-4 1.52469015 3.92040619 
TLE1 Transducin-like enhancer protein 1 1.66097678 4.79954223 
ZNF148 Zinc finger protein 148 1.35028795 2.4495498 
ZNF154 Zinc finger protein 154 1.49868713 3.2498285 
ZNF25 Zinc finger protein 25 1.35972547 2.48145445 
ZNF257 Zinc finger protein 257 1.78503777 4.8307937 
ZNF350 Zinc finger protein 350 1.33624881 2.4110275 
ZNF516 Zinc finger protein 516 1.33031517 2.28218382 
ZNF539 Zinc finger protein 539 1.65134444 4.06973236 
ZNF562 Zinc finger protein 562 1.35179955 2.561984 
ZNF588 Zinc finger protein 588 1.5441345 3.43947161 
ZNF711 Zinc finger protein 711 1.48458433 3.23903503 
ZNF77 Zinc finger protein 77 1.4429681 2.71418556 
ZNF85 Zinc finger protein 85 1.39072222 2.5222804 
ZNF93 Zinc finger protein 93 1.75314079 4.97421035 
ZSCAN2 Zinc finger and SCAN domain containing 2 1.34368311 2.78814967 
ZBTB7A Zinc finger and BTB domain containing 7A 1.30347568 2.27027589 
ZFP64 Zinc finger protein 64 1.35889496 2.60905321 
DR1 Down-regulator of transcription 1 0.72412681 -2.58629918 
CRSP6 Cofactor required for Sp1 transcriptional activation, subunit 6 0.69365641 -3.29408341 
GTF2A2 General transcription factor IIA, 2 0.59151487 -4.70473678 
HIF1A Hypoxia-inducible factor 1 alpha 0.75572392 -2.34033564 
LBX2 Ladybird homeobox homolog 2 (Drosophila) 0.73465781 -2.45051559 
MAFG v-maf musculoaponeurotic fibrosarcoma oncogen homolog G (avian) 0.63249762 -3.48412529 
NPM1 Nucleophosmin 0.64128313 -3.55471191 
RDBP RD RNA binding protein 0.65307586 -3.8351949 
RELA v-rel reticuloendotheliosis viral oncogen homolog A 0.7484415 -2.41428433 
TRIM25 Tripartite motif-containing 25 0.73494299 -2.57053527 
    
Protein biosynthesis 
EIF3S2 Eukaryotic translation initiation factor 3, subunit 2 beta 1.29839183 2.33339833 
RPL15 Ribosomal protein L15 1.55955374 2.76556456 
RPS6KB1 Ribosomal protein S6 kinase, 70kDa, polypeptide 1 1.41461526 2.91887674 
BXDC2 Brix domain containing 2 0.62778446 -2.63289232 
EIF1AX Eukaryotic translation initiation factor 1A, X-linked 0.63624377 -3.21042145 
EIF4G2 Eukaryotic translation initiation factor 4 gamma, 2 0.66276356 -2.9289305 
EIF5A Eukaryotic translation initiation factor 5A 0.63919136 -3.80973593 
EIF3S1 Eukarytic translation initiation factor 3, subunit 1 alpha 0.59292889 -3.27564382 
ETF1 Eukaryotic translation termination factor 1 0.69935248 -2.96492683 
RARS Arginyl-tRNA synthetase 0.72623583 -2.52859147 
KARS Lysyl-tRNA synthetase 0.7096688 -2.80301925 
MRRF Mitochondrial ribosome recycling factor 0.67015086 -3.14898986 
MTIF2 Mitochondrial translational initiation factor 2 0.71972669 -3.09158056 
MRPS2 Mitochondrial ribosomal protein S2 0.68009218 -2.80356902 
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MRPS21 Mitochondrial ribosomal protein S21 0.74624741 -2.49683403 
RPL35 Ribosomal protein L35 0.63007113 -2.41985813 
RPL6 Ribosomal protein L6 0.70632771 -2.34652836 
RPS27A Ribosomal protein S27A 0.64516206 -2.29586512 
RPSA Ribosomal protein SA 0.60634426 -2.62094334 
    
Protein folding and secretion 
DNAJB6 DNAJ (Hsp40) homolog, subfamily B, member 6 1.32912642 2.27378249 
DNAJB9 DNAJ (Hsp40) homolog, subfamily B, member 9 1.48277505 3.2645933 
CCT3 Chaperonin containing TCP1, subunit 3  0.69482582 -3.20058906 
CCT5 Chaperonin containing TCP1, subunit 5 0.58798466 -2.78201688 
PPIF Peptidylprolyl isomerase F 0.68140944 -2.28713363 
    
Protein degradation 
CPE Carboxipeptidase E 1.79432184 4.26864274 
CTSB Cathepsin B  2.10685177 6.59857524 
DET1 De-etiolated homolog 1 (Arabidopsis) 1.34185917 2.31541883 
PRSS1 Protease, serine, 1 2.48033721 6.23311521 
PRSS7 Protease, serine, 7 1.46481556 3.2570814 
QPCT Glutaminyl-peptide cyclotransferase  2.73103881 7.70652938 
UCHL1 Ubiquitin carboxyl-terminal esterase L1 1.58948645 3.92859894 
USP34 Ubiquitin specific protease 34 1.33982461 2.48385939 
UBE2D3 Ubiquitin-conjugating enzyme E2 D3 1.48941968 3.01468981 
USP15 Ubiquitin specific protease 15 1.41530897 2.86048378 
USP32 Ubiquitin specific protease 32 1.62895059 4.38396107 
PSMA3 Proteasome subunit, alpha type, 3 0.72243294 -2.95342313 
PSMB7 Proteasome subunit, beta type, 7 0.54451429 -3.18438138 
PSMD2 Proteasome, 26S subunit, non-ATPase, 2 0.77223605 -2.37960134 
UBE2M Ubiquitin-conjugating enzyme E2M 0.64486165 -3.35493238 
UBQLN1 Ubiquilin 1 0.74116747 -2.598481 
UCHL3 Ubiquitin carboxyl-terminal esterase L3 0.69807835 -2.9856338 
    
Cell cycle / cell proliferation 
CCND1 Cyclin D1 1.57244336 4.17721854 
CCNG1 Cyclin G1 1.38747381 2.37289798 
CCNJL Cyclin J-like 1.38294191 2.457603 
CDC2L2 Cell division cycle 2-like 2 1.45305789 2.92941568 
CDC2L6 Cell division cycle 2-like 6 1.37873476 2.685863 
CHES1 Check point suppressor 1 1.3736702 2.52626936 
EGR1 Early growth response protein 1 1.56166189 4.16011838 
MAPK1 Mitogen-activated protein kinase 1 3.75962187 10.1187443 
MDM4 Mdm4, transformed 3T3 cell double minute 4 1.32454138 2.65653248 
S100A12 S100 calcium-binding protein A12 1.5744013 3.26919462 
TP53 Tumor protein p53 1.38940668 2.91713307 
CYLD Cylindromatosis 1.34009448 2.3118973 
GAS2 Growth-arrest specific protein 2 1.4326843 2.75504528 
KLK10 Kallikrein-related peptidase 10 1.3822572 2.8595219 
CDK5RAP3 CDK5 regulatory subunit associated protein 3 1.37763166 2.65243917 
DDR2 Discoidin domain receptor family, member 2 1.30900128 2.46134716 
ERBB3 v-erb-B2 erythroblastic leukemia viral oncogene homolog 3 (avian) 1.52956178 3.39757225 
FOS v-fos FBJ murine osteosarcoma viral 1.3343976 2.78526197 
  
 
242
TABLE E.1. (continued) 
    
Symbol Gene product Fold-change z-score 
    
    
MYB v-myb myeloblastosis viral oncogen homolog (avian) 1.77265465 4.16701161 
SRC v-src sarcoma viral oncogen homolog (avian) 1.41008744 2.26239951 
FGF5 Fibroblast growth factor 5 1.31957471 2.36670783 
FGFR2 Fibroblast growth factor receptor 2 1.40397966 2.61505016 
GAB1 GRB2-associated binder 1 1.36552448 2.9423508 
HOXC10 Homeobox C10 1.37954251 2.46726183 
IGF2 Insulin-like growth factor II 2.25163425 5.33288161 
PDGFRA Platelet-derived growth factor receptor, alpha 2.62226 7.44349863 
PIM1 Pim 1 oncogen 1.68315464 4.07710952 
VEGF Vascular endothelial growth factor 1.46844684 3.20649729 
MCC Mutated in colorectal cancers 1.3282819 2.39548411 
MDFI MyoD family inhibitor 1.31553577 2.39609787 
GPC1 Glypican 1 1.74226479 4.42631559 
GPC3 Glypican 3 4.31796195 12.1236823 
DCBLD2 Discoidin, CUB and LCCL domain containing 2 1.43402004 3.07271434 
DUSP6 Dual specificity phosphatase 6 1.75209287 4.39842565 
ESR1 Estrogen receptor 1 1.37283953 2.51066343 
GPNMB Glycoprotein nmb 3.51891919 8.98178452 
IGFBP2 Insulin-like growth factor binding protein 2 1.81273375 5.08259798 
IGFBP3 Insulin-like growth factor binding protein 3 2.98629032 9.67892132 
MNT Max binding protein 1.4117326 2.80414686 
PPP2R4 Protein phosphatase 2A, regulatory subunit B 1.34272531 2.426593 
PRRX1 Paired related homeobox 1 1.43787825 2.64686109 
ATR Ataxia telangiectasia and Rad3 related 0.75153017 -2.42279103 
BCAR3 Breast cancer anti-estrogen resistance 3 0.62224344 -3.32951623 
CSE1L Chromosome segregation 1-like 0.66164997 -3.51980099 
CSNK1G1 Casein kinase 1, gamma 1 0.6920897 -2.55745827 
CRIP1 Cysteine-rich protein 1 0.64118677 -3.5967121 
FGF7 Fibroblast growth factor 7 0.66223796 -3.5487114 
FGFRL1 Fibroblast growth factor receptor-like 1 0.72437967 -2.25652156 
GSPT1 G1 to S phase transition protein 1 homolog 0.72030679 -2.98713414 
JUND junD proto-oncogene 0.79195892 -2.24327777 
KPNA2 Karyopherin alpha 2 0.73440135 -2.73694357 
MYC v-myc myelocytomatosis viral oncogene homolog (avian) 0.57465018 -4.52724227 
PA2G4 Proliferation-associated 2G4, 38kDa 0.64663808 -2.28389357 
PTP4A1 Protein tyrosine phosphate type IV A, member 1 0.57636246 -2.88660231 
PBK PDZ binding kinase 0.75089718 -2.31791396 
RSN Restin 0.71425977 -2.76001253 
S100A1 S100 calcium-binding protein A1 0.71484421 -2.71094875 
S100A10 S100 calcium-binding protein A10 0.57534683 -3.2566169 
S100A6 S100 calcium-binding protein A6 0.44447501 -6.83542389 
TIMP1 TIMP metallopeptidase inhibitor 1 0.55557917 -4.83106403 
IFRD2 Interferon-related developmental regulator 2 0.64864023 -3.06355135 
NME1 Non-metastatic cells 1 0.72388559 -2.60204105 
PPP2CA Protein phosphatase 2, catalytic subunit, alpha 0.7433722 -2.51476873 
S100A11 S100 calcium-binding protein A11 0.5360633 -5.10001361 
TM4SF4 Transmembrane 4 L six family member 4 0.71445433 -2.82152881 
    
Cell adhesion 
ADD2 Adducin 2 1.36268875 2.57327759 
CAMK2N1 Calcium/calmodulin-dependent protein kinase II inhibitor 1 2.1118672 5.79943898 
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CDH1 Cadherin 1, type 1, E-cadherin 1.47555734 3.0703373 
CDH11 Cadherin 11, type 2, OB-cadherin (osteoblast) 1.49677177 3.09468838 
CDH3 Cadherin 3, type 1, P-cadherin (placental) 1.32676655 2.31457101 
CDH6 Cadherin 6, type 2, K-cadherin (fetal kidney) 1.42473285 2.68191677 
CEACAM5 Carcinoembrionic antigen-related cell adhesion molecule 5 1.75298794 4.89237531 
COL18A1 Collagen, type 18 alpha 1  1.3172008 2.27979411 
COL2A1 Collagen, type II, alpha 1 1.3465128 2.31639156 
COL4A2 Collagen , type IV, alpha 2 1.43979161 2.82579349 
COL6A3 Collagen, type VI, alpha 3 1.37667037 2.40449901 
CTNND2 Catenin, delta 2 1.33512987 2.26972992 
CD47 CD47 molecule 1.72974107 4.74776656 
CDH16 Cadherin 16 1.46639152 3.16430826 
CELSR3 Cadherin, EGF LAG seven-pass G-type receptor 3 (Drosophila) 1.33284108 2.42262456 
CNTNAP2 Contactin associated protein-like 2 1.47861211 2.55162029 
COL9A2 Collagen, type IX, alpha 2 1.35802216 2.53199352 
EMILIN1 Elastin microfibril interfacer 1 2.07733039 5.69432799 
EVL Ena-vasodilator stimulate phosphoprotein 1.34955719 2.37186796 
FN1 Fibronectin 1 1.37314257 2.66920781 
HSPG2 Heparan sulfate preteoglycan 2 1.31472717 2.39974994 
ITGA8 Integrin, alpha 8 1.43333526 2.65995252 
ITGAL Integrin, alpha L 1.43358588 3.10683665 
ITGB3 Integrin, beta 3 1.46017223 3.20715914 
ITGB7 Integrin, beta 7 2.15294983 5.34984602 
LGALS4 Lectin, galactose binding, soluble 4 1.63503341 4.32995983 
MFAP4 Microfibrillar-associated glycoprotein 4 1.45533536 3.37036407 
SDC2 Syndecan 2 1.75117147 3.97432168 
THBS1 Thrombospondin 1 1.56670076 3.75380685 
THBS4 Thrombospondin 4 1.46778099 3.25578429 
TACSTD1 Tumor-associated calcium signal transducer 1.50098222 3.58500634 
ARHGDIB Rho GDP dissociation inhibitor (GDI) beta 1.97906828 5.66077213 
EPDR1 Ependymin related protein 1 0.62791651 -3.59372943 
L1CAM L1 cell adhesion molecule 0.68134811 -3.02852759 
    
Cytoskeleton organization 
AMOT Angiomotin 1.54917681 2.95610436 
DCN Decorin 1.56279152 3.76246873 
CDC42EP3 CDC42 effector protein 3 1.57361287 3.55821634 
MARCKS Myristoylated alanine-rich C-kinase substrate 2.1935282 6.50294642 
LCP1 Lymphocyte cytosolic protein 1 2.22514114 6.70170921 
MAP1B Microtubule-associated protein 1B 3.31310641 9.90914709 
MARK3 MAP/microtubule affinity-regulating kinase 3 1.49409928 3.22446335 
NEB Nebulin 1.34490503 2.34471577 
NEBL Nebulette 1.3528287 2.45863066 
PFN2 Profilin 2 1.49893635 3.20677329 
RHOJ Ras homolog gene family, member J 1.40640567 2.83502338 
SGCD Sarcoglycan, delta 1.43996636 2.92209503 
SGCE Sarcoglycan, epsilon 1.33583061 2.62940388 
VIL1 Villin 1 1.73805376 4.00208029 
MYO10 Myosin X 1.34557864 2.48487963 
SNTB1 Syntrophin, beta 1 1.56927548 3.66966483 
TPM1 Tropomyosin 1 (alpha) 1.40102582 2.56540417 
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ABLIM1 Actin-binding LIM protein 1 0.78650662 -2.25814895 
FOXC1 Forkhead box C1 0.71322099 -2.70445188 
KRT18 Keratin 18 0.44141382 -4.28403717 
KRT20 Keratin 20 0.66154362 -3.17430657 
MYO1E Myosin IE 0.7559879 -2.27954326 
PFN1 Profilin 1 0.61523229 -3.39803745 
TMOD3 Tropomodulin 3 0.61542961 -3.44982659 
CART1 Cartilage paired-class homeoprotein 1 0.755282 -2.42938519 
ppl Periplakin 0.69637454 -2.89259009 
    
Development 
ANGPT1 Angiopoietin 1 1.4969981 2.99551335 
DZIP1 DAZ interating protein 1 1.49156858 3.21413194 
SERPINA5 Serine proteinase inhibitor, clade A, member 5 1.94498944 4.77288373 
SERPINA7 Serine proteinase inhibitor, clade A, member 7 1.48472277 3.03158298 
HEXIM1 Hexamethylene bis-acetamide inducible 1 1.34123051 2.24340197 
KRT5 Keratin 5 1.35600707 2.4337124 
DIP2A Disco-interacting protein 2 homolog A (Drosophila) 1.31093057 2.37805422 
DLK1 Delta-like 1 homolog (Drosophila) 1.73041517 4.68237492 
DLL3 Delta-like 3 (Drosophila) 1.54072658 3.61336602 
GHR Growth hormone receptor 1.60952377 3.57737179 
LMO2 LIM domain only 2 1.52550575 2.83605201 
NUMB Numb homolog (Drosophila) 1.49151173 2.76240141 
PPAP2B Phosphatidic acid phosphatase type 2B 1.95397032 5.26227155 
PLXNC1 Plexin C1 1.66635044 3.97535569 
DKK3 Dickkopf homolog 3 (Xenopus laevis) 2.33885695 6.40724114 
CSRP1 Cysteine and glycine-rich protein 1 0.6879742 -2.91519832 
    
Apoptosis 
BCL2 B-cell CLL/lymphoma 2 1.39721031 2.92720266 
BIRC4 Baculoviral IAP repeat-containing 4 1.47475976 3.12549012 
DAD1 Defender against cell death 1  1.36053336 2.37186354 
BNIP3I BCL2/adenovirus E1B 19kDa-interacting protein 3-like 1.65399425 4.17577146 
CD38 CD38 molecule 1.56697161 3.47040907 
MDM4 Mdm4, transformed 3T3 cell double minute 4 1.32454138 2.65653248 
MAGEH1 Melanoma antigen, family H, member 1 1.67045487 4.16928454 
PRG1 Proteoglycan 1, secretory granule 1.66053857 4.10784106 
TP53BP2 Tumor protein p53 binding protein, 2 1.29338127 2.36915684 
BCL2L1 BCL2-like 1 0.72210355 -2.78702097 
BIRC3 Baculoviral IAP repeat-containing 3 0.75013452 -2.4869422 
BAG1 BCL2-associated athanogen 1 0.73222617 -2.53752448 
CSE1L Chromosome segregation 1-like 0.66164997 -3.51980099 
TEGT Testis enhanced gene transcript 0.60705412 -3.6307224 
MCL1 Myeloid cell leukemia sequence 1 0.63062629 -3.88173901 
ANXA1 Annexin A1 0.42901542 -4.81455638 
CASP1 Caspase 1 0.69636311 -3.25735884 
    
Immuno and Inflammatory response 
AHSG Alpha-2-HS-Glycoprotein  3.93303463 11.3953659 
BDKRB2 Bradykinin receptor B2 1.32775448 2.48659283 
C2 Complement component 2 1.41090764 2.62835721 
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C5 Complement component 5 1.38553768 2.34831937 
CCL16 Chemokine (C-C motif) ligand 16 1.36068668 2.63295429 
CD1C CD1c molecule 1.39280467 2.5395196 
CD8B1 CD8 molecule, beta 1 1.45102614 3.0873735 
CD24 CD24 molecule 1.73283937 4.1015192 
CD28 CD28 molecule 1.58821172 3.63784665 
CD84 CD84 molecule 1.30121962 2.26534313 
CD86 CD86 molecule 1.43250073 2.81126283 
COLEC10 Collectin sub-family member 10 1.31773552 2.37642842 
CTLA4 Cytotoxic T-lymphocyte associated protein 4 1.52297843 3.44617889 
CMTM7 CKLF-like MARVEL transmembrane domain containing 7 1.37425969 2.85340126 
FPRL2 Formyl peptide receptor-like 2 1.49834282 3.54572797 
HLA-A Major histocompatibility complex, class I, A 1.31863973 2.49841716 
HLA-B Major histocompatibility complex, class I, B 1.46325155 3.07795523 
HLA-DQA1 Major histocompatibility complex, class II, DQ alpha 1 1.3095408 2.47766477 
HLA-DRB1 Major histocompatibility complex, class II, DR beta 1 1.42660068 2.73997063 
IGLL1 Immunoglobulin lambda-like polypeptide 1 3.92222738 12.9721865 
IKBKAP Inhibitor of kappa B-cells, kinase complex-associated protein 1.36727964 2.53348658 
IL1F5 Interleukin 1 family, member 5 1.33380579 2.48904754 
IL1R1 Interleukin 1 receptor, type 1 1.41913355 2.80514327 
IL2RG Interleukin 2 receptor, gamma 1.83847323 5.10022215 
IRF4 Interferon regulatory factor 4 1.49865927 3.06580757 
ICOSLG Inducible T-cell co-stimulator ligand 1.49361984 3.57674597 
IGJ Immunoglobulin joining chain 5.56342293 11.2948463 
LYZ Lysozyme 2.36619324 7.01251088 
NCF1 Neutrophil cytosolic factor 1 1.32149752 2.34952369 
NFIL3 Nuclear factor, interleukin 3 regulated 1.31910484 2.63331256 
TNFRSF17 Tumor necrosis factor receptor superfamily, member 17 1.39478379 2.88500711 
ANXA1 Annexin A1 0.42901542 -4.81455638 
CD46 CD46 molecule 0.70189729 -2.82131293 
CD59  CD59 molecule, complement regulatory protein 0.47079519 -4.31038972 
CRIP1 Cysteine-rich protein 1 0.64118677 -3.5967121 
DAF Decay acceleratin factor for complement (CD55 molecule) 0.74589635 -2.62878615 
F3 Coagulation factor III 0.56049858 -5.11722015 
IFIT1 Interferon-induced protein with tetratricopeptide repeats 1 0.44180147 -6.71630506 
IFIT2 Interferon-induced protein with tetratricopeptide repeats 2 0.63468656 -3.35102169 
IFITM2 Interferon-induced transmembrane protein 2 0.56652492 -3.92969628 
IFITM3 Interferon induced transmembrane protein 3 0.69497068 -2.30372743 
IL18 Interleukin 18 0.59304953 -4.23492351 
IL8 Interleukin 8 0.68783796 -3.01058498 
IFI30 Interferon, gamma-inducible protein 30 0.75522337 -2.35041666 
KLRC3 Killer cell lectin-like receptor subfamily C, member 3 0.63774985 -3.46947982 
SOCS1 Suppressor of cytokine signaling 1 0.69881711 -3.02963162 
    
Nervous system development and proliferation 
CDK5RAP1 CDK5 regulatory subunit associated protein 1 1.34486228 2.5146975 
DCT Dopachrome tautomerase 3.98044135 11.581189 
MDK Midkine 1.8252039 4.46656528 
NGFRAP1 Nerve growth factor receptor associated protein 1 1.30715829 2.53392347 
MYEF2 Myelin basic protein expression factor 2 1.45559037 3.42963605 
NES Nestin 1.77741941 4.90787046 
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NGFR Nerve growth factor receptor 1.38314993 2.59344061 
NRG3 Neuregulin 3 1.37672522 3.18463153 
SEMA3C Semaphorin 3C 1.71485936 5.18370452 
ROBO1 Roundabout, axon guidance receptor, homolog 1 (Drosophila) 1.45648671 3.11902941 
CLN8 Ceroid-lipofuscinosis, neuronal 8 1.38711102 2.33800532 
RTN4 Reticulon 4 1.4467759 2.89293079 
HPCAL1 Hippocalcin-like 1 1.33684274 2.42743985 
NPIP Nuclear pore complex interacting protein 1.75648993 4.00162409 
EFNB3 Ephrin B3 1.45069469 2.45079187 
NPFF Neuropeptide FF-amide peptide precursor 1.38598666 2.70015539 
PIK4CA Phosphoinositide-3-kinase, catalytic, alpha polypeptide 1.46819621 3.40721939 
PPFIA4 Protein tyrosine phosphatase, receptor-type, f polypeptide, interating protein, alpha 4 1.50512565 3.39738862 
CHRNA3 Cholinergic receptor nicotinic alpha polipeptide 3 1.43895608 3.50046108 
CPLX2 Complexin 2 1.31909405 2.54753348 
NTS Neurotensin 3.57038253 10.0185218 
SV2B Synaptic vesicle glycoprotein 2B 1.33280448 2.5143609 
GDI1 GDP dissociation inhibitor 1 1.38759786 2.8244956 
SORL1 Sortilin-related receptor, L1 1.44122535 2.90976483 
CRABP2 Cellular retinoic acid-binding protein II 1.49554488 3.21555239 
CRX Cone-rod homeobox protein 1.44234535 3.11630575 
LUM Lumican 3.32532992 8.95013489 
RABGGTA Rab geranylgeranyltransferase alpha subunit 1.3354206 2.31244659 
BBS5 Bardet-Biedl syndrome 5 1.32451727 2.38463048 
TRIOBP TRIO and F-actin binding protein 1.4290213 2.98409845 
SNAP25 Synaptosomal-associated protein 25 0.65161648 -3.42986776 
SLC6A15 Solute carrier family 6, member 15 0.43735625 -5.72640287 
    
Metabolism 
Nucleic acids 
AK3L1 Adenylate kinase 3 like 1 1.35868119 2.39545282 
ENPP3 Ectonucleotide pyrophosphatase/phosphodiesterase 3 1.34726476 2.49657784 
NME4 Non-metastatic cells 4 1.43488069 3.17587834 
NT5E 5'-nucleotidase, ecto 1.46971975 3.54922515 
PAPSS2 3'-phosphoadenosine 5'-phosphosulfate synthase 2 1.38552039 2.67899937 
CTPS CTP synthase 0.58207028 -3.76632256 
TYMS Thymidylate synthase 0.73111215 -2.36865469 
HPRT1 Hypoxanthine phosphoribosyltransferase 0.63435195 -3.88587975 
PRPS2 Phosphoribosyl pyrophosphate synthetase 2 0.63515259 -2.59969318 
    
Carbohydrates 
CHST2 Carbohydrate sulfotransferase 2 1.50579224 3.32723512 
HK1 Hexokinase 1 1.91382216 5.71558137 
HS3ST3B Heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 1.41454494 2.66426755 
HYAL1 Hyaluronoglucosaminidase 1 3.03443775 8.09165151 
HAS2 Hyaluronan synthase 2 1.73087125 4.10218405 
IDS Iduronate 2-sulfatase 1.48393298 3.12853776 
MPI Mannose phosphate isomerase 1.42562129 3.08417271 
PDK3 Pyruvate dehydrogenase kinase, isoenzyme 3 1.30900038 2.32661045 
CHGN Chondroitin beta 1, 4 N-acetylgalactosaminyltransferase 0.6936003 -2.79525741 
SLC35A1 Solute carrier family 35, member 1 0.7108504 -2.83837696 
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Lipids 
APOB Apolipoprotein B 4.53711173 11.2637478 
APOA2 Apolipoprotein A2 3.70707679 10.2811419 
CAV1 Caveolin 1 1.88129671 5.30126973 
FDFT1 Farnesyl-diphosphate farnesyltransferase 1 1.39131233 2.87158262 
SC4MOL Sterol-C4-methyl oxidase-like 1.40718068 2.78833567 
ACSS2 Acyl-CoA synthetase short-chain family member 2 1.3178339 2.67107162 
APOC2 Apolipoprotein C2 1.55208711 3.62817828 
ASAH1 N-acylsphingosine amidohydralase 1 1.33415623 2.48474078 
BBOX1 Butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1.51376845 3.23128431 
ELOVL2 Elongation of very long chain fatty acids-like 2 1.40900097 2.61191543 
LPIN1 Lipin 1 1.30417895 2.26170236 
LRP10 Low density lipoprotein receptor-related protein 10 1.35588214 2.44136741 
PCCA Propionyl coenzyme A carboxylase, alpha 1.30481396 2.38066018 
VLDLR Very low density lipoprotein receptor 2.16157571 6.40017845 
OSBP2 Oxysterol binding protein 2 0.69107939 -2.80857689 
    
Amino acids 
DDC DOPA decarboxylase 1.3427939 2.28005408 
DMGDH Dimethylglycine dehydrogenase 1.39081017 2.72445958 
GATM Glycine amidinotransferase 1.31521292 2.30747407 
OAT Ornithine aminotransferase 1.37152958 2.74254232 
ASL Argininosuccinate Lyase 1.63073996 3.91862349 
ASNS Aspargine synthetase 1.51767554 3.78542345 
DDOST Dolichyl-diposphooligosaccharide-protein glycosyltransferase 1.51487156 3.53884923 
GLDC Glycine dehydrogenase (decarboxylatin) 1.34037049 2.50461897 
GLS Glutaminase 1.34936818 2.71093841 
CCDC91 Coil-coil domain containing 91 1.34899065 2.41416936 
ODC1 Ornithine decarboxylase  0.64562492 -3.15950612 
SDF2 Stromal cell-derived factor 2 0.70229373 -3.15978524 
TM4SF3 Transmembrane 4 superfamily member 3 0.51737057 -5.24922684 
FNTB Farnesyltrasferase, CAAX box, beta 0.64221781 -3.5238036 
    
Coenzymes metabolism 
BTD Biotinidase 1.499606 3.67518414 
FBP1 Folate binding protein 1 1.53282551 3.54352971 
FOLR2 Folate receptor 2 0.69630437 -3.20992386 
FOLR1 Folate receptor 1 0.76058393 -2.44230841 
    
General metabolism 
NAGK N-acetylglucosamine kinase 1.42600673 2.86490201 
ITIH2 Inter-alpha (globulin) inhibitor H2 2.91856162 7.09241628 
MAOA Monoamine oxidase A 1.56885897 3.48886458 
ALDH1A1 Aldehyde dehydrogenase 1 family, member A1 1.74987649 4.51026047 
HIBCH 3-hydroxyisobutyryl-coenzyme A hydrolase 1.30016245 2.30890812 
PPARD Peroxisome proliferative activated receptor, delta 1.34562962 2.59824078 
ALOX12 Arachidonate 12-lipoxigenase 1.31775469 2.2884762 
CA11 Carbonic anhydrase XI 1.29432748 2.24233123 
CASD1 CAS1 domain containing 1 1.33719212 2.28231182 
NNMT Nicotinamide N-methyltransferase 0.61712849 -3.85390281 
FVT1 Follicular variant translocation protein 1 0.75644557 -2.59695465 
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Symbol Gene product Fold-change z-score 
    
    
TCA 
IDH3A Isocitrate dehydrogenase 3 alpha 0.71572209 -2.55178195 
LDHA Lactate dehydrogenase A 0.71729902 -2.73084932 
    
Eletron transport 
ATP11A ATPase, class VI, Type 11A 1.37744631 2.63982716 
ATP8B2 ATPase, class I, type 8B, member 2 1.35041019 2.33334146 
CYB5A Cytochrome b5 type A (microsomal) 1.55043029 3.29428238 
CYP27A1 Cytochrome p450, family 27, subfamily A, polypeptide 1 1.36702215 2.92581736 
FMO5 Flavin containing monooxygenase 5 1.4669254 2.96883815 
NDUFV3 NADH dehydrogenase (Ubiquinone) flavoprotein 3 1.40768279 2.91966216 
NDUFV1 NADH dehydrogenase (Ubiquinone) flavoprotein 1 1.35528831 2.64889472 
STEAP1 Six transmembrane epithelial antigen of the prostate 1 1.96768815 5.22293885 
ATP5I ATP synthase, H+ transporting, mitochondrial F0 complex 0.73130093 -2.86327607 
ATP5J2 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2 0.72132806 -2.83400209 
COX7B2 Cytochrome c oxidase subunit VIIb2 0.5815765 -3.10704942 
ETFA Electron transfer flavoprotein alpha-subunit precursor 0.74312287 -2.38255574 
HCCS Holocytochrome c synthase 0.57075552 -5.10020156 
TXNL5 Thioredoxin-like 5 0.74463801 -2.54202603 
    
Surface receptors 
ADRBK2 Adrenergic receptor beta, kinase 2 1.43442795 2.6287744 
ASGR2 Asialoglycoprotein receptor 2 1.40161663 2.90118968 
EDNRB Endothelin receptor type B 1.47142258 3.17921931 
GRB7 Growth factor receptor bound protein 7 1.32299783 2.43281461 
OPRL1 Opiate receptor-like 1 1.31161818 2.32493003 
PLA2R1 Phospholipase A2 receptor 1 1.76374038 4.68431754 
PTPRZ1 Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 1.44525561 2.64621592 
CD200 CD200 molecule 1.80610218 3.77848999 
    
Signal transduction 
APBB1IP Amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein 1.4647806 3.35222881 
ARHGAP15 Rho GTPase activating protein 15 1.83182457 5.00696334 
ARHGAP18 Rho GTPase activating protein 18 1.41434193 2.63185089 
CNIH4 Cornichon homolog 4 (Drosophila) 1.51225761 3.54321999 
CSNK1G2 Casein kinase 1, gamma 2 1.32886635 2.26393768 
GPR161 G protein-coupled receptor 161 1.50989873 3.48762387 
GNG2 Guanine nucleotide binding protein, gamma 2 1.54097189 3.65347611 
GPR143 G protein-coupled receptor 143 1.35368956 2.47775237 
INPP4B Inositol polyphosphate-4-phosphatase, type II 1.54861704 4.20432562 
LPHN2 Latrophilin 2 1.55306859 3.30453342 
MPDZ Multiple PDZ domain protein 1.50571283 3.46603738 
PIK3C3 Phosphoinositide-3-kinase, class 3 1.38787937 2.66435422 
PIK3CG Phosphoinositide-3-kinase, catalytic, gamma polypeptide 1.81382367 4.33332906 
PIK3R1 Phosphoinositide-3-kinase, regulatory subunit, polypeptide 1 1.59656768 3.54225972 
PLCB4 Phospholipase C, beta 4 1.31542978 2.32344275 
PRKAR1A Protein kinase, cAMP-dependent, regulatory, type I alpha 1.43757154 3.25542087 
PRKD3 Protein kinase D3 1.3454365 2.79819669 
RAB30 Rab30, member RAS oncogene family 1.37405128 2.6425958 
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RASGRP2 Ras guanyl releasing protein 2 1.30941025 2.24290377 
RAB3GAP2 RAB3 GTPase activating protein subunit 2 1.37992076 2.72664696 
RAP2B RAP2B, member of RAS oncogen family 1.30897022 2.53237368 
RASSF4 Ras assocciation domain family 4 1.32134789 2.32855869 
RGL1 RAL guanine nucleotide dissociation stimulator-like 1 1.56453607 3.19491149 
SH2D1A SH2 domain protein 1A 1.45954309 3.04705319 
TPTE Transmembrane phosphate with tensin homology 1.6530772 3.94957843 
WSB1 WD repeat and SOCS box-containing 1 1.72004535 4.48196458 
RGS2 Regulator of G-protein signalling 2 0.54509321 -5.27130607 
RHOC Ras homolog gene family, member C 0.73329149 -2.73281877 
RHOF Ras homolog gene family, member F 0.58739484 -3.13224783 
RAI3 Retinoic acid induced 3 0.42262328 -6.13242229 
WDR5 WD repeat domain 5 0.65798724 -2.90534861 
SH2D4A SH2 domain containing 4A 0.61310313 -3.92385828 
    
Transport 
ABCG2 ATP-binding cassette, sub-family G, member 2 1.43755663 2.83030926 
KCNH8 Potassium voltage-gated channel, subfamily H, member 8 1.39093245 2.55614003 
PDPN Podoplanin 1.3853533 2.4383033 
RHAG Rh-associated glycoprotein 2.21134892 6.1047486 
SLC2A14 Solute carrier family 2, member 14 1.39908252 2.43649873 
SLC9A7 Solute carrier family 9, member A7 1.32075865 2.36520355 
SLC13A5 Solute carrier family 13, member 5 1.38708512 2.70201508 
SLC25A36 Solute carrier family 25, member 36 1.40386266 2.9032339 
SLC36A3 Solute carrier family 36, member 3 1.31714821 2.28263811 
SLC43A1 Solute carrier family 43, member 1 1.36705916 2.68377439 
SLC44A4 Solute carrier family 44, member 4 1.46503723 3.4473516 
SLC4A3 Solute carrier family 4, member 3 1.53222799 3.41760562 
TOMM40 Translocase of outer mitochondrial membrane 40 homolog (yeast) 1.87417375 5.01940063 
TRPC1 Transient receptor potential cation channel, subfamily C, member1  1.52843966 3.42222961 
TRPM1 Transient receptor potential cation channel, subfamily M, member1 1.45942239 3.1891183 
CP Ceruloplasmin 2.15175794 5.68997276 
FTH1 Ferritin, heavy polypeptide 1 0.65502243 -2.33685813 
FTMT Ferritin mitochondrial 0.64162349 -2.32467712 
KCNK1 Potassium channel, subfamily K, member 1 0.76022069 -2.27483854 
MTCH2 Mitochondrial carrier homolog 2 (C. elegants) 0.78205611 -2.25929331 
PLP2 Proteolipid protein 2 0.42372356 -7.24495193 
SGK Serum/glucocorticoid regulated kinase 0.57105637 -3.92424421 
    
Endocytosis and intracellular trafficking 
AP1S2 Adaptor-related protein complex 1, sigma 2 subunit 1.52440155 3.19621278 
COG8 Component of oligomeric golgi complex 8 1.46134492 3.05920623 
EXOC4 Exocyst complex component 4 1.49997571 3.25142779 
GOLGA2 Golgi autoantigen, golgi subfamily A, 2 1.40892463 2.87713287 
GOLGA8A Golgi autoantigen, golgi subfamily A, 8A 1.55191477 3.40998883 
KDELR3 KDEL endoplasmic reticulum protein retention receptor 3 1.34135887 2.44771414 
M6PRBP1 Mannose-6-phosphate receptor binding protein 1 1.34143036 2.42061974 
STX7 Syntaxin 7 1.45031769 3.1616294 
SNX9 Sorting nexin 9 1.33261237 2.31777377 
SYTL2 Synaptotagmin-like 2 1.94777692 5.16749699 
TLOC1 Translocation protein 1 1.36905438 2.72626598 
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VPS11 Vacuolar protein sorting 11 (yeast) 1.32652323 2.32376442 
PICALM Phosphatidylinositol binding clathrin assembly protein 0.70161119 -2.81106818 
TMED2 Transmembrane emp24 domain trafficking protein 2 0.66271615 -2.87984175 
    
Skeletal development 
ALPL Alkaline phosphatase, liver 1.54932151 3.6288474 
COMP Cartilage oligomeric matrix protein 1.38479396 2.68595317 
ENAM Enamelin 2.7900519 7.51967567 
MGP Matrix Gla protein 1.75538219 4.86503301 
SPARC Secreted protein acidic and rich in cysteine 3.88613122 10.6819484 
SPP1 Secreted phosphoprotein 1 3.21141268 10.1456247 
TNFRSF11B Tumor necrosis factor receptor superfamily, member 11b 1.78366558 4.39802099 
STC1 Stanniocalcin 1 1.40063078 2.85229563 
VDR Vitamin D3 receptor 1.33776292 2.41708464 
BMP2 Bone morphogenetic protein 2 0.74330416 -2.61239007 
    
Blood coagulation 
EFEMP2 EGF-containing fibulin-like extracellular matrix protein 2 1.32588096 2.32864565 
F7 Coagulation factor VII 1.74156023 4.80480432 
FGA Fibrinogen, A alpha polypeptide 1.75926095 4.57347696 
FGG Fibrinogen, gamma polypeptide 2.05458225 5.44521082 
    
Other functions 
ALAD Aminolevulinate, delta-, dehydratase 1.32699147 2.35293334 
FECH Ferrochelatase 1.41518748 2.99521549 
HBG1 Hemoglobin, gamma A 9.28434474 17.672231 
NOX4 NADPH oxidase 4 1.40532609 2.73494326 
RCN1 Reticulocalbin 1 0.72115746 -2.34261783 
PRDX6 Peroxiredoxin 6 1.31262834 2.27499884 
SEPP1 Selenoprotein P, plasma 1 5.39862299 14.1782683 
PRDX1 Peroxiredoxin 1 0.61920071 -2.51102794 
ADH6 Alcohol dehydrogenase 6 (class V) 1.27253883 2.27743271 
AGT Angiotensinogen 2.3094322 6.97514445 
AFP Alpha-fetoprotein 5.65569314 11.9631022 
ALB Albumin 3.78573358 8.80240457 
PDE4B Phosphodiesterase 4B 1.60244828 3.90158206 
PDE4DIP Phosphodiesterase 4D interacting protein 1.46822461 3.19671564 
PDE5A Phosphodiesterase 5A 1.39223303 2.61934907 
PDE7A Phosphodiesterase 7A 1.46417191 3.05559312 
ADCK4 AARF domain containing kinase 4 1.43181342 2.94427016 
CD3D CD3d molecule, delta 2.57848218 7.46910708 
ENPP2 Ectonucleotide pyrophosphatase/phosphodiesterase 2 1.51887873 2.82755567 
FCER1G FC-epsilon-receptor gamma subunit 1.41840593 2.79377546 
GPX3 Glutathione peroxidase 3 1.51394359 3.13299008 
PEX6 Peroxisomal biogenesys factor 6 1.30679434 2.31735651 
OPTN Optineurin 1.42360136 2.36924095 
PKIG Protein kinase inhibitor, gamma 1.34610402 2.36923763 
PKIB Protein kinase inhibitor, beta 1.68975865 3.92398926 
PSG9 Pregnancy specific beta-1-glycoprotein 9 1.39997832 2.55802365 
RNF144 Ring finger protein 144 1.60564901 3.61246968 
SCRN1 Secernin 1 1.53132664 3.73580579 
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ST6GAL1 ST6 beta-galactosamide alpha-2,6-sialyltransferase 1 1.894161 4.74431473 
TANK TRAF family member-associated NFKB activator 1.36600355 2.51119771 
TFF1 Trefoil factor 1 1.76124013 4.65933284 
TTR Transthyretin  1.4944669 2.94968394 
WT1 Wilms' tumor protein 1.48859889 3.06063609 
ANTXR1 Anthrax toxin receptor 1 0.71055456 -2.80189381 
CUTC CutC cooper transporter homolog (E. coli) 0.74205523 -2.37245576 
DCTN6 Dynactin 6 0.75646073 -2.60291864 
    
 
 
325 up- & 81 down-regulated genes of Unknown function were not listed 
 
Negative sign (-) before the z-score numbers and fold-change below 1 indicate down-regulation 
of the gene expression  
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APPENDIX F 
TABLE F.1. Core set of genes differentially expressed by intracellular B. melitensis 
in the first 4 h post infection of bovine Peyer’s patch, compared to the inoculum 
 
Locus ID Symbol Gene product Expression 
    
    
  Replication, recombination and repair  
BMEI0537  Integrase/recombinase Down 
BMEI0728 recJ Single-stranded-DNA-specific exonuclease RecJ Down 
BMEI0787 recA RecA protein  Up 
BMEI0877  DNA-binding protein Hu-alpha Up 
BMEI0880  Single-strand binding protein  Up 
BMEI1052  Transposase Down 
BMEI1093  Exodeoxyribonuclease III Up 
BMEI1399  Transposase Up 
BMEI1408  Transposase Down 
BMEI1412  Transposase Up 
BMEI1442  A/G-specific adenine glycosylase Down 
BMEI1444  Adenine-specific methyltransferase  Up 
BMEI1485 dnaB Replicative DNA helicase Up 
BMEI1661  Recombinase Down 
BMEI1794 ihfB Integration host factor beta subunit Up 
BMEI1801 mutS DNA mismatch repair protein Down 
BMEI1876  DNA polymerase III, alpha chain  Up 
BMEI1943  Chromosomal replication initiation protein Up 
BMEI1980  DNA protection during starvation protein  Up 
BMEII0712  Transposase Up 
    
  Transcription  
BMEI0003 rho Transcription termination factor Rho Up 
BMEI0010 parB Chromosome partitioning protein ParB Up 
BMEI0253  Transcriptional regulator, MarR family  Up 
BMEI0279  Transcriptional regulator CarD family Up 
BMEI0280 rpoH RNA polymerase sigma factor Up 
BMEI0320  Transcriptional regulator, GntR family Down 
BMEI0410  Transcriptional regulator, MerR family Up 
BMEI0446  Transcriptional regulator, MarR family Up 
BMEI0494  Transcriptional regulatory protein PetP Down 
BMEI0532 rpoD RNA polymerase sigma factor Up 
BMEI0626  Transcriptional regulator, GntR family  Up 
BMEI0744 nusG Transcription antitermination protein NusG Up 
BMEI0749 rpoB DNA-directed RNA polymerase beta subunit Up 
BMEI0750 rpoC DNA-directed RNA polymerase beta' subunit Up 
BMEI0785  Transcriptional regulatory protein Up 
BMEI1297 rpoZ DNA-directed RNA polymerase omega subunit Up 
BMEI1364  Transcriptional regulatory protein MucR Up 
BMEI1384  Transcriptional regulator, AraC family Down 
BMEI1582  Transcriptional regulatory protein DegU Down 
BMEI1641  Transcriptional regulator, TetR family Down 
BMEI1642  Transcriptional regulator, TetR family Down 
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BMEI1885  Transcriptional regulatory protein, LysR family Down 
BMEI2050  Transcriptional regulator Down 
BMEII0104  Transcriptional regulator, AraC family Down 
BMEII0128  Transcriptional regulator Down 
BMEII0299  Transcriptional regulator, IclR family Down 
BMEII0370  Histidine utilization repressor Down 
BMEII0372  Transcriptional regulator, MerR family Down 
BMEII0486  NikR nickel-responsive regulator NikR  Down 
BMEII0563  Proline dehydrogenase transcriptional activator Up 
BMEII0807  Transcriptional regulator, GntR family Down 
BMEII0820  ALS operon regulatory protein Down 
BMEII0858  Transcriptional regulator, GntR family Down 
BMEII0878  Transcriptional regulator, GntR family Down 
BMEII0966  Transcription regulator, Crp family Down 
BMEII0975  Regulatory protein NosR Down 
BMEII0985  Ribitol operon repressor Down 
BMEII1077  Transcriptional regulatory protein, LysR family Down 
    
  Translation, ribosomal structure and biogenesis  
BMEI0056 rpmB Ribosomal protein L28 Up 
BMEI0156 rplS Ribosomal protein L19 Up 
BMEI0171  Ribosomal protein L11 methyltransferase  Down 
BMEI0201 rplU Ribosomal protein L21 Up 
BMEI0202 rpmA Ribosomal protein L27 Up 
BMEI0272 rpmF Ribosomal protein L32 Up 
BMEI0294  LSU ribosomal protein L36P  Up 
BMEI0322 rpmE Ribosomal protein L31 Up 
BMEI0428 trmU tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase Down 
BMEI0463  Poly(A) polymerase / tRNA nucleotidyltransferase Down 
BMEI0479  GTP-binding protein Up 
BMEI0481 rplY 50S ribosomal protein L25 Up 
BMEI0745 rplK Ribosomal protein L11 Up 
BMEI0746 rplA Ribosomal protein L1 Up 
BMEI0752 rpsL Ribosomal protein S12 Up 
BMEI0753 rpsG Ribosomal protein S7 Up 
BMEI0755  Elongation factor Tu Up 
BMEI0756 rpsJ Ribosomal protein S10 Up 
BMEI0757 rplC Ribosomal protein L3 Up 
BMEI0758 rplD Ribosomal protein L4 Up 
BMEI0759 rplW Ribosomal protein L23 Up 
BMEI0760 rplB Ribosomal protein L2 Up 
BMEI0761 rpsS Ribosomal protein S19 Up 
BMEI0762 rplF Ribosomal protein L22 Up 
BMEI0763 rpsC 30S ribosomal protein S3 Up 
BMEI0764 rplP Ribosomal protein L16 Up 
BMEI0765 rpmC Ribosomal protein L29 Up 
BMEI0768 rplX 50S ribosomal protein L24 Up 
BMEI0770 rpsN 30S ribosomal protein S14 Up 
BMEI0771 rpsH 30S ribosomal protein S8 Up 
BMEI0772 rplV Ribosomal protein L6 Up 
BMEI0773 rplR 50S ribosomal protein L18 Up 
  
 
254
TABLE F.1. (continued) 
    
Locus ID Symbol Gene product Expression 
    
    
BMEI0775 rpmD 50S ribosomal protein L30 Up 
BMEI0776 rplO LSU ribosomal protein L15P Up 
BMEI0779 rpsM Ribosomal protein S13/S18 Up 
BMEI0780 rpsK Ribosomal protein S11 Up 
BMEI0782 rplQ Ribosomal protein L17 Up 
BMEI0823 rpsB 30S ribosomal protein S2 Up 
BMEI0826  Ribosome releasing factor Up 
BMEI0915  Threonyl-tRNA synthetase Up 
BMEI1054  Peptide chain release factor 2 Up 
BMEI1057  Ribonuclease E / Zinc metalloprotease Up 
BMEI1133 rpsD Ribosomal protein S4 Up 
BMEI1168 rplM 50S ribosomal protein L13 Up 
BMEI1184  Small protein A Up 
BMEI1199  Arginyl-tRNA-protein transferase  Up 
BMEI1203  Ribonuclease D Up 
BMEI1247  Ribonuclease precursor  Up 
BMEI1272 cysS Cysteinyl-tRNA synthetase Up 
BMEI1418  GDP-mannose 4,6-dehydratase / GDP-4-amino-4,6-dideoxy-D-mannose formyltransferase Up 
BMEI1480 rpsE 30S ribosomal protein S6 Up 
BMEI1483 rplI 50S ribosomal protein L9 Up 
BMEI1529 glyS Glycyl-tRNA synthetase beta subunit Up 
BMEI1798  23S ribosomal RNA methyltransferase  Down 
BMEI1862  2'-5' RNA ligase  Up 
BMEI1962 rpsO Ribosomal protein S15 Up 
BMEI2008  50S ribosomal protein L35  Up 
BMEI2010  Translation initiation factor IF-3 Up 
BMEII0276  Ribonuclease P Up 
BMEII0332 rpsU Ribosomal protein S21 Up 
BMEII0661 rpmG Ribosomal protein L33 Up 
BMEII0812 def Peptide deformylase Down 
BMEII1055  Histidyl-tRNA synthetase Up 
    
  Posttranslational modification, protein turnover, chaperones  
BMEI0047  Molecular chaperones (DnaJ family) Up 
BMEI0517  Glutathione S-transferase Up 
BMEI0874 clpP ATP-dependent Clp protease proteolytic subunit Up 
BMEI1030  Protein-L-isoaspartate O-methyltransferase Up 
BMEI1129  Glutaredoxin  Up 
BMEI1172 ctaA Cytochrome C oxidase assembly protein COX15 Up 
BMEI1331 cycL Cythchrome C-type biogenesis protein CycL precursor Down 
BMEI1440  Thiol:disulfide interchange protein DsbA Down 
BMEI1513 dnaJ Chaperone protein DnaJ Up 
BMEI1650  Urease accessory protein UreF  Down 
BMEI1777 grpE GrpE protein Up 
BMEI1784  Small heat shock protein HspA Up 
BMEI1804 glnD PII uridylyl-transferase Up 
BMEI1851 cmcC Heme exporter protein C Down 
BMEII0230 msrA Peptide methionine sulfoxide reductase Down 
BMEII0294 gst Glutathione S-transferase Down 
BMEII0577  Alkyl hydroperoxide reductase c22 protein  Up 
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  Amino acid transport and metabolism  
BMEI0025  L-sorbose dehydrogenase (FAD) Down 
BMEI0105  L-asparaginase II Down 
BMEI0124 argJ Bifunctional ornithine acetyltransferase/N-acetylglutamate synthase protein Down 
BMEI0189  Aspartate kinase  Up 
BMEI0207 proB Gamma-glutamyl kinase Up 
BMEI0231  NAD-specific glutamate dehydrogenase  Up 
BMEI0256  D-amino acid dehydrogenase small subunit  Up 
BMEI0257  Proline racemase Up 
BMEI0258 livH High affinity branched-chain amino acid transport system permease protein LivH Up 
BMEI0259 livM High affinity branched-chain amino acid transport system permease protein LivM Up 
BMEI0261 livF High affinity branched chain amino acid transport ATP-binding protein BraG Up 
BMEI0433 oppA Periplasmic dipeptide transport protein precursor Up 
BMEI0435 dppB Dipeptide transport system permease protein DppB Up 
BMEI0441 proX Glycine betaine/L-proline-binding protein ProX Up 
BMEI0526 carA Carbamoyl-phosphate synthase small subunit Up 
BMEI0617 ilvI Acetolactate synthase III large subunit Up 
BMEI0624 ilvC Ketol-acid reductoisomerase  Up 
BMEI0734 cysE Serine acetyltransferase Up 
BMEI0844 trpD Anthranilate phosphoribosyltransferase  Up 
BMEI0978 glnB Nitrogen regulatory protein P-II Up 
BMEI1192  Serine hydroxymethyltransferase Up 
BMEI1211 gltL General L-amino acid-binding periplasmic protein AapJ precursor Up 
BMEI1261  Leucyl aminopeptidase Up 
BMEI1308  Histidinol-phosphate aminotransferase  Down 
BMEI1309  Histidinol-phosphate aminotransferase  Down 
BMEI1495  Lysine decarboxylase Up 
BMEI1643  N-carbamoyl-L-amino acid amidohydrolase  Up 
BMEI1721  Sarcosine oxidase delta subunit  Down 
BMEI1722  Sarcosine oxidase beta subunit  Down 
BMEI1774  Lactoylglutathione lyase, putative Up 
BMEI1848 ilvD Dihydroxy-acid dehydratase Up 
BMEI1869  Homoserine/homoserine lactone efflux protein Down 
BMEI1888  Lactoylglutathione lyase Up 
BMEI2018 trpB Tryptophan synthase subunit beta Up 
BMEII0012 pepF Oligoendopeptidase F Up 
BMEII0016  Homospermidine synthase  Down 
BMEII0061  2-oxoisovalerate dehydrogenase alpha and beta subunit  Down 
BMEII0136  Homoprotocatechuate 2,3-dioxygenase Down 
BMEII0195 potC Spermidine/putrescine transport system permease protein PotC Down 
BMEII0249  Dihydrodipicolinate reductase Down 
BMEII0295  Biphenyl-2,3-diol 1,2-dioxygenase III  Up 
BMEII0348  4-aminobutyrate aminotransferase Down 
BMEII0351  Acetolactate synthase large subunit  Down 
BMEII0560  Glycine cleavage system protein H Up 
BMEII0582  Sarcosine oxidase beta subunit  Up 
BMEII0741  D-aminopeptidase  Up 
BMEII0783  Na(+)-linked D-alanine glycine permease  Up 
BMEII0862  Dihydrodipicolinate synthase  Up 
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BMEII0863 appD Oligopeptide transport ATP-binding protein AppD Down 
BMEII0874 livG 
High-affinity branched-chain amino acid transport system permease protein 
LivH / High affinity branched-chain amino acid transport ATP-binding protein 
livG 
Down 
BMEII0875 livK Leucine-specific binding protein precursor Down 
BMEII0923 potD Spermidine/putrescine-binding periplasmic protein Down 
BMEII0950 narG Nitrate reductase alpha chain Down 
    
  Nucleotide transport and metabolism  
BMEI0476  Adenine phosphoribosyltransferase Up 
BMEI0778 adk Adenylate kinase Up 
BMEI0849 pirG CTP synthetase  Up 
BMEI1256  Nucleoside diphosphate kinase Up 
BMEI1430  Ureidoglycolate hydrolase  Down 
BMEII0420  Thymidylate synthase Down 
BMEII0598  Exopolyphosphatase Up 
BMEII0617  Xanthine/uracil permease  Down 
BMEII0888  5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase  Down 
BMEII0930 nrdE Ribonucleotide-diphosphate reductase alpha subunit Down 
    
  Carbohydrate transport and metabolism  
BMEI0399  Dihydroxyacetone kinase  Up 
BMEI0605  Bicyclomycin resistance protein Up 
BMEI0664 rbsC Sugar transport system permease protein Down 
BMEI0667 fucU Fucose operon FucU protein Up 
BMEI0726 glpX GlpX protein Up 
BMEI0851  Enolase Up 
BMEI0927  Multidrug resistance protein B  Down 
BMEI1036  ATP-NAD kinase  Up 
BMEI1116  Ribulose-phosphate 3-epimerase Up 
BMEI1395 rfbA Mannose-1-phosphate guanylyltransferase Up 
BMEI1436  Pyruvate phosphate dikinase Up 
BMEI1636  Glucose-6-phosphate isomerase / glucose-6-phosphate 1-epimerase Up 
BMEI1716  Trehalose/maltose binding protein Up 
BMEI1997  Gluconolactonase Up 
BMEII0089 rbsK Ribokinase Up 
BMEII0106  Xylose repressor Down 
BMEII0300 rbsA Ribose transport ATP-binding protein RbsA Down 
BMEII0360 rbsB Multiple sugar-binding periplasmic receptor ChvE precursor Up 
BMEII0474  Mannonate dehydratase Down 
BMEII0621 ugpC Glycerol-3-phosphate ABC transporter, ATP-binding protein Up 
BMEII0795  Multidrug resistance protein B Up 
BMEII0850  GDP-fucose synthetase Down 
BMEII0940 malK Maltose/maltodextrin transport ATP-binding protein MalK Down 
BMEII1092  Hydroxypyruvate isomerase  Down 
    
  Lipid transport and metabolism  
BMEI0021  Acetyl CoA:Acetoacetyl CoA transferase alpha subunit Down 
BMEI0238  Acetyl-CoA synthetase Up 
BMEI0827 uppS Undecaprenyl pyrophosphate synthetase Up 
BMEI0832  (3R)-hydroxymyristoyl-[acyl carrier protein] dehydratase Up 
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BMEI1024  3-hydroxyisobutyrate dehydrogenase  Down 
BMEI1062 accB Acetyl-CoA carboxylase Up 
BMEI1112  3-oxoacyl-(acyl carrier protein) synthase  Down 
BMEI1113 fabF 3-oxoacyl-(acyl carrier protein) synthase Up 
BMEI1512  Enoyl-(acyl carrier protein) reductase Up 
BMEII0214  Enoyl-CoA hydratase  Down 
BMEII0495  Acyl-CoA dehydrogenase Down 
BMEII0645  3-oxoadipate CoA-transferase subunit B Down 
    
  Energy production and conversion  
BMEI0076  Inorganic pyrophosphatase Up 
BMEI0137  Malate dehydrogenase Up 
BMEI0161 shdA Succinate dehydrogenase Up 
BMEI0248 atpH ATP synthase subunit D Up 
BMEI0249 atpA ATP synthase subunit A Up 
BMEI0250 atpG ATP synthase subunit C Up 
BMEI0251 atpD ATP synthase subunit B Up 
BMEI0252 atpC ATP synthase subunit epsilon Up 
BMEI0278  Ferredoxin II  Up 
BMEI0473  Ubiquinol-cytochrome C reductase iron-sulfur subunit Up 
BMEI0475  Cytochrome C1 Up 
BMEI0791  Isocitrate dehydrogenase  Up 
BMEI0836  Citrate synthase Up 
BMEI0854 pdhA Pyruvate dehydrogenase E1 component alpha subunit  Up 
BMEI0911  NifU protein Down 
BMEI0928  Acetate CoA-transferase alpha subunit Up 
BMEI0959  Ferredoxin, 2Fe-2S K04755 ferredoxin, 2Fe-2S Up 
BMEI1148 nuoK NADH dehydrogenase kappa subunit Up 
BMEI1150 nuol NADH dehydrogenase subunit I Up 
BMEI1152 nuoG NADH dehydrogenase gamma subunit Up 
BMEI1153 nuoF NADH-quinone oxidoreductase chain F Up 
BMEI1154 nuoE ATP synthase subunit E Up 
BMEI1155 nuoD NADH dehydrogenase delta subunit Up 
BMEI1157 nuoB NADH-quinone oxidoreductase chain B Up 
BMEI1158 nuoA NADH dehydrogenase alpha subunit Up 
BMEI1320  Electron transfer flavoprotein-ubiquinone oxidoreductase precursor  Up 
BMEI1466 coxB Cytochrome C oxidase polypeptide II Up 
BMEI1543 atpF ATP synthase subunit B Up 
BMEI1855 acnA Aconitate hydratase Up 
BMEI1903  Cytochrome c-552 Up 
BMEII0124  Aldehyde dehydrogenase Down 
BMEII0141  Aldehyde dehydrogenase Down 
BMEII0242  Aldehyde dehydrogenase Down 
BMEII0744  Dihydrolipoamide dehydrogenase Down 
BMEII0768  NADH dehydrogenase subunit N  Down 
BMEII0880  Acetate kinase Down 
BMEII1068  Cytochrome c2 precursor Down 
    
  Coenzyme transport and metabolism  
BMEI0177  Uroporphyrinogen-III synthetase Up 
BMEI0209 nadD Nicotinic acid mononucleotide adenyltransferase Up 
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BMEI0221  Pyridoxine kinase Down 
BMEI0286  Putative nucleotide-binding protein Up 
BMEI0329  Thiamine-phosphate pyrophosphorylase Up 
BMEI0347  Phosphoserine aminotransferase  Up 
BMEI0467  Coproporphyrinogen III oxidase Up 
BMEI0546  Metal-activated pyridoxal enzyme Up 
BMEI0695 cobN Cobaltochelatase Up 
BMEI0696 cobA Cob(I)yrinic acid a,c-diamide adenosyltransferase Up 
BMEI0954  2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase Down 
BMEI0956  Dihydropteroate synthase Down 
BMEI1144  Biotin-protein ligase  Up 
BMEI1207  Salicylate hydroxylase  Down 
BMEI1464  Protoheme IX farnesyltransferase Down 
BMEI2012  Benzoate membrane transport protein  Up 
BMEII0110  Choline-sulfatase  Down 
BMEII0589 ribH Riboflavin synthase subunit beta Up 
    
  Inorganic ion transport and metabolism  
BMEI0044  CBS domain containing protein Down 
BMEI0569  Manganese transport protein MntH  Up 
BMEI0622 kup KUP system potassium uptake protein up 
BMEI0640  CbiM protein  Up 
BMEI0675 cysW Sulfate transport system permease protein cysW Up 
BMEI0790  Alkaline phosphatase Up 
BMEI0869 trkA Trk system potassium uptake protein TrkA Up 
BMEI0882 phnN Phosphonates transport ATP-binding protein PhnN Down 
BMEI0931  Putative thiosulfate sulfurtransferase  Up 
BMEI1021  Molybdopterin-guanine dinucleotide biosynthesis protein B Up 
BMEI1986 pstB Phosphate transport ATP-binding protein PstB Down 
BMEII0105 frpB Iron-regulated outer membrane protein FrpB Down 
BMEII0581 sodC Superoxide dismutase (CU-ZN)  Up 
BMEII0566 sfuB Iron(III)-transport system permease protein SfuB  Down 
BMEII0606 fatD Ferric anguibactin transport system permease protein FatD Down 
BMEII0766 phaF PhaF potassium efflux system protein Down 
BMEII0797  ABC transporter substrate-binding protein Down 
BMEII0962 tauC Taurine transport permease protein TauC  Up 
BMEII0972  Copper-binding periplasmic protein precursor Down 
BMEII1011  Sulfite reductase (NADPH) flavoprotein alpha-component  Down 
    
  Defense mechanisms  
BMEI0945  6-aminohexanoate-dimer hydrolase  Down 
BMEI0984  Beta-(1->2)glucan export ATP-binding protein NdvA  Up 
BMEI1138  Lipoprotein releasing system ATP-binding protein LolD Down 
BMEI1630 acrA Acriflavin resistance protein A precursor  Down 
BMEI1645 acrB Acriflavin resistance protein B Down 
BMEI1742  ABC transporter ATP-binding protein Up 
BMEII0452  Type I restriction-modification enzyme, S subunit Down 
BMEII0473 acrF Acriflavin resistance protein F Down 
BMEII0916 acrD Acriflavin resistance protein D  Down 
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  Signal transduction mechanism  
BMEI0372  Two-component response regulator Up 
BMEI0492 cpxA Osmolarity sensor protein EnvZ Down 
BMEI0867 ntrY Nitrogen regulation protein NtrY Up 
BMEI0868 ntrX Nitrogen assimilation regulatory protein NtrX Up 
BMEI0949  DnaK suppressor protein homolog Up 
BMEI1624 phoR Phosphate regulon sensor protein PhoR Down 
BMEI1751  Two-component response regulator Down 
BMEI1863  Low molecular weight phosphotyrosine protein phosphatase  Up 
BMEI1975 phoH PhoH protein Up 
BMEI2035 chvG Sensor protein ChvG  Down 
BMEII0659  Two component response regulator Up 
BMEII0853  Two component response regulator Down 
BMEII1009  C-di-GMP phosphodiesterase A Down 
    
  Cell wall/membrane biogenesis  
BMEI0214  Tail-specific protease  Up 
BMEI0223  Membrane-bound lytic murein transglycosylase B Up 
BMEI0271 mtgA Monofunctional biosynthetic peptidoglycan transglycosylase Down 
BMEI0340  Peptidoglycan-associated lipoprotein Up 
BMEI0421  Pleiotropic regulatory protein Up 
BMEI0579 murG UDP-N-acetylenolpyruvoylglucosamine reductase Up 
BMEI0580  UDP-N-acetylmuramate--L-alanine ligase Up 
BMEI0717  22 kDa outer membrane protein precursor Up 
BMEI0830  Outer membrane protein  Up 
BMEI0831  LpxD UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase  Up 
BMEI0833  Acyl-(acyl-carrier-protein)-UDP-N- acetylglucosamine O-acyltransferase  Up 
BMEI0913 dacA Penicillin-binding protein 6 (D-alanyl-D-alanine carboxypeptidase fraction C) Up 
BMEI0998  Glycosyltransferase Up 
BMEI1007  25 kDa outer-membrane immunogenic protein precursor Up 
BMEI1029  Outer membrane protein TolC  Up 
BMEI1037  Glycosyltransferase involved in cell wall biogenesis Up 
BMEI1056  N-acetylmuramoyl-L-alanine amidase Up 
BMEI1079 nlpD Lipoprotein NlpD Up 
BMEI1096  Succinoglycan biosynthesis protein ExoI Down 
BMEI1249  25 kDa outer-membrane immunogenic protein precursor Up 
BMEI1404  Mannosyltransferase Up 
BMEI1602  Glycosyltransferase Up 
BMEI1829  25 kDa outer-membrane immunogenic protein precursor Up 
BMEI1830  25 kDa outer-membrane immunogenic protein precursor  Up 
BMEII0374 alr Alanine racemace, catabolic Down 
BMEII0827  Glucose-1-phosphate cytidylyltransferase  Down 
BMEII0837  Glycosyl transferase Down 
BMEII0840  Glycosyltransferase involved in cell wall biogenesis  Down 
BMEII0844  31 kDa outer-membrane immunogenic protein precursor Up 
BMEII0846  Glycosyl transferase  Down 
BMEII0847  Glycosyl transferase  Down 
BMEII0848  GDP-mannose 4,6-dehydratase Down 
    
  Cell division  
BMEI0213  Membrane proteins related to metalloendopeptidase Up 
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BMEI0584 ftsA Cell division protein FtsA Up 
BMEI0633 crcB Camphor resistance protein CrcB Up 
BMEI1132  ATPase of the PP superfamily Down 
BMEII0927 minC Septum formation inhibitor Up 
    
  Cell motility  
BMEI0324 motB Flagellar motor protein Up 
BMEII0156 motD Chemotaxis MotD protein Down 
BMEII0163  Flagellum biosynthesis repressor Up 
BMEII1105 fliL Flagellum-specific ATP synthase FliI Down 
BMEII1107 flgF Flagellar basal-body rod protein FlgF  Down 
BMEII1112 fliN Flagellar motor switch protein FliN Down 
    
  Intracellular trafficking and secretion  
BMEI0339 tolB Translocation protein TolB precursor Up 
BMEI0364 exbD Biopolymer transport ExbD protein Down 
BMEI0777 secY Preprotein translocase SecY Up 
BMEI1873  Cell surface protein Down 
BMEI2055 secB Export protein SecB Up 
BMEII0029 virB5 Attachment mediating protein virB5 homolog Down 
BMEII0035 virB11 ATPase virB11 homolog Down 
BMEII0148  Extracellular serine protease  Down 
    
  General function prediction only  
BMEI0020  Glucose-fructose oxidoreductase precursor Down 
BMEI0125  Acetyltransferase Down 
BMEI0129  Hydroxyacylglutathione hydrolase, mitochondrial  Down 
BMEI0183  Competence protein F Down 
BMEI0222  Carbonic anhydrase  Up 
BMEI0240  Fusaric acid resistance protein FusB / fusaric acid resistance protein FusC Up 
BMEI0244  Transaldolase Up 
BMEI0282  Zinc metalloprotease  Up 
BMEI0293  2-hydroxy-6-oxo-2,4-heptadienoate hydrolase Down 
BMEI0356  Type 1 capsular polysaccharide biosynthesis protein J Up 
BMEI0420  Oxidoreductase Up 
BMEI0452  Putative phosphohydrolase, Icc family Down 
BMEI0506  Transporter, DME family Up 
BMEI0587  ComL, competence lipoprotein  Up 
BMEI0630 phzF Phenazine biosynthesis protein PhzF Down 
BMEI0634  Integral membrane protein Up 
BMEI0668  Calcium binding protein Up 
BMEI0709  4-hydroxyphenylacetate 3-monooxygenase  Up 
BMEI0712  CbiG protein / precorrin-3B C17-methyltransferase Up 
BMEI0796  31 kDa immunogenic protein precursor Up 
BMEI0852  Methyltransferase Up 
BMEI0862 cinA Putative competence-damage protein Up 
BMEI0872 hfq RNA-binding protein Hfq Up 
BMEI0917  Nitroreductase family Up 
BMEI0946  NAD(FAD)-utilizing dehydrogenases Down 
BMEI0951  Amino acid regulated cytosolic protein Up 
BMEI0970  Diacylglycerol kinase  Up 
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BMEI0977  Putative sugar kinase Up 
BMEI0995  Secretion activator protein Down 
BMEI1042  ABC transporter ATP-associated protein Up 
BMEI1067  Acetyltransferase Down 
BMEI1095  Hypothetical protein Up 
BMEI1110  Secretion activator protein Up 
BMEI1134  Extensin-like protein Down 
BMEI1143  Metal dependent hydrolase Down 
BMEI1185  HppA membrane-bound proton-translocating pyrophosphatase Up 
BMEI1231  NADH-ubiquinone oxidoreductase 18 KD subunit  Up 
BMEI1276  Phosphohydrolase (mutT/nudix family protein) Down 
BMEI1376  Death on curing protein Down 
BMEI1470  Protein YicC Up 
BMEI1504  Acetylspermidine deacetylase  Down 
BMEI1520  Response regulator protein Up 
BMEI1541  Transporter Up 
BMEI1556  Integral membrane protein Down 
BMEI1625  UDP-galactose-lipid carrier transferase  Down 
BMEI1634  Phosphoglycolate phosphatase Up 
BMEI1790  ABC transporter ATP-binding protein Up 
BMEI1872  Cell surface protein Up 
BMEI1877  Hemolysin III Down 
BMEI1973  CBS domain containing protein Up 
BMEI1978  Ribosomal-protein-alanine acetyltransferase  Up 
BMEII0129  Hydrolase family protein Down 
BMEII0149  Extracellular serine protease  Down 
BMEII0179  Low affinity zinc transport membrane protein Down 
BMEII0272  Phosphoglycolate phosphatase Down 
BMEII0440  dTDP-glucose 4,6-dehydratase  Down 
BMEII0463  Putative ICC-like phosphoesterases Down 
BMEII0465  Permease Down 
BMEII0499  Succinoglycan biosynthesis protein ExoI Down 
BMEII0836  dTDP-4-dehydrorhamnose 3,5-epimerase  Down 
BMEII0838  Succinoglycan biosynthesis transport protein ExoT Down 
BMEII0865  1-carboxy-3-chloro-3,4-dihydroxycyclo hexa-1,5-diene dehydrogenase Up 
BMEII0999  Nitric-oxide reductase cytochrome C chain  Down 
BMEII1035  Serine protease  Down 
BMEII1096  Putative tartrate transporter  Down 
    
  Unknown function   
BMEI0004  Hypothetical cytosolic protein Down 
BMEI0016  Hypothetical protein Down 
BMEI0031  Hypothetical cytosolic protein Down 
BMEI0064  Hypothetical protein Up 
BMEI0071  Hypothetical protein Down 
BMEI0088  Hypothetical protein Up 
BMEI0098  Hypothetical protein Down 
BMEI0117  Hypothetical protein Down 
BMEI0119  Hypothetical protein Up 
BMEI0134  Hypothetical protein Down 
BMEI0146  Hypothetical protein Down 
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BMEI0154  Hypothetical membrane spanning protein Down 
BMEI0186  Hypothetical cytosolic protein Down 
BMEI0210  Iojap protein family Up 
BMEI0216  Hypothetical protein Down 
BMEI0220  Hypothetical protein Down 
BMEI0224  Hypothetical protein Up 
BMEI0290  Hypothetical cytosolic protein Up 
BMEI0298  Hypothetical protein Down 
BMEI0330  OpgC Up 
BMEI0362  Hypothetical protein Down 
BMEI0373  Hypothetical protein Down 
BMEI0376  Hypothetical protein Up 
BMEI0390  Hypothetical cytosolic protein Up 
BMEI0404  Hypothetical protein Down 
BMEI0427  Hypothetical protein Up 
BMEI0458  Hypothetical membrane spanning protein Down 
BMEI0490  Hypothetical cytosolic protein Down 
BMEI0497  Hypothetical membrane spanning protein Up 
BMEI0498  Cold shock protein CspA Up 
BMEI0514  Hypothetical protein Up 
BMEI0521  Hypothetical protein Up 
BMEI0567  Hypothetical protein Up 
BMEI0603  Hypothetical protein Up 
BMEI0620  Hypothetical protein Down 
BMEI0625  Hypothetical protein Up 
BMEI0629  Hypothetical protein Down 
BMEI0631  Hypothetical protein Down 
BMEI0641  Hypothetical protein Down 
BMEI0670  Putative membrane-associated alkaline phosphatase Down 
BMEI0722  Hypothetical protein Down 
BMEI0735  Hypothetical protein Up 
BMEI0751  Hypothetical protein Up 
BMEI0788  Hypothetical protein Up 
BMEI0805  Hypothetical protein Up 
BMEI0815  ATP-dependent Clp protease adaptor protein ClpS Up 
BMEI0821  Hypothetical protein Up 
BMEI0822  Hypothetical protein Up 
BMEI0848  Probable carnitine operon oxidoreductase CaiA Up 
BMEI0853  Hypothetical protein Up 
BMEI0860  Hypothetical cytosolic protein Up 
BMEI0870  Hypothetical protein Up 
BMEI0871  Hypothetical protein Up 
BMEI0885  Hypothetical protein Up 
BMEI0907  Hypothetical protein Down 
BMEI0957  Hypothetical protein Up 
BMEI0973  Hypothetical protein Up 
BMEI0996  Hypothetical protein Up 
BMEI1000  Hypothetical protein Up 
BMEI1004  Hypothetical protein Up 
BMEI1011  Hypothetical protein Down 
BMEI1013  Hypothetical membrane spanning protein Down 
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BMEI1031  Hypothetical protein Up 
BMEI1077  Hypothetical protein Up 
BMEI1101  Hypothetical protein Up 
BMEI1119  Hypothetical cytosolic protein Down 
BMEI1162  Hypothetical protein Up 
BMEI1176  Hypothetical protein Up 
BMEI1182  Hypothetical cytosolic protein Down 
BMEI1220  Hypothetical protein Up 
BMEI1222  Hypothetical protein Up 
BMEI1230  Hypothetical cytosolic protein Up 
BMEI1310  Hypothetical membrane spanning protein Down 
BMEI1313  Hypothetical cytosolic protein Up 
BMEI1340  Phage host specificity protein Down 
BMEI1341  Phage host specificity protein Down 
BMEI1343  Hypothetical protein Down 
BMEI1344  Hypothetical protein Down 
BMEI1345  Phage minor tail protein H Down 
BMEI1349  Phage portal protein  Down 
BMEI1350  Phage DNA packaging protein Down 
BMEI1363  Hypothetical cytosolic protein Down 
BMEI1375  Hypothetical protein Up 
BMEI1453  Diguanylate cyclase/phosphodiesterase domain 2 (EAL) Down 
BMEI1501  Transglycosylase associated protein Up 
BMEI1515  17 kDa common-antigen Up 
BMEI1524  Hypothetical protein Down 
BMEI1525  Helix-turn-helix protein, CopG family Up 
BMEI1538  Hypothetical protein Up 
BMEI1539  Hypothetical protein Down 
BMEI1578  Glyoxylate induced protein Down 
BMEI1584  Invasion protein B Up 
BMEI1610  Hypothetical cytosolic protein Down 
BMEI1619  HslO HSP33-like chaperonin  Down 
BMEI1647  Hypothetical protein Down 
BMEI1664  Hypothetical cytosolic protein Down 
BMEI1667  Hypothetical cytosolic protein Down 
BMEI1676  Hypothetical protein Down 
BMEI1681  Hypothetical protein Up 
BMEI1688  Hypothetical protein Up 
BMEI1691  Hypothetical membrane spanning protein Down 
BMEI1696  Hypothetical membrane spanning protein Down 
BMEI1698  Hypothetical protein Down 
BMEI1705  Hypothetical protein Down 
BMEI1724  Hypothetical protein Up 
BMEI1763  Hypothetical protein Down 
BMEI1783  Hypothetical membrane spanning protein Up 
BMEI1785  Hypothetical protein Up 
BMEI1792  Hypothetical periplasmic protein Up 
BMEI1795  Hypothetical protein Up 
BMEI1812  Hypothetical protein Up 
BMEI1865  Hypothetical protein Up 
BMEI1918  Hypothetical cytosolic protein Up 
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BMEI1929  Hypothetical protein Down 
BMEI1933  Hypothetical protein Up 
BMEI1947  Hypothetical cytosolic protein Down 
BMEI1991  Hypothetical protein Up 
BMEI2016  Hypothetical protein Up 
BMEII0008  Hypothetical protein Down 
BMEII0037  Hypothetical cytosolic protein Down 
BMEII0073  Hypothetical protein Up 
BMEII0091  Replication protein C Down 
BMEII0118  Hypothetical protein Down 
BMEII0157  Hypothetical protein Down 
BMEII0187  Hypothetical cytosolic protein Down 
BMEII0188  Hypothetical cytosolic protein Down 
BMEII0211  Penicillin acylase  Down 
BMEII0238  HdeD protein Down 
BMEII0262  Hypothetical protein Down 
BMEII0277  Hypothetical protein Up 
BMEII0279  Hypothetical membrane spanning protein Up 
BMEI0368  Hypothetical protein Up 
BMEII0398  Sec-independent protein translocase protein TatC Down 
BMEII0434  Hypothetical protein Up 
BMEII0442  Hypothetical membrane spanning protein Up 
BMEII0464  Hypothetical membrane associated protein Down 
BMEII0516  Hypothetical protein Down 
BMEII0522  Hypothetical protein Down 
BMEII0552  Hypothetical protein Up 
BMEII0555  Hypothetical cytosolic protein Down 
BMEII0595  Hypothetical protein Up 
BMEII0652  Hypothetical protein Up 
BMEII0692  Hypothetical membrane associated protein Up 
BMEII0705  Hypothetical protein Up 
BMEII0709  Hypothetical protein Up 
BMEII0726  Hypothetical protein Down 
BMEII0749  Hypothetical protein Down 
BMEII0789  Hypothetical protein Down 
BMEII0829  Possible S-adenosylmethionine-dependent methyltransferase  Down 
BMEII0833  Hypothetical protein Down 
BMEII0841  Hypothetical protein Down 
BMEII0877  Hypothetical protein Down 
BMEII0886  Hypothetical protein Down 
BMEII0906  Protein HdeA precursor Up 
BMEII0919  Hypothetical protein Up 
BMEII0933  Hypothetical protein Up 
BMEII0936  Hypothetical protein Down 
BMEII0989  Hypothetical protein Down 
BMEII0992  MRP protein homolog A Down 
BMEII1013  Hypothetical cytosolic protein Down 
BMEII1024  CIS,CIS-muconate transport protein  Down 
BMEII1030  Putative lipoprotein Up 
BMEII1046  Hypothetical protein Up 
BMEII1059  Protein YbiS precursor Down 
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BMEII1067  Hypothetical cytosolic protein Up 
BMEII1071  Hypothetical protein Down 
BMEII1079  Hypothetical protein Down 
BMEII1138  Hypothetical protein Down 
    
 
Genes were ordered in cluster of ortholog groups (COGs) functional categories (downloaded 
from NCBI/genome projects/bacteria/B. melitensis) with adaptations 
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APPENDIX G 
TABLE G.1. Host genes differentially expressed in B. melitensis-infected bovine 
Peyer’s patches during the first hour post-infection, compared to non-infected 
tissue 
 
Oligo 
sequence ID Unigene ID Symbol Gene product Expression 
     
     
DNA replication and repair 
CR452654 Bt.1184 APEX2 Apurinic/apyrimidinic endonuclease 2 Up 
BF044044 Bt.46083 CGI-41 CGI-41 protein Up 
AW464155 Bt.16022 SMARCAL1 
SWI/SNF related, matrix associated, actin 
dependent regulator of chromatin, subfamily a-like 
1 
Up 
BF039990 Bt.76849  Similar to DNase1-Like III protein Up 
CN437632 Bt.25809  Similar to downregulated in ovarian cancer 1  Down 
     
Chromosome organization 
CR453453 Bt.51509  
Transcribed locus, moderately similar to 
XP_001075299.1 H1 histone family, member X 
[Rattus norvegicus] 
Up 
CK952836 Bt.10510 H2AFX H2A histone family, member X Up 
     
RNA processing 
CK771600 Bt.3261  Transcribed locus, strongly similar to XP_546630.2 elaC homolog 2 [Canis familiaris] Up 
DR749310 Bt.21472  Similar to splicing factor, arginine/serine-rich 16 (Suppressor of white-apricot homolog 2) Up 
AY563745 Bt.48707  Similar to related to CPSF subunits 74 kDa (MGC128672) Up 
BC103457 Bt.18030  Similar to SH3 domain-binding protein SNP70 Up 
     
Transcription regulation 
CN436893 Bt.46244 CDX2 Caudal-type homeobox transcription factor 2 Up 
AW466208 Bt.29568 EAF2 ELL associated factor 2 (EAF2) Up 
BF041568 Bt.45294  Similar to elongation factor RNA polymerase II-like 3 Up 
AY318753 Bt.16536 HNF4G Hepatocyte nuclear factor 4 gamma Up 
BF440215 Bt.9027 NFKBIA Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha Up 
AW345084 Bt.30875 HOXC11 Homeo box C11, mRNA (incomplete sequence) Up 
AW461981 Bt.1686  
Transcribed locus, strongly similar to XP_548832.2 
DNA segment on chromosome X and Y (unique) 
155 expressed sequence isoform 1 [Canis 
familiaris] 
Up 
CN441669 Bt.21965  Transcribed locus, strongly similar to XP_854273.1 Zinc finger protein 358 [Canis familiaris] Up 
BC109904 Bt.27825  Similar to zinc finger protein 414 Up 
BM362847 Bt.77958  Transcribed locus, strongly similar to XP_220921.3 similar to aiolos [Rattus norvegicus] Up 
CN436168 Bt.33949  
Transcribed locus, strongly similar to 
XP_001068534.1 similar to Ewing sarcoma 
breakpoint region 1 isoform EWS isoform 5 
Up 
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Oligo 
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BF042964 Bt.6148 STAT6 Signal transducer and activator of transcription 6, interleukin-4 induced  Up 
CN442245 Bt.9198  
Transcribed locus, weakly similar to 
XP_001058638.1 HIV TAT specific factor 1 [Rattus 
norvegicus] 
Up 
AW463092 Bt.18791  Transcribed locus, strongly similar to XP_216633.4 metastasis associated 3 [Rattus norvegicus] Up 
AW461405 Bt.4606  Similar to Kruppel-like factor 6 Up 
DR697576 Bt.65045 SETD8 SET domain containing (lysine methyltransferase) 8 Up 
CR453442 Bt.934  
Transcribed locus, moderately similar to 
XP_001065863.1 PHD finger protein 20 
(Hepatocellular carcinoma-associated antigen 58 
homolog) [Rattus norvegicus] 
Down 
     
Protein biosynthesis 
BF045013 Bt.49029 UTP14C UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) Up 
BM361943 Bt.20487 MRPL28 
Similar to 39S ribosomal protein L28, mitochondrial 
precursor (L28mt) (MRP-L28) (Melanoma antigen 
p15) (Melanoma-associated antigen recognized by 
T lymphocytes) 
Down 
     
Intracellular protein transport 
BM362579 Bt.3152  Similar to endoplasmic reticulum protein 29 precursor Up 
BT021891 Bt.1494 GGA1 Golgi associated, gamma adaptin ear containing, ARF binding protein 1 isoform 1 Up 
BF042266 Bt.1494 GGA1 Golgi associated, gamma adaptin ear containing, ARF binding protein 1 isoform 1 Up 
BF040787 Bt.28252  Transcribed locus, strongly similar to NP_003756.1 syntaxin 10 [Homo sapiens] Up 
CN435987 Bt.4048 STXBP1 Syntaxin binding protein 1 Down 
     
Protein folding and secretion 
CB458419 Bt.19205  
Transcribed locus, moderately similar to 
XP_858724.1 DnaJ (Hsp40) homolog, subfamily C, 
member 11 isoform 2 [Canis familiaris] 
Up 
CK845963 Bt.6680 FKBP2 Similar to FK506-binding protein 2 precursor (Peptidyl-prolyl cis-trans isomerase) Up 
AW465477 Bt.4415 HSPB1 Heat shock 27kDa protein 1 Up 
NM_174143 Bt.4695 PIGR Polymeric immunoglobulin receptor Up 
BF042163 Bt.57833 SCAMP4 Secretory carrier membrane protein 4 Up 
     
Protein degradation 
CK950309 Bt.77784  
Transcribed locus, moderately similar to 
NP_063947.1 transmembrane protease, serine 4 
[Homo sapiens] 
Up 
NM_174202 Bt.336 TPSB1 Tryptase beta 1 Up 
NM_174481 Bt.4689 UCHL5 Ubiquitin carboxyl-terminal hydrolase L5 Up 
CK955446 Bt.9636 SPINK1 Serine protease inhibitor, Kazal type 1 Up 
CK961416 Bt.9625  
Transcribed locus, weakly similar to XP_854581.1 
Serine protease inhibitor Kazal-type 4 precursor 
(Peptide PEC-60 homolog) [Canis familiaris] 
Up 
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CR453031 Bt.28262  
Transcribed locus, weakly similar to XP_534433.1 
similar to Elafin precursor (Elastase-specific 
inhibitor) (ESI) (Skin-derived antileukoproteinase) 
(SKALP) (WAP four-disulfide core domain protein 
14) (Protease inhibitor WAP3) [Canis familiaris] 
Up 
CN437618 Bt.76319  
Transcribed locus, moderately similar to 
XP_001065510.1 Ubiquitin carboxyl-terminal 
hydrolase 40 (Ubiquitin thiolesterase 40) 
(Ubiquitin-specific processing protease 40) 
(Deubiquitinating enzyme 40) [Rattus norvegicus] 
Up 
     
Cell cycle / cell differentiation and proliferation 
CK943568 Bt.49472 AGR2 Anterior gradient 2, homolog Up 
AJ293900 Bt.29719 EGR4 Early growth response 4 Up 
BM363411 Bt.17081  Similar to Rhombotin-2  Up 
CR452401 Bt.13110 MDFI MyoD family inhibitor Up 
CN441928 Bt.4307  
Transcribed locus, strongly similar to XP_542335.2 
Rho-related GTP-binding protein RhoG (Sid 
10750) [Canis familiaris] 
Up 
BE757891 Bt.52956  
Transcribed locus, moderately similar to 
XP_419263.1 mitogen-activated protein kinase 12 
isoform 1 [Gallus gallus] 
Up 
CR453045 Bt.1286 RARRES2 Retinoic acid receptor responder 2 Up 
BM364258 Bt.43053 SEPT11 Septin 11 Up 
BF039597 Bt.16930  
Transcribed locus, moderately similar to 
XP_001076127.1 B-cell leukemia/lymphoma 3 
[Rattus norvegicus] 
Up 
BC103128 Bt.11341 NNAT Neuronatin Down 
CK963451 Bt.45679  Transcribed locus, weakly similar to XP_363162.1 protein MG08746.4 [Magnaporthe grisea 70-15] Down 
 Bt.64848 YWHAZ 
Tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, zeta 
polypeptide 
Down 
     
Cytoskeleton organization 
BM363541 Bt.351 CORO1A Coronin, actin binding protein, 1A Up 
BM363211 Bt.6089  Similar to kaptin Up 
CR452106 Bt.55923  Transcribed locus, strongly similar to NP_113915.1 LIM motif-containing protein kinase 1 Up 
NM_174395 Bt.1354 MYO1A Myosin IA Up 
BM361850 Bt.59716  
Transcribed locus, strongly similar to NP_055973.1 
ankyrin repeat domain protein 15; kidney ankyrin 
repeat-containing protein [Homo sapiens] 
Up 
BM430199 Bt.56652  Transcribed locus, moderately similar to NP_775151.1 20 [Rattus norvegicus] Up 
     
Cell adhesion 
AW462342 Bt.6074 CLDN3 Claudin 3 Up 
CR454875 Bt.51822  
Transcribed locus, strongly similar to NP_001847.2 
alpha 1 type XVI collagen precursor; collagen XVI, 
alpha-1 polypeptide [Homo sapiens] 
Up 
NM_174748 Bt.8130 ITGA4 Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) Up 
CK973750 Bt.80510  
Transcribed locus, moderately similar to 
NP_037107.1 galactoside-binding, soluble, 4 
(galectin 4) [Rattus norvegicus] 
Up 
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DR697630 Bt.13362 TSPAN1 Tetraspanin-1 Up 
NM_174399 Bt.5166 NCAM1 Neural cell adhesion molecule 1 Down 
BF042923 Bt.7220 LSP1 Similar to lymphocyte-specific protein 1 (MGC142338) Down 
 
Apoptosis 
CN794327 Bt.21648 CIDEB Similar to Cell death activator CIDE-B (Cell death-inducing DFFA-like effector B) Up 
BM361824 Bt.687  
Transcribed locus, moderately similar to 
XP_221961.3 caspase recruitment domain family 
member 11 [Rattus norvegicus] 
Up 
CN433496 Bt.9054  
Transcribed locus, strongly similar to XP_240178.3 
apoptotic chromatin condensation inducer in the 
nucleus (Acinus) [Rattus norvegicus] 
Up 
 Bt.8953 PTGES Prostaglandin E synthase Up 
     
Immune and inflammatory response 
BM363735 Bt.49700 AIF1 Allograft inflammatory factor 1 Up 
BM365194 Bt.20164 C1QB Complement component 1, q subcomponent, B chain Up 
CR551837 Bt.21736  
Transcribed locus, moderately similar to 
XP_520228.1 complement component 5 [Pan 
troglodytes] 
Up 
BC105174 Bt.14139  Similar to Complement component C9 precursor Up 
BF043775 Bt.103 BPI Bactericidal/permeability-increasing protein Up 
BF706855 Bt.78164  Transcribed locus, strongly similar to NP_000241.1 myeloperoxidase [Homo sapiens] Up 
BF601278 Bt.24637  Similar to azurocidin 1 preproprotein Up 
BF040406 Bt.11022  
Transcribed locus, strongly similar to NP_116584.2 
mitogen-activated protein kinase-activated protein 
kinase 2 isoform 2 [Homo sapiens] 
Up 
BM363549 Bt.55288 NCR3 Similar to natural cytotoxicity triggering receptor 3 Up 
BM363697 Bt.8939 TYROBP TYRO protein tyrosine kinase binding protein Up 
CB464199 Bt.33292 STAT1 Signal transducer and activator of transcription 1 Up 
BM364871 Bt.76115 FGL2 Fibrinogen-like 2 Up 
BF044744 Bt.8227 MAIL Molecule possessing ankyrin repeats induced by lipopolysaccharide (MAIL), homolog of mouse Up 
CK774743 Bt.45674 CD2 CD2 antigen Up 
BM362452 Bt.37553  
Transcribed locus, moderately similar to 
XP_526582.1 small inducible cytokine B9 
precursor; monokine induced by gamma interferon 
[Homo sapiens] 
Up 
CR452037 Bt.80577  
Transcribed locus, moderately similar to 
XP_001063501.1 tumor necrosis factor receptor 
superfamily, member 11a [Rattus norvegicus] 
Down 
NM_205787 Bt.25528 PTP Pancreatic thread protein Down 
     
Surface receptors 
NM_174011 Bt.49707 CD3E Antigen CD3E, epsilon polypeptide (TiT3 complex) Up 
NM_174266 Bt.4436 CD79A CD79A antigen (immunoglobulin-associated alpha) Up 
CB468269 Bt.20540  Transcribed locus, strongly similar to XP_850416.1 CD79B antigen isoform 1 [Canis familiaris] Up 
BF044748 Bt.12274  Protein tyrosine phosphatase, receptor type, G Up 
BM361923 Bt.52082 ARRB1 Arrestin, beta 1 Up 
CR454049 Bt.4693 ADRBK1 Adrenergic, beta, receptor kinase 1 Up 
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BM365343 Bt.9510 TIMD4 T-cell immunoglobulin and mucin domain containing 4 (TIMD4) Up 
     
Pregnancy 
BC102264 Bt.28223  20-beta-hydroxysteroid dehydrogenase-like Up 
 Bt.259 PAG7 Pregnancy-associated glycoprotein 7 Down 
     
Intracellular signal transduction 
DR697486 Bt.21018 CSNK1E Casein kinase 1, epsilon Up 
AJ696239 Bt.48141  Similar to cAMP responsive element modulator Up 
CR452358 Bt.39665  Transcribed locus, strongly similar to XP_515921.1 G protein-coupled receptor 155 [Pan troglodytes] Up 
DV918428 Bt.76522  Transcribed locus, strongly similar to NP_065871.2 PREX1 protein [Homo sapiens] Up 
AY124008 Bt.76198 PTK9L Protein tyrosine kinase 9-like (A6-related protein) Up 
CK953727 Bt.12645  Similar to Ras-related protein RAB15 Up 
BC102327 Bt.8189  
Similar to Ran-specific GTPase-activating protein 
(Ran binding protein 1) (RANBP1) (HpaII tiny 
fragments locus 9a protein) 
Up 
CB170921 Bt.4310  
Transcribed locus, strongly similar to XP_545702.2 
Regulator of G-protein signaling 1 (RGS1) (Early 
response protein 1R20) (B-cell activation protein 
BL34) isoform 1 [Canis familiaris] 
Up 
BF043554 Bt.6067  
Transcribed locus, strongly similar to XP_548447.2 
SH2 domain containing 3C isoform 2 isoform 2 
[Canis familiaris] 
Up 
DY096353 Bt.59664 MAP4K1 Mitogen-activated protein kinase kinase kinase kinase 1 (MAP4K1) Up 
CN432715 Bt.68727  
Transcribed locus, strongly similar to XP_243623.3 
Mitogen-activated protein kinase kinase kinase 7 
interacting protein 1 [Rattus norvegicus] 
Up 
AW463722 Bt.21193  
Transcribed locus, moderately similar to 
NP_001030092.1 B-lineage lymphoma c [Rattus 
norvegicus] 
Up 
BM364434 Bt.15678  
Transcribed locus, moderately similar to 
NP_055265.1 SHP2-interacting transmembrane 
adaptor protein [Homo sapiens] 
Up 
BM363771 Bt.78550  Membrane tyrosine phosphatase (cd45) Up 
     
Metabolism 
Carbohydrates 
BI775802 Bt.60417 CLP-1 Chitinase-like protein 1 (CLP-1) Up 
CN435752 Bt.46035  Similar to Fructose-bisphosphate aldolase B (Liver-type aldolase) Up 
BM363586 Bt.49614 ALDOC Aldolase C, fructose-bisphosphate Down 
     
Lipids 
NM_174242 Bt.49157 APOA1 Apolipoprotein A1 Up 
NM_001001175 Bt.7741 APOC3 Apolipoprotein C-III Up 
CB431786 Bt.59123  Similar to myo-inositol 1-phosphate synthase A1 Up 
BF045303 Bt.20496 OSBPL2 Oxysterol-binding protein-like protein 2 isoform 2 Up 
BM363855 Bt.37581 PLA2G2D4 Calcium-dependent phospholipase A2 PLA2G2D4 Up 
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Amino acids 
CN439230 Bt.20121 CTSD Cathepsin D (lysosomal aspartyl protease) Up 
AW464108 Bt.24605  
Transcribed locus, moderately similar to 
NP_004112.1 gamma-glutamyltransferase-like 
activity 1 [Homo sapiens] 
Up 
CR452225 Bt.16774  
Transcribed locus, strongly similar to XP_538655.2 
glycine dehydrogenase [decarboxylating], 
mitochondrial precursor (Glycine decarboxylase) 
Up 
AW465225 Bt.45287  Similar to glutathione transferase zeta 1 Up 
DR697552 Bt.20369  Similar to proline dehydrogenase (oxidase) 1 Up 
     
Nucleotides 
CR452228 Bt.5439  
Transcribed locus, strongly similar to XP_544332.2 
dihydropyrimidinase related protein-3 (DRP-3) 
(Unc-33-like phosphoprotein) (ULIP protein) 
(Collapsin response mediator protein 4) (CRMP-4)  
Up 
     
General metabolism 
AV607074 Bt.19064  
Transcribed locus, moderately similar to 
XP_534255.2 biotinidase precursor [Canis 
familiaris] 
Up 
CR455833 Bt.29206  Similar to CG14648-PA Up 
     
Ion transport 
NM_174276 Bt.194 CLIC5 Chloride intracellular channel 5 Up 
AW358407 Bt.20296 SFXN2 Sideroflexin 2 Up 
CK960601 Bt.28307  
Transcribed locus, moderately similar to 
NP_001002968.1 ileal sodium/bile acid 
cotransporter [Canis familiaris] 
Up 
CK846142 Bt.22759  Similar to solute carrier family 40, member 1 (Ferroportin-1) (Iron-regulated transporter 1) Up 
AF508807 Bt.73273 SLC5A1 Solute carrier family 5 (sodium/glucose cotransporter), member 1 (SLC5A1) Up 
DV887766 Bt.44386  
Transcribed locus, strongly similar to XP_868392.1 
solute carrier family 25 (mitochondrial carrier; 
phosphate carrier), member 23 isoform 3 [Canis 
familiaris] 
Up 
NM_174540 Bt.172 GABRA1 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 Down 
     
Electron transport 
NM_174724 Bt.5029 ATP5H ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d Up 
BM362197 Bt.4558 CYBB Cytochrome b-245, beta polypeptide [chronic granulomatous disease] Up 
BF044616 Bt.47439  
Transcribed locus, strongly similar to NP_110437.2 
thioredoxin domain containing 5 isoform 1; 
thioredoxin related protein 
Up 
CN441199 Bt.25241  Transcribed locus, strongly similar to XP_547307.2 mucolipin 2 [Canis familiaris] Down 
     
Other functions 
BC103101 Bt.49205 GMFG Glia maturation factor, gamma Up 
BF043702 Bt.10027 CEACAM1 Carcinoembryonic antigen-related cell adhesion molecule 1 Up 
BC102496 Bt.48849 ETHE1 Similar to ETHE1 protein Up 
  
 
272
TABLE G.1. (continued) 
     
Oligo 
sequence ID Unigene ID Symbol Gene product Expression 
     
BM431520 Bt.28227  
Transcribed locus, weakly similar to 
XP_001076797.1 similar to mucin 17 [Rattus 
norvegicus] 
Up 
BP111364 Bt.12140  
Transcribed locus, moderate similar to 
NP_149038.1 mucin 13, epithelial transmembrane 
[Homo sapiens] 
Up 
NM_174462 Bt.8126 SFTPC Surfactant, pulmonary-associated protein C Up 
BF043667 Bt.11788  Muscleblind-like 2 (Drosophila) (MBNL2), mRNA, incomplete 3' cds Down 
BC113321 Bt.33127 ANXA8 Annexin A8 Down 
     
Unknown function 
CN432436   mRNA sequence Up 
AW461357   PREDICTED: Homo sapiens hypothetical protein LOC649277 (LOC649277), mRNA Up 
AY563847   mRNA complete sequence Up 
AY563876   mRNA complete sequence Up 
BF041945   mRNA sequence Up 
BF042201   mRNA sequence Up 
BF044141   PREDICTED: Bos taurus similar to Proteinase activated receptor 4 precursor (PAR-4), mRNA Up 
BF045250   mRNA sequence Up 
BF046297 BF046297 mRNA sequence Up 
 Bt.10529  
Transcribed locus, moderately similar to 
NP_001014186.1 protein LOC361729 [Rattus 
norvegicus] 
Up 
CR452752 Bt.11855 COX4NB Similar to Neighbor of COX4 Up 
CB440232 Bt.12609  Transcribed locus Up 
CN438935 Bt.12732  
PREDICTED: Bos taurus similar to 
Suppressor/Enhancer of Lin-12 family member 
(sel-10) (LOC616020), mRNA 
Up 
DR697309 Bt.12944  Hypothetical protein MGC127568 Up 
CK848330 Bt.13367  Transcribed locus Up 
CK971966 Bt.13721  
Transcribed locus, moderately similar to 
XP_574585.1 similar to transmembrane protein 
16D [Rattus norvegicus] 
Up 
BF046097 Bt.1633  Similar to CG31957-PA Up 
CN439347 Bt.20220  Transcribed locus Up 
CR552577 Bt.21092  
Transcribed locus, strongly similar to XP_860597.1 
PREDICTED: similar to nudE nuclear distribution 
gene E homolog like 1 (A. nidulans) isoform B 
isoform 3 [Canis familiaris] 
Up 
CV798766 Bt.22408  Transcribed locus Up 
CR456138 Bt.26523  
Transcribed locus, moderately similar to 
XP_533005.2 PREDICTED: similar to ALMS1 
[Canis familiaris] 
Up 
BM364898 Bt.27364  Transcribed locus  Up 
CK848330 Bt.27713  Transcribed locus Up 
DR697653 Bt.28171  Hypothetical LOC616560 Up 
BM363396 Bt.28517  
Transcribed locus, weakly similar to XP_370586.1 
PREDICTED: hypothetical protein XP_370586 
[Homo sapiens] 
Up 
CK955406 Bt.29106  Transcribed locus Up 
CN434957 Bt.30368  Transcribed locus Up 
DR697494 Bt.33157  Transcribed locus  Up 
CR454151 Bt.3352  Transcribed locus Up 
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DR697435 Bt.3546  
Transcribed locus, moderately similar to 
NP_001014238.1 protein LOC363227 [Rattus 
norvegicus] 
Up 
CR454523 Bt.37350 CRYGC Crystallin, gamma C Up 
CN433087 Bt.40425 MGC137951 Similar to CG14353-PA Up 
CN436507 Bt.42091  Transcribed locus, weakly similar to XP_363777.1 protein MG01703.4 [Magnaporthe grisea 70-15] Up 
CR553946 Bt.43143  Transcribed locus Bos taurus Up 
BF041490 Bt.45497  
Transcribed locus, strongly similar to XP_342937.1 
similar to RIKEN cDNA D030015G18 [Rattus 
norvegicus] 
Up 
BF045949 Bt.48862  Proline synthetase co-transcribed bacterial homolog protein Up 
AY563754 Bt.53373  Transcribed locus Up 
BF043518 Bt.56758  
Transcribed locus, strongly similar to NP_062126.3 
tyrosine phosphatase, non-receptor type 5 [Rattus 
norvegicus] 
Up 
AW266954 Bt.634  Transcribed locus Up 
BF039755 Bt.6436  
Transcribed locus, weakly similar to NP_997256.1 
chromosome 10 open reading frame 99 [Homo 
sapiens] 
Up 
AW465810 Bt.65260  Butyrate response factor 2 (ZFP36L2) Up 
AY563880 Bt.66499  mRNAcomplete sequence Up 
BF042192 Bt.66528  
Transcribed locus, moderately similar to 
XP_546163.2  similar to Group XIIB secretory 
phospholipase A2-like protein precursor (Group 
XIII secretory phospholipase A2-like protein) (GXIII 
sPLA2-like) (GXIIB) [Canis familiaris]Bos taurus, 1 
sequence(s) 
Up 
BF046389 Bt.66575  Transcribed locus Bos taurus Up 
BF440171 Bt.6781  Transcribed locus Bos taurus Up 
CN439346 Bt.69334  Transcribed locus Bos taurus Up 
CR550880 Bt.7468  Transcribed locus Up 
BE683354 Bt.7639  
Transcribed locus, moderately similar to 
XP_541742.2 PREDICTED: similar to CG11986-
PA isoform 1 [Canis familiaris] 
Up 
 Bt.78057  Transcribed locus Up 
CR452941 Bt.80635  Transcribed locus, weakly similar to XP_369999.1 protein MG06514.4 [Magnaporthe grisea 70-15] Up 
CR552274 Bt.9097  Hypothetical protein LOC57655 (GRAMD1A) Up 
CB424527   mRNA sequence Up 
CN437025   mRNA sequence Up 
CN437967   mRNA sequence Up 
CR452335   mRNA sequence Up 
CR453443   mRNA sequence Up 
CR455536   
PREDICTED: Bos taurus similar to Iroquois-class 
homeodomain protein IRX-4 (Iroquois homeobox 
protein 4) (Homeodomain protein IRXA3) 
(LOC614900), mRNA 
Up 
BM362799 Bt.20356  
Transcribed locus, moderately similar to 
NP_001019411.1 protein LOC291675 [Rattus 
norvegicus] 
Up 
CR453802 Bt.77643  
Transcribed locus, weakly similar to 
NP_001017375.1 phosphoprotein, mpp8 [Rattus 
norvegicus] 
Up 
CK394179 Bt.58024  Transcribed locus Up 
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CK979128 Bt.65012  
Transcribed locus, moderately similar to 
NP_446101.1 transmembrane protein 1 [Rattus 
norvegicus] 
Up 
CN436261   mRNA sequence Up 
BF046022   mRNA sequence Down 
CR553683 Bt.13778  Transcribed locus Down 
AW267095 Bt.22633  Transcribed locus Down 
CN436791 Bt.30413  Transcribed locus Down 
CN439053 Bt.30510  Transcribed locus Down 
CR456291 Bt.32761  Transcribed locus Down 
CR552210 Bt.3376 GBL G protein beta subunit-like Down 
CB425308 Bt.6087  
Transcribed locus, strongly similar to XP_516815.1 
PREDICTED: similar to transmembrane 4 
superfamily member 1; membrane component, 
chromosome 3, surface marker 1; tumor-
associated antigen L6 [Pan troglodytes] 
Down 
DR749302 Bt.64984  
Transcribed locus, strongly similar to 
XP_001060645.1 similar to downregulated in renal 
cell carcinoma isoform 2 [Rattus norvegicus] 
Down 
CN433241 Bt.67490  Transcribed locus Bos taurus Down 
CN435725 Bt.74624 MLL Similar to MLLT11 protein Down 
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APPENDIX H 
TABLE H.1. Host genes differentially expressed in B. melitensis-infected bovine 
Peyer’s patches after one hour post-infection, compared to non-infected tissue 
 
Oligo 
sequence ID 
Unigene 
ID Symbol Gene product Expression 
     
     
DNA replication and repair 
NM_174427 Bt.4749 POLD1 Polymerase (DNA directed), delta 1, catalytic subunit 125kDa Up 
NM_174428 Bt.5282 POLD2 Polymerase (DNA directed), delta 2, regulatory subunit 50kDa Up 
BI541210 Bt.20817  Transcribed locus, strongly similar to NP_058633.1 polymerase (DNA-directed), alpha [Homo sapiens] Up 
CN433291 Bt.10510 H2AFX H2A histone family, member X Up 
DR697479 Bt.47468  Transcribed locus, weakly similar to NP_986566.1 [Eremothecium gossypii] Up 
BM364987 Bt.24693  
Transcribed locus, moderately similar to NP_068741.1 
Fanconi anemia, complementation group E [Homo 
sapiens] 
Up 
CV798789 Bt.76662  cDNA clone MGC:139804 IMAGE:8282843 Up 
CN433185 Bt.12876  Transcribed locus, strongly similar to NP_000225.1 DNA ligase I [Homo sapiens] Up 
BF041685 Bt.20450  Transcribed locus, strongly similar to XP_540761.2 cryptochrome 2 (photolyase-like) [Canis familiaris] Up 
CO888038 Bt.4215  
Excision repair cross-complementing rodent repair 
deficiency, complementation group 2 protein; 
malignancy-associated protein [Homo sapiens] 
Up 
CN433360 Bt.20277  Transcribed locus, moderately similar to XP_534241.2 DNA topoisomerase II, beta isozyme [Canis familiaris] Down 
CN438188 Bt.14643 RAD17 Similar to RAD17 homolog Down 
CN439458 Bt.55499  Similar to paraspeckle protein 1 Down 
CN441968 Bt.28179  
Transcribed locus, strongly similar to NP_115519.1 
zinc finger, RAN-binding domain containing 3; 
4933425L19Rik [Homo sapiens] 
Down 
CN436133 Bt.9810  Transcribed locus, strongly similar to XP_540212.2 DNA polymerase epsilon subunit 4 [Canis familiaris] Down 
AW289217 Bt.12578  
Transcribed locus, strongly similar to NP_002544.1 
origin recognition complex subunit 5 isoform 1; origin 
recognition complex, subunit 5 (yeast homolog)-like 
[Homo sapiens] 
Down 
BF039466 Bt.17967  Transcribed locus, strongly similar to XP_544336.2 uracil-DNA glycosylase 2 isoform a [Canis familiaris] Down 
CN439685 Bt.49518 MCM7 Minichromosome maintenance protein 7 Down 
CK394174 Bt.62454 H3F3A H3 histone, family 3A Down 
CR453487 Bt.3750 S100A11 S100 calcium binding protein A11 (calgizzarin) Down 
CR455462 Bt.49109 MGC128567 Similar to replication protein A3, 14kDa Down 
     
Chromosome organization 
BF043528 Bt.4638 SMARCB1 
SWI/SNF related, matrix associated, actin dependent 
regulator of chromatin, subfamily b, member 1 
(SMARCB1) 
Up 
AW463379 Bt.38062  Transcribed locus, moderately similar to NP_071789.1 attachment factor B [Rattus norvegicus] Up 
BM363362 Bt.22333  Similar to HP1-BP74 Up 
CN435397 Bt.18798 NASP Nuclear autoantigenic sperm protein (histone-binding) Up 
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CN437487 Bt.76210  
Transcribed locus, strongly similar to XP_227444.3 
similar to SET domain ERG-associated histone 
methyltransferase [Rattus norvegicus] 
Down 
CN436405 Bt.27318  Transcribed locus, strongly similar to XP_229124.3 Smarca1 protein [Rattus norvegicus] Down 
BF041479 Bt.51581  Transcribed locus, strongly similar to NP_062036.2 1 [Rattus norvegicus] Down 
     
RNA processing 
CN433309 Bt.15722 FBL Fibrillarin Up 
BF040218 Bt.76570  
Transcribed locus, strongly similar to NP_006377.2 
DEAD box polypeptide 17 isoform p82; probable RNA-
dependent helicase p72; DEAD/H (Asp-Glu-Ala-
Asp/His) box polypeptide 17 (72kD) [Homo sapiens] 
Up 
AW462347 Bt.15762  Similar to tRNA-dihydrouridine synthase 2-like Up 
BF045266 Bt.22762  Similar to U1 small nuclear ribonucleoprotein A (U1 snRNP protein A) (U1A protein) (U1-A) Up 
CN435437 Bt.70615  
Transcribed locus, strongly similar to XP_001063720.1 
small nuclear ribonucleoprotein polypeptide G [Rattus 
norvegicus] 
Up 
CR453324 Bt.33504  
Transcribed locus, moderately similar to 
XP_001058353.1 U11/U12 snRNP 48K [Rattus 
norvegicus] 
Down 
CB445726 Bt.21871  
Transcribed locus, strongly similar to XP_418176.1 U6 
snRNA-associated Sm-like protein LSm7 [Gallus 
gallus] 
Down 
CR454324 Bt.65106  Similar to PDZ domain containing 6 Down 
CR453923 Bt.77200  
Transcribed locus, strongly similar to XP_535238.2 
DEAH (Asp-Glu-Ala-His) box polypeptide 29 [Canis 
familiaris] 
Down 
CR452146 Bt.27146 CPSF6 Cleavage and polyadenylation specific factor 6 Down 
AW462196 Bt.4077 CPSF2 Cleavage and polyadenylation specific factor 2, 100kDa Down 
CN438395 Bt.49583  Similar to DEAQ RNA-dependent ATPase Down 
CN439678 Bt.34334  Transcribed locus, strongly similar to XP_215739.3 formin binding protein 11 [Rattus norvegicus] Down 
CN440452 Bt.9783  Transcribed locus, strongly similar to XP_228701.3 RNA helicase [Rattus norvegicus] Down 
CN433615 Bt.65284  
Transcribed locus, strongly similar to XP_851746.1 
Nucleolar RNA helicase II (Nucleolar RNA helicase 
Gu) (RH II/Gu) (DEAD-box protein 21) [Canis 
familiaris] 
Down 
CN442388 Bt.3040 SERBP1 SERPINE1 mRNA binding protein 1 Down 
CN441379 Bt.18263  Transcribed locus,strongly similar to Ser/Arg-related nuclear matrix protein Down 
BF042942 Bt.77649  
Transcribed locus, strongly similar to XP_214053.2 
Putative pre-mRNA splicing factor RNA helicase 
(DEAH box protein 15) [Rattus norvegicus] 
Down 
BF043575 Bt.9055 TRMU Similar to tRNA (5-methylaminomethyl-2-thiouridylate)-methyltransferase 1 Down 
BF440514 Bt.43563  Hypothetical gene supported by BC069011 Down 
BF440242 Bt.41473  Similar to fragile X mental retardation 1 Down 
BT021017 Bt.4620 PCBP1 Poly(rC) binding protein 1 Down 
BC107553 Bt.38355 SFRS6 Splicing factor, arginine/serine-rich 6 Down 
CN436610 Bt.3377  Similar to DEAD (Asp-Glu-Ala-Asp) box polypeptide 48 Down 
CR454453 Bt.23170 HNRPF Heterogeneous nuclear ribonucleoprotein F Down 
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BF041133 Bt.10199 HNRPC Heterogeneous nuclear ribonucleoprotein C (C1/C2) Down 
CN441824 Bt.61931  Transcribed locus, weakly similar to XP_367160.1 protein MG07085.4 [Magnaporthe grisea 70-15] Down 
BF044406 Bt.48320  Similar to splicing factor p54 Down 
AW462759 Bt.41342  Similar to RNA-binding region (RNP1, RRM) containing 2 (predicted) Down 
CR452378 Bt.18313  
Transcribed locus, strongly similar to XP_852169.1 
splicing factor, arginine/serine-rich 14 isoform 1 [Canis 
familiaris] 
Down 
CR452942 Bt.49361 FUSIP1 FUS interacting protein (serine/arginine-rich) 1 Down 
CR550423 Bt.15513 SSB Sjogren syndrome antigen B (autoantigen La) Down 
U83008 Bt.14661 ELAC1 ElaC homolog 1 (E. coli) Down 
     
Transcription regulation 
AW266874 Bt.4851  Similar to transcriptional regulator protein Up 
CR451866 Bt.14038 NT5C 5', 3'-nucleotidase, cytosolic Up 
CR455869 Bt.34468 MTF2 Metal response element binding transcription factor 2 Up 
CN434628 Bt.80550  Transcribed locus, strongly similar to NP_446244.1 LIM binding factor homolog [Rattus norvegicus] Up 
CN437285 Bt.41503  Similar to cytoplasmic nuclear factor of activated T-cells 4 Up 
BF041444 Bt.45162  
Transcribed locus, strongly similar to XP_512184.1 
nuclear factor of activated T-cells, cytosolic 
component 1; NFAT transcription complex cytosolic 
component [Pan troglodytes] 
Up 
CN437384 Bt.80575  
Transcribed locus, strongly similar to XP_001069461.1 
Homeobox protein Hox-C9 (Hox-3.2) isoform 2 [Rattus 
norvegicus] 
Up 
BF045946 Bt.6669  Transcribed locus, strongly similar to NP_055028.2 homeo box D9 [Homo sapiens] Up 
DN282097 Bt.45247  Transcribed locus, weakly similar to XP_854664.1 zinc finger protein 75 [Canis familiaris] Up 
BF046240 Bt.10189  
Transcribed locus, strongly similar to XP_533171.2 
zinc finger protein 91 isoform 1 isoform 1 [Canis 
familiaris] 
Up 
AW462887 Bt.10173  
Transcribed locus, strongly similar to NP_955459.1 
zinc finger protein 64 isoform d; zinc finger protein 338 
[Homo sapiens] 
Up 
CK950589 Bt.26862  Transcribed locus, moderately similar to XP_540750.2 zinc finger protein 408 [Canis familiaris] Up 
DR749266 Bt.12205  Transcribed locus, moderately similar to XP_544486.2 zinc finger protein 593 [Canis familiaris] Up 
CR452704 Bt.9141  
Transcribed locus, strongly similar to NP_666288.1 
CCR4-NOT transcription complex, subunit 3 [Mus 
musculus] 
Up 
AW463970 Bt.4009 MTA1 Metastasis associated 1 Up 
BM363285 Bt.49602 TNIP1 Nef-associated factor 1 Up 
AW461580 Bt.1662  
Transcribed locus, strongly similar to XP_859184.1 
megakaryoblastic leukemia 1 protein isoform 5 [Canis 
familiaris] 
Up 
CR453213 Bt.36917 TRIM38 Tripartite motif-containing 38 Up 
BF045219 Bt.44514  Similar to protein phosphatase 1, regulatory (inhibitor) subunit 13 like Up 
CR451784 Bt.5242 SSRP1 Structure-specific recognition protein 1 Up 
CR551087 Bt.74747  Transcribed locus, moderately similar to XP_227009.2 heterogeneous nuclear ribonucleoprotein K  Up 
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CR452705 Bt.23529  
Transcribed locus, strongly similar to XP_536425.2 
activated RNA polymerase II transcriptional 
coactivator [Canis familiaris] 
Up 
BM365730 Bt.59240  Similar to SP140 nuclear body protein Up 
CK946422 Bt.2268 LASS4 LAG1 longevity assurance homolog 4 Up 
DT848843 Bt.59250  Transcribed locus, strongly similar to NP_005332.1 GLI-Kruppel family member HKR3 [Homo sapiens] Up 
CB442177 Bt.51623  
Transcribed locus, moderately similar to XP_539481.2 
nuclear factor (erythroid-derived 2)-like 3 [Canis 
familiaris] 
Up 
CN787113 Bt.20425 GTF2E2 General transcription factor IIE, polypeptide 2, beta 34kDa Up 
CR550783 Bt.53763 NR2F2 Nuclear receptor subfamily 2, group F, member 1 Down 
CR550616 Bt.11325  
Transcribed locus, strongly similar to XP_543051.2 
activity-dependent neuroprotector isoform 1 [Canis 
familiaris] 
Down 
CR453558 Bt.33613 SSBP2 Single-stranded DNA binding protein 2 Down 
CN436724 Bt.17324 NFE2L2 Nuclear factor (erythroid-derived 2)-like 2 Down 
CR454351 Bt.48498  
Transcribed locus, moderately similar to 
XP_001081621.1 helicase with zinc finger domain 
isoform 2 [Rattus norvegicus] 
Down 
CR455811 Bt.36422  Transcribed locus, moderately similar to XP_574241.1 Zfp1 protein [Rattus norvegicus] Down 
AW465775 Bt.62231  Transcribed locus, strongly similar to XP_001077663.1 zinc ring finger protein 1 [Rattus norvegicus] Down 
CN439477 Bt.64680  Transcribed locus, weakly similar to XP_853644.1 zinc finger protein 91 (HPF7, HTF10) [Canis familiaris] Down 
CN438154 Bt.14262  Transcribed locus, moderately similar to XP_533370.2 zinc finger protein 407 [Canis familiaris] Down 
CN438588 Bt.55996  
Transcribed locus, strongly similar to XP_001070473.1 
nuclear receptor coactivator 1 (NCoA-1) [Rattus 
norvegicus] 
Down 
AW465215 Bt.28984  Transcribed locus, strongly similar to XP_535440.2 MAX-interacting protein [Canis familiaris] Down 
BF042975 Bt.42395  Similar to LBP-1a=transcription factor binding to initiation site of HIV-1 (alternatively spliced) Down 
BF043277 Bt.10953  
Similar to TSC22 domain family protein 1 
(Transforming growth factor beta 1 induced transcript 
4 protein) (Regulatory protein TSC-22) (TGFB 
stimulated clone 22 homolog) (Cerebral protein 2) 
Down 
BF044371 Bt.5469 SURB7 Similar to SRB7 suppressor of RNA polymerase B homolog Down 
BF440358 Bt.13902  
Transcribed locus, strongly similar to 
NP_001008722.1 consensus sequence binding 
protein 1 (predicted) [Rattus norvegicus] 
Down 
BM365270 Bt.29952  Transcribed locus, strongly similar to transcriptional repressor NAC1 [H.s.] Down 
CV798817 Bt.14560  Similar to short form transcription factor C-MAF Down 
AW461546 Bt.59779  
Transcribed locus, strongly similar to NP_062189.1 
musculoaponeurotic fibrosarcoma oncogene family, 
protein B [Rattus norvegicus] 
Down 
BF044727 Bt.48975 MED4 Mediator of RNA polymerase II transcription, subunit 4 homolog (yeast) Down 
BF040723 Bt.12854  
Similar to TATA box binding protein-like protein 1 
(TBP-like protein 1) (TATA box binding protein-related 
factor 2) (TBP-related factor 2) (21-kDa TBP-like 
protein) 
Down 
BF440163 Bt.49104 EED Embryonic ectoderm development protein Down 
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AW462462 Bt.22999  
Transcribed locus, strongly similar to NP_004372.3 
cAMP responsive element binding protein-like 1; Creb-
related protein [Homo sapiens] 
Down 
CN436757 Bt.28148  
Transcribed locus, strongly similar to XP_538914.2 
Forkhead box protein P4 (Fork head-related protein 
like A) [Canis familiaris] 
Down 
CR454537 Bt.23598 POLR1D Polymerase (RNA) I polypeptide D, 16kDa Down 
CN438915 Bt.76715  
Transcribed locus, strongly similar to NP_891847.1 
myeloid/lymphoid or mixed-lineage leukemia 5 [Homo 
sapiens] 
Down 
BF039367 Bt.50935  Transcribed locus, strongly similar to NP_071585.1 Sam68-like protein SLM-2 [Rattus norvegicus] Down 
BF440342 Bt.5788  
Transcribed locus, strongly similar to XP_001080272.1 
ETS domain-containing protein Elk-3 (ETS-related 
protein NET) (ETS-related protein ERP) [Rattus 
norvegicus] 
Down 
AW462147 Bt.61520  
Transcribed locus, strongly similar to XP_541963.2 
cofactor required for Sp1 transcriptional activation, 
subunit 7, 70kDa [Canis familiaris] 
Down 
BF045698 Bt.49606  Similar to XAP-5 protein Down 
BF041691 Bt.51416 HBP1 HMG-box transcription factor 1 Down 
BM363624 Bt.26220  Transcribed locus, strongly similar to v-rel reticuloendotheliosis viral oncogene homolog A Down 
AW465659 Bt.12647  
Transcribed locus, strongly similar to XP_001080653.1 
mediator of RNA polymerase II transcription, subunit 9 
homolog [Rattus norvegicus] 
Down 
CN435519 Bt.16917  Transcribed locus, moderately similar to XP_509442.1 MondoA [Pan troglodytes] Down 
CN439520 Bt.4184 HIF1A Hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) Down 
AJ696239 Bt.48141  Similar to cAMP responsive element modulator Down 
CK955473 Bt.52726  
Transcribed locus, strongly similar to XP_543008.2 
hepatocyte nuclear factor 4 alpha isoform a isoform 1 
[Canis familiaris] 
Down 
     
Protein biosynthesis 
CR550906 Bt.33930 EEF1A2 Eukaryotic translation elongation factor 1 alpha 2 Up 
CR455062 Bt.35903 EIF1AX Eukaryotic translation initiation factor 1A, X-linked Up 
CR551876 Bt.2249 EIF4E2 Similar to eukaryotic translation initiation factor 4E-like 3 Up 
CR456180 Bt.49332 TARS Similar to threonyl-tRNA synthetase Up 
AW463888 Bt.43860 FARS2 
Similar to phenylalanyl-tRNA synthetase, 
mitochondrial precursor (Phenylalanine--tRNA ligase) 
(PheRS) 
Up 
AW465478 Bt.21727  
Transcribed locus, strongly similar to NP_004452.1 
phenylalanine-tRNA synthetase-like protein; 
phenylalanine-tRNA synthetase alpha-subunit; 
phenylalanine-tRNA synthetase-like [Homo sapiens] 
Up 
CN441874 Bt.44540  Transcribed locus, weakly similar to XP_361064.1 protein MG03607.4 [Magnaporthe grisea 70-15] Up 
CN435490 Bt.20025 MRPL21 Similar to mitochondrial ribosomal protein L21 Up 
BF042958 Bt.47838 MRPL24 Similar to mitochondrial ribosomal protein L24 Up 
BF046336 Bt.4900 MRPS5 Similar to mitochondrial ribosomal protein S5 Up 
CR451830 Bt.9242  
Transcribed locus, moderately similar to XP_548346.2 
mitochondrial ribosomal protein L41 (predicted) [Canis 
familiaris] 
Up 
CR456168 Bt.22248  RPL13 protein-like Up 
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AW464060 Bt.23981 RPL12 Ribosomal protein L12 Up 
BM362760 Bt.22568 RPL29 Ribosomal protein L29 Up 
CR453525 Bt.7908 RPS6 Ribosomal protein S6 Up 
BM363753 Bt.11697  Similar to 60S ribosomal protein L35 Up 
AW266961 Bt.7648  Similar to ribosomal protein S19 Up 
CN437563 Bt.21351 EIF2S3 Similar to eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked Down 
AW267040 Bt.5471 EIF4G2 Eukaryotic translation initiation factor 4 gamma, 2 Down 
CN433201 Bt.21295  
Transcribed locus, strongly similar to XP_543492.2 
eukaryotic translation initiation factor 4E transporter 
(eIF4E transporter) [Canis familiaris] 
Down 
BF043574 Bt.21351  Similar to eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked Down 
CN434717 Bt.48825 EIF3S6 Eukaryotic translation initiation factor 3, subunit 6 48kDa Down 
CN437842 Bt.65927  
Transcribed locus, moderately similar to XP_226707.4 
elongation factor G 2, mitochondrial precursor (mEF-G 
2) (Elongation factor G2) [Rattus norvegicus] 
Down 
CN432384 Bt.22038  Transcribed locus, strongly similar to XP_866928.1 arginyl-tRNA synthetase isoform 3 [Canis familiaris] Down 
CN437058 Bt.59370  
Transcribed locus, strongly similar to NP_056155.1 
leucyl-tRNA synthetase 2, mitochondrial precursor; 
leucine-tRNA ligase; leucine translase [Homo sapiens] 
Down 
CN435019 Bt.10387 ABCF1 ATP-binding cassette, sub-family F (GCN20), member 1 Down 
BF440250 Bt.76165  Transcribed locus, weakly similar to XP_359792.1 protein MG04985.4 [Magnaporthe grisea 70-15] Down 
BF045126 Bt.64764 MRPS25 Mitochondrial 28S ribosomal protein S25 Down 
CR452009 Bt.45917  Transcribed locus, moderately similar to XP_508954.1 mitochondrial ribosomal protein L51 Down 
CR454801 Bt.49151  Similar to 60S ribosomal protein L17 (L23) (Amino acid starvation-induced protein) (ASI) Down 
CR452611 Bt.15460 RPS3 Ribosomal protein S3 Down 
CR551597 Bt.8462 RPLP0 Ribosomal protein, large, P0 Down 
BF440544 Bt.2191  Similar to ribosomal protein S27, cytosolic - human Down 
BM363457 Bt.64475 RPL6 Ribosomal protein L6 Down 
     
Protein folding 
CN432290 Bt.76948  Transcribed locus, weakly similar to NP_985611.1 [Eremothecium gossypii] Up 
BM364159 Bt.55432 FKBP11 FK506 binding protein 11, 19 kDa Up 
BM363860 Bt.20070 SIL1 SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae) Up 
BF040464 Bt.23263 HSP90AB1 Heat shock 90kDa protein 1, beta Up 
BM364981 Bt.1430 PFDN5 Prefoldin 5 Up 
CN436671 Bt.26818  
Transcribed locus, strongly similar to XP_532518.2 
DnaJ (Hsp40) homolog, subfamily B, member 9 [Canis 
familiaris] 
Down 
CN437208 Bt.59854 PPIA Peptidylprolyl isomerase A (cyclophilin A) Down 
CN433513 Bt.77630  
Transcribed locus, strongly similar to NP_005376.2 
natural killer-tumor recognition sequence [Homo 
sapiens] 
Down 
CN433111 Bt.35339 HSPA9B Heat shock 70kDa protein 9B (mortalin-2) Down 
AW462623 Bt.16330  Similar to GrpE protein homolog 2, mitochondrial precursor (Mt-GrpE#2) Down 
CN440377 Bt.28845  CCT3 T-complex protein 1, gamma subunit (TCP-1-gamma)  Down 
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Protein degradation 
AW463522 Bt.58848 UCHL1 Ubiquitin carboxy-terminal hydrolase L1 Up 
BF041154 Bt.7631  Ubiquitin specific peptidase 5 (isopeptidase T) (USP5), mRNA, incomplete 3' cds Up 
CN786388 Bt.2294 UBE1L Ubiquitin-activating enzyme E1-like Up 
CK776819 Bt.79993  Transcribed locus, strongly similar to XP_543159.2 ubiquitin-specific protease 12-like 1 [Canis familiaris] Up 
BF042633 Bt.10807  
Transcribed locus, moderately similar to XP_533174.1 
ubiquitin-conjugating enzyme E2L 6 isoform 1 [Canis 
familiaris] 
Up 
BM361936 Bt.32465  Similar to Ubiquitin-conjugating enzyme E2 J2 (Non-canonical ubiquitin conjugating enzyme 2) (NCUBE2) Up 
BF045963 Bt.2915  Similar to Ubiquitin-conjugating enzyme E2 T (Ubiquitin-protein ligase T) (Ubiquitin carrier protein T) Up 
AW462624 Bt.4902 CTSZ CTSZ protein Up 
BF046162 Bt.46077 CPA5 Similar to carboxypeptidase A5 Up 
BM363286 Bt.29297 CAPN13 Calpain 13 Up 
CR552780 Bt.7040 PSMB1 Proteasome (prosome, macropain) subunit, beta type, 1 Up 
BM362302 Bt.3624 PSMB10 Proteasome (prosome, macropain) subunit, beta type, 10 Up 
CR455154 Bt.8062 PSMC5 Proteasome (prosome, macropain) 26S subunit, ATPase, 5 Up 
BF041904 Bt.17968  Similar to 26S proteasome non-ATPase regulatory subunit 8 (26S proteasome regulatory subunit S14) Up 
CN439748 Bt.43820 PRSS15 ATP-dependent Lon protease Up 
AW462384 Bt.1722  Transcribed locus, weakly similar to XP_226175.3 mind bomb [Rattus norvegicus] Up 
BF041804 Bt.77192  
Transcribed locus, strongly similar to XP_533702.2 
Xaa-Pro dipeptidase (X-Pro dipeptidase) [Canis 
familiaris] 
Up 
DT824345 Bt.77217  
Transcribed locus, strongly similar to NP_005459.1 N-
acetylated alpha-linked acidic dipeptidase-like 1 
[Homo sapiens] 
Up 
BF603068 Bt.24739  
Transcribed locus, moderately similar to 
XP_001077083.1 neutrophil elastase [Rattus 
norvegicus] 
Up 
AF135232 Bt.18504 MMP3 Metalloproteinase 3 receptor Up 
DR697439 Bt.63794 BMSC-UbP Bone marrow stromal cell-derived ubiquitin-like protein Up 
CN432461 Bt.12304 ISG15 Interferon-stimulated protein, 15 kDa Up 
BM362485 Bt.48919 PSMB9 Proteasome subunit beta type 9 Down 
CN437905 Bt.48909 PSMC4 Proteasome (prosome, macropain) 26S subunit, ATPase, 4 Down 
BM365916 Bt.24017 PSMC2 Proteasome (prosome, macropain) 26S subunit, ATPase 2 Down 
BM364855 Bt.53697 PSMB8 Proteasome subunit, beta type 8 Down 
CR452517 Bt.52452 PSME1 Proteasome activator 28 alpha subunit Down 
CR453736 Bt.77042  Transcribed locus, strongly similar to XP_547643.2 mind bomb homolog 1 [Canis familiaris] Down 
CR452352 Bt.15687  Similar to hect domain and RLD 4 Down 
CR552096 Bt.30905  Transcribed locus, strongly similar to NP_973717.1 I [Rattus norvegicus] Down 
CN434103 Bt.80549  
Transcribed locus, strongly similar to XP_511577.1 
SMAD specific E3 ubiquitin protein ligase 2; E3 
ubiquitin ligase SMURF2 [Pan troglodytes] 
Down 
CN437394 Bt.76260 ADAMTSL4 Thrombospondin repeat containing 1 Down 
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CR456240 Bt.48960 UBL4A Ubiquitin-like 4A Down 
AW465059 Bt.53978 USP15 Ubiquitin specific peptidase 15 Down 
AW465929 Bt.55273 UBE2E3 Ubiquitin-conjugating enzyme E2E 3 Down 
BF440277 Bt.49039 UBD Similar to ubiquitin D Down 
BM445341 Bt.5070 UBC Polyubiquitin Down 
CN437184 Bt.16935  
Similar to Sentrin-specific protease 2 (Sentrin/SUMO-
specific protease SENP2) (SMT3-specific isopeptidase 
2) (Smt3ip2) (Axam2) [Canis familiaris] 
Down 
BF043307 Bt.12014  
Transcribed locus, moderately similar to XP_545298.2 
N-acetylated alpha-linked acidic dipeptidase 2 [Canis 
familiaris] 
Down 
BF039836 Bt.45767  Similar to CNDP dipeptidase 2 (metallopeptidase M20 family) (predicted) Down 
AW464210 Bt.8282 DPP4 Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2) Down 
CR451940 Bt.12194 FBXW2 F-box and WD-40 domain protein 2 (FBXW2) Down 
CR452920 Bt.41339 RNF8 Ring finger protein 8 Down 
BF043610 Bt.1613 PRSS11 Protease, serine, 11 [IGF binding] Down 
BF440339 Bt.7938 CTSS Cathepsin S Down 
BF045684 Bt.27994 ANPEP Alanyl (membrane) aminopeptidase Down 
     
Cell cycle / cell proliferation and differentiation 
CR453197 Bt.55596  
Transcribed locus, strongly similar to NP_571977.1 
kinase inhibitor 2C (p18, inhibits CDK4) [Rattus 
norvegicus] 
Up 
AW461358 Bt.63446  Similar to Interferon-induced 35 kDa protein (IFP 35) Up 
BF040980 Bt.58473  Transcribed locus, strongly similar to XP_545921.2 Max dimerization protein 4 isoform 1 [Canis familiaris] Up 
CN438129 Bt.149 IGFBP2 Insulin-like growth factor binding protein 2, 36kDa Up 
CN432245 Bt.9958 IGFBP6 Insulin-like growth factor-binding protein 6 Up 
BF042760 Bt.59584 GAK Cyclin G associated kinase Up 
DR749213 Bt.4267 MIA Melanoma inhibitory activity Up 
CR453343 Bt.7181 CAPNS1 Calpain, small subunit 1 Up 
BM365942 Bt.49712 TP53 p53 tumor suppressor phosphoprotein Up 
BF039606 Bt.56334 MAD2L1 MAD2 mitotic arrest deficient-like 1 (yeast) Up 
BF041588 Bt.20229 TBFG4 Transforming growth factor beta regulator 4 Up 
NM_174385 Bt.5011 LTBP2 Latent transforming growth factor beta binding protein 2 Up 
NM_174435 Bt.2813 PRKCA Protein kinase, C alpha Up 
AU233257 Bt.11071  
Transcribed locus, strongly similar to XP_543975.2 
leucine zipper, putative tumor suppressor 2 [Canis 
familiaris] 
Up 
CN438167 Bt.3383  Similar to Transcription factor Dp-1 (E2F dimerization partner 1) (DRTF1-polypeptide-1) Down 
CR451824 Bt.27716 NOV Nephroblastoma overexpressed Down 
CN440114 Bt.74621  
Transcribed locus, moderately similar to 
XP_001079831.1 proto-oncogene tyrosine-protein 
kinase ABL1 (p150) (c-ABL) (Abelson murine 
leukemia viral oncogene homolog 1) [Rattus 
norvegicus] 
Down 
BF045140 Bt.24497 FGFR1OP FGFR1 oncogene partner 1 Down 
BF043260 Bt.5750  Similar to carcinoma related gene Down 
CK960109 Bt.37175 CCNE2 Cyclin E2 Down 
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CR550550 Bt.20570  Similar to cyclin-dependent kinases regulatory subunit 1 (CKS-1) (Sid 1334) Down 
CK769923 Bt.7907 CDK10 Similar to cyclin-dependent kinase (CDC2-like) 10 Down 
AW463849 Bt.28600 RBM22 RNA binding motif protein 22 Down 
CN442154 Bt.58299 CAMK2D Calcium/calmodulin-dependent protein kinase II, delta Down 
BM366553 Bt.7519  
Transcribed locus, moderately similar to NP_058888.1 
differentiation, sphingolipid G-protein-coupled 
receptor, 5 [Rattus norvegicus] 
Down 
CR451837 Bt.23576  Transcribed locus, strongly similar to NP_002586.2 PCTAIRE protein kinase 2 [Homo sapiens] Down 
CR453819 Bt.49763 PNN Pinin, desmosome associated protein Down 
AW465475 Bt.28337  
Transcribed locus, strongly similar to NP_057217.2 
insulin induced protein 2; INSIG2 membrane protein 
[Homo sapiens] 
Down 
BF043720 Bt.6705  
Transcribed locus, strongly similar to NP_008994.1 
TBC1 domain family, member 8 (with GRAM domain); 
vascular Rab-GAP/TBC-containing; BUB2-like protein 
1 [Homo sapiens] 
Down 
BM362277 Bt.10855  Similar to regulator of G-protein signaling 2 Down 
AF305199 Bt.74168 IGFBP3 Insulin-like growth factor binding protein 3 Down 
AW289255 Bt.19650  Similar to cell division cycle 7-related protein kinase (CDC7-related kinase) Down 
CR453568 Bt.12473 CDC37 CDC37 homolog Down 
AW461388 Bt.23999  Transcribed locus, weakly similar to XP_363890.1 protein MG01816.4 [Magnaporthe grisea 70-15] Down 
CN434391 Bt.13476  
Transcribed locus, strongly similar to NP_612565.1 
kinesin family member 23 isoform 1; mitotic kinesin-
like 1; kinesin-like 5 (mitotic kinesin-like protein 1) 
[Homo sapiens] 
Down 
CN440232 Bt.37915  Transcribed locus, moderately similar to XP_534964.2 kinesin family member 11 [Canis familiaris] Down 
CB423716 Bt.22733  
Transcribed locus, moderately similar to 
NP_001017470.1 protein LOC367153 [Rattus 
norvegicus] 
Down 
BF046203 Bt.4831 NDP52 Nuclear domain 10 protein Down 
     
Cell adhesion 
NM_198221 Bt.13022 ITGAL Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) Up 
AJ535320 Bt.35830 ITGAM Integrin alpha M Up 
BF041132 Bt.9972 ITGB6 Integrin beta6 Up 
CR454674 Bt.4615 ITGB2 Integrin, beta 2 (antigen CD18 subunit (p95), lymphocyte function-associated antigen 1, integrin B2) Up 
BF041823 Bt.5372 ICAM1 Intercellular adhesion molecule 1 (CD54), human rhinovirus receptor Up 
BM365946 Bt.2657 URP2 UNC-112 related protein 2 Up 
AW464620 Bt.2573 CD9 CD9 antigen (p24) Up 
BF040131 Bt.59823 ZO3 Tight junction protein 3 Up 
BF042339 Bt.12589  
Transcribed locus, moderately similar to 
XP_001061082.1 Laminin alpha-3 chain precursor 
(Nicein alpha subunit) isoform 1 [Rattus norvegicus] 
Up 
BI540051 Bt.33617  
Transcribed locus, strongly similar to NP_032755.1 
catenin (cadherin associated protein), delta 2 [Mus 
musculus] 
Up 
CR454750 Bt.32490 CLSTN3 Calsyntenin 3 Up 
CR453007 Bt.58521  Similar to claudin 5 Up 
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BF040930 Bt.11942 COL18a1 Collagen, type XVIII, alpha 1 Up 
DR697468 Bt.61880  Transcribed locus, strongly similar to NP_604447.1 type V, alpha 1 [Rattus norvegicus] Up 
CR553272 Bt.46833  
Transcribed locus, strongly similar to NP_000349.1 
transforming growth factor, beta-induced [Homo 
sapiens] 
Down 
CN435002 Bt.7380 COL12A1 Collagen, type XII, alpha 1 Down 
CR452494 Bt.53485 COL1A2 Collagen, type I, alpha 2 Down 
BF043071 Bt.28231 CLDN7 Similar to Claudin-7 Down 
CN441870 Bt.7043 VCAM1 Vascular cell adhesion molecule 1 Down 
CR455078 Bt.64827 CDH1 Cadherin 1, type 1, E-cadherin (epithelial) Down 
CN438657 Bt.23618 SPON1 Spondin 1, (f-spondin) extracellular matrix protein Down 
     
Cell-cell communication 
BF045641 Bt.35935 GJB6 Gap junction protein, beta 6 (connexin 30) Up 
BF042809 Bt.17182  
Transcribed locus, moderately similar to XP_539605.2 
gap junction protein, beta 5 (connexin 31.1) [Canis 
familiaris] 
Up 
CR550859 Bt.516 GJB1 Gap junction protein, beta 1, 32 kD [connexin 32] Up 
BE237149 Bt.5976  
Transcribed locus, moderately similar to XP_539604.1 
Gap junction beta-4 protein (Connexin 30.3) [Canis 
familiaris] 
Up 
     
Cytoskeletal organization 
CR454452 Bt.36476  Similar to gamma adducin (Adducin-like protein 70) Up 
CN440623 Bt.79717  Transcribed locus, strongly similar to myosin-IC Up 
AW461752 Bt.52428 CFL1 Cofilin 1 (non-muscle) Up 
DR697464 Bt.57772 ACTN1 Similar to actinin, alpha 1 Up 
AW463298 Bt.59155 KRT19 Cytokeratin 19 Up 
DT815327 Bt.6141 DES Desmin Up 
BM366406 Bt.55987 TPM3 Tropomyosin 3 Up 
CN432869 Bt.11149 VIM Vimentin Up 
CN441758 Bt.23146 MYH8 Myosin, heavy polypeptide 8, skeletal muscle, perinatal Up 
CR452914 Bt.3684 ACTR2 ARP2 (actin-related protein 2, yeast) homolog Down 
CN440821 Bt.56769 WASPIP Wiskott-Aldrich syndrome protein interacting protein Down 
AW461549 Bt.57467 ANK3 Similar to ankyrin 3 Down 
CN433500 Bt.13391 CAPZA2 Capping protein (actin filament) muscle Z-line, alpha 2 Down 
CN437939 Bt.4329 SVIL Supervillin Down 
CR451851 Bt.23180 PFN1 Profilin 1 Down 
CR553471 Bt.38667  Actin, cytoplasmic 2 Down 
CR451994 Bt.48990 CAP1 CAP, adenylate cyclase-associated protein 1 (yeast) Down 
CR552253 Bt.64976 CALD1 Caldesmon, smooth muscle Down 
CR453003 Bt.2847 MYL6 Myosin, light peptide 6, alkali, smooth  muscle and non-muscle Down 
BF043297 Bt.76268  Transcribed locus, strongly similar to XP_236444.3 myosin VI [Rattus norvegicus] Down 
CB438714 Bt.18044  Transcribed locus, strongly similar to XP_533351.2 kinesin heavy chain isoform 5C [Canis familiaris] Down 
CN438269 Bt.61392  Transcribed locus, strongly similar to NP_034310.1 fibulin 1 [Mus musculus] Down 
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Morphogenesis and development 
CR451786 Bt.44967  Transcribed locus, moderately similar to NP_114452.1 1 [Rattus norvegicus] Up 
CN436901 Bt.2886 DKKL1 Dickkopf-like protein 1 Up 
BF039742 Bt.37857  
Transcribed locus, strongly similar to XP_001060983.1 
Wolf-Hirschhorn syndrome candidate 1 [Rattus 
norvegicus] 
Up 
BF046291 Bt.48832 MESDC2 Mesoderm development candidate 2 Up 
CR552730 Bt.4235  Transcribed locus, weakly similar to XP_342600.2 alpha-3 type IX collagen [Rattus norvegicus] Up 
CN440721 Bt.18467  
Transcribed locus, weakly similar to XP_517386.1 T-
cell receptor alpha enhancer-binding protein, short 
form - human [Pan troglodytes] 
Up 
DR749253 Bt.47429  
Transcribed locus, strongly similar to XP_001078859.1 
FERMRhoGEF (Arhgef) and pleckstrin domain protein 
1 [Rattus norvegicus] 
Up 
BF044858 Bt.20145 PX19 Px19-like protein Up 
NM_174403 Bt.7422 NR5A1 Nuclear receptor subfamily 5, group A, member 1 Up 
AW430313 Bt.76414  Transcribed locus, moderately similar to NP_055595.2 cullin 7 [Homo sapiens] Up 
DR697687 Bt.5219 TCF21 Transcription factor 21 Up 
CN434722 Bt.13780  Transcribed locus, strongly similar to sprouty homolog 1 Down 
AW464650 Bt.16749  Similar to plexin A3 Down 
AW465346 Bt.10941  Transcribed locus, moderately similar to NP_060858.2 muscleblind-like 3 isoform G [Homo sapiens] Down 
AW464984 Bt.4908 RBBP7 Retinoblastoma binding protein 7 Down 
BF045944 Bt.13880  Transcribed locus, strongly similar to XP_507795.1 Dickkopf related protein-1 precursor (Dkk-1) Down 
CR553196 Bt.5223 DLK1 Delta-like homolog (Drosophila) Down 
BM087872 Bt.28900  Similar to annexin XIIIb Down 
BF044804 Bt.62052 SOX6 Similar to SOX6  Down 
DR697405 Bt.45570 EPAS1 Endothelial PAS domain protein 1 Down 
CK951897 Bt.65686  Transcribed locus, strongly similar to XP_858787.1 Jagged-1 precursor (Jagged1) (hJ1) [Canis familiaris] Down 
BF440263 Bt.1424  
Transcribed locus, strongly similar to NP_004226.2 
Kruppel-like factor 4 (gut); endothelial Kruppel-like zinc 
finger protein [Homo sapiens] 
Down 
NM_174302 Bt.81 CYLC1 Cylicin, basic protein of sperm head cytoskeleton 1 Down 
     
Apoptosis 
CN440401 Bt.30544  Similar to p75-like apoptosis-inducing death domain protein PLAIDD Up 
DR697322 Bt.1411  Similar to BCL2/adenovirus E1B 19-kDa protein-interacting protein 3 Up 
BF041764 Bt.2386 DEDD2 Similar to death effector domain-containing DNA binding protein 2 Up 
BF046452 Bt.20111  
Transcribed locus, moderately similar to NP_851600.1 
necrosis factor receptor superfamily, member 12a 
[Rattus norvegicus] 
Up 
CR454566 Bt.62236 WWOX WW domain-containing oxidoreductase Up 
CN441881 Bt.49187 GRIM19 Cell death-regulatory protein GRIM19 Up 
BF044468 Bt.7776 TPT1 Tumor protein, translationally-controlled 1 Up 
BF041733 Bt.35629 BID BH3 interacting domain death agonist Up 
CR550989 Bt.48127 TIA1 Similar to TIA1 protein Down 
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CN434930 Bt.32255 PDCD5 Similar to programmed cell death protein 5 (TFAR19 protein) (TF-1 cell apoptosis related gene-19 protein) Down 
CR454209 Bt.14155 PDCD10 Similar to programmed cell death 10 Down 
BF043121 Bt.45655 STK17B Similar to serine/threonine-protein kinase 17B (DAP kinase-related apoptosis-inducing protein kinase 2) Down 
BF045339 Bt.61869 CYCS Similar to cytochrome c, somatic Down 
AW465842 Bt.1793  
Transcribed locus, moderately similar to 
XP_001080523.1 cell death regulator Aven [Rattus 
norvegicus] 
Down 
AW464030 Bt.4675 MX1 Myxovirus (influenza) resistance 1, (murine homolog) Down 
BF440414 Bt.11884 BCL2A1 B-cell leukemia/lymphoma 2 related protein A1 Down 
BF040981 Bt.13981  Similar to TM2 domain containing 2 Down 
CB538194 Bt.64777  Transcribed locus, moderately similar to NP_068520.1 IAP repeat-containing 2 [Rattus norvegicus] Down 
BF045590 Bt.20494  
Transcribed locus, strongly similar to NP_036366.2 
RING1 and YY1 binding protein; Ring1 interactor 
RYBP; YY1 and E4TF1 associated factor 1; apoptin-
associating protein 1 [Homo sapiens] 
Down 
CN440606 Bt.12183 RRAGA Ras-related GTP binding A Down 
     
Immuno and Inflammatory response 
AF081273 Bt.45933 IL4R Interleukin-4 receptor alpha chain Up 
BE808976 Bt.49236 IL11RA Interleukin 11 receptor, alpha Up 
BM366533 Bt.26527 IL16 Interleukin 16 Up 
BM362640 Bt.26847  Linker for activation of T cells Up 
CK959898 Bt.18368  Transcribed locus, weakly similar to NP_891997.1 (C-X-C motif) ligand 11 [Rattus norvegicus] Up 
BM363136 Bt.27680  Transcribed locus, strongly similar to NP_997498.2 cytokine [Rattus norvegicus] Up 
CR452319 Bt.8140 FCER1G Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide Up 
AW461905 Bt.41326 DF D component of complement (adipsin) Up 
CK959382 Bt.68981  Transcribed locus, weakly similar to NP_001037692.1 component factor h-like 1 [Rattus norvegicus] Up 
CN436532 Bt.43647 C1R Complement component 1, r subcomponent Up 
CB434668 Bt.76479  
Transcribed locus, strongly similar to NP_006601.2 
mannan-binding lectin serine protease 2 [Homo 
sapiens] 
Up 
CR452765 Bt.15528 MIF Macrophage migration inhibitory factor (glycosylation-inhibiting factor) Up 
AW463930 Bt.46809  Similar to CD74 antigen Up 
BF045350 Bt.5356 BoLA-DRB3 Major histocompatibility complex, class II, DRB3 Up 
AB117946 Bt.53299 BOLA-DOB Major histocompatibility complex, class II, DO beta Up 
BF041352 Bt.23126 NOS2A Nitric oxide synthase 2A (inducible, hepatocytes) Up 
CB224338 Bt.9360  Similar to Calgranulin A (Migration inhibitory factor-related protein 8) (MRP-8) Up 
CK770058 Bt.44261 TNFRSF8 Tumor necrosis factor receptor superfamily, member 8 Up 
CR452792 Bt.1577 C1QA Complement component 1, q subcomponent, alpha polypeptide Down 
AJ535317 Bt.79131 CD21 Complement receptor type 2 Down 
NM_205773 Bt.24326  Eotaxin Down 
AY574996 Bt.80445 CCR3 C-C motif chemokine receptor 3 Down 
AY575855 Bt.62596 CCR1 Chemokine C-C motif receptor 1 Down 
BF043950 Bt.2408 CCL2 Chemokine (C-C motif) ligand 2 Down 
BM364516 Bt.2524 SDF1 Stromal cell-derived factor 1 Down 
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CN792099 Bt.28088 CXCL13 Chemokine (C-X-C motif) ligand 13-like Down 
BF074924 Bt.9468 SYK Spleen tyrosine kinase Down 
BF039564 Bt.49740 IL8 Interleukin 8 Down 
BM364841 Bt.24247  Transcribed locus, weakly similar to NP_476541.1 10 receptor, alpha [Rattus norvegicus] Down 
CN439007 Bt.234 IL18 Interleukin 18 (interferon-gamma-inducing factor) Down 
AW465344 Bt.49121 IL22RA1 Interleukin 22 receptor, alpha 1 Down 
BF440593 Bt.74191 IGJ Immunoglobulin J chain Down 
BF440378 Bt.143 NCF2 Neutrophil cytosolic factor 2 [65kD, human : chronic granulomatous disease, autosomal 2] Down 
BM364912 Bt.46153  Transcribed locus, weakly similar to XP_854209.1 osteoclast inhibitory lectin isoform 1 [Canis familiaris] Down 
BM365025 Bt.55988  
Similar to SAM domain and HD domain-containing 
protein 1 (Dendritic cell-derived IFNG-induced protein) 
(DCIP) (Monocyte protein 5) (MOP-5) 
Down 
CB459644 Bt.24959  
Transcribed locus, weakly similar to NP_001770.1 
antigen, (lymphocyte function-associated antigen 3) 
[Homo sapiens] 
Down 
CN439508 Bt.15157 CNIH Cornichon-like isoform 1 Down 
AW461498 Bt.42359 PLA2G7 Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) Down 
DN825756 Bt.12775 BOLA Classical MHC class I antigen Down 
CN999995 Bt.12775 BOLA Classical MHC class I antigen Down 
BF440417 Bt.5269 B2M Beta-2-microglobulin Down 
BM362427 Bt.8552 BOLA-DRA Major histocompatibility complex, class II, DR alpha Down 
BF046359 Bt.1548  
Transcribed locus, moderately similar to XP_533874.2 
gamma-interferon inducible lysosomal thiol reductase 
precursor (Gamma-interferon-inducible protein IP-30) 
[Canis familiaris] 
Down 
     
Pregnancy 
CR456002 Bt.2047 ADM Adrenomedullin Down 
CK845888 Bt.43717 PGDH Hydroxyprostaglandin dehydrogenase 15-(NAD) Down 
BF042058 Bt.30437 PGRMC2 Progesterone receptor membrane component 2 Down 
     
Nervous system development and proliferation 
BF045655 Bt.54949  Similar to huntingtin-associated protein 1 Up 
CR453582 Bt.361 SLC1A3 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 Up 
NM_173884 Bt.3864 TH Tyrosine hydroxylase Up 
CB442833 Bt.16310  
Transcribed locus, strongly similar to XP_508369.1 
dJ68D18.1.2 (solute carrier family 1 (glial high affinity 
glutamate transporter) member 2) [Pan troglodytes] 
Up 
CR552897 Bt.49592  Similar to protein CGI-38 Up 
CR452742 Bt.53943  
Similar to ectoderm-neural cortex-1 protein (ENC-1) 
(p53-induced protein 10) (Nuclear matrix protein 
NRP/B) 
Up 
BM363307 Bt.78537  
Transcribed locus, moderately similar to NP_060719.3 
CDK5 regulatory subunit associated protein 2; CDK5 
activator-binding protein C48 [Homo sapiens] 
Up 
CR451719 Bt.69592  
Transcribed locus, strongly similar to 
NP_001002953.1 related with YRPW motif 1 [Canis 
familiaris] 
Up 
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CR452081 Bt.76692  
Transcribed locus, strongly similar to NP_443100.1 
immunoglobulin superfamily, member 8; CD81 partner 
3 [Homo sapiens] 
Up 
CR455513 Bt.56845  
Transcribed locus, strongly similar to XP_532931.2 
cysteine rich transmembrane BMP regulator 1 (chordin 
like) [Canis familiaris] 
Up 
NM_174229 Bt.517 ADCY1 Adenylate cyclase 1 (brain) Up 
CR454056 Bt.22534  Transcribed locus, moderately similar to NP_058733.1 myelin protein 22 [Rattus norvegicus] Down 
AW463945 Bt.41007 GABARAPL2 GABA(A) receptor-associated protein-like 2 Down 
NM_174272 Bt.4231 CHRNE Cholinergic receptor, nicotinic, epsilon polypeptide Down 
CN438259 Bt.21731  Similar to drebrin (Developmentally regulated brain protein) Down 
BF043908 Bt.3940  Similar to transcription factor 12 Down 
CR455649 Bt.275 NEDD8 Neural precursor cell expressed, developmentally down-regulated 8 Down 
AW464306 Bt.48322  Similar to developmentally regulated RNA-binding protein 1 (RB-1) Down 
CR453508 Bt.46270  Transcribed locus, strongly similar to XP_540253.2 nescient helix loop helix 2 [Canis familiaris] Down 
     
Metabolism 
Amino acids 
CR454264 Bt.5422 PYCRL Pyrroline-5-carboxylate reductase-like Up 
BF042101 Bt.49106 SHMT2 Serine hydroxymethyltransferase 2 (mitochondrial) Up 
BE682393 Bt.16050  Similar to mitochondrial glutamate carrier 1 Up 
AW461608 Bt.27135  
Similar to Kynurenine--oxoglutarate transaminase I 
(Kynurenine aminotransferase I) (KATI) (Glutamine--
phenylpyruvate transaminase) (Glutamine 
transaminase K) (GTK) (Cysteine-S-conjugate beta-
lyase) 
Up 
AW465008 Bt.52357 HRMT1L2 HMT1 hnRNP methyltransferase-like 2 Up 
CR451970 Bt.4269 OTC Ornithine carbamoyltransferase Down 
BF046362 Bt.49448 OAT Similar to Ornithine aminotransferase, mitochondrial precursor (Ornithine--oxo-acid aminotransferase) Down 
CR453522 Bt.26471  
Transcribed locus, strongly similar to NP_056962.2 
ornithine decarboxylase antizyme inhibitor; antizyme 
inhibitor [Homo sapiens] 
Down 
CN437959 Bt.20701  
Transcribed locus, strongly similar to NP_858058.1 O-
linked GlcNAc transferase isoform 1; O-GlcNAc 
transferase p110 subunit; uridinediphospho-N-
acetylglucosamine 
Down 
CN438569 Bt.57999  
Transcribed locus, strongly similar to XP_862154.1 
carbamoyl-phosphate synthetase 1, mitochondrial 
isoform 30 [Canis familiaris] 
Down 
CN439799 Bt.52500 ST3GAL-V Alpha 2,3-sialyltransferase Down 
BF043883 Bt.25099 PSPH Similar to phosphoserine phosphatase Down 
CR455498 Bt.4733 PHGDH Phosphoglycerate dehydrogenase Down 
CR454540 Bt.16072 SERINC2 Serine incorporator 2 Down 
     
Nucleic acids 
BF045425 Bt.1087  
Transcribed locus, strongly similar to XP_521542.1 3'-
phosphoadenosine 5'-phosphosulfate synthase 2 [Pan 
troglodytes] 
Up 
BF041430 Bt.42575 UCK1 Similar to Uridine-cytidine kinase 1 Up 
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DR697437 Bt.48820 DERA 
Similar to Putative deoxyribose-phosphate aldolase 
(Phosphodeoxyriboaldolase) (Deoxyriboaldolase) 
(DERA) 
Down 
BF045108 Bt.34369  
Transcribed locus, strongly similar to XP_856623.1 
ribose-phosphate pyrophosphokinase II 
(Phosphoribosyl pyrophosphate synthetase II) (PRS-II) 
isoform 4 [Canis familiaris] 
Down 
BM363371 Bt.31640 OAS1 2',5'-oligoadenylate synthetase 1, 40/46kDa Down 
CR452386 Bt.61486  Transcribed locus, weakly similar to XP_453052.1 protein product [Kluyveromyces lactis] Down 
DR697447 Bt.65253  Transcribed locus, weakly similar to NP_983600.1 [Eremothecium gossypii] Down 
CR454063 Bt.5340 NBR-A Nucleoside-diphosphate kinase NBR-A Down 
CR452418 Bt.18730 DHFR Dihydrofolate reductase Down 
     
Carbohydrates 
AW465422 Bt.22533  Transcribed locus, strongly similar to NP_036627.1 A [Rattus norvegicus] Up 
BF042384 Bt.62233  
Transcribed locus, moderately similar to 
XP_001077726.1 carbohydrate sulfotransferase 5 (N-
acetylglucosamine 6-O-sulfotransferase 3) 
Up 
CN440595 Bt.5061  
Transcribed locus, moderately similar to NP_000280.1 
phosphofructokinase, muscle; Phosphofructokinase, 
muscle type [Homo sapiens] 
Up 
CN440641 Bt.59986  Similar to ketohexokinase Up 
BM363300 Bt.12474 GALE UDP-galactose-4-epimerase Up 
CN434306 Bt.49794 PDHB Pyruvate dehydrogenase (lipoamide) beta Up 
AW463251 Bt.11825  
Transcribed locus, strongly similar to 
NP_001015032.2 N-acetylgalactosaminyltransferase 3 
[Rattus norvegicus] 
Down 
CN437656 Bt.44041  Similar to Aldehyde dehydrogenase, mitochondrial precursor (ALDH class 2) (ALDH1) (ALDH-E2) Down 
CR455987 Bt.20235  Similar to N-acetylglucosamine-6-sulfatase precursor (G6S) (Glucosamine-6-sulfatase) Down 
CR454616 Bt.57867  Similar to Alpha-N-acetylgalactosaminidase precursor (Alpha-galactosidase B) Down 
CN437540 Bt.49587 GPI Glucosephosphate isomerase Down 
CB165214 Bt.13737 GALK2 Similar to N-acetylgalactosamine kinase (GalNAc kinase) (Galactokinase 2) Down 
     
Lipids 
BE480377 Bt.61867  Similar to carnitine acetyltransferase isoform 1 precursor Up 
CB223494 Bt.28966 PLA2G2A Phospholipase A2 group IIA-like Up 
CN441201 Bt.12 FABP1 Fatty acid binding protein 1, liver Up 
CR454069 Bt.76327  
Transcribed locus, strongly similar to NP_689572.1 
carnitine palmitoyltransferase 1C; carnitine 
palmitoyltransferase I related C [Homo sapiens] 
Up 
BF040744 Bt.24308  Transcribed locus, moderately similar to NP_446126.1 hydroxylase [Rattus norvegicus] Up 
BF040540 Bt.31329 PNPLA6 Patatin-like phospholipase domain containing 6 Up 
BF039919 Bt.46917  Hypothetical LOC768330 (LOC768330) Up 
CR551554 Bt.34980 APOE Apolipoprotein E Up 
CR451929 Bt.2342 CDS2 Similar to phosphatidate cytidylyltransferase 2 Down 
CR453248 Bt.61205  Transcribed locus, weakly similar to XP_363106.1 protein MG08690.4 [Magnaporthe grisea 70-15] Down 
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CN435714 Bt.56578  
Transcribed locus, strongly similar to XP_538788.1 
ceramide glucosyltransferase (Glucosylceramide 
synthase) (GCS) (UDP-glucose:N-acylsphingosine D-
glucosyltransferase) (UDP-glucose ceramide 
glucosyltransferase) (GLCT-1) 
Down 
CN438868 Bt.4909 TCAP Titin-cap Down 
CN441562 Bt.18340  Similar to choline/ethanolaminephosphotransferase 1 Down 
BF039216 Bt.49359 DEGS1 Similar to degenerative spermatocyte homolog 1, lipid desaturase Down 
CN439703 Bt.22589  Transcribed locus, moderately similar to XP_342341.1 group XII-1 phospholipase A2 [Rattus norvegicus] Down 
CN438214 Bt.1539  Transcribed locus, moderately similar to NP_000396.2 GM2 ganglioside activator protein [Homo sapiens] Down 
CK770880 Bt.62243  Transcribed locus, strongly similar to NP_058864.1 phospholipase C, gamma 2 [Rattus norvegicus] Down 
CF613729 Bt.23226 ACADSB Acyl-Coenzyme A dehydrogenase, short/branched chain Down 
BF044267 Bt.37818 ACACB Acetyl-CoA carboxylase, type beta Down 
     
General metabolism 
CN435970 Bt.20720 CES2 Carboxylesterase 2 Up 
AW461717 Bt.49713 CKMT1 Creatine kinase, mitochondrial 1 (ubiquitous) Up 
BM363130 Bt.53580 SEPX1 Selenoprotein X, 1 Up 
BF039387 Bt.20141  Similar to Hydroxyacylglutathione hydrolase (Glyoxalase II) (GLX II) Up 
BF042117 Bt.21822  Similar to Aldehyde dehydrogenase 3B1 Up 
AW461432 Bt.13628  Transcribed locus, strongly similar to XP_534370.2 transglutaminase 3 precursor [Canis familiaris] Up 
BF044308 Bt.44647 NADK NAD kinase Up 
CK838210 Bt.9081  Similar to Selenocysteine lyase  Up 
CN433788 Bt.56538  
Transcribed locus, moderately similar to XP_848651.1 
phosphotriesterase related protein (Parathion 
hydrolase-related protein) isoform 2 [Canis familiaris] 
Down 
CN434037 Bt.49673 GSTM1 Glutathione S-transferase M1 Down 
CN436549 Bt.3314  Similar to Pleckstrin homology domain containing, family M (with RUN domain) member 1 Down 
CN441882 Bt.15996 ACAS2L Acetyl-Coenzyme A synthetase 2 (AMP forming)-like Down 
BF045987 Bt.43990  Similar to ATPase, H+ transporting, V0 subunit D isoform 2 Down 
BF044672 Bt.64780  
Transcribed locus, strongly similar to NP_005902.1 
methionine adenosyltransferase II, alpha [Homo 
sapiens] 
Down 
CF766726 Bt.67756  Transcribed locus, strongly similar to NP_078771.1 carbonic anhydrase 13 [Mus musculus] Down 
AW463631 Bt.69 NDUFA1 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa Down 
BF042402 Bt.11993  
Similar to dehydrogenase/reductase SDR family 
member 8 precursor (17-beta-hydroxysteroid 
dehydrogenase 11) (17-beta-HSD 11) 
Down 
AW464695 Bt.4113  
Transcribed locus, strongly similar to XP_534612.2 
COP9 signalosome complex subunit 8 (Signalosome 
subunit 8) (SGN8) (JAB1-containing signalosome 
subunit 8) (COP9 homolog) (hCOP9) [Canis familiaris] 
Down 
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TCA 
BF042003 Bt.24449 SDHA Succinate dehydrogenase flavoprotein subunit A Up 
AW464637 Bt.3809 LDHA Lactate dehydrogenase A Down 
CN439286 Bt.13487  Similar to 6-phosphogluconate dehydrogenase (decarboxylating) Down 
     
Eletron transport 
CR551153 Bt.665 CYP2D6 Cytochrome P450, family 2, subfamily D, polypeptide 6 Up 
DR697628 Bt.3985 CYP17 Cytochrome P450, subfamily XVII Up 
CR453506 Bt.16025 COX4 Cytochrome c oxydase subunit 4 Up 
CN440220 Bt.63247  
Transcribed locus, moderately similar to 
NP_001032415.1 dehydrogenase (ubiquinone) 1 beta 
subcomplex, 4, 15kDa [Rattus norvegicus] 
Up 
BF043169 Bt.2562 GRP58 Glucose regulated protein 58kD Up 
CR455817 Bt.231 TXN Thioredoxin Up 
AW464776 Bt.5288 TXN2 Thioredoxin 2 Up 
CN441299 Bt.74430 TXNDC4 Thioredoxin domain containing 4 (endoplasmic reticulum) Up 
CN441116 Bt.49189 NDUFV2 
NADH dehydrogenase flavoprotein 2 (24kD) 
[ubiquinone] [NADH-ubiquinone reductase 24 kDa 
mitochondrial] 
Up 
CN437522 Bt.5483 NDUFS8 NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kDa (NADH-coenzyme Q reductase) Up 
BF039175 Bt.76309  Similar to NADH:ubiquinone oxidoreductase MLRQ subunit homolog Up 
BF044713 Bt.20 NDUFA7 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa Up 
BM363889 Bt.23164 UQCRC1 UQCRC1 protein Up 
NM_176654 Bt.4211 ATP6V1B1 ATPase, H+ transporting, V1 subunit B, isoform 1 Up 
CN441269 Bt.62703  
Similar to ATP synthase, H+ transporting, 
mitochondrial F1 complex, alpha subunit, isoform 1, 
cardiac muscle 
Down 
AV612395 Bt.8845 ACAD9 Acyl-Coenzyme A dehydrogenase family, member 9 Down 
CK773196 Bt.25731  Transcribed locus, moderately similar to NP_080460.2 endoplasmic oxidoreductase 1 beta [Mus musculus] Down 
BM363367 Bt.27327 UQCRH 
Similar to Ubiquinol-cytochrome c reductase complex 
11 kDa protein, mitochondrial precursor (Mitochondrial 
hinge protein) (Cytochrome C1, nonheme 11 kDa 
protein) (Complex III subunit VIII) 
Down 
CN439862 Bt.60 NDUFB2 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa Down 
CN442294 Bt.55686 COX5A COX5A protein Down 
     
Signal transduction 
CR553533 Bt.10903 TSE1 Similar to cAMP-dependent protein kinase type I-alpha regulatory subunit (Tissue-specific extinguisher-1) Up 
CN440527 Bt.5371 GAP1IP4BP RAS p21 protein activator (GTPase activating protein) 3 (Ins(1,3,4,5)P4-binding protein) Up 
CN441423 Bt.4559  Transcribed locus, strongly similar to NP_077322.1 3 [Rattus norvegicus] Up 
CN442144 Bt.3876 ARL2 ADP-ribosylation factor-like 2 Up 
BF043403 Bt.29937 CENTB1 Similar centaurin beta1 Up 
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BF040565 Bt.8204  
Transcribed locus, strongly similar to XP_509190.1 
SLIT-ROBO Rho GTPase-activating protein 1 [Pan 
troglodytes] 
Up 
NM_174466 Bt.8137 SOCS3 Suppressor of cytokine signaling 3 Up 
BM363844 Bt.11924  
Transcribed locus, strongly similar to 
NP_001003264.1 signal recognition particle,72 kDa 
subunit [Canis familiaris] 
Up 
CB442289 Bt.8543 TIMAP CAAX box protein TIMAP Up 
AW464303 Bt.12575  Similar to Ras-related protein rab-4B Up 
BF042882 Bt.20180 RAB25 RAB25, member RAS oncogene family Up 
CV798843 Bt.167 MAPK1 Mitogen-activated protein kinase 1 Up 
BF045624 Bt.42665  
Transcribed locus, strongly similar to NP_060241.2 PX 
domain containing serine/threonine kinase [Homo 
sapiens] 
Up 
BF043288 Bt.46188  Similar to cAMP-dependent protein kinase inhibitor beta Up 
NM_174229 Bt.517 ADCY1 Adenylate cyclase 1 (brain) Up 
NM_174647 Bt.4706 PPP1R1B Protein phosphatase 1, regulatory (inhibitor) subunit 1B Up 
BI680681 Bt.78165  Transcribed locus, strongly similar to NP_001657.2 Rho GTPase activating protein 4 [Homo sapiens] Up 
AW445383 Bt.24520 BLNK B-cell linker Up 
CK775260 Bt.34847  Transcribed locus, strongly similar to NP_058039.1 Rap2 interacting protein [Mus musculus] Up 
CK770933 Bt.74982  
Transcribed locus, weakly similar to NP_445781.2 
growth factor binding protein, acid labile subunit 
[Rattus norvegicus] 
Up 
CR452271 Bt.26628 RAP2C Similar to RAP2C, member of RAS oncogene family Down 
CR453466 Bt.14122  Transcribed locus, strongly similar to XP_227600.4 protein vav-3 [Rattus norvegicus] Down 
CR452307 Bt.18279 FZD3 Frizzled homolog 3 (Drosophila) Down 
CN432293 Bt.43141  
Transcribed locus, strongly similar to XP_544104.2 
phosphodiesterase 7A isoform a isoform 1 [Canis 
familiaris] 
Down 
CN433357 Bt.36230  Transcribed locus, strongly similar to XP_543734.2 leucine-rich repeat kinase 2 [Canis familiaris] Down 
CN435008 Bt.45586  
Transcribed locus, strongly similar to XP_535785.2 
triple functional domain (PTPRF interacting) [Canis 
familiaris] 
Down 
CN435042 Bt.21189  Transcribed locus, strongly similar to XP_865394.1 protein kinase D2 isoform 5 [Canis familiaris] Down 
CN441383 Bt.30379 CDKN3 Cyclin-dependent kinase inhibitor 3 (CDK2-associated dual specificity phosphatase) Down 
BF041110 Bt.4641 STAT5A Signal transducer and activator of transcription 5A Down 
BF044335 Bt.6801  
Transcribed locus, strongly similar to XP_344278.2 
ankyrin repeat and SOCS box-containing protein 3 
[Rattus norvegicus] 
Down 
AW289213 Bt.53393 RHOH Ras homolog gene family, member H Down 
CV798830 Bt.3504  
Transcribed locus, strongly similar to XP_508296.1 
related RAS viral (r-ras) oncogene homolog 2 [Pan 
troglodytes] 
Down 
CR453020 Bt.3192 RABL2A RAB, member of RAS oncogene family-like 2A Down 
CN441075 Bt.44630 RAB11A Similar to RAB11a, member RAS oncogene family Down 
CR454061 Bt.49090 COMMD3 COMM domain containing 3 Down 
CR454313 Bt.60794  Transcribed locus, moderately similar to NP_036620.1 [Rattus norvegicus] Down 
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AW289359 Bt.46977  
Similar to dual adapter for phosphotyrosine and 3-
phosphotyrosine and 3-phosphoinositide (hDAPP1) (B 
cell adapter molecule of 32 kDa) (B lymphocyte 
adapter protein Bam32) 
Down 
BF040319 Bt.64564  Transcribed locus, weakly similar to XP_369329.1 protein MG06135.4 [Magnaporthe grisea 70-15] Down 
CR454899 Bt.19807 SCAP2 SRC family associated phosphoprotein 2 Down 
BF440395 Bt.16911  Transcribed locus, weakly similar to XP_360001.1 protein MG05376.4 [Magnaporthe grisea 70-15] Down 
BM362982 Bt.24347 MRGPRF MAS-related GPR, member F Down 
CR452711 Bt.9450  Similar to A-kinase anchor protein 13 Down 
CR452657 Bt.5451 RAB5B RAB5B, member RAS oncogene family Down 
BM364131 Bt.49073 CD3D Antigen CD3D, delta polypeptide (TiT3 complex) Down 
CN432988 Bt.39894  Transcribed locus, weakly similar to NP_604463.1 protein kinase I [Rattus norvegicus] Down 
BF040754 Bt.9569 TACSTD1 Tumor-associated calcium signal transducer 1 Down 
DV780245 Bt.20562 NCOA4 Nuclear receptor coactivator 4 Down 
NM_174765 Bt.7214 COL4A3BP Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein Down 
CK944372 Bt.2150  
Transcribed locus, strongly similar to NP_037428.2 G-
protein signalling modulator 2 (AGS3-like, C. elegans); 
LGN protein [Homo sapiens] 
Down 
AW670539 Bt.2462 SH2D2A SH2 domain protein 2A Down 
CB539028 Bt.38707 RAB8B RAB8B, member RAS oncogene family Down 
NM_178109 Bt.20923 PRKR Protein kinase, interferon-inducible double stranded RNA dependent Down 
BF040014 Bt.64692 RAB18 Similar to Ras-related protein Rab-18 Down 
BF440362 Bt.37348 LPXN Leupaxin Down 
     
Surface receptors 
CR452313 Bt.56413  
Transcribed locus, strongly similar to XP_001053288.1 
receptor tyrosine kinase-like orphan receptor 2 [Rattus 
norvegicus] 
Up 
BF046224 Bt.2996  
Transcribed locus, strongly similar to XP_536222.2 G 
protein-coupled receptor kinase 4 isoform alpha [Canis 
familiaris] 
Up 
BF039474 Bt.4990 ACVR2B Activin A receptor, type IIB Up 
CK770943 Bt.37189 BLR1 Burkitt lymphoma receptor 1 Up 
NM_174640 Bt.11204 GPR73L1 G protein-coupled receptor 73-like 1 Up 
NM_175715 Bt.486 ADCYAP1R1 Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I Up 
CB432832 Bt.16889 LTB4R Leukotriene B4 receptor Up 
AJ618974 Bt.29889 TLR6 Toll-like receptor 6 Down 
CR550392 Bt.7319  
Transcribed locus, moderately similar to XP_342569.3 
protein tyrosine phosphatase, receptor type, T [Rattus 
norvegicus] 
Down 
CR456081 Bt.15558 GRM7 Similar to metabotropic glutamate receptor 7 precursor (mGluR7) Down 
NM_174547 Bt.4538 GUCY2C Guanylate cyclase 2C [heat stable enterotoxin receptor] Down 
NM_174051 Bt.541 ESR2 Estrogen receptor 2 (ER beta) Down 
     
Transport 
CN437574 Bt.7980 LASP1 LIM and SH3 protein 1 Up 
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AW461699 Bt.11804  
Transcribed locus, strongly similar to XP_538934.2 
ATP-binding cassette, sub-family C, member 10 
[Canis familiaris] 
Up 
AW464787 Bt.63034  Transcribed locus, weakly similar to XP_368776.1 protein MG00468.4 [Magnaporthe grisea 70-15] Up 
AW464903 Bt.64977 SLCO2B1 Organic anion transporting polypeptide 2b1 Up 
BF039974 Bt.53065  Similar to copper chaperone for superoxide dismutase (Superoxide dismutase copper chaperone) Up 
NM_174221 Bt.5067 ABCA4 ATP-binding cassette, sub-family A (ABC1), member 4 Up 
BF046658 Bt.49082 TIMM50 Translocase of inner mitochondrial membrane 50 homolog Up 
CN435414 Bt.1143 LAPTM4B Similar to lysosomal associated protein transmembrane 4 beta Down 
CN441107 Bt.15708 MON1A MON1 homolog A (yeast) Down 
BF046414 Bt.8872 ATP2B1 ATPase, Ca++ transporting, plasma membrane 1 Down 
CB424419 Bt.27240  
Transcribed locus, moderately similar to XP_543087.2 
solute carrier organic anion transporter family, 
member 4A1 (Organic anion transporting polypeptide 
E) (OATP-E) [Canis familiaris] 
Down 
CK774482 Bt.759 SLC4A2 SLC4A2 anion exchanger Down 
CN792196 Bt.46115 SLC7A9 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 Down 
AW464260 Bt.19972  
Transcribed locus, moderately similar to NP_005064.1 
solute carrier family 15 (oligopeptide transporter), 
member 1; peptide transporter HPEPT1 [Homo 
sapiens] 
Down 
BF044502 Bt.77860  
Transcribed locus, strongly similar to NP_112410.1 
carrier family 20 (phosphate transporter), member 1 
[Rattus norvegicus] 
Down 
NM_174655 Bt.19 SLC24A1 Solute carrier family 24, member 1 Down 
CN442091 Bt.45842 SLC27A1 Solute carrier family 27 (fatty acid transporter), member 1 Down 
BF040441 Bt.6359  
Transcribed locus, strongly similar to NP_742063.1 
carrier family 30 (zinc transporter), member 4 [Rattus 
norvegicus] 
Down 
CN433928 Bt.9238 SLC38A2 Solute carrier family 38, member 2 Down 
BF044778 Bt.8735 TIMM22 Translocase of inner mitochondrial membrane 22 homolog Down 
BF044937 Bt.29968 ENSA Endosulfine alpha Down 
AW462521 Bt.51973 ABCG2 ATP-binding cassette, sub-family G, member 2 Down 
AW289347 Bt.5346  Transcribed locus, weakly similar to XP_362105.1 protein MG04550.4 [Magnaporthe grisea 70-15] Down 
AW487381 Bt.24395  
Transcribed locus, strongly similar to NP_055406.2 Kv 
channel interacting protein 2 ; A-type potassium 
channel modulatory protein 2; cardiac voltage gated 
potassium channel modulatory subunit; Kv channel-
interacting protein 2 [Homo sapiens] 
Down 
CK954948 Bt.29087 ABCG8 ATP-binding cassette sub-family G member 8 Down 
BF040532 Bt.19423 ABCA1 ATP-binding cassette sub-family A member 1 Down 
     
Endocytosis and Intracellular trafficking 
CN438703 Bt.41539  
Transcribed locus, strongly similar to NP_002324.1 
low density lipoprotein receptor-related protein 3 
[Homo sapiens] 
Up 
CN441088 Bt.48457 TNPO1 Transportin 1 Up 
BF043219 Bt.49381 RAB1A GTP binding protein Rab1a Up 
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AW465699 Bt.20269  Transcribed locus, strongly similar to NP_001654.1 ADP-ribosylation factor 6 [Homo sapiens] Up 
AW462308 Bt.49453  Similar to SEC13-like 1 Up 
AW465155 Bt.11133  
Similar to USE1-like protein (Hematopoietic 
stem/progenitor cells protein MDS032) (Putative 
MAPK activating protein PM26) (Protein p31) isoform 
3 [Canis familiaris] 
Up 
BF039386 Bt.6096  
Similar to conserved oligomeric Golgi complex 
component 2 (Low density lipoprotein receptor defect 
C-complementing protein) 
Up 
CR451981 Bt.57991 TRAPPC5 Trafficking protein particle complex 5 Up 
BF045579 Bt.53665  Similar to NSFL1 (p97) cofactor (p47) Up 
CR455769 Bt.7758  Transcribed locus, strongly similar to NP_446006.1 clathrin assembly protein [Rattus norvegicus] Down 
CR456173 Bt.5969 VPS35 Vacuolar protein sorting 35 (yeast) Down 
CR451664 Bt.4070 SNX1 Similar to sorting nexin 1 Down 
CN433789 Bt.39859  
Transcribed locus, strongly similar to XP_537403.2 
vesicle transport-related protein isoform a [Canis 
familiaris] 
Down 
AW465446 Bt.48523  Similar to vacuolar protein sorting 29 (Vesicle protein sorting 29) Down 
BF044109 Bt.49605  Similar to amyloid beta (A4) precursor protein-binding, family A, member 3 Down 
CN436560 Bt.7175  Transcribed locus, strongly similar to NP_446230.1 importin 13 [Rattus norvegicus] Down 
AW461450 Bt.64628  Transcribed locus, strongly similar to XP_532669.2 nucleoporin Nup37 (p37) [Canis familiaris] Down 
AW464321 Bt.19243  Similar to sorting nexin 6 Down 
CR451855 Bt.12416  Similar to syntaxin-5 Down 
BF039953 Bt.1248  
Transcribed locus, strongly similar to XP_850701.1 
ADP-ribosylation factor binding protein GGA2 (Golgi-
localized, gamma ear-containing, ARF-binding protein 
2) [Canis familiaris] 
Down 
CK954544 Bt.7273  
Transcribed locus, strongly similar to XP_538631.2 
protein transport protein Sec24A (SEC24-related 
protein A) isoform 1 [Canis familiaris] 
Down 
CR452427 Bt.52483  
Transcribed locus, strongly similar to NP_005478.2 
high-mobility group protein 2-like 1 isoform a [Homo 
sapiens] 
Down 
     
Other functions 
AW266929 Bt.12916 GPX3 Glutathione peroxidase 3 (plasma) Up 
CN442255 Bt.59546 WDR1 WD repeat domain 1 Up 
DR697417 Bt.16452 PRRG2 Proline rich Gla (G-carboxyglutamic acid) 2 Up 
BF039730 Bt.36654 SRP54 Signal recognition particle 54kDa Up 
BF046378 Bt.8244  
Transcribed locus, weakly similar to NP_659449.3 
cyclin fold protein 1; cyclin-box carrying protein 1 
[Homo sapiens] 
Up 
AW465190 Bt.21634  Similar to 3-mercaptopyruvate sulfurtransferase Up 
CR452840 Bt.61076 ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase Up 
AW461380 Bt.76489  
Transcribed locus, moderately similar to 
XP_001079086.1 NF-kappa B inhibitor [Rattus 
norvegicus] 
Up 
CN440351 Bt.21035  Similar to S100 calcium binding protein A16 Up 
BF041492 Bt.5126 COMMD5 COMM domain-containing protein 5 Up 
  
 
296
TABLE H.1. (continued) 
     
Oligo 
sequence ID 
Unigene 
ID Symbol Gene product Expression 
     
     
BF042692 Bt.53903  
Transcribed locus, strongly similar to XP_853516.1 
tyrosine-protein phosphatase, non-receptor type 3 
(Protein-tyrosine phosphatase H1) (PTP-H1) isoform 1 
[Canis familiaris] 
Up 
BM366427 Bt.4001 HMOX1 Heme oxygenase (decyclizing) 1 Up 
CK394103 Bt.1639 GALNT6 UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) Up 
CR455867 Bt.20383 MGST1 Microsomal glutathione S-transferase 1 Up 
NM_173937 Bt.4516 MIP Major intrinsic protein of lens fiber Up 
NM_174453 Bt.108 RPE65 Retinal pigment epithelium-specific protein (65kD) Up 
NM_174462 Bt.8126 SFTPC Surfactant, pulmonary-associated protein C Up 
AJ693807 Bt.10814  
Transcribed locus, moderately similar to XP_546059.2 
proteinase activated receptor 1 precursor (PAR-1) 
(Thrombin receptor) (Coagulation factor II receptor) 
[Canis familiaris] 
Up 
CR452580 Bt.2689 PRDX2 Peroxiredoxin 2 Up 
A34676 Bt.13106 F9 Coagulation factor IX Down 
CR551847 Bt.30982  Similar to calcium/calmodulin-dependent protein kinase IG Down 
CN434569 Bt.65013  Transcribed locus, moderately similar to XP_940679.1 hypothetical protein XP_940679 [Homo sapiens] Down 
CN434601 Bt.9482  Transcribed locus, weakly similar to NP_071580.1 [Rattus norvegicus] Down 
CN440242 Bt.28278 ACE2 Angiotensin I converting enzyme 2 precursor Down 
CN436832 Bt.24903  Transcribed locus, moderately similar to XP_545854.2 peroxisomal biogenesis factor 11A [Canis familiaris] Down 
CN440825 Bt.32810 PDLIM1 PDZ and LIM domain 1 (elfin) Down 
BF046111 Bt.21926  
Transcribed locus, moderately similar to 
NP_001037709.1 outer mitochondrial membrane 34 
[Rattus norvegicus] 
Down 
BF041041 Bt.21023 AS3MT Arsenic (+3 oxidation state) methyltransferase Down 
DR697599 Bt.3362  Transcribed locus, strongly similar to NP_032935.1 periplakin [Mus musculus] Down 
CR451915 Bt.41083  Similar to interferon induced transmembrane protein 5 Down 
AW465015 Bt.45496  Similar to peroxisomal biogenesis factor 16 Down 
L41691 Bt.4771 RANBP2 RAN binding protein 2 Down 
CR454282 Bt.49339  
Similar to Alcohol dehydrogenase class III chi chain 
(Glutathione-dependent formaldehyde 
dehydrogenase) (FDH) 
Down 
CR552774 Bt.12704 AOC2 Amine oxidase, copper containing 2 (retina-specific) Down 
CR551770 Bt.52556  
Transcribed locus, strongly similar to XP_519126.1 
calcitonin gene-related peptide-receptor component 
protein (CGRP-receptor component protein) [Pan 
troglodytes] 
Down 
BM364227 Bt.52556  
Similar to calcitonin gene-related peptide-receptor 
component protein (CGRP-receptor component 
protein) (CGRP-RCP) (CGRPRCP) 
Down 
CN433335 Bt.4067  Similar to myristoylated alanine-rich C-kinase substrate (MARCKS) Down 
BF045638 Bt.47401  Similar to serine protease inhibitor, Kunitz type, 2 Down 
     
 
176 up- and 332 down-regulated genes of Unknown function were not listed 
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APPENDIX I 
TABLE I.1. Host genes differentially expressed in B. melitensis heat inactivated-
inoculated bovine Peyer’s patch during the first 4 hours post-infection, compared 
to non-infected tissue 
 
Oligo 
sequence ID 
Unigene 
ID 
Gene 
symbol Gene product Expression 
     
     
DNA replication and repair 
BF046176 Bt.22960 DNMT2 DNA (cytosine-5-)-methyltransferase 2 Up 
AJ677808 Bt.28672  
Transcribed locus, moderately similar to XP_542244.2 
double-strand break repair protein MRE11A (MRE11 
homolog 1) [Canis familiaris] 
Down 
     
Chromatin modification 
BF041316 Bt.77188  Transcribed locus, strongly similar to XP_536904.2 histone acetyltransferase MYST1 [Canis familiaris] Down 
BF046031 Bt.53293  Similar to histone H3 methyltransferase DOT1 Down 
NM_174200 Bt.45043 TNP2 Transition protein 2 (during histone to protamine replacement) Down 
     
RNA processing 
BF043207 Bt.21089  Transcribed locus, strongly similar to XP_512420.1 TRM1_Human Probable  Down 
U83008 Bt.14661* ELAC1 ElaC homolog 1 (E. coli) Down 
     
Transcription regulation 
CR551218 Bt.69615  
Transcribed locus, strongly similar to XP_001073379.1 
wingless-related MMTV integration site 7A isoform 2 
[Rattus norvegicus] 
Up 
DR697591 Bt.45570* EPAS1 Endothelial PAS domain protein 1 Up 
CR553822 Bt.28727 NFKBIL1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1 Up 
AW461405 Bt.4606*  Similar to Kruppel-like factor 6 Up 
CR452893 Bt.65959  
Transcribed locus, moderately similar to XP_539196.2 zinc 
finger protein 84 (Zinc finger protein HPF2) [Canis 
familiaris] 
Down 
AW465975 Bt.7079  
Transcribed locus, strongly similar to XP_001066346.1 
transcriptional enhancer factor TEF-3 (TEA domain family 
member 4) (TEAD-4) [Rattus norvegicus] 
Down 
CN440952 Bt.7492 CREB3 cAMP responsive element binding protein 3 (luman) Down 
BF044910 Bt.45442  Similar to SIN3B long Down 
BI681052 Bt.78081  
Transcribed locus, strongly similar to XP_548294.2 PHD 
finger protein 12 (PHD factor 1) (Pf1) isoform 1 [Canis 
familiaris] 
Down 
     
Protein biosynthesis 
CN437058 Bt.59370*  Similar to probable leucyl-tRNA synthetase, mitochondrial precursor (Leucine--tRNA ligase) (LeuRS) Down 
CN441874 Bt.44540*  Transcribed locus, strongly similar to Human Alanyl-tRNA synthetase Down 
BM361943 Bt.20487*  Similar to 39S ribosomal protein L28, mitochondrial precursor (L28mt) (MRP-L28) (Melanoma antigen p15) Down 
  
 
298
TABLE I.1. (continued) 
     
Oligo 
sequence ID 
Unigene 
ID 
Gene 
symbol Gene product Expression 
     
     
AW462348 Bt.20442  Transcribed locus, moderately similar to NP_076426.1 mitochondrial ribosomal protein L34 [Homo sapiens] Down 
     
Protein degradation 
BF045351 Bt.62312  Transcribed locus, strongly similar to XP_541630.2 F-box protein FBG4 isoform 1 [Canis familiaris] Up 
CN439280 Bt.2056  Transcribed locus, strongly similar to XP_533826.2 hydrolase [Canis familiaris] Up 
BF046516 Bt.26715 ST14 Suppression of tumorigenicity 14 Down 
AW464210 Bt.8282* DPP4 Dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2) Down 
     
Inflammatory and immune response 
CV576045 Bt.7541  
Similar to pentraxin-related protein PTX3 precursor 
(Pentaxin-related protein PTX3) (Tumor necrosis factor-
inducible protein TSG-14) 
Up 
BF046359 Bt.1548*  
Transcribed locus, moderately similar to XP_533874.2 
gamma-interferon inducible lysosomal thiol reductase 
precursor (Gamma-interferon-inducible protein IP-30) 
[Canis familiaris] 
Up 
BF440380 Bt.42822  Transcribed locus, weakly similar to NP_058716.1 IL6 receptor [Rattus norvegicus] Up 
BM363499 Bt.552 CCL5 Chemokine (C-C motif) ligand 5 Up 
NM_174007 Bt.154 CCL8 Chemokine (C-C motif) ligand 8 Up 
NM_183365 Bt.23155 NCR1 Natural cytotoxicity triggering receptor 1 Up 
AV617024 Bt.29824 JSP.1 MHC class I JSP.1 Up 
CB533935 Bt.14139*  Similar to complement component C9 precursor Down 
AJ535317 Bt.79131* cd21 Complement receptor type 2 Down 
BF043775 Bt.103* BPI Bactericidal/permeability-increasing protein Down 
BM362452 Bt.37553*  Transcribed locus, weakly similar to NP_663705.1 inducible cytokine B9 [Rattus norvegicus] Down 
BM363549 Bt.21431* NCR3 Natural cytotoxicity triggering receptor 3 Down 
NM_205787 Bt.25528* PTP Pancreatic thread protein Down 
     
Cell adhesion 
CR550740 Bt.40988  Similar to dermatopontin precursor (Tyrosine-rich acidic matrix protein) (TRAMP) Up 
CR456127 Bt.2696  
Transcribed locus, strongly similar to NP_001788.2 
cadherin 11, type 2 isoform 1 preproprotein; osteoblast 
cadherin; cadherin-11; OB-cadherin [Homo sapiens] 
Up 
CN439845 Bt.49521  Similar to platelet-endothelial tetraspan antigen 3 (PETA-3) (GP27) (Membrane glycoprotein SFA-1) (CD151 antigen) Up 
BM365343 Bt.9510* TIMD4 T-cell immunoglobulin and mucin domain containing 4 (TIMD4) Down 
     
Cytoskeleton organization 
CR455803 Bt.45308  Transcribed locus, weakly similar to XP_360353.1 protein MG05727.4 [Magnaporthe grisea 70-15] Up 
BF046528 Bt.59065  Transcribed locus, strongly similar to XP_536692.2 hook homolog 1 (h-hook1) (hHK1) [Canis familiaris] Up 
AW463298 Bt.59155* KRT19 Cytokeratin 19 Up 
CR454496 Bt.24937  Transcribed locus, strongly similar to NP_001448.1 filamin B, beta (actin binding protein 278) [Homo sapiens] Up 
BM430199 Bt.56652*  Transcribed locus, moderate similar to XP_511487.1 S37780 keratin 20, type I-like, cytoskeletal - human Up 
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NM_174395 Bt.438 MYO1A Myosin IA Down 
CR552526 Bt.48647  Transcribed locus, moderately similar to NP_001013148.1 beta 2 [Rattus norvegicus] Down 
     
Apoptosis 
AW463573 Bt.14503  Similar to death associated transcription factor 1 Up 
BF440414 Bt.11884* BCL2A1 B-cell leukemia/lymphoma 2 related protein A1 Down 
     
Metabolism 
CN437812 Bt.73269 P4HA3 Collagen prolyl 4-hydroxylase alpha III subunit Up 
BF043681 Bt.29367  Transcribed locus, weakly similar to NP_036903.2 [Rattus norvegicus] Up 
CR552975 Bt.315 NDUFS7 NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa Up 
CB223494 Bt.28966* PLA2G2A Phospholipase A2 group IIA-like Up 
CN441201 Bt.12* FABP1 Fatty acid binding protein 1, liver Up 
CN435446 Bt.49234 GPX4 Glutathione peroxidase 4 (phospholipid hydroperoxidase) Down 
BM363586 Bt.49614* ALDOC Aldolase C, fructose-bisphosphate Down 
     
Intracellular signal transduction 
CN441896 Bt.76242  Transcribed locus, strongly similar to NP_001032635.1 RhoGEF and PH domain containing 1 [Rattus norvegicus] Up 
BM362357 Bt.20905  
Transcribed locus, strongly similar to XP_576543.1 zeta-
chain (TCR) associated protein kinase 70kDa [Rattus 
norvegicus] 
Up 
AW461747 Bt.35642  Transcribed locus, moderately similar to XP_001075684.1 similar to sorting nexin 22 [Rattus norvegicus] Up 
NM_174229 Bt.517* ADCY1 Adenylate cyclase 1 (brain) Up 
NM_174322 Bt.5511 GNA11 GNA11 protein Up 
CK960359 Bt.32575 RASGRP4 RAS guanyl releasing protein 4 isoform 1 Up 
NM_176873 Bt.16023 RAB3C RAB3C, member RAS oncogene family Up 
AW415585 Bt.24461  Transcribed locus, strongly similar to XP_539166.2 adenylate cyclase 8 [Canis familiaris] Down 
CR551967 Bt.32878  Similar to islet-brain 1 Down 
NM_174785 Bt.117 GNG12 Guanine nucleotide binding protein (G protein), gamma 12 Down 
     
Intracellular protein transport 
CN435987 Bt.4048* STXBP1 Syntaxin binding protein 1 Down 
BC112867 Bt.28467  Similar to sorting nexin 8 Down 
     
Ion transport 
CB424419 Bt.27240*  
Transcribed locus, moderately similar to NP_598292.2 
carrier organic anion transporter family, member 4a1 
[Rattus norvegicus] 
Up 
CB442833 Bt.16310*  
Transcribed locus, strongly similar to XP_508369.1 
dJ68D18.1.2 (solute carrier family 1 (glial high affinity 
glutamate transporter) member 2) [Pan troglodytes] 
Down 
     
Unknown function 
CR550829  mRNA sequence Up 
CR551657  mRNA sequence Up 
CR452802 Bt.61866  Similar to Leucine-rich repeat-containing protein 8 Up 
CR452775 Bt.52278  Similar to CG11388-PA Up 
CR456265  mRNA sequence Up 
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TABLE I.1. (continued) 
     
Oligo 
sequence ID 
Unigene 
ID 
Gene 
symbol Gene product Expression 
     
     
CR553319 Bt.69622  Transcribed locus Up 
CR553013  Transcribed locus Up 
CN432282 Bt.62095 YPEL4 Yippee-like 4 Up 
CN433027  Transcribed locus Up 
CN434647  mRNA sequence Up 
CN434725  mRNA sequence Up 
CN432585  Transcribed locus Up 
CN437147 Bt.30419  Transcribed locus Up 
CN437455 Bt.8337  Transcribed locus Up 
CN437575 Bt.73598  Transcribed locus Up 
CN438028 Bt.73608  Transcribed locus Up 
CN439347 Bt.20220  Transcribed locus Up 
CN439579 Bt.34378  Transcribed locus Up 
CN440911 Bt.30628  Transcribed locus Up 
CN441174 Bt.30634  Transcribed locus Up 
CN441793  mRNA sequence Up 
CN442181  mRNA sequence Up 
AW462087 Bt.26810 EPB41L5 Erythrocyte membrane protein band 4.1 like 5 Up 
BF045800  mRNA sequence Up 
BF440526  mRNA sequence Up 
BM362543  mRNA sequence Up 
CB436617 Bt.27877  Transcribed locus, strongly similar to NP_036467.2 myosin IF; myosin-ID [Homo sapiens] Up 
BF046061 Bt.17337  Transcribed locus, moderately similar to XP_001077274.1 similar to F-box only protein 31 [Rattus norvegicus] Up 
AW462360  mRNA sequence Up 
AW462410  mRNA sequence Up 
CN438100 Bt.13769  Transcribed locus Up 
CN441927 Bt.30813  Transcribed locus Up 
CN440721 Bt.18467  CDNA clone IMAGE:8055185, containing frame-shift errors Up 
BF045955 Bt.59465  
Transcribed locus, weakly similar to XP_001076965.1 
similar to alanine-glyoxylate aminotransferase 2-like 1 
[Rattus norvegicus] 
Up 
CK394179 Bt.58024  Transcribed locus Up 
CR553683 Bt.13778  Transcribed locus Up 
BM362443  mRNA sequence Up 
CR454045 Bt.58864 GDPD5 Glycerophosphodiester phosphodiesterase domain containing 5 Up 
CN440585  mRNA sequence Up 
CK943568 Bt.49472 agr2 Anterior gradient 2 homologue Up 
CK775551 Bt.80256  Transcribed locus Up 
CK847243  mRNA sequence Up 
CK847243  mRNA sequence Down 
TC238026  mRNA sequence Down 
CR451776 Bt.43709  Hypothetical protein Down 
CR451870 Bt.21001  Similar to B-cell CLL/lymphoma 7C Down 
CR454897 Bt.13789  Transcribed locus Down 
CR552029 Bt.20478  Transcribed locus, moderately similar to XP_220593.2 similar to novel protein [Rattus norvegicus] Down 
CN432620 Bt.9518  Transcribed locus, strongly similar to XP_001055834.1 similar to phospholipase C-like 2 [Rattus norvegicus] Down 
AW463013 Bt.58877  Similar to coiled-coil domain containing 12 [Canis familiaris] Down 
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TABLE I.1. (continued) 
     
Oligo 
sequence ID 
Unigene 
ID 
Gene 
symbol Gene product Expression 
     
     
BF041442 Bt.4582 RBED1 RNA binding motif and ELMO domain 1 Down 
BF041187 Bt.58358  Similar to leader-binding protein 32 Down 
BF044402 Bt.66549  
Transcribed locus, weakly similar to XP_001071232.1 
similar to synaptonemal complex central element protein 2 
[Rattus norvegicus] 
Down 
BM364950 Bt.28267  Transcribed locus Down 
CK778378 Bt.26584  Similar to mFLJ00019 protein Down 
CV798736 Bt.37371  Bernardinelli-Seip congenital lipodystrophy 2 Down 
BF044803 Bt.52325  
Transcribed locus, moderately similar to XP_372723.2 RP2 
protein, testosterone-regulated - ricefield mouse [Homo 
sapiens] 
Down 
CR551628 Bt.2112  Transcribed locus, weakly similar to NP_002408.3 identified by monoclonal antibody Ki-67 [Homo sapiens] Down 
CN432740 Bt.61506  Transcribed locus, weakly similar to XP_363567.1 protein MG01493.4 [Magnaporthe grisea 70-15] Down 
BF043616  mRNA sequence Down 
CK394018 Bt.15798  Transcribed locus Down 
BM363899 Bt.77395  Transcribed locus Down 
BF045344  mRNA sequence Down 
AW465301 Bt.33127 ANXA8 Annexin A8 Down 
BM362340 Bt.37556 PDDC1 Parkinson disease 7 domain containing 1 Down 
CR452375 Bt.49618  Similar to Protein C20orf35 (HSMNP1) Down 
CN433241 Bt.67490  Transcribed locus Down 
AV613881 Bt.31739  
Transcribed locus, strongly similar to XP_535721.2 
PREDICTED: similar to ABI gene family, member 3 
(NESH) binding protein isoform 2 [Canis familiaris] 
Down 
CR452089 Bt.17274  Transcribed locus Down 
     
 
Genes labeled with * in Unigene ID column were also differentially expressed in B. melitensis-
infected bovine Peyer’s patches 
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APPENDIX J 
TABLE J.1. Set of B. melitensis candidate genes identified in silico as important for 
bovine Peyer’s patch infection in the first 4 h of Brucella:host interaction  
 
Locus ID Symbol Gene product Mechanistic candidate at 
   15 min 
30 
min 1 h 2 h  4 h 
        
  Replication, recombination and repair      
BMEI1794 ihfB Integration host factor beta subunit    Up Up 
BMEI1980  DNA protection during starvation protein  Up Up  Up Up 
        
  Transcription      
BMEI0749 rpoC DNA-directed RNA polymerase beta subunit  Up Up Up Up Up 
BMEI0750 rpoB DNA-directed RNA polymerase beta' subunit Up Up Up Up Up 
BMEI0781 rpoA DNA-directed RNA polymerase alpha subunit    Up 
BMEI1297 rpoZ DNA-directed RNA polymerase omega subunit  Up Up Up Up Up 
BMEI1377 greA Transcription elongation factor GreA     Up 
        
  Translation, ribosomal structure and biogenesis      
BMEI1862  2'-5' RNA ligase      Up 
        
Posttranslational modification, protein turnover, chaperones 
BMEI0195 clpB ATP-dependent Clp protease, ATP binding subunit   Up 
BMEI0236 htpX Heat shock protein HtpX  Up   Up 
BMEI0874 clpP ATP-dependent Clp protease proteolytic subunit Up   Up 
BMEI0876 lon ATP-dependent protease La  Up   Up 
BMEI1777 grpE GrpE protein     Up 
BMEI1804 glnD PII uridylyl-transferase  Up  Up  
        
  Amino acid transport and metabolism      
BMEI0114  Asparagine-binding periplasmic protein precursor   Up 
BMEI0124 argJ Bifunctional ornithine acetyltransferase/N-acetylglutamate synthase protein Dw     
BMEI0207 proB Gamma-glutamyl kinase  Up Up Up Up Up 
BMEI0208 proA Gamma-glutamyl phosphate reductase NDE     
BMEI0441 proX Glycine betaine/L-proline-binding protein ProX   Up 
BMEI0522 carB Carbamoyl-phosphate synthase large subunit  Up Up NDE ND Up 
BMEI0526 carA Carbamoyl-phosphate synthase small subunit Up Up Up Up Up 
BMEI0624 ilvC Ketol-acid reductoisomerase  Up Up Up  Up 
BMEI0844 trpD Anthranilate phosphoribosyltransferase Up Up Up Up Up 
BMEI1211 gltI General L-amino acid-binding periplasmic protein  AapJ precursor Up  Up Up 
BMEI1506 aroC Chorismate synthase Up NDE Up  Up 
BMEI1848 ilvD Dihydroxy-acid dehydratase  Up Up  Up  
BMEI1869  Homoserine/homoserine lactone efflux protein  Dw  Dw 
BMEI2017 trpF N-(5'-phosphoribosyl)anthranilate isomerase  Dw  Dw   
BMEI2018 trpB Tryptophan synthase subunit beta Up Up Up Up Up 
BMEII0411 leuD Isopropylmalate isomerase small subunit Up    
BMEII0441 argD Acetylornithine aminotransferase  Up    
BMEII0783 Na(+)-linked D-alanine glycine permease  Up  Up Up 
BMEII0871 aroE Shikimate 5-dehydrogenase Up Up    
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TABLE J.1. (continue) 
        
Locus ID Symbol Gene product Mechanistic candidate at 
   15 min 
30 
min 1 h 2 h  4 h 
        
BMEII0875 livK Leucine-specific binding protein precursor  Dw  Dw Dw 
BMEII0923 potD Spermidine/putrescine-binding periplasmic protein  Dw   Dw 
BMEII0952  Nitrate reductase delta chain Up     
        
  Nucleotide transport and metabolism      
BMEI0825 pyrH Uridylate kinase  Up    
BMEI0849 pyrG CTP synthetase Up   Up Up 
BMEI1256  Nucleoside diphosphate kinase   Up   
BMEI1295 pyrE Orotate phosphoribosyltransferase    Up  
        
  Carbohydrate transport and metabolism      
BMEI0187  Transporter, DME family     Dw  
BMEI0927  Multidrug resistance protein B   Dw   Dw 
BMEII0106 Xylose repressor    Dw  
BMEII0794 Multidrug resistance protein B  Up    
BMEII0795 Multidrug resistance protein B    Up  
        
  Lipid transport and metabolism      
BMEI0075  1-acyl-sn-glycerol-3-phosphate acyltransferase Dw   
BMEI0827 uppS Undecaprenyl pyrophosphate synthetase Up  Up  
BMEI1024  3-hydroxyisobutyrate dehydrogenase     Dw 
BMEI1112  3-oxoacyl-(acyl carrier protein) synthase   Dw   
        
  Energy production and conversion      
BMEI0137  Malate dehydrogenase     Up 
BMEI0138 sucC Succinyl-CoA synthetase beta subunit NDE    
BMEI0278  Ferredoxin II  Up     
BMEI0791  Isocitrate dehydrogenase      Up 
BMEI0836  Citrate synthase     Up 
BMEI0959  Ferredoxin, 2Fe-2S K04755 ferredoxin, 2Fe-2S Up     
BMEI1899  Cytochrome O ubiquinol oxidase subunit III Dw     
BMEII0768 NADH dehydrogenase subunit N Dw Dw Dw   
BMEII1068 Cytochrome c2 precursor Dw     
        
  Coenzyme transport and metabolism     
BMEI1144  Biotin--protein ligase  Up     
        
  Inorganic ion transport and metabolism      
BMEI0077  Cation transport protein ChaC     Up 
BMEI0637  Cobalt transport protein CbiQ  Dw    
BMEI0679  Potassium/proton antiporter RosB  Up  Up  Up 
BMEII0105 Iron-regulated outer membrane protein FrpB   Dw  
BMEII0537 FecE Iron (III) dicitrate transport ATP-binding protein FecE Up   Up 
BMEII0566 sfuB IRON(III)-transport system permease protein SfuB Dw Dw  Dw 
BMEII0581 sodC Superoxide dismutase (CU-ZN) Up  Up Up  
BMEII0606 fatD Ferric anguibactin transport system permease  protein FatD  Up 
BMEII0766 PhaF potassium efflux system protein  Dw Dw Dw   
        
        
  
 
304
TABLE J.1. (continue) 
        
Locus ID Symbol Gene product Mechanistic candidate at 
   15 min 
30 
min 1 h 2 h  4 h 
        
Secondary metabolites biosynthesis, transport and catabolism 
BMEI0666  Short chain dehydrogenase Up     
BMEI2012  Benzoate membrane transport protein  Up  Up  
        
  Defense mechanisms      
BMEI0893 acrB Acriflavin resistance protein B  Up    
BMEI1742  ABC transporter ATP-binding protein Up  Up  
BMEI1743  ABC transporter ATP-binding protein  Up  Up  
BMEII0382 AcrD Acriflavin resistance protein D  Dw  Dw  Dw 
BMEII0916 AcrD Acriflavin resistance protein D   Dw Dw   
        
  Cell wall/membrane biogenesis      
BMEI0135  Outer membrane lipoprotein    Up  
BMEI0223  Membrane-bound lytic murein transglycosylase B   Up 
BMEI0340  Peptidoglycan-associated lipoprotein    Up  
BMEI0500  Soluble lytic murein transglycosylase    Up 
BMEI0566  Soluble lytic murein transglycosylase    Up 
BMEI0717  22 kDa outer membrane protein precursor  Up  Up  Up 
BMEI0795 murI Glutamate racemase  Up  Up  
BMEI0830  Outer membrane protein     Up  
BMEI0831  LpxD UDP-3-O-[3-hydroxymyristoyl] glucosamine  N-acyltransferase  Up  
BMEI0833  Acyl-(acyl-carrier-protein)-UDP-N- acetylglucosamine  O-acyltransferase  Up  
BMEI0850  2-dehydro-3-deoxyphosphooctonate aldolase Up    
BMEI0998  Glycosyltransferase    Up  
BMEI1007  25 kDa outer-membrane immunogenic protein precursor  Up Up Up  Up 
BMEI1029  Outer membrane protein TolC    Up  
BMEI1037  Glycosyltransferase involved in cell wall biogenesis  Up  
BMEI1249  25 kDa outer-membrane immunogenic protein precursor Up  Up  Up 
BMEI1829  25 kDa outer-membrane immunogenic protein precursor Up Up Up  Up 
BMEI1830  25 kDa outer-membrane immunogenic protein precursor Up Up Up  Up 
BMEII0827 Glucose-1-phosphate cytidylyltransferase    Dw  
BMEII0844 31 kDa outer-membrane immunogenic protein  precursor  Up  
        
  Intracellular trafficking and secretion      
BMEII0029 virB5 Attachment mediating protein VirB5 homolog  Dw Dw    
        
  General function prediction only      
BMEI0020  Glucose-fructose oxidoreductase precursor   Dw  
BMEI0244  Transaldolase  Up    
BMEI0420  Oxidoreductase    Up  
BMEI0506  Transporter, DME family    Up  
BMEI0587  ComL, competence lipoprotein    Up  
BMEI0630 phzF Phenazine biosynthesis protein PhzF   Dw  
BMEI0668  Calcium binding protein  Up Up  Up Up 
BMEI0796  31 kDa immunogenic protein precursor   Up  
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TABLE J.1. (continue) 
        
Locus ID Symbol Gene product Mechanistic candidate at 
   15 min 
30 
min 1 h 2 h  4 h 
        
BMEI0970  Diacylglycerol kinase    Up   
BMEI1185  HppA membrane-bound proton-translocating pyrophosphatase   Up Up Up  Up 
BMEI1231  NADH-ubiquinone oxidoreductase 18 KD subunit  Up     
BMEI1859  Integral membrane protein    Up  
BMEI2053  Transporter     Up  
BMEII1096 Putative tartrate transporter    Dw  
        
  Function unknown       
BMEI0338  Hypothetical protein     Up  
BMEI0497  Hypothetical membrane spanning protein   Up  
BMEI0498 cspA Cold shock protein CspA  Up Up  Up Up 
BMEI0505  Hypothetical membrane associated protein    Up  
BMEI0518 cspA Cold shock protein CspA Up Up   Up 
BMEI0678  Low PH-induced protein A    Up  
BMEI1303  Hipothetical cytosolic protein Up     
BMEI1349  Phage portal protein Dw  Dw   
BMEI1510 cspA Cold shock protein CspA      Up 
BMEI1795  Hypothetical protein     Up  
BMEI1866  Hypothetical protein  Up   Up 
BMEII0053 MG(2+) transport ATPase protein C Dw  Dw   
BMEII0157 Hypothetical protein     Dw  
BMEII0987 NIRV precursor  Up    
        
 
Up = Up-regulated  
 
Dw = Down-regulated 
 
NDE = Non differentially expressed at this time point 
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